UID,Searchword,API,URL,Title,Summary,Article,Title_Sentiment,Title_Positive,Title_Neutral,Title_Negative,Article_Sentiment,Article_Positive,Article_Neutral,Article_Negative,Verified,Language,Topics,Date,Load_Date,Source
11225,EuroNext,Twitter API,Twitter,Buyouts group is seeking IPO on Euronext exchange,nan,Buyouts group is seeking IPO on Euronext exchange,neutral,0.02,0.97,0.0,neutral,0.02,0.97,0.0,True,English,"['Buyouts group', 'Euronext exchange', 'IPO', 'Buyouts group', 'Euronext exchange', 'IPO']",2022-12-06,2022-12-06,Unknown
11475,Euroclear,Twitter API,Twitter,Euroclear shuts off exit route for rouble bond investors,nan,ğŸ“ğŸğŸ¥¨ğŸğŸ³ğŸ¥šğŸ¥¨ğŸ¥©ğŸ–ğŸ—ğŸğŸ‘ğŸ¥“ğŸ¥™ğŸ‘ğŸ³ğŸ¥šğŸ¤ğŸ–ğŸ—ğŸŠğŸ‡ğŸ“ğŸ¬ğŸ«ğŸ¿ğŸ©ğŸªğŸ’ğŸˆğŸ¥‘ğŸ³ğŸ¥šEuroclear shuts off exit route for rouble bond investors,neutral,0.0,0.99,0.01,neutral,0.0,0.99,0.01,True,English,"['exit route', 'bond investors', 'Euroclear', 'exit route', 'bond investors', 'Euroclear']",2022-12-05,2022-12-06,Unknown
13433,Deutsche Boerse,Twitter API,Twitter,First Centrally Cleared Short Bitcoin ETP Launched on Deutsche BoerseÂ Xetra https://t.co/4J3UZncHns,nan,First Centrally Cleared Short Bitcoin ETP Launched on Deutsche BoerseÂ Xetra https://t.co/4J3UZncHns,neutral,0.0,0.99,0.0,neutral,0.0,0.99,0.0,True,English,"['Short Bitcoin ETP', 'Deutsche Boerse\xa0Xetra', 'J3UZncHns', 'Short Bitcoin ETP', 'Deutsche Boerse\xa0Xetra', 'J3UZncHns']",2022-12-06,2022-12-06,Unknown
14153,EuroNext,Twitter API,Twitter,This week's #ESG #tech and #tools report includes @issesg  @euronext  @Your_Stake and more here: https://t.co/7G30TWZJK1,nan,This week's #ESG #tech and #tools report includes @issesg  @euronext  @Your_Stake and more here: https://t.co/7G30TWZJK1,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['Stake', 'G30TWZJK1', 'Stake', 'G30TWZJK1']",2022-12-06,2022-12-06,Unknown
14180,Euroclear,NewsApi.org,https://finance.yahoo.com/news/shell-plc-third-quarter-2022-070000931.html,Shell Plc Third Quarter 2022 Euro and Gbp Equivalent Dividend Payments,SHELL PLC THIRD QUARTER 2022 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS December 5  2022 The Board of Shell plc (â€œShellâ€) today announced the pounds sterling ...,SHELL PLC THIRD QUARTER 2022 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTSDecember 5  2022The Board of Shell plc (â€œShellâ€) today announced the pounds sterling and euro equivalent dividend payments in respect of the third quarter 2022 interim dividend  which was announced on October 27  2022 at US$0.25 per ordinary share.Shareholders have been able to elect to receive their dividends in US dollars  euros or pounds sterling. Holders of ordinary shares who have validly submitted US dollars  euros or pounds sterling currency elections by November 25  2022 will be entitled to a dividend of US$0.25  â‚¬0.2398 or 20.61p per ordinary share  respectively.Absent any valid election to the contrary  persons holding their ordinary shares through Euroclear Nederland will receive their dividends in euros at the euro rate per ordinary share shown above. Absent any valid election to the contrary  shareholders (both holding in certificated and uncertificated form (CREST members)) and persons holding their shares through the Shell Corporate Nominee will receive their dividends in pounds sterling  at the pound sterling rate per ordinary share shown above.Euro and pounds sterling dividends payable in cash have been converted from US dollars based on an average of market exchange rates over the three dealing days from November 30 to December 2  2022. This dividend will be payable on December 19  2022 to those members whose names were on the Register of Members on November 11  2022.Taxation - cash dividendWith Shellâ€™s tax residence moved to the UK  dividends paid to shareholders on their ordinary shares will not attract Dutch dividend withholding tax. This means that holders of the former A shares receive their dividends in full as Dutch dividend withholding tax is no longer withheld on these dividends. Holders of the former B shares receive their dividends directly from Shell as these dividends will no longer be paid through the Dividend Access Mechanism.Story continuesIf you are uncertain as to the tax treatment of any dividends you should consult your tax advisor.NoteA different currency election date may apply to shareholders holding shares in a securities account with a bank or financial institution ultimately holding through Euroclear Nederland. This may also apply to other shareholders who do not hold their shares either directly on the Register of Members or in the corporate sponsored nominee arrangement. Shareholders can contact their broker  financial intermediary  bank or financial institution for the election deadline that applies.EnquiriesShell Media RelationsInternational +44 (0) 207 934 5550Americas +1 832 337 4355CAUTIONARY NOTEThe companies in which Shell plc directly and indirectly owns investments are separate legal entities. In this announcement â€œShellâ€  â€œShell Groupâ€ and â€œGroupâ€ are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general. Likewise  the words â€œweâ€  â€œusâ€ and â€œourâ€ are also used to refer to Shell plc and its subsidiaries in general or to those who work for them. These terms are also used where no useful purpose is served by identifying the particular entity or entities. â€˜â€˜Subsidiariesâ€™â€™  â€œShell subsidiariesâ€ and â€œShell companiesâ€ as used in this announcement refer to entities over which Shell plc either directly or indirectly has control. Entities and unincorporated arrangements over which Shell has joint control are generally referred to as â€œjoint venturesâ€ and â€œjoint operationsâ€  respectively. â€œJoint venturesâ€ and â€œjoint operationsâ€ are collectively referred to as â€œjoint arrangementsâ€. Entities over which Shell has significant influence but neither control nor joint control are referred to as â€œassociatesâ€. The term â€œShell interestâ€ is used for convenience to indicate the direct and/or indirect ownership interest held by Shell in an entity or unincorporated joint arrangement  after exclusion of all third-party interest.Forward-Looking StatementsThis announcement contains forward-looking statements (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995) concerning the financial condition  results of operations and businesses of Shell. All statements other than statements of historical fact are  or may be deemed to be  forward-looking statements. Forward-looking statements are statements of future expectations that are based on managementâ€™s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results  performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include  among other things  statements concerning the potential exposure of Shell to market risks and statements expressing managementâ€™s expectations  beliefs  estimates  forecasts  projections and assumptions. These forward-looking statements are identified by their use of terms and phrases such as â€œaimâ€  â€œambitionâ€  â€˜â€˜anticipateâ€™â€™  â€˜â€˜believeâ€™â€™  â€˜â€˜couldâ€™â€™  â€˜â€˜estimateâ€™â€™  â€˜â€˜expectâ€™â€™  â€˜â€˜goalsâ€™â€™  â€˜â€˜intendâ€™â€™  â€˜â€˜mayâ€™â€™  â€œmilestonesâ€  â€˜â€˜objectivesâ€™â€™  â€˜â€˜outlookâ€™â€™  â€˜â€˜planâ€™â€™  â€˜â€˜probablyâ€™â€™  â€˜â€˜projectâ€™â€™  â€˜â€˜risksâ€™â€™  â€œscheduleâ€  â€˜â€˜seekâ€™â€™  â€˜â€˜shouldâ€™â€™  â€˜â€˜targetâ€™â€™  â€˜â€˜willâ€™â€™ and similar terms and phrases. There are a number of factors that could affect the future operations of Shell and could cause those results to differ materially from those expressed in the forward-looking statements included in this announcement  including (without limitation): (a) price fluctuations in crude oil and natural gas; (b) changes in demand for Shellâ€™s products; (c) currency fluctuations; (d) drilling and production results; (e) reserves estimates; (f) loss of market share and industry competition; (g) environmental and physical risks; (h) risks associated with the identification of suitable potential acquisition properties and targets  and successful negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative  judicial  fiscal and regulatory developments including regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks  including the risks of expropriation and renegotiation of the terms of contracts with governmental entities  delays or advancements in the approval of projects and delays in the reimbursement for shared costs; (m) risks associated with the impact of pandemics  such as the COVID-19 (coronavirus) outbreak; and (n) changes in trading conditions. No assurance is provided that future dividend payments will match or exceed previous dividend payments. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Additional risk factors that may affect future results are contained in Shell plcâ€™s Form 20-F for the year ended December 31  2021 (available at www.shell.com/investor and www.sec.gov). These risk factors also expressly qualify all forward-looking statements contained in this announcement and should be considered by the reader. Each forward-looking statement speaks only as of the date of this announcement  December 5  2022. Neither Shell plc nor any of its subsidiaries undertake any obligation to publicly update or revise any forward-looking statement as a result of new information  future events or other information. In light of these risks  results could differ materially from those stated  implied or inferred from the forward-looking statements contained in this announcement.Shellâ€™s net carbon footprintAlso  in this announcement we may refer to Shellâ€™s â€œNet Carbon Footprintâ€ or â€œNet Carbon Intensityâ€  which include Shellâ€™s carbon emissions from the production of our energy products  our suppliersâ€™ carbon emissions in supplying energy for that production and our customersâ€™ carbon emissions associated with their use of the energy products we sell. Shell only controls its own emissions. The use of the term Shellâ€™s â€œNet Carbon Footprintâ€ or â€œNet Carbon Intensityâ€ are for convenience only and not intended to suggest these emissions are those of Shell plc or its subsidiaries.Shellâ€™s net-Zero Emissions TargetShellâ€™s operating plan  outlook and budgets are forecasted for a ten-year period and are updated every year. They reflect the current economic environment and what we can reasonably expect to see over the next ten years. Accordingly  they reflect our Scope 1  Scope 2 and Net Carbon Footprint (NCF) targets over the next ten years. However  Shellâ€™s operating plans cannot reflect our 2050 net-zero emissions target and 2035 NCF target  as these targets are currently outside our planning period. In the future  as society moves towards net-zero emissions  we expect Shellâ€™s operating plans to reflect this movement. However  if society is not net zero in 2050  as of today  there would be significant risk that Shell may not meet this target.Forward Looking Non-GAAP measuresThis announcement may contain certain forward-looking non-GAAP measures such as cash capital expenditure and divestments. We are unable to provide a reconciliation of these forward-looking Non-GAAP measures to the most comparable GAAP financial measures because certain information needed to reconcile those Non-GAAP measures to the most comparable GAAP financial measures is dependent on future events some of which are outside the control of Shell  such as oil and gas prices  interest rates and exchange rates. Moreover  estimating such GAAP measures with the required precision necessary to provide a meaningful reconciliation is extremely difficult and could not be accomplished without unreasonable effort. Non-GAAP measures in respect of future periods which cannot be reconciled to the most comparable GAAP financial measure are calculated in a manner which is consistent with the accounting policies applied in Shell plcâ€™s consolidated financial statements.The contents of websites referred to in this announcement do not form part of this announcement.We may have used certain terms  such as resources  in this announcement that the United States Securities and Exchange Commission (SEC) strictly prohibits us from including in our filings with the SEC. Investors are urged to consider closely the disclosure in our Form 20-F  File No 1-32575  available on the SEC website www.sec. gov .LEI number of Shell plc: 21380068P1DRHMJ8KU70Classification: Additional regulated information required to be disclosed under the laws of a Member State,neutral,0.0,1.0,0.0,mixed,0.14,0.12,0.74,True,English,"['Gbp Equivalent Dividend Payments', 'Shell Plc', 'Third Quarter', 'Euro', 'U.S. Private Securities Litigation Reform Act', 'Enquiries Shell Media Relations International', 'third quarter 2022 interim dividend', 'Dutch dividend withholding tax', 'different currency election date', 'euro equivalent dividend payments', 'Dividend Access Mechanism', 'three dealing days', 'sterling currency elections', 'market exchange rates', 'indirect ownership interest', 'pound sterling rate', 'former A shares', 'former B shares', 'separate legal entities', 'unincorporated joint arrangement', 'securities account', 'Shell Corporate Nominee', 'nominee arrangement', 'tax residence', 'tax treatment', 'tax advisor', 'cash dividend', 'valid election', 'euro rate', 'election deadline', 'unincorporated arrangements', 'market risks', 'third-party interest', 'joint ventures', 'joint arrangements', 'Shell interest', 'The Board', 'ordinary share', 'US dollars', 'Euroclear Nederland', 'uncertificated form', 'financial institution', 'financial intermediary', 'useful purpose', 'significant influence', 'financial condition', 'historical fact', 'unknown risks', 'other things', 'potential exposure', 'pounds sterling', 'joint operations', 'SHELL PLC', 'future expectations', 'current expectations', 'joint control', 'sterling dividends', 'CAUTIONARY NOTE', 'particular entity', 'Forward-Looking Statements', 'actual results', 'Shell Group', 'Shell companies', 'CREST members', 'other shareholders', 'Shell subsidiaries', 'GBP', 'December', 'respect', 'October', 'euros', 'November', 'contrary', 'persons', 'average', 'names', 'Register', 'Taxation', 'UK', 'Story', 'bank', 'broker', 'Americas', 'investments', 'announcement', 'convenience', 'references', 'words', 'terms', 'associates', 'exclusion', 'meaning', 'businesses', 'management', 'assumptions', 'uncertainties', 'performance', 'events', 'beliefs', 'estimates', 'forecasts', 'projections', 'phrases', 'aim', 'ambition', 'goals', 'milestones']",2022-12-05,2022-12-06,finance.yahoo.com
14181,Euroclear,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567043/0/en/Shell-Plc-Third-Quarter-2022-Euro-and-Gbp-Equivalent-Dividend-Payments.html,Shell Plc Third Quarter 2022 Euro and Gbp Equivalent Dividend Payments,SHELL PLC THIRD QUARTER 2022 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS  Â   December 5  2022  Â   The Board of Shell plc (â€œShellâ€) today announced the...,SHELL PLC THIRD QUARTER 2022 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTSDecember 5  2022The Board of Shell plc (â€œShellâ€) today announced the pounds sterling and euro equivalent dividend payments in respect of the third quarter 2022 interim dividend  which was announced on October 27  2022 at US$0.25 per ordinary share.Shareholders have been able to elect to receive their dividends in US dollars  euros or pounds sterling. Holders of ordinary shares who have validly submitted US dollars  euros or pounds sterling currency elections by November 25  2022 will be entitled to a dividend of US$0.25  â‚¬0.2398 or 20.61p per ordinary share  respectively.Absent any valid election to the contrary  persons holding their ordinary shares through Euroclear Nederland will receive their dividends in euros at the euro rate per ordinary share shown above. Absent any valid election to the contrary  shareholders (both holding in certificated and uncertificated form (CREST members)) and persons holding their shares through the Shell Corporate Nominee will receive their dividends in pounds sterling  at the pound sterling rate per ordinary share shown above.Euro and pounds sterling dividends payable in cash have been converted from US dollars based on an average of market exchange rates over the three dealing days from November 30 to December 2  2022. This dividend will be payable on December 19  2022 to those members whose names were on the Register of Members on November 11  2022.Taxation - cash dividendWith Shellâ€™s tax residence moved to the UK  dividends paid to shareholders on their ordinary shares will not attract Dutch dividend withholding tax. This means that holders of the former A shares receive their dividends in full as Dutch dividend withholding tax is no longer withheld on these dividends. Holders of the former B shares receive their dividends directly from Shell as these dividends will no longer be paid through the Dividend Access Mechanism.If you are uncertain as to the tax treatment of any dividends you should consult your tax advisor.NoteA different currency election date may apply to shareholders holding shares in a securities account with a bank or financial institution ultimately holding through Euroclear Nederland. This may also apply to other shareholders who do not hold their shares either directly on the Register of Members or in the corporate sponsored nominee arrangement. Shareholders can contact their broker  financial intermediary  bank or financial institution for the election deadline that applies.EnquiriesShell Media RelationsInternational +44 (0) 207 934 5550Americas +1 832 337 4355CAUTIONARY NOTEThe companies in which Shell plc directly and indirectly owns investments are separate legal entities. In this announcement â€œShellâ€  â€œShell Groupâ€ and â€œGroupâ€ are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general. Likewise  the words â€œweâ€  â€œusâ€ and â€œourâ€ are also used to refer to Shell plc and its subsidiaries in general or to those who work for them. These terms are also used where no useful purpose is served by identifying the particular entity or entities. â€˜â€˜Subsidiariesâ€™â€™  â€œShell subsidiariesâ€ and â€œShell companiesâ€ as used in this announcement refer to entities over which Shell plc either directly or indirectly has control. Entities and unincorporated arrangements over which Shell has joint control are generally referred to as â€œjoint venturesâ€ and â€œjoint operationsâ€  respectively. â€œJoint venturesâ€ and â€œjoint operationsâ€ are collectively referred to as â€œjoint arrangementsâ€. Entities over which Shell has significant influence but neither control nor joint control are referred to as â€œassociatesâ€. The term â€œShell interestâ€ is used for convenience to indicate the direct and/or indirect ownership interest held by Shell in an entity or unincorporated joint arrangement  after exclusion of all third-party interest.Forward-Looking StatementsThis announcement contains forward-looking statements (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995) concerning the financial condition  results of operations and businesses of Shell. All statements other than statements of historical fact are  or may be deemed to be  forward-looking statements. Forward-looking statements are statements of future expectations that are based on managementâ€™s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results  performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include  among other things  statements concerning the potential exposure of Shell to market risks and statements expressing managementâ€™s expectations  beliefs  estimates  forecasts  projections and assumptions. These forward-looking statements are identified by their use of terms and phrases such as â€œaimâ€  â€œambitionâ€  â€˜â€˜anticipateâ€™â€™  â€˜â€˜believeâ€™â€™  â€˜â€˜couldâ€™â€™  â€˜â€˜estimateâ€™â€™  â€˜â€˜expectâ€™â€™  â€˜â€˜goalsâ€™â€™  â€˜â€˜intendâ€™â€™  â€˜â€˜mayâ€™â€™  â€œmilestonesâ€  â€˜â€˜objectivesâ€™â€™  â€˜â€˜outlookâ€™â€™  â€˜â€˜planâ€™â€™  â€˜â€˜probablyâ€™â€™  â€˜â€˜projectâ€™â€™  â€˜â€˜risksâ€™â€™  â€œscheduleâ€  â€˜â€˜seekâ€™â€™  â€˜â€˜shouldâ€™â€™  â€˜â€˜targetâ€™â€™  â€˜â€˜willâ€™â€™ and similar terms and phrases. There are a number of factors that could affect the future operations of Shell and could cause those results to differ materially from those expressed in the forward-looking statements included in this announcement  including (without limitation): (a) price fluctuations in crude oil and natural gas; (b) changes in demand for Shellâ€™s products; (c) currency fluctuations; (d) drilling and production results; (e) reserves estimates; (f) loss of market share and industry competition; (g) environmental and physical risks; (h) risks associated with the identification of suitable potential acquisition properties and targets  and successful negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative  judicial  fiscal and regulatory developments including regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks  including the risks of expropriation and renegotiation of the terms of contracts with governmental entities  delays or advancements in the approval of projects and delays in the reimbursement for shared costs; (m) risks associated with the impact of pandemics  such as the COVID-19 (coronavirus) outbreak; and (n) changes in trading conditions. No assurance is provided that future dividend payments will match or exceed previous dividend payments. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Additional risk factors that may affect future results are contained in Shell plcâ€™s Form 20-F for the year ended December 31  2021 (available at www.shell.com/investor and www.sec.gov). These risk factors also expressly qualify all forward-looking statements contained in this announcement and should be considered by the reader. Each forward-looking statement speaks only as of the date of this announcement  December 5  2022. Neither Shell plc nor any of its subsidiaries undertake any obligation to publicly update or revise any forward-looking statement as a result of new information  future events or other information. In light of these risks  results could differ materially from those stated  implied or inferred from the forward-looking statements contained in this announcement.Shellâ€™s net carbon footprintAlso  in this announcement we may refer to Shellâ€™s â€œNet Carbon Footprintâ€ or â€œNet Carbon Intensityâ€  which include Shellâ€™s carbon emissions from the production of our energy products  our suppliersâ€™ carbon emissions in supplying energy for that production and our customersâ€™ carbon emissions associated with their use of the energy products we sell. Shell only controls its own emissions. The use of the term Shellâ€™s â€œNet Carbon Footprintâ€ or â€œNet Carbon Intensityâ€ are for convenience only and not intended to suggest these emissions are those of Shell plc or its subsidiaries.Shellâ€™s net-Zero Emissions TargetShellâ€™s operating plan  outlook and budgets are forecasted for a ten-year period and are updated every year. They reflect the current economic environment and what we can reasonably expect to see over the next ten years. Accordingly  they reflect our Scope 1  Scope 2 and Net Carbon Footprint (NCF) targets over the next ten years. However  Shellâ€™s operating plans cannot reflect our 2050 net-zero emissions target and 2035 NCF target  as these targets are currently outside our planning period. In the future  as society moves towards net-zero emissions  we expect Shellâ€™s operating plans to reflect this movement. However  if society is not net zero in 2050  as of today  there would be significant risk that Shell may not meet this target.Forward Looking Non-GAAP measuresThis announcement may contain certain forward-looking non-GAAP measures such as cash capital expenditure and divestments. We are unable to provide a reconciliation of these forward-looking Non-GAAP measures to the most comparable GAAP financial measures because certain information needed to reconcile those Non-GAAP measures to the most comparable GAAP financial measures is dependent on future events some of which are outside the control of Shell  such as oil and gas prices  interest rates and exchange rates. Moreover  estimating such GAAP measures with the required precision necessary to provide a meaningful reconciliation is extremely difficult and could not be accomplished without unreasonable effort. Non-GAAP measures in respect of future periods which cannot be reconciled to the most comparable GAAP financial measure are calculated in a manner which is consistent with the accounting policies applied in Shell plcâ€™s consolidated financial statements.The contents of websites referred to in this announcement do not form part of this announcement.We may have used certain terms  such as resources  in this announcement that the United States Securities and Exchange Commission (SEC) strictly prohibits us from including in our filings with the SEC. Investors are urged to consider closely the disclosure in our Form 20-F  File No 1-32575  available on the SEC website www.sec. gov .LEI number of Shell plc: 21380068P1DRHMJ8KU70Classification: Additional regulated information required to be disclosed under the laws of a Member State,neutral,0.0,1.0,0.0,negative,0.0,0.06,0.93,True,English,"['Gbp Equivalent Dividend Payments', 'Shell Plc', 'Third Quarter', 'Euro', 'U.S. Private Securities Litigation Reform Act', 'Enquiries Shell Media Relations International', 'third quarter 2022 interim dividend', 'Dutch dividend withholding tax', 'different currency election date', 'euro equivalent dividend payments', 'Dividend Access Mechanism', 'three dealing days', 'sterling currency elections', 'market exchange rates', 'indirect ownership interest', 'pound sterling rate', 'former A shares', 'former B shares', 'separate legal entities', 'unincorporated joint arrangement', 'securities account', 'Shell Corporate Nominee', 'nominee arrangement', 'tax residence', 'tax treatment', 'tax advisor', 'cash dividend', 'valid election', 'euro rate', 'election deadline', 'unincorporated arrangements', 'market risks', 'third-party interest', 'joint ventures', 'joint arrangements', 'Shell interest', 'The Board', 'ordinary share', 'US dollars', 'Euroclear Nederland', 'uncertificated form', 'financial institution', 'financial intermediary', 'useful purpose', 'significant influence', 'financial condition', 'historical fact', 'unknown risks', 'other things', 'potential exposure', 'pounds sterling', 'joint operations', 'SHELL PLC', 'future expectations', 'current expectations', 'joint control', 'sterling dividends', 'CAUTIONARY NOTE', 'particular entity', 'Forward-Looking Statements', 'actual results', 'CREST members', 'Shell Group', 'Shell companies', 'other shareholders', 'Shell subsidiaries', 'GBP', 'December', 'respect', 'October', 'euros', 'November', 'contrary', 'persons', 'average', 'names', 'Register', 'Taxation', 'UK', 'bank', 'broker', 'Americas', 'investments', 'announcement', 'convenience', 'references', 'words', 'terms', 'associates', 'exclusion', 'meaning', 'businesses', 'management', 'assumptions', 'uncertainties', 'performance', 'events', 'beliefs', 'estimates', 'forecasts', 'projections', 'phrases', 'aim', 'ambition', 'goals', 'milestones', 'objectives']",2022-12-05,2022-12-06,globenewswire.com
14182,Euroclear,Twitter API,Twitter,Service Designer  Euroclear Finland Oy  Helsinki https://t.co/BwrdN8TJbP #ohjelmointi #it #rekry https://t.co/34kOqFmzFv,nan,Service Designer  Euroclear Finland Oy  Helsinki https://t.co/BwrdN8TJbP #ohjelmointi #it #rekry https://t.co/34kOqFmzFv,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['Euroclear Finland Oy', 'Service Designer', 'Helsinki', 'BwrdN8TJbP', 'ohjelmointi', 'Euroclear Finland Oy', 'Service Designer', 'Helsinki', 'BwrdN8TJbP', 'ohjelmointi']",2022-12-05,2022-12-06,Unknown
14183,Euroclear,Twitter API,Twitter,Full Stack Developer (Back-end)  Euroclear Finland Oy  Helsinki https://t.co/h2y1Vpx7ab #ohjelmointi #it #rekry https://t.co/vvR2Kw3tc5,nan,Full Stack Developer (Back-end)  Euroclear Finland Oy  Helsinki https://t.co/h2y1Vpx7ab #ohjelmointi #it #rekry https://t.co/vvR2Kw3tc5,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['Full Stack Developer', 'Euroclear Finland', 'Helsinki', 'Full Stack Developer', 'Euroclear Finland', 'Helsinki']",2022-12-05,2022-12-06,Unknown
14184,Euroclear,Twitter API,Twitter,Todayâ€™s main developments: Euroclear stops accepting payments in roubles; Russian foreign minister says nuclear warâ€¦ https://t.co/FoJ4fcsqbm,nan,Todayâ€™s main developments: Euroclear stops accepting payments in roubles; Russian foreign minister says nuclear warâ€¦ https://t.co/FoJ4fcsqbm,negative,0.01,0.39,0.6,negative,0.01,0.39,0.6,True,English,"['Russian foreign minister', 'main developments', 'nuclear war', 'Euroclear', 'payments', 'Russian foreign minister', 'main developments', 'nuclear war', 'Euroclear', 'payments']",2022-12-05,2022-12-06,Unknown
14185,Euroclear,Twitter API,Twitter,ğŸ‘ğŸ³ğŸ¥šğŸ¤ğŸ–ğŸ—ğŸŠğŸ‡ğŸ“ğŸ¬ğŸ«ğŸ¿ğŸ©ğŸªğŸ’ğŸˆğŸ¥‘ğŸ³ğŸ¥šğŸ¤ğŸ’ğŸŠğŸ¯ğŸğŸ¥ğŸ¥–ğŸ¥ğŸ¯ğŸTodayâ€™s main developments: Euroclear stops accepting payments in roubles; Russian foreâ€¦ https://t.co/26ROGjZrpA,nan,ğŸ‘ğŸ³ğŸ¥šğŸ¤ğŸ–ğŸ—ğŸŠğŸ‡ğŸ“ğŸ¬ğŸ«ğŸ¿ğŸ©ğŸªğŸ’ğŸˆğŸ¥‘ğŸ³ğŸ¥šğŸ¤ğŸ’ğŸŠğŸ¯ğŸğŸ¥ğŸ¥–ğŸ¥ğŸ¯ğŸTodayâ€™s main developments: Euroclear stops accepting payments in roubles; Russian foreâ€¦ https://t.co/26ROGjZrpA,neutral,0.05,0.94,0.01,neutral,0.05,0.94,0.01,True,English,"['main developments', 'Russian fore', 'Today', 'Euroclear', 'payments', 'main developments', 'Russian fore', 'Today', 'Euroclear', 'payments']",2022-12-05,2022-12-06,Unknown
14186,Euroclear,Twitter API,Twitter,ğŸ‘ğŸ³ğŸ¥šğŸ¤ğŸ–ğŸ—ğŸŠğŸ‡ğŸ“ğŸ¬ğŸ«ğŸ¿ğŸ©ğŸªğŸ’ğŸˆğŸ¥‘ğŸ³ğŸ¥šğŸ¤ğŸ’ğŸŠğŸ¯ğŸğŸ¥ğŸ¥–ğŸ¥ğŸ¯ğŸTodayâ€™s main developments: Euroclear stops accepting payments in roubles; Russian foreâ€¦ https://t.co/d6JhvVetfD,nan,ğŸ‘ğŸ³ğŸ¥šğŸ¤ğŸ–ğŸ—ğŸŠğŸ‡ğŸ“ğŸ¬ğŸ«ğŸ¿ğŸ©ğŸªğŸ’ğŸˆğŸ¥‘ğŸ³ğŸ¥šğŸ¤ğŸ’ğŸŠğŸ¯ğŸğŸ¥ğŸ¥–ğŸ¥ğŸ¯ğŸTodayâ€™s main developments: Euroclear stops accepting payments in roubles; Russian foreâ€¦ https://t.co/d6JhvVetfD,neutral,0.06,0.93,0.01,neutral,0.06,0.93,0.01,True,English,"['main developments', 'Russian fore', 'Today', 'Euroclear', 'payments', 'main developments', 'Russian fore', 'Today', 'Euroclear', 'payments']",2022-12-05,2022-12-06,Unknown
14187,Euroclear,Twitter API,Twitter,ROS Agro : Rusagro announces support for ROS AGRO PLC GDRs transfer from NSD to Euroclear https://t.co/udzkJ3qp3t https://t.co/jBiQH0P6Tx,nan,ROS Agro : Rusagro announces support for ROS AGRO PLC GDRs transfer from NSD to Euroclear https://t.co/udzkJ3qp3t https://t.co/jBiQH0P6Tx,neutral,0.02,0.98,0.0,neutral,0.02,0.98,0.0,True,English,"['AGRO PLC GDRs transfer', 'Rusagro', 'support', 'NSD', 'Euroclear', 'AGRO PLC GDRs transfer', 'Rusagro', 'support', 'NSD', 'Euroclear']",2022-12-05,2022-12-06,Unknown
14188,Euroclear,Twitter API,Twitter,@London888174 Cvsa euroclear clearstream Dtc,nan,@London888174 Cvsa euroclear clearstream Dtc,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['London888174 Cvsa', 'London888174 Cvsa']",2022-12-05,2022-12-06,Unknown
14189,Euroclear,Twitter API,Twitter,ğŸ‘ğŸ³ğŸ¥šğŸ¤ğŸ–ğŸ—ğŸŠğŸ‡ğŸ“ğŸ¬ğŸ«ğŸ¿ğŸ©ğŸªğŸ’ğŸˆğŸ¥‘ğŸ³ğŸ¥šğŸ¤ğŸ’ğŸŠğŸ¯ğŸğŸ¥ğŸ¥–ğŸ¥ğŸ¯ğŸTodayâ€™s main developments: Euroclear stops accepting payments in roubles; Russian foreâ€¦ https://t.co/hh1ktZJDUR,nan,ğŸ‘ğŸ³ğŸ¥šğŸ¤ğŸ–ğŸ—ğŸŠğŸ‡ğŸ“ğŸ¬ğŸ«ğŸ¿ğŸ©ğŸªğŸ’ğŸˆğŸ¥‘ğŸ³ğŸ¥šğŸ¤ğŸ’ğŸŠğŸ¯ğŸğŸ¥ğŸ¥–ğŸ¥ğŸ¯ğŸTodayâ€™s main developments: Euroclear stops accepting payments in roubles; Russian foreâ€¦ https://t.co/hh1ktZJDUR,neutral,0.06,0.93,0.01,neutral,0.06,0.93,0.01,True,English,"['main developments', 'Russian fore', 'Today', 'Euroclear', 'payments', 'main developments', 'Russian fore', 'Today', 'Euroclear', 'payments']",2022-12-04,2022-12-06,Unknown
14191,Deutsche Boerse,NewsApi.org,https://www.fxempire.com/news/article/porsche-will-join-germanys-blue-chip-index-deutsche-boerse-1220460,Porsche will join Germanyâ€™s blue-chip index â€“ Deutsche Boerse,BERLIN (Reuters) -   German sportscar maker Porsche AG will join the blue-chip index  just over two months after its market debut  exchange operator Deutsche Boerse said on Monday.,Shares in Porsche have gained around 30% since their listing in Germany in late September. The carmaker quickly overtook its former parent Volkswagen â€“ which holds 75% minus one ordinary share of Porsche AGâ€™s total share capital â€“ as Europeâ€™s most valuable carmaker.Both Volkswagen and its majority owner Porsche SE are on the DAX index as well.Deutsche Boerse periodically reassesses the composition of the index using trading data to measure market value and trading volume as a basis for deciding which companies to include.Last year  the index was expanded to 40 companies from 30 in its biggest overhaul in history.Bioenergy company Verbio will also join the mid-cap MDAX index  while real estate firm Deutsche Wohnen and battery maker Varta will be demoted to the small-cap SDAX.(Reporting by Sarah Marsh; Editing by Mark Porter and Sandra Maler),neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['blue-chip index', 'Deutsche Boerse', 'Porsche', 'Germany', 'one ordinary share', 'total share capital', 'real estate firm', 'battery maker Varta', 'former parent Volkswagen', 'mid-cap MDAX index', 'late September', 'majority owner', 'Deutsche Boerse', 'trading data', 'market value', 'trading volume', 'biggest overhaul', 'Bioenergy company', 'Deutsche Wohnen', 'small-cap SDAX', 'Sarah Marsh', 'Mark Porter', 'Sandra Maler', 'Porsche AG', 'Porsche SE', 'valuable carmaker', 'Shares', 'listing', 'Germany', '75% minus', 'Europe', 'composition', 'basis', 'companies', 'history', 'Verbio', 'Editing']",2022-12-05,2022-12-06,fxempire.com
14192,Deutsche Boerse,NewsApi.org,https://biztoc.com/x/f54bc2ad1774a6ed,Porsche will join Germany's blue-chip index,BERLIN  Dec 5 (Reuters) - German sportscar maker Porsche AG (P911_p.DE) will join the blue-chip index  just over two months after its market debut  exchange operator Deutsche Boerse (DB1Gn.DE) said on Monday. Porsche AG will replace sportswear maker Puma (PUMâ€¦,BERLIN  Dec 5 (Reuters) - German sportscar maker Porsche AG (P911_p.DE) will join the blue-chip index  just over two months after its market debut  exchange operator Deutsche Boerse (DB1Gn.DE) said on Monday.Porsche AG will replace sportswear maker Puma (PUMG.DE) on the DAX stock index (.GDAXI) on Dec. 19  it said.This story appeared first on reuters.com   2022-12-05.,neutral,0.0,1.0,0.0,neutral,0.0,0.99,0.0,True,English,"['blue-chip index', 'Porsche', 'Germany', 'German sportscar maker', 'DAX stock index', 'blue-chip index', 'sportswear maker', 'Porsche AG', 'market debut', 'exchange operator', 'Deutsche Boerse', 'DB1Gn.DE', 'Dec', 'Reuters', 'Monday', 'Puma', 'GDAXI', 'story']",2022-12-05,2022-12-06,biztoc.com
14193,Deutsche Boerse,NewsApi.org,https://biztoc.com/x/509ece29349479f4,Germany stocks lower at close of trade; DAX down 0.56% By Investing.com,Investing.com â€“ Germany stocks were lower after the close on Monday  as losses in the Construction  Financial Services and Pharmaceuticals & Healthcare sectors led shares lower. At the close in Frankfurt  the DAX declined 0.56%  while the MDAX index fell 1.07â€¦,Investing.com â€“ Germany stocks were lower after the close on Monday  as losses in the Construction  Financial Services and Pharmaceuticals & Healthcare sectors led shares lower.At the close in Frankfurt  the DAX declined 0.56%  while the MDAX index fell 1.07%  and the TecDAX index fell 0.84%.The best performers of the session on the DAX were Siemens Energy AG (ETR:ENR1n)  which rose 2.83% or 0.46 points to trade at 16.69 at the close. Meanwhile  Volkswagen AG VZO O.N. (ETR:VOWG_p) added 1.31% or 1.82 points to end at 140.84 and Deutsche Bank AG NA O.N. (ETR:DBKGn) was up 1.26% or 0.13 points to 10.15 in late trade.The worst performers of the session were Bayer AG NA (ETR:BAYGN)  which fell 3.19% or 1.75 points to trade at 53.09 at the close. Zalando SE (ETR:ZALG) declined 2.25% or 0.71 points to end at 30.88 and Deutsche Boerse AG (ETR:DB1Gn) was down 2.24% or 4.00 points to 174.60.The top performers on the MDAX were Aixtron SE (ETR:AIXGn) which rose 1.74% to 31.65  Befesa SAâ€¦This story appeared first on investing.com   2022-12-05.,neutral,0.0,0.97,0.02,mixed,0.23,0.2,0.57,True,English,"['Germany stocks', 'close', 'trade', 'DAX', 'Investing', 'com', 'Volkswagen AG VZO O.N.', 'NA O.N.', 'Siemens Energy AG', 'Deutsche Bank AG', 'Bayer AG NA', 'Deutsche Boerse AG', 'Germany stocks', 'Financial Services', 'Healthcare sectors', 'TecDAX index', 'best performers', 'late trade', 'worst performers', 'Zalando SE', 'top performers', 'Aixtron SE', 'Befesa SA', 'MDAX index', 'ETR:ZALG', 'close', 'Monday', 'losses', 'Construction', 'Pharmaceuticals', 'shares', 'Frankfurt', 'session', 'VOWG_p', '1.82 points', 'DBKGn', 'BAYGN', 'DB1Gn', 'AIXGn', 'story', 'investing.', '0.', '1.75', '4.00']",2022-12-05,2022-12-06,biztoc.com
14198,Deutsche Boerse,Twitter API,Twitter,Porsche Will Join Germany's Blue-Chip Index - Deutsche Boersehttps://t.co/kYNlZxYFXw  via LiveSquawk,nan,Porsche Will Join Germany's Blue-Chip Index - Deutsche Boersehttps://t.co/kYNlZxYFXw  via LiveSquawk,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['Blue-Chip Index', 'Deutsche Boerse', 'Porsche', 'Germany', 'LiveSquawk', 'Blue-Chip Index', 'Deutsche Boerse', 'Porsche', 'Germany', 'LiveSquawk']",2022-12-05,2022-12-06,Unknown
14199,Deutsche Boerse,Twitter API,Twitter,âš ï¸ PORSCHE WILL JOIN GERMANY'S BLUE-CHIP INDEX - DEUTSCHE BOERSE- Full story via Reuters at https://t.co/TekYV0MSjb,nan,âš ï¸ PORSCHE WILL JOIN GERMANY'S BLUE-CHIP INDEX - DEUTSCHE BOERSE- Full story via Reuters at https://t.co/TekYV0MSjb,neutral,0.03,0.96,0.01,neutral,0.03,0.96,0.01,True,English,"['PORSCHE WILL', 'BLUE-CHIP INDEX', 'DEUTSCHE BOERSE', 'Full story', 'Reuters', 'TekYV0MSjb', 'PORSCHE WILL', 'BLUE-CHIP INDEX', 'DEUTSCHE BOERSE', 'Full story', 'Reuters', 'TekYV0MSjb']",2022-12-05,2022-12-06,Unknown
14200,Deutsche Boerse,Twitter API,Twitter,Retweet selected by the https://t.co/kmOCQTFIJb team |  Deutsche Boerse  Swisscom Settle Securities with Corda andâ€¦ https://t.co/eqSgrXqFrZ,nan,Retweet selected by the https://t.co/kmOCQTFIJb team |  Deutsche Boerse  Swisscom Settle Securities with Corda andâ€¦ https://t.co/eqSgrXqFrZ,neutral,0.05,0.94,0.01,neutral,0.05,0.94,0.01,True,English,"['kmOCQTFIJb team', 'Deutsche Boerse', 'Retweet', 'Swisscom', 'Securities', 'Corda', 'kmOCQTFIJb team', 'Deutsche Boerse', 'Retweet', 'Swisscom', 'Securities', 'Corda']",2022-12-05,2022-12-06,Unknown
14203,EuroNext,NewsApi.org,https://finance.yahoo.com/news/upward-adjustment-expectations-2022-074100938.html,Upward adjustment of expectations for 2022,Nasdaq CopenhagenLondon Stock Exchange Euronext DublinOther stakeholders Date 5 December 2022 Upward adjustment of expectations for 2022 RingkjÃ¸bing...,RingkjÃ¸bing Landbobank A/SNasdaq CopenhagenLondon Stock ExchangeEuronext DublinOther stakeholdersDate 5 December 2022Upward adjustment of expectations for 2022RingkjÃ¸bing Landbobank is upwardly adjusting its expectations for core earnings and profit before tax for 2022.The expectations for core earnings are upwardly adjusted from the DKK 1 600-1 850 million range to the DKK 1 850-2 000 million range and the expectations for profit before tax are upwardly adjusted from the DKK 1 550-1 800 million range to the DKK 1 700-1 950 million range.The upward adjustment is primarily a result of:A continued good level of activityThe value of the higher interest rate level and the growth in lending in the first three quarters of the yearContinued good credit quality and a loss level that has remained on a very satisfactory levelThe annual report for 2022 will be published on 1 February 2023  as previously announced.Yours sincerelyRingkjÃ¸bing LandbobankJohn FiskerCEOAttachment,positive,0.69,0.29,0.01,positive,0.96,0.04,0.0,True,English,"['Upward adjustment', 'expectations', '2022', 'DKK 1,600-1,850 million range', 'DKK 1,850-2,000 million range', 'DKK 1,550-1,800 million range', 'DKK 1,700-1,950 million range', 'John Fisker CEO Attachment', 'higher interest rate level', 'RingkjÃ¸bing Landbobank A/S', 'London Stock Exchange', 'Other stakeholders Date', 'first three quarters', 'good credit quality', 'good level', 'loss level', 'satisfactory level', 'Nasdaq Copenhagen', 'Euronext Dublin', 'Upward adjustment', 'core earnings', 'annual report', 'December', 'expectations', 'profit', 'tax', 'result', 'activity', 'value', 'growth', 'lending', 'year', '1 February', '2022']",2022-12-05,2022-12-06,finance.yahoo.com
14204,EuroNext,NewsApi.org,https://finance.yahoo.com/news/virbac-declaration-number-shares-voting-172000801.html,Virbac : Declaration of the number of shares and voting rights 11/2022,DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article ...,DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTSInformation on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority â€“ AutoritÃ©des MarchÃ©s Financiers)Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577Date Total number of shares representing the share capital Total number of voting rights November  30 2022 8 458 000 Gross total of voting rights : 12 765 861 Net total* of voting rights : 12 751 087Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.VIRBAC: Shaping the future of animal healthNYSE Euronext - Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRPCorporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.comWebsite: www.virbac.comAttachment,neutral,0.0,1.0,0.0,neutral,0.03,0.97,0.0,True,English,"['voting rights', 'Virbac', 'Declaration', 'number', 'shares', 'French Financial Market Authority', 'animal health NYSE Euronext', 'MarchÃ©s Financiers', 'Euronext Paris', 'total number', 'share capital', 'General regulations', 'Compartiment A', 'ISIN code', 'Gross total', 'Net total', 'Code ISIN', 'Corporate Finance', 'voting rights', 'DECLARATION', 'THE', 'SHARES', 'Information', 'Article', 'place', 'Date', 'VIRBAC', 'future', 'MNEMO', 'VIRP', 'tel.', 'Email', 'finances', 'Website', 'Attachment']",2022-12-05,2022-12-06,finance.yahoo.com
14205,EuroNext,NewsApi.org,https://finance.yahoo.com/news/fl-entertainment-enters-liquidity-agreement-164000658.html,FL Entertainment: enters into liquidity agreement with Kepler Cheuvreux,Press Release Paris â€“ December 05th  2022 FL Entertainment N.V. enters into liquidity agreement with Kepler Cheuvreux As of 05/12/2022  FL Entertainment N.V....,"FL EntertainmentPress ReleaseParis â€“ December 05th  2022FL Entertainment N.V. enters into liquidity agreement with Kepler CheuvreuxAs of 05/12/2022  FL Entertainment N.V. (""FLE"") has entrusted Kepler Cheuvreux S.A. with the implementation of a liquidity agreement to ensure liquidity and foster regular trading for FLE shares (ISIN Code NL0015000X07) on Euronext Amsterdam  within the limit of FLEâ€™s authorizations granted by the shareholdersâ€˜ meeting dated June 30  2022.This agreement has an initial period ending on December 31  2022 and is automatically renewable for successive 12-month periods.For the implementation of the liquidity agreement  the following resources were allocated by FLE to the liquidity account: a maximum amount of â‚¬1 000 000.The liquidity agreement may be terminated at any time by FLE or with a notice period by Kepler Cheuvreux S.A. under the conditions stipulated in the liquidity agreement. The execution of the liquidity agreement may also be suspended under the conditions set forth in the agreement.FLE will publish the trades under the liquidity agreement on a weekly basis on its website  available at https://fl-entertainment.com/investor-relations/.This press release contains or may contain information about FL Entertainment N.V. within the meaning of Article 7(1) to (4) of EU Regulation No 596/2014.AgendaFY 2022 results: 16 March 2023Investor RelationsCaroline Cohen â€“ Phone: +33 1 44 95 23 34 â€“ c.cohen@flentertainment.comPress RelationsAnne-France Malrieu - afmalrieu@image7.frAbout FL EntertainmentFounded by StÃ©phane Courbit  a 30-year entertainment industry pioneer and entrepreneur  FL Entertainment Group is a global leader in multimedia content and gambling  combining the strengths of Banijay  the worldâ€™s largest independent producer distributor  with Betclic Everest Group  the fastest-growing online sports betting platform in Europe. In 2021  FL Entertainment recorded through Banijay and Betclic Everest Group  a combined revenue  and adjusted EBITDA  of â‚¬3.5bn and â‚¬609m respectively. FL Entertainment listed on Euronext Amsterdam in July 2022.ISIN: NL0015000X07 - Bloomberg: FLE NA - Reuters: FLE.ASStory continuesRegulated information related to this press release is available on the website:https://fl-entertainment.com/investor-relations/https://fl-entertainment.com/Attachment",neutral,0.02,0.98,0.0,positive,0.7,0.29,0.01,True,English,"['FL Entertainment', 'liquidity agreement', 'Kepler Cheuvreux', 'growing online sports betting platform', 'largest independent producer distributor', 'Kepler Cheuvreux S.A.', '30-year entertainment industry pioneer', 'FL Entertainment N.V.', 'successive 12-month periods', 'StÃ©phane Courbit', 'Betclic Everest Group', 'FL Entertainment Group', 'Press Release', 'regular trading', 'Euronext Amsterdam', 'shareholdersâ€˜ meeting', 'initial period', 'following resources', 'maximum amount', 'notice period', 'weekly basis', 'EU Regulation', 'FY 2022 results', 'Investor Relations', 'Press Relations', 'Anne-France Malrieu', 'global leader', 'multimedia content', 'combined revenue', 'adjusted EBITDA', 'liquidity account', 'liquidity agreement', 'ISIN Code', 'Caroline Cohen', 'Regulated information', 'FLE shares', 'FLE NA', 'FLE.AS', 'Paris', 'December', '05/12', 'implementation', 'limit', 'authorizations', 'conditions', 'execution', 'trades', 'website', 'investor-relations', 'meaning', 'Article', 'Agenda', '16 March', 'Phone', 'image', 'strengths', 'Banijay', 'world', 'Europe', 'July', 'Bloomberg', 'Reuters', 'Story', 'Attachment']",2022-12-05,2022-12-06,finance.yahoo.com
14206,EuroNext,NewsApi.org,https://finance.yahoo.com/news/forfarmers-n-v-forfarmers-convenes-060000391.html,ForFarmers N.V.: ForFarmers convenes Extraordinary General Meeting of Shareholders on 17 January  2023,Lochem  5 December  2022 ForFarmers convenes Extraordinary General Meeting of Shareholders on 17 January  2023 ForFarmers N.V. announces that Extraordinary...,ForFarmers N.V.Lochem  5 December  2022ForFarmers convenes Extraordinary General Meeting of Shareholders on 17 January  2023ForFarmers N.V. announces that Extraordinary General Meeting of Shareholders will be held (as a virtual meeting) on Tuesday 17 January  2023  starting at 10.00 am (CET) in relation to the appointment of Theo Spierings as member of the Executive Board (CEO). The convocation announcement and the agenda and explanatory notes to the agenda are available via the corporate website of ForFarmers (www.forfarmersgroup.eu/en) under Investors / General Meeting of Shareholders.This press release contains information that qualifies as inside information within the meaning of Article 7 paragraph 1 of the EU Market Abuse Regulation.Note to the editor / For additional information:Caroline Vogelzang  Director Investor RelationsM: 0031 6 10 94 91 61E: caroline.vogelzang@forfarmers.euCompany profileForFarmers N.V. (â€˜ForFarmersâ€™  Lochem  the Netherlands) is an internationally operating feed company that offers total feed solutions for conventional and organic livestock farming. ForFarmers gives its very best â€œFor the Future of Farmingâ€: for the continuity of farming and for a financially secure sector that will continue to serve society for generations to come in a sustainable way. By working side-by-side with farmers ForFarmers delivers real benefits: better returns  healthier livestock and greater efficiency. This is achieved by offering tailored and Total Feed solutions and a targeted approach with specialist and expert support.With sales of around 10 million tonnes of feed  ForFarmers is market leader in Europe. ForFarmers has approximately 2 500 employees and is active in the Netherlands  Belgium  Germany  Poland and the United Kingdom. In 2021  revenues amounted to approximately â‚¬2.7 billion. ForFarmers N.V. is listed at Euronext Amsterdam.ForFarmers N.V.  Postbus 91  7240 AB Lochem  T: +31 (0)573 28 88 00info@forfarmers.eu  www.forfarmersgroup.eu/en.Story continues,neutral,0.01,0.99,0.0,mixed,0.49,0.14,0.38,True,English,"['Extraordinary General Meeting', 'ForFarmers N.V.', 'Shareholders', '17 January', 'EU Market Abuse Regulation', 'Director Investor Relations', 'total feed solutions', 'Extraordinary General Meeting', 'operating feed company', 'ForFarmers N.V.', 'organic livestock farming', 'market leader', 'virtual meeting', 'Company profile', 'healthier livestock', 'Theo Spierings', 'Executive Board', 'convocation announcement', 'explanatory notes', 'corporate website', 'press release', 'Article 7 paragraph', 'secure sector', 'sustainable way', 'real benefits', 'greater efficiency', 'targeted approach', 'expert support', '10 million tonnes', 'United Kingdom', 'Euronext Amsterdam', 'inside information', 'additional information', '7240 AB Lochem', 'Caroline Vogelzang', '5 December', 'Shareholders', '17 January', 'Tuesday', 'CET', 'appointment', 'member', 'CEO', 'agenda', 'Investors', 'meaning', 'editor', 'Netherlands', 'conventional', 'Future', 'continuity', 'society', 'generations', 'returns', 'tailored', 'specialist', 'sales', 'Europe', '2,500 employees', 'Belgium', 'Germany', 'Poland', 'revenues', 'Postbus', 'Story', '10.00']",2022-12-05,2022-12-06,finance.yahoo.com
14207,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221205005158/en/Wolters-Kluwer-software-recognized-as-Product-of-the-Year-in-the-2022-BIG-Awards-for-Business,Wolters Kluwer software recognized as Product of the Year in the 2022 BIG Awards for Business,NEW YORK--(BUSINESS WIRE)-- #audit--Wolters Kluwer Tax & Accounting innovative TeamMate+ suite of expert audit solutions wins Product of the Year by the 2022 BIG Awards for Business,Wolters Kluwer Tax & Accounting innovative TeamMate+ suite of expert audit solutions wins Product of the Year by the 2022 BIG Awards for Business (Photo: Business Wire)Wolters Kluwer Tax & Accounting innovative TeamMate+ suite of expert audit solutions wins Product of the Year by the 2022 BIG Awards for Business (Photo: Business Wire)NEW YORK--(BUSINESS WIRE)--Wolters Kluwer Tax & Accounting announced its innovative TeamMate+ suite of expert audit solutions was recognized as Product of the Year by the 2022 BIG Awards for Business. The Business Intelligent Group uses these awards annually to identify companies  products  and people leading their respective industries.â€œWe are honored once again  to be recognized by the Business Intelligence Group as a global leader in internal audit solutions and services through TeamMate+ products â€ said Frans Klaassen  Senior Vice President & General Manager  Wolters Kluwer TeamMate. â€œTeamMate continues to provide organizations with innovative solutions to ensure they stay ahead of risk  optimize performance and deliver value.â€TeamMate+ Audit enables auditors from all geographies and industries to apply a digital mindset to manage the complex world of audit across the entire workflow â€“ risk assessments  audit planning  audit execution  and issue tracking. TeamMate+ delivers decisive integration to collaborate with key systems  audit analytics to test data real-time  and data-driven insights to the business where it matters most.TeamMateâ€™s global expert solutions include TeamMate+ Audit  TeamMate+ Audit Public Sector  TeamMate+ Controls  and TeamMate Analytics.â€œThis yearâ€™s nominees have shown that resilience and determination are needed in todayâ€™s economy â€ said Maria Jimenez  chief nominations officer for Business Intelligence Group. â€œWe are so proud to reward each of our winners for setting such an inspirational example for the global business community.â€About Business Intelligence GroupThe Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs  business executivesâ€”those with experience and knowledgeâ€”judge the programs. The organizationâ€™s proprietary and unique scoring system selectively measures performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers.About Wolters KluwerWolters Kluwer (WKL) is a global leader in professional information  software solutions  and services for the healthcare; tax and accounting; governance  risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.Wolters Kluwer reported 2021 annual revenues of â‚¬4.8 billion. The group serves customers in over 180 countries  maintains operations in over 40 countries  and employs approximately 19 800 people worldwide. The company is headquartered in Alphen aan den Rijn  the Netherlands.Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).For more information  visit www.wolterskluwer.com  follow us on Twitter  Facebook  LinkedIn  and YouTube.,neutral,0.4,0.6,0.0,positive,0.71,0.29,0.0,True,English,"['Wolters Kluwer software', '2022 BIG Awards', 'Product', 'Year', 'Business', 'Alphen aan den Rijn', 'Level 1 American Depositary Receipt', 'other industry award programs', 'TeamMate+ Audit Public Sector', 'The Business Intelligent Group', 'Accounting innovative TeamMate+ suite', 'The Business Intelligence Group', 'Senior Vice President', 'chief nominations officer', 'unique scoring system', 'multiple business domains', 'internal audit solutions', 'deep domain knowledge', 'global expert solutions', 'Wolters Kluwer shares', 'expert audit solutions', 'global business community', 'Wolters Kluwer Tax', 'innovative solutions', 'TeamMate+ Controls', 'software solutions', 'global leader', 'audit planning', 'audit execution', 'audit analytics', 'Business Wire', 'business world', 'business executives', 'TeamMate+ products', 'NEW YORK', 'Frans Klaassen', 'General Manager', 'digital mindset', 'complex world', 'entire workflow', 'issue tracking', 'decisive integration', 'key systems', 'data-driven insights', 'Maria Jimenez', 'inspirational example', 'true talent', 'regulatory sectors', 'critical decisions', 'advanced technology', '2021 annual revenues', 'Euronext Amsterdam', 'Euronext 100 indices', 'ADR) program', 'counter market', 'U.S.', '2022 BIG Awards', 'respective industries', 'professional information', 'risk assessments', 'superior performance', 'TeamMate Analytics', 'Year', 'Photo', 'companies', 'people', 'services', 'organizations', 'value', 'auditors', 'geographies', 'real-time', 'nominees', 'resilience', 'determination', 'today', 'economy', 'winners', 'mission', 'experience', 'proprietary', 'achievements', 'peers', 'WKL', 'healthcare', 'governance', 'compliance', 'legal', 'customers', '180 countries', 'operations', '40 countries', 'company', 'Netherlands', 'AEX', 'ADRs', 'WTKWY', 'Twitter', 'Facebook', 'LinkedIn', 'YouTube']",2022-12-05,2022-12-06,businesswire.com
14208,EuroNext,NewsApi.org,https://finance.yahoo.com/news/dassault-syst-mes-declaration-number-133400156.html,Dassault SystÃ¨mes: declaration of the number of outstanding shares and voting rights as of November 30  2022,Press ReleaseVELIZY-VILLACOUBLAY  France â€” December 5  2022 Declaration of the number of outstanding shares and voting rights as of November 30  2022...,Press ReleaseVELIZY-VILLACOUBLAY  France â€” December 5  2022Declaration of the number of outstanding shares andvoting rights as of November 30  2022Dassault SystÃ¨mes (Euronext Paris: FR0014003TT8  DSY.PA) today announced below the total number of its outstanding shares and voting rights as of November 30  2022  according to articles 223-16 and 221-3 of the General Regulation of the AutoritÃ© des marchÃ©s financiers.Number of outstanding shares: 1 334 891 109Number of voting rights*: 2 033 581 125*The total number of voting rights is calculated on the basis of the total number of outstanding shares  even if the voting rights attached thereto are suspended  pursuant to Article 223-11 of the General Regulation of the AutoritÃ© des marchÃ©s financiers relating to the method for calculating the percentages of holdings in shares and in voting rights. We invite our shareholders to refer to this article should they need to declare crossing of thresholds.Declarations related to crossing of threshold must be sent to:Dassault SystÃ¨mes  Investors Relations Service  10  rue Marcel Dassault  CS 40501  78946 VÃ©lizy-Villacoublay Cedex (France). E-mail address: Investors@3ds.com###ABOUT DASSAULT SYSTÃˆMESDassault SystÃ¨mes  the 3DEXPERIENCE Company  is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications  our customers push the boundaries of innovation  learning and production to achieve a more sustainable world for patients  citizens  and consumers. Dassault SystÃ¨mes brings value to more than 300 000 customers of all sizes  in all industries  in more than 140 countries. For more information  visit www.3ds.comDassault SystÃ¨mes Investor Relationsâ€™ ContactsFranÃ§ois-JosÃ© BORDONADO / BÃ©atrix MARTINEZinvestors@3ds.com+33 (0)1 61 62 69 24USA & Canada: callie.gauzer@3ds.comStory continuesÂ© Dassault SystÃ¨mes. All rights reserved. 3DEXPERIENCE  the Compass icon  the 3DS logo  CATIA  BIOVIA  GEOVIA  SOLIDWORKS  3DVIA  ENOVIA  NETVIBES  MEDIDATA  CENTRIC PLM  3DEXCITE  SIMULIA  DELMIA  and IFWE are commercial trademarks or registered trademarks of Dassault SystÃ¨mes  a French â€œsociÃ©tÃ© europÃ©enneâ€ (Versailles Commercial Register # B 322 306 440)  or its subsidiaries in the United States and/or other countries.Attachment,neutral,0.01,0.99,0.0,neutral,0.04,0.96,0.0,True,English,"['Dassault SystÃ¨mes', 'outstanding shares', 'voting rights', 'declaration', 'number', 'November', 'French â€œsociÃ©tÃ© europÃ©enne', 'Dassault SystÃ¨mes Investor Relations', 'collaborative 3D virtual environments', 'des marchÃ©s financiers', 'virtual twin experiences', 'rue Marcel Dassault', 'Investors Relations Service', 'VÃ©lizy-Villacoublay Cedex', 'FranÃ§ois-JosÃ© BORDONADO', 'BÃ©atrix MARTINEZ', 'Versailles Commercial Register', 'commercial trademarks', 'Press Release', 'Euronext Paris', 'General Regulation', 'mail address', 'human progress', 'sustainable innovations', 'real world', 'sustainable world', 'Compass icon', '3DS logo', 'CENTRIC PLM', 'registered trademarks', 'United States', 'voting rights', 'outstanding shares', '3DEXPERIENCE Company', '3DEXPERIENCE platform', 'total number', 'other countries', '140 countries', 'VELIZY-VILLACOUBLAY', 'France', 'December', 'Declaration', 'November', 'DSY', 'articles', 'basis', 'method', 'percentages', 'holdings', 'shareholders', 'crossing', 'thresholds', 'CS', 'catalyst', 'business', 'people', 'applications', 'customers', 'boundaries', 'learning', 'production', 'patients', 'citizens', 'consumers', 'value', 'sizes', 'industries', 'information', 'Contacts', 'USA', 'Canada', 'gauzer', 'Story', 'CATIA', 'BIOVIA', 'GEOVIA', 'SOLIDWORKS', '3DVIA', 'ENOVIA', 'NETVIBES', 'MEDIDATA', '3DEXCITE', 'SIMULIA', 'DELMIA', 'IFWE', 'subsidiaries', 'Attachment', 'Â©']",2022-12-05,2022-12-06,finance.yahoo.com
14209,EuroNext,NewsApi.org,https://finance.yahoo.com/news/vgp-nv-disclosure-accordance-law-180000202.html,VGP NV: Disclosure in accordance with the Law of 2 May 2007 - Transparency law - Transparency notification by Mrs. Griet Van Malderen,Press ReleaseRegulated InformationAntwerp  5 December 2022â€“ 07:00 p.m. CET VGP NV has received a transparency notification dated 1 December 2022 that by...,VGP NVPress ReleaseRegulated InformationAntwerp  5 December 2022â€“ 07:00 p.m. CETVGP NV has received a transparency notification dated 1 December 2022 that by virtue of the new shares issued by VGP NV following the capital increase which occurred on 29 November 2022  that LVM & Family NV and Mrs. Griet Van Malderen now hold 4.39% of the voting rights of VGP NV. Therefore  their voting rights have crossed the threshold of 3%.The notification dated 1December 2022 contains the following information:Reason for notification:Passive threshold crossingAn acquisition or disposal of voting securities or voting rightsNotification by:A parent undertaking or a controlling person.Persons subject to the notification requirement:LVM & Family NV  Spinnerijstraat 12  9240 ZeleGriet Van MalderenDate on which the threshold is crossed:30 November 2022.Threshold that is crossed:3%Denominator:39 611 782Notified details:Previous notification After the transaction Number of voting rights Number of voting rights % of voting rights LVM & Family NV (previously Vadebo France NV) 655 738 1 475 410 3.72% Griet Van Malderen 118 000 265 500 0.67% Total 773 738 1 740 910 4.39%Chain of controlled undertakings through which the holding is effectively held:LVM & Family NV (previously Vadebo France NV) is exclusively controlled by Mrs. Griet Van Malderen.ABOUT VGPVGP is a pan-European owner  manager and developer of high-quality logistics and semi-industrial real estate. VGP operates a fully integrated business model with capabilities and longstanding expertise across the value chain. Founded in 1998 as a Belgian family-owned real estate developer in the Czech Republic  VGP has a staff of circa 380 FTEs today and operates in 19 European countries directly and through several 50:50 joint ventures. As of June 2022  the Gross Asset Value of VGP  including the joint ventures at 100%  amounted to â‚¬ 6.53 billion and the company had a Net Asset Value (EPRA NTA) of â‚¬ 2.34 billion. VGP is listed on Euronext Brussels. (ISIN: BE0003878957).For more information  please visit: http://www.vgpparks.euStory continuesAttachment,neutral,0.0,1.0,0.0,neutral,0.02,0.97,0.01,True,English,"['Mrs. Griet Van Malderen', 'VGP NV', 'Transparency notification', 'Transparency law', 'Disclosure', 'accordance', '2 May', 'VGP NV Press Release Regulated Information', 'Belgian family-owned real estate developer', 'Mrs. Griet Van Malderen', 'semi-industrial real estate', 'integrated business model', 'Gross Asset Value', 'Net Asset Value', 'Vadebo France NV', 'several 50:50 joint ventures', 'Passive threshold crossing', 'following information', 'Family NV', 'value chain', 'new shares', 'capital increase', 'voting rights', 'voting securities', 'parent undertaking', 'controlling person', 'controlled undertakings', 'pan-European owner', 'high-quality logistics', 'longstanding expertise', 'Czech Republic', '19 European countries', 'EPRA NTA', 'Euronext Brussels', 'transparency notification', 'notification requirement', 'Previous notification', 'transaction Number', 'Antwerp', '5 December', 'CET', 'virtue', '29 November', 'LVM', '1December', 'Reason', 'acquisition', 'disposal', 'Persons', 'Spinnerijstraat', '9240 Zele', 'Date', 'Denominator', 'details', 'holding', 'manager', 'capabilities', 'staff', '380 FTEs', 'June', 'company', 'ISIN', 'vgpparks', 'Story', 'Attachment', '07:00', '30']",2022-12-05,2022-12-06,finance.yahoo.com
14210,EuroNext,NewsApi.org,https://finance.yahoo.com/news/stmicroelectronics-announces-status-common-share-130000991.html,STMicroelectronics Announces Status of Common Share Repurchase Program,STMicroelectronics Announces Status ofCommon Share Repurchase Program Disclosure of Transactions in Own Shares â€“ Period from Nov 28  2022 to Dec 02  2022...,STMicroelectronics N.V.STMicroelectronics Announces Status ofCommon Share Repurchase ProgramDisclosure of Transactions in Own Shares â€“ Period from Nov 28  2022 to Dec 02  2022AMSTERDAM â€“ December 5  2022 -- STMicroelectronics N.V. (the â€œCompanyâ€ or â€œSTMicroelectronicsâ€)  a global semiconductor leader serving customers across the spectrum of electronics applications  announces full details of its common share repurchase program (the â€œProgramâ€) disclosed via a press release dated July 1  2021. The Program was approved by a shareholder resolution dated May 27  2021 and by the supervisory board.STMicroelectronics N.V. (registered with the trade register under number 33194537) (LEI: 213800Z8NOHIKRI42W10) (Ticker: â€œSTMâ€) announces the repurchase (by a broker acting for the Company) on the regulated market of Euronext Paris  in the period between Nov 28  2022 to Dec 02  2022 (the â€œPeriodâ€)  of 108 169 ordinary shares (equal to 0.01% of its issued share capital) at the weighted average purchase price per share of EUR 36.5237 and for an overall price of EUR 3 950 731.28.The purpose of these transactions under article 5(2) of Regulation (EU) 596/2014 (the Market Abuse Regulation) was to meet obligations arising from share option programmes  or other allocations of shares  to employees or to members of the administrative  management or supervisory bodies of the issuer or of an associate company.The shares may be held in treasury prior to being used for such purpose and  to the extent that they are not ultimately needed for such purpose  they may be used for any other lawful purpose under article 5(2) of the Market Abuse Regulation.Below is a summary of the repurchase transactions made in the course of the Period in relation to the ordinary shares of STM (ISIN: NL0000226223)  in detailed form.Transactions in PeriodDates of transaction Number of shares purchased Weighted average purchase price per share (EUR) Total amount paid (EUR) Market on which the shares were bought (MIC code) 28/11/2022 21 888 36.5766 800 588.62 XPAR 29/11/2022 22 056 36.0945 796 100.29 XPAR 30/11/2022 22 107 35.9466 794 671.49 XPAR 01/12/2022 21 135 37.2471 787 217.46 XPAR 02/12/2022 20 983 36.7990 772 153.42 XPAR Total for Period 108 169 36.5237 3 950 731.28Following the share buybacks detailed above  the Company holds in total 7 098 346 treasury shares  which represents approximately 0.8% of the Companyâ€™s issued share capital.Story continuesIn accordance with Article 5(1)(b) of the Market Abuse Regulation and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052  a full breakdown of the individual trades in the Program are disclosed on the ST website (https://investors.st.com/stock-and-bond-information/share-buyback).About STMicroelectronicsAt ST  we are 48 000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities. An integrated device manufacturer  we work with more than 200 000 customers and thousands of partners to design and build products  solutions  and ecosystems that address their challenges and opportunities  and the need to support a more sustainable world. Our technologies enable smarter mobility  more efficient power and energy management  and the wide-scale deployment of the Internet of Things and connectivity. ST is committed to becoming carbon neutral by 2027. Further information can be found at www.st.com.For further information  please contact:INVESTOR RELATIONS:CÃ©line BerthierGroup VP  Investor RelationsTel: +41.22.929.58.12celine.berthier@st.comMEDIA RELATIONS:Alexis BretonCorporate External CommunicationsTel: + 33.6.59.16.79.08alexis.breton@st.comAttachment,neutral,0.0,1.0,0.0,negative,0.0,0.34,0.65,True,English,"['Common Share Repurchase Program', 'STMicroelectronics', 'Status', 'CÃ©line Berthier Group VP', 'Common Share Repurchase Program', 'art manufacturing facilities', 'integrated device manufacturer', 'Corporate External Communications', 'global semiconductor leader', 'average purchase price', 'semiconductor supply chain', 'Commission Delegated Regulation', 'share option programmes', 'STMicroelectronics N.V.', 'Market Abuse Regulation', 'other lawful purpose', 'overall price', 'other allocations', 'regulated market', 'share capital', 'share buybacks', 'semiconductor technologies', 'electronics applications', 'full details', 'press release', 'shareholder resolution', 'supervisory board', 'trade register', 'Euronext Paris', 'administrative, management', 'supervisory bodies', 'repurchase transactions', 'detailed form', 'MIC code', 'full breakdown', 'individual trades', 'sustainable world', 'smarter mobility', 'efficient power', 'energy management', 'wide-scale deployment', 'INVESTOR RELATIONS', 'MEDIA RELATIONS', 'Total amount', 'Own Shares', '108,169 ordinary shares', 'ST website', 'investors.st', 'Alexis Breton', 'Further information', 'associate company', 'Period Dates', '7,098,346 treasury shares', 'XPAR Total', 'Status', 'Disclosure', 'Nov', 'Dec', 'AMSTERDAM', 'customers', 'spectrum', 'number', 'Ticker', 'broker', 'article', 'obligations', 'employees', 'members', 'issuer', 'extent', 'summary', 'course', 'ISIN', 'Story', 'accordance', 'bond', '48,000 creators', 'makers', 'state', 'thousands', 'partners', 'products', 'solutions', 'ecosystems', 'challenges', 'opportunities', 'need', 'Internet', 'Things', 'connectivity', 'Tel', 'Attachment']",2022-12-05,2022-12-06,finance.yahoo.com
14211,EuroNext,NewsApi.org,https://finance.yahoo.com/news/share-repurchase-program-kbc-ancora-164000470.html,Update on share repurchase program KBC Ancora until 02 December 2022,Regulated information  inside information  Leuven  05 December 2022 (17:40 CET) Update on share repurchase program KBC Ancora until 02 December 2022 As part ...,KBC AncoraRegulated information  inside information  Leuven  05 December 2022 (17:40 CET)Update on share repurchase program KBC Ancora until 02 December 2022As part of the EUR 50 million share repurchase program  as confirmed on 20 May 2022  KBC Ancora has announced that it bought back a total of 27 755 shares in the period from 28 November 2022 to 02 December 2022.The following transactions were carried out during the period in question:Transaction date Number of shares Average price (EUR) Lowest price (EUR) Highest price (EUR) Total amount (EUR) Mon 28 November 2022 6 005 39.16 38.92 39.52 235 181.02 Tue 29 November 2022 5 000 39.19 38.68 39.42 195 937.50 Wed 30 November 2022 5 500 39.44 39.20 39.64 216 938.70 Thu 1 December 2022 7 000 39.48 39.10 39.82 276 383.10 Fri 2 December 2022 4 250 40.26 39.22 40.88 171 121.58 TOTAL(period concerned) 27 755 39.47 38.68 40.88 1 095 561.90 TOTAL (overall repurchase program) 838 993 35.19 31.68 40.88 29 524 579.51All transactions were carried out in the central order book of Euronext Brussels.Since the start of the share repurchase program on 10 June 2022  KBC Ancora has bought back 838 993 of its own shares  or 1.07% of the total number of shares issued (i.e. 78 301 314)  for an average price of 35.19 euros per share and for a total amount of 29 524 580 euros. KBC Ancora has currently implemented 59.05% of the repurchase program.The repurchase program runs within the limits of the share repurchase authorization granted by the Extraordinary General Meeting of Shareholders on 30 October 2020.---------------------------------KBC Ancora is a listed company that holds 18.6% of the shares in KBC Group. Together with Cera  MRBB and the Other Permanent Shareholders  it ensures shareholder stability and the ongoing development of the KBC Group. As core shareholders of KBC Group  they have concluded a shareholdersâ€™ agreement to this end.Financial calendar:27 January 2023 Interim financial report (1H)1 September 2023 Annual press release for the financial year 2022/202327 October 2023 Annual General Meeting of ShareholdersStory continuesThis press release is available in Dutch  French and English on the website www.kbcancora.be.KBC Ancora Investor Relations & Press contact: Jan BergmansTel. +32 (0)16 27 96 72email: jan.bergmans@kbcancora.be or mailbox@kbcancora.beAttachment,neutral,0.01,0.99,0.0,neutral,0.01,0.97,0.02,True,English,"['share repurchase program', 'KBC Ancora', 'Update', '02 December', 'EUR 50 million share repurchase program', 'KBC Ancora Investor Relations', 'central order book', 'Extraordinary General Meeting', 'Annual General Meeting', 'share repurchase authorization', 'Interim financial report', 'Annual press release', 'Other Permanent Shareholders', 'Financial calendar', 'financial year', 'Press contact', 'KBC Group', 'Transaction date', 'Average price', 'Lowest price', 'Highest price', 'Euronext Brussels', 'listed company', 'shareholder stability', 'ongoing development', 'core shareholders', 'shareholdersâ€™ agreement', 'Total amount', 'Regulated information', 'following transactions', 'total number', 'Jan Bergmans', 'Leuven', '05 December', 'Update', '02 December', 'part', '20 May', '27,755 shares', 'period', '28 November', 'question', 'Mon', 'Wed', '30 November', 'start', '10 June', '35.19 euros', '29,524,580 euros', 'limits', '30 October', 'Cera', 'MRBB', '27 January', '1 September', '27 October', 'Story', 'Dutch', 'French', 'English', 'website', 'Tel.', 'email', 'kbcancora', 'Attachment']",2022-12-05,2022-12-06,finance.yahoo.com
14212,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221205005515/en/Eurofins-Launches-BQ.1-and-BQ.1.1-Droplet-Digital-PCR-Assay-ddPCR-for-SARS-CoV-2-Wastewater-Testing,Eurofins Launches BQ.1 and BQ.1.1 Droplet Digital PCR Assay (ddPCR) for SARS-CoV-2 Wastewater Testing,WEST SACRAMENTO  Calif.--(BUSINESS WIRE)--Eurofins Environment Testing Northern California: Wastewater (EWW) and Eurofins Pandemic Prevention Services (EPPS) today launched a droplet digital PCR (ddPCR) assay for the combined quantitative analysis of SARS-CoVâ€¦,WEST SACRAMENTO  Calif.--(BUSINESS WIRE)--Eurofins Environment Testing Northern California: Wastewater (EWW) and Eurofins Pandemic Prevention Services (EPPS) today launched a droplet digital PCR (ddPCR) assay for the combined quantitative analysis of SARS-CoV-2 Variants of Concern (VoC) BQ.1 and BQ.1.1 in wastewater. This expansion of EWW and EPPSâ€™ comprehensive SARS-CoV-2 wastewater monitoring platform follows a strategic initiative to continuously monitor novel VoC showing significant incidence within the United States. Omicron subvariants BQ.1 and BQ.1.1 currently comprise >35% of the SARS-CoV-2 virus variant distribution in the US and are increasing at rates that supersede all other current SARS-CoV-2 variants. The World Health Organization has stated that while there is currently no data on severity or immune escape in human studies  BQ.1 shows a significant growth advantage over other circulating Omicron variants and thus warrants monitoring.Empowering community leaders and stakeholders to make evidence-based decisions is central to the Eurofins networkâ€™s wastewater surveillance offering - accomplished through robust scientific techniques  complete project development/support  and access to teams of established industry experts in wastewater epidemiology.Optimized management of personnel and resources is essential to mitigating the effects of public health issues and protecting community welfare. Governments  public institutions  and businesses have leveraged wastewater monitoring to protect the populations they serve  and Eurofins companies continue to offer technical expertise and support to ensure their strategies and mitigation efforts remain effective.Key FeaturesAdaptable and scalable wastewater monitoring platform for total SARS-CoV-2 and currently circulating VoC.Complete project development services and ongoing professional support from the global Eurofins network of established wastewater monitoring professionals.ddPCR platform provides analytical sensitivity unobtainable through other biological monitoring methods.72-hour data turnaround time provides a near real-time source of community health information.EPPSâ€™ ddPCR wastewater monitoring platform and project design services are available immediately.ENDSAbout Eurofinsâ€“ the global leader in bio-analysisEurofins is Testing for Life. With 61 000 staff across a network of 940 laboratories in 59 countries  Eurofinsâ€™ companies offer a portfolio of over 200 000 analytical methods.Eurofins Shares are listed on Euronext Paris Stock Exchange.,neutral,0.0,1.0,0.0,positive,0.72,0.27,0.01,True,English,"['BQ.1.1 Droplet Digital PCR Assay', 'SARS-CoV-2 Wastewater Testing', 'Eurofins', 'ddPCR', 'EPPSâ€™ comprehensive SARS-CoV-2 wastewater monitoring platform', 'Euronext Paris Stock Exchange', 'SARS-CoV-2 virus variant distribution', 'The World Health Organization', 'other current SARS-CoV-2 variants', 'Complete project development services', '72-hour data turnaround time', 'other circulating Omicron variants', 'other biological monitoring methods', 'Eurofins Pandemic Prevention Services', 'scalable wastewater monitoring platform', 'project design services', 'complete project development/support', 'wastewater monitoring professionals', 'droplet digital PCR', 'combined quantitative analysis', 'robust scientific techniques', 'public health issues', 'wastewater surveillance offering', 'community health information', 'significant growth advantage', 'Eurofins Environment Testing', 'ongoing professional support', 'global Eurofins network', 'ddPCR platform', 'total SARS-CoV-2', 'Omicron subvariants', '200,000 analytical methods', 'wastewater epidemiology', 'significant incidence', 'public institutions', 'global leader', 'community leaders', 'community welfare', 'Eurofins companies', 'Eurofinsâ€™ companies', 'Eurofins Shares', 'WEST SACRAMENTO', 'BUSINESS WIRE', 'Northern California', 'ddPCR) assay', 'strategic initiative', 'United States', 'immune escape', 'human studies', 'evidence-based decisions', 'industry experts', 'Optimized management', 'technical expertise', 'mitigation efforts', 'Key Features', 'analytical sensitivity', 'real-time source', 'novel VoC', 'VoC.', 'Calif.', 'EWW', 'Concern', 'BQ.1', 'expansion', 'rates', 'severity', 'stakeholders', 'access', 'teams', 'personnel', 'resources', 'effects', 'Governments', 'businesses', 'populations', 'strategies', 'Adaptable', 'near', 'ENDS', 'bio-analysis', 'Life', '61,000 staff', '940 laboratories', '59 countries', 'portfolio']",2022-12-05,2022-12-06,businesswire.com
14213,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567054/0/en/Upward-adjustment-of-expectations-for-2022.html,Upward adjustment of expectations for 2022,Nasdaq CopenhagenLondon Stock ExchangeÂ Â Â Â Â Â Â Â Euronext DublinOther stakeholders  Date 5 December 2022  Upward adjustment of expectations for 2022 ......,English DanishNasdaq CopenhagenLondon Stock ExchangeEuronext DublinOther stakeholdersDate 5 December 2022Upward adjustment of expectations for 2022RingkjÃ¸bing Landbobank is upwardly adjusting its expectations for core earnings and profit before tax for 2022.The expectations for core earnings are upwardly adjusted from the DKK 1 600-1 850 million range to the DKK 1 850-2 000 million range and the expectations for profit before tax are upwardly adjusted from the DKK 1 550-1 800 million range to the DKK 1 700-1 950 million range.The upward adjustment is primarily a result of:A continued good level of activityThe value of the higher interest rate level and the growth in lending in the first three quarters of the yearContinued good credit quality and a loss level that has remained on a very satisfactory levelThe annual report for 2022 will be published on 1 February 2023  as previously announced.Yours sincerelyRingkjÃ¸bing LandbobankJohn FiskerCEOAttachment,positive,0.69,0.29,0.01,positive,0.96,0.04,0.0,True,English,"['Upward adjustment', 'expectations', '2022', 'DKK 1,600-1,850 million range', 'DKK 1,850-2,000 million range', 'DKK 1,550-1,800 million range', 'DKK 1,700-1,950 million range', 'John Fisker CEO Attachment', 'higher interest rate level', 'London Stock Exchange', 'Other stakeholders Date', 'RingkjÃ¸bing Landbobank', 'first three quarters', 'good credit quality', 'good level', 'loss level', 'satisfactory level', 'English Danish', 'Nasdaq Copenhagen', 'Euronext Dublin', 'Upward adjustment', 'core earnings', 'annual report', 'December', 'expectations', 'profit', 'tax', 'result', 'activity', 'value', 'growth', 'lending', 'year', '1 February', '2022']",2022-12-05,2022-12-06,globenewswire.com
14214,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567453/0/en/GOVERNOR-ELECT-HOBBS-TO-VISIT-ASM-IN-PHOENIX.html,GOVERNOR-ELECT HOBBS TO VISIT ASM IN PHOENIX,Phoenix  The U.S.December 5  2022      ASM International N.V. (Euronext Amsterdam: ASM) announces that Arizonaâ€™s Governor-elect Katie Hobbs will visit......,"Phoenix  The U.S.December 5  2022ASM International N.V. (Euronext Amsterdam: ASM) announces that Arizonaâ€™s Governor-elect Katie Hobbs will visit today the ASM facility in Phoenix.Today  Governor-elect Hobbs will meet with ASM  a leading global supplier of semiconductor equipment founded in the Netherlands in 1968. Governor-elect Hobbs will tour ASM Americaâ€™s headquarters in Phoenix. The Phoenix facility houses an R&D center for the company that is key to ASMâ€™s leading ALD (atomic layer deposition) and epitaxy technologies. ASM America was established in 1976.â€œArizona is a global leader in the semiconductor industry thanks to companies like ASM  which play a pivotal role in our state's rich and diverse semiconductor ecosystem "" Governor-elect Katie Hobbs said. ""I am proud to tour ASM's US operations and see firsthand how they are helping shape the world's future  right here in Arizona.""Benjamin Loh  CEO of ASM  said: â€œASM has an incredibly talented team working unabatedly and around the globe to engineer the technological breakthroughs of tomorrow. We are thrilled to welcome Governor-elect Katie Hobbs to our Phoenix facility. This visit provides an excellent opportunity to showcase the leading role ASM plays in the semiconductor industry.â€For more than 50 years  ASM has been driving innovation  supporting the worldâ€™s top semiconductor manufacturers with their relentless push for more powerful and power-efficient semiconductors. With hubs in 14 countries  ASM employs more than 4 000 people globally. Phoenix represents ASMâ€™s largest technology development site worldwide  employing over 750 colleagues.â€œFor decades  ASMâ€™s growth in Phoenix has been  and continues to be  pivotal to our global success â€ said Hichem Mâ€™Saad  Chief Technology Officer  ASM. â€œOur company  and especially our Phoenix team  are elated to see the Silicon Desert taking center stage in the semiconductor industry. We are committed to serving our customers as they expand with their new fab projects  in Arizona and around the world.â€About ASM InternationalASM International N.V.  headquartered in Almere  the Netherlands  and its subsidiaries design and manufacture equipment and process solutions to produce semiconductor devices for wafer processing  and have facilities in the United States  Europe  and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol ASM). For more information  visit ASM's website at www.asm.comCautionary Note Regarding Forward-Looking Statements: All matters discussed in this press release  except for any historical data  are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include  but are not limited to  economic conditions and trends in the semiconductor industry generally and the timing of the industry cycles specifically  currency fluctuations  corporate transactions  financing and liquidity matters  the success of restructurings  the timing of significant orders  market acceptance of new products  competitive factors  litigation involving intellectual property  shareholders or other issues  commercial and economic disruption due to natural disasters  terrorist activity  armed conflict or political instability  changes in import/export regulations  epidemics and other risks indicated in the Company's reports and financial statements. The Company assumes no obligation nor intends to update or revise any forward-looking statements to reflect future developments or circumstances.CONTACTInvestor and media contact:Victor BareÃ±oT: +31 88 100 8500E: investor.relations@asm.comFor images of Governor-Elect Hobbs's visit to ASM:Alyx CimaT: +1 619 961 7957",neutral,0.05,0.95,0.0,mixed,0.76,0.07,0.17,True,English,"['GOVERNOR-ELECT HOBBS', 'ASM', 'PHOENIX', 'largest technology development site', 'Victor BareÃ±o T', 'Euronext Amsterdam Stock Exchange', 'ASM International N.V.', 'Chief Technology Officer', 'common stock trades', 'Alyx Cima T', 'atomic layer deposition', 'Hichem Mâ€™Saad', 'The U.S.', 'R&D center', 'new fab projects', 'diverse semiconductor ecosystem', 'top semiconductor manufacturers', 'Governor-elect Katie Hobbs', 'leading global supplier', 'The Phoenix facility', 'Governor-elect Hobbs', 'center stage', 'new products', 'leading ALD', 'global leader', 'leading role', 'semiconductor industry', 'semiconductor devices', 'epitaxy technologies', 'pivotal role', 'US operations', 'Benjamin Loh', 'talented team', 'technological breakthroughs', 'excellent opportunity', 'relentless push', 'power-efficient semiconductors', 'Silicon Desert', 'process solutions', 'wafer processing', 'United States', 'Cautionary Note', 'Forward-Looking Statements', 'press release', 'historical data', 'actual results', 'economic conditions', 'industry cycles', 'currency fluctuations', 'corporate transactions', 'significant orders', 'market acceptance', 'competitive factors', 'intellectual property', 'other issues', 'economic disruption', 'natural disasters', 'terrorist activity', 'armed conflict', 'political instability', 'import/export regulations', 'financial statements', 'The Company', 'global success', 'ASM facility', 'semiconductor equipment', 'Phoenix team', 'liquidity matters', 'other risks', 'future developments', 'media contact', 'ASM America', 'December', 'Arizona', 'Netherlands', 'headquarters', 'companies', 'rich', 'world', 'CEO', 'globe', 'tomorrow', 'visit', '50 years', 'innovation', 'powerful', 'hubs', '14 countries', '4,000 people', '750 colleagues', 'decades', 'growth', 'customers', 'Almere', 'subsidiaries', 'facilities', 'Europe', 'Asia', 'symbol', 'information', 'website', 'uncertainties', 'trends', 'timing', 'financing', 'restructurings', 'litigation', 'shareholders', 'commercial', 'changes', 'epidemics', 'reports', 'obligation', 'circumstances', 'Investor', 'images']",2022-12-05,2022-12-06,globenewswire.com
14215,EuroNext,NewsApi.org,https://finance.yahoo.com/news/press-release-biocartis-group-nv-164000168.html,Press release Biocartis Group NV: Mandatory Conversion Bondholder Notification,PRESS RELEASE: REGULATED INFORMATION5 December 2022  17:40 CET Mandatory Conversion Bondholder Notification Capitalised terms not otherwise defined in this...,"Biocartis NVPRESS RELEASE: REGULATED INFORMATION5 December 2022  17:40 CETMandatory Conversion Bondholder NotificationCapitalised terms not otherwise defined in this notice shall have the meaning given to them in the Terms and Conditions of the Bonds.Mechelen  Belgium  5 December 2022 â€“ This announcement constitutes a notice (the â€œMandatory Conversion Bondholder Notificationâ€) in accordance with  respectively  Condition 5(m)(v) of the terms and conditions of the 4.00% convertible bonds due 2024/2027 (the ""Existing Convertible Bonds"") (ISIN BE0002651322) and Condition 6(b)(v) of the terms and conditions of the 4.50% new second lien secured convertible bonds due 2024/2026 (the ""New Convertible Bonds"") (together  the ""Terms and Conditions of the Bonds"") (ISIN BE6338582206) issued by Biocartis Group NV (the ""Company"" or ""Biocartis"")  an innovative molecular diagnostics company (Euronext Brussels: BCART).The Company today announces  that the Recapitalisation Transactions (as such term is defined in the Terms and Conditions of the Bonds) have completed on Friday  2 December 2022 (the â€œRecapitalisation Transactions Completion Dateâ€).In accordance with the Terms and Conditions of the Bonds  the occurrence of the Recapitalisation Transactions Completion Date results in a number of consequences for the holders of the Existing Convertible Bonds and/or the New Convertible Bonds  including (but not limited to):the automatic extension of the Final Maturity Dates of such Bonds to 9 November 2026 (in the case of the New Convertible Bonds) and 9 November 2027 (in the case of the Existing Convertible Bonds);the start of the Bondholder Conversion Option Period for the New Convertible Bonds from the Mandatory Conversion Date (as defined in the terms and conditions of the New Convertible Bonds) of Friday  16 December 2022. In accordance with Condition 6(b)(v) of the terms and conditions of the New Convertible Bonds  the Company informs the Bondholders that the lowest price per Share at which Shares were sold to investors in the Required Topco Equity Offering was EUR 0.75 per Share. Accordingly  the initial ""Bondholder Conversion Option Conversion Price"" (as defined in the terms and conditions of the New Convertible Bonds) is EUR 1.125 per Share; andthe Mandatory Conversion of 10% of the principal amount outstanding under each of the Existing Convertible Bonds and the New Convertible Bonds. For the Mandatory Conversion of the Existing Convertible Bonds the Conversion Price in effect on the Conversion Date is EUR 12.8913 per Share; the Mandatory Conversion Price for the New Convertible Bonds is EUR 12.8913 per Share as well.Story continuesThe aforementioned Mandatory Conversion will occur 10 Brussels business days after the Recapitalisation Transactions Completion Date. Accordingly  the Mandatory Conversion Date (in the case of the New Convertible Bonds) and the Conversion Date (in the case of the Existing Convertible Bonds) (both as defined in the Terms and Conditions of the Bonds) is Friday  16 December 2022.In accordance with the Terms and Conditions of the Bonds  the Bondholders are required to complete the following formalities in order to obtain delivery of the shares issued pursuant to the aforementioned Mandatory Conversion:a duly completed and signed Mandatory Conversion Investor Notice needs to be provided by the Bondholder to the Agent (copying such other persons as indicated in the form of the Mandatory Conversion Investor Notice) by 17:00 CET on the Cut-Off Date on Friday  9 December 2022 . In order to complete the Mandatory Conversion Investor Notice  a Bondholder may need to contact the financial institution at which the Bonds are held to its order  for assistance in providing the required securities and bank account details; andthe Bondholder must request the financial institution at which the Bonds are held to its order to provide the Agent with proof that the Bonds   as specified in the submitted Mandatory Conversion Investor Notice  are held to its order or under its control and blocked by it . This proof must either be a certificate of blocking from the financial institution at which the Bonds are held  or a proof by the recognized account holder of the NBB-SSS Clearing System at which the Bonds are held  delivered by swift messaging directly to the Agent. Such proof must reach the Agent at the latest by 17:00 CET on Monday  12 December 2022.A copy of the current form of the ""Mandatory Conversion Investor Notice"" can be obtained from the Agent (via its specified office or via regulations@belfius.be) or directly from the Company (via rdegrave@biocartis.com).Failure to comply with the formalities by the applicable deadlines will result in the relevant shares being sold by the Share Settlement Agent and the proceeds (if any  after deducting a.o. the costs of such procedure) being distributed rateably to the relevant Bondholders. In view thereof  the Company encourages the Bondholders that have not yet been in contact with the Company in the context of the Recapitalisation Transactions to contact the Company urgently.The Terms and Conditions of the Bonds can be consulted  subject to applicable legal restrictions  on https://investors.biocartis.com/en/convertible-bonds .--- END ---More information:Renate DegraveHead of Corporate Communications & Investor Relations Biocartise-mail rdegrave@biocartis.comtel +32 15 631 729mobile +32 471 53 60 64About BiocartisWith its revolutionary and proprietary Idyllaâ„¢ platform  Biocartis (Euronext Brussels: BCART) aspires to enable personalized medicine for patients around the world through universal access to molecular testing  by making molecular testing actionable  convenient  fast and suitable for any lab. The Idyllaâ„¢ platform is a fully automated sample-to-result  real-time PCR (Polymerase Chain Reaction) based system designed to offer in-house access to accurate molecular information in a minimum amount of time for faster  informed treatment decisions. Idyllaâ„¢'s continuously expanding menu of molecular diagnostic tests address key unmet clinical needs  with a focus in oncology. This is the fastest growing segment of the molecular diagnostics market worldwide. Today  Biocartis offers tests supporting melanoma  colorectal  lung and liver cancer  as well as for COVID-19  Flu  RSV and sepsis. For more information  visit www.biocartis.com or follow Biocartis on Twitter @Biocartis_   Facebook or LinkedIn.Biocartis and Idyllaâ„¢ are registered trademarks in Europe  the United States and other countries. The Biocartis and Idyllaâ„¢ trademark and logo are used trademarks owned by Biocartis. Please refer to the product labeling for applicable intended uses for each individual Biocartis product.This press release is not for distribution  directly or indirectly  in any jurisdiction where to do so would be unlawful. Any persons reading this press release should inform themselves of and observe any such restrictions. Biocartis takes no responsibility for any violation of any such restrictions by any person. This press release does not constitute an offer or invitation for the sale or purchase of securities in any jurisdiction. No securities of Biocartis may be offered or sold in the United States of America absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933  as amended.Important informationThis announcement is not a prospectus for the purposes of Regulation 2017/1129  as amended (together with any applicable implementing measures in any Member State of the European Economic Area  the â€œProspectus Regulationâ€) or the Prospectus Regulation as it forms part of UK domestic law by virtue of the UK European Union (Withdrawal) Act 2018 and as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019 (each as amended) (the ""UK Prospectus Regulation"").THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION  DIRECTLY OR INDIRECTLY  IN THE UNITED STATES OF AMERICA  AUSTRALIA  CANADA  JAPAN  SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW.THIS ANNOUNCEMENT IS FOR GENERAL INFORMATION ONLY AND DOES NOT FORM PART OF ANY OFFER TO SELL OR PURCHASE  OR THE SOLICITATION OF ANY OFFER TO SELL OR PURCHASE  ANY NEW BONDS  OUTSTANDING BONDS OR OTHER SECURITIES. THE DISTRIBUTION OF THIS ANNOUNCEMENT AND THE OFFER  SALE AND PURCHASE OF THE NEW BONDS  NEW TERM LOANS OR THE OUTSTANDING BONDS DESCRIBED IN THIS ANNOUNCEMENT IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAW. ANY PERSONS READING THIS ANNOUNCEMENT SHOULD INFORM THEMSELVES OF AND OBSERVE ANY SUCH RESTRICTIONS.There shall be no offer  solicitation  sale or purchase or exchange of the Existing Convertible Bonds or the New Convertible Bonds in any jurisdiction in which such offer  solicitation  sale  or purchase would be unlawful prior to registration  exemption from registration or qualification under the securities laws of any such jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933  as amended from time to time (the ""U.S. Securities Act"") or the securities laws of any state of the United States  and may not be offered or sold in the United States unless these securities are registered under the U.S. Securities Act  or an exemption from the registration requirements of the U.S. Securities Act is available.Biocartis has not registered  and does not intend to register  any portion of the offering of the securities concerned in the United States  and does not intend to conduct a public offering of securities in the United States. This communication is only addressed to and directed at persons in member states of the European Economic Area (each a ""Member States"") and in the United Kingdom who are ""qualified investors"" within the meaning of Article 2(e) of the Prospectus Regulation and of the UK Prospectus Regulation  respectively (""Qualified Investors""). This communication is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the ""Order"") or (iii) high net worth companies  and other persons to whom it may lawfully be communicated  falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as ""relevant persons""). The securities referred to herein are only available to  and any invitation  offer or agreement to subscribe  purchase or otherwise acquire such securities will be engaged in only with  relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. This announcement cannot be used as a basis for any investment agreement or decision. Biocartis is not liable if the aforementioned restrictions are not complied with by any person.",neutral,0.0,1.0,0.0,mixed,0.27,0.17,0.56,True,English,"['Mandatory Conversion Bondholder Notification', 'Biocartis Group NV', 'Press release', '4.50% new second lien secured convertible bonds', 'Bondholder Conversion Option Conversion Price', 'Bondholder Conversion Option Period', 'Recapitalisation Transactions Completion Date', 'Mandatory Conversion Investor Notice', 'innovative molecular diagnostics company', 'Mandatory Conversion Bondholder Notification', 'Mandatory Conversion Date', 'Mandatory Conversion Price', 'Final Maturity Dates', 'Topco Equity Offering', 'NBB-SSS Clearing System', 'bank account details', 'New Convertible Bonds', 'Existing Convertible Bonds', 'Biocartis Group NV', 'Share Settlement Agent', 'lowest price', 'Cut-Off Date', '4.00% convertible bonds', 'Biocartis NV', 'account holder', 'PRESS RELEASE', 'REGULATED INFORMATION', 'Euronext Brussels', 'automatic extension', 'principal amount', 'Brussels business', 'other persons', 'financial institution', 'swift messaging', 'applicable deadlines', 'The Company', 'following formalities', 'current form', 'relevant shares', 'Such proof', 'relevant Bondholders', 'Capitalised terms', '5 December', 'CET', 'meaning', 'Conditions', 'Mechelen', 'Belgium', 'announcement', 'accordance', 'ISIN', 'BCART', 'Friday', '2 December', 'number', 'consequences', '9 November', 'case', 'start', 'investors', 'effect', 'Story', 'order', 'delivery', '9 December', 'assistance', 'required', 'securities', 'control', 'certificate', 'blocking', 'Monday', 'copy', 'office', 'regulations', 'rdegrave', 'Failure', 'proceeds', 'costs', 'procedure', 'view', 'contact', 'context']",2022-12-05,2022-12-06,finance.yahoo.com
14216,EuroNext,NewsApi.org,https://finance.yahoo.com/news/bghl-eur-nav-063000954.html,BGHL (EUR): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for...,"BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 02 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5420 Â£ 24.1925 Estimated MTD return 0.06 % 0.09 % Estimated YTD return -5.68 % -4.40 % Estimated ITD return 175.42 % 141.92 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.40 N/A Premium/discount to estimated NAV -18.67 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.33 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 240.7411 Class GBP A Shares (estimated) Â£ 129.0392The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.Story continuesFor further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,mixed,0.07,0.22,0.71,True,English,"['BGHL', 'EUR', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'A N/A Average Price', 'London Stock Exchange plc', 'N/A Sterling Shares Amsterdam', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Euro Shares Amsterdam', 'Sterling Shares Shares', 'US Investment Company Act', 'A N/A Range', 'GAVAUDAN HOLDING LIMITED', 'expert financial advice', 'Guernsey Policy Council', 'collective investment scheme', 'other professional advice', 'BG Fund ICAV', 'closed-ended investment company', 'UK Listing Authority', 'US Securities Act', 'Gavaudan Investment Management', 'A Shares', 'investment manager fees', 'BG Fund NAV', 'The Shares', 'A Premium/discount', 'Dutch Authority', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Emmanuel Gavaudan', 'Financial Markets', 'The Directors', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'United States', 'following information', 'information purposes', 'necessary approval', 'main market', 'future results', 'listed securities', 'Market information', 'BOUSSARD', 'business', 'returns', 'AEX', 'LSE', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'Story', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-05,2022-12-06,finance.yahoo.com
14217,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567024/0/en/Valneva-Reports-Positive-12-Month-Antibody-Persistence-Data-for-Single-Shot-Chikungunya-Vaccine-Candidate.html,Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate,Saint-Herblain (France)  December 5  2022 â€“ Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  a specialty vaccine company  today reported positive antibody persistence data twelve months after vaccination with a single dose of its chikungunya vaccine candidate â€¦,"English FrenchPrimary endpoint met with 99% seroresponse rate 12 months after single-dose vaccinationAntibody levels remained stable from month 6 to month 12No safety concern identified during follow-up  confirming the safety profile observed in earlier studiesValneva currently on track to complete rolling submission for Biologics License Application (BLA) with U.S. Food and Drug Administration (FDA) by end of 2022Saint-Herblain (France)  December 5  2022 â€“ Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  a specialty vaccine company  today reported positive antibody persistence data twelve months after vaccination with a single dose of its chikungunya vaccine candidate  VLA1553.Following positive immunogenicity and safety data for Phase 3 study VLA1553-301 in March 20221  Valneva set up a dedicated antibody persistence trial (VLA1553-303) to monitor a subset of participants for a period of at least five years and confirm the anticipated long-term durability of the antibody response after a single vaccination.The antibody persistence trial enrolled 363 healthy adult participants and followed them from month 6 after vaccination to month 12. 99% of participants retained neutralizing antibody titers above the seroresponse threshold of 1502 12 months after the single-dose vaccination. These antibody levels confirm the antibody persistence profile observed in an earlier study3. The antibody persistence was similar in older adults aged â‰¥65 years  who retained neutralizing antibody titers comparable to younger adults throughout the follow-up. These results follow completion of the pivotal study VLA1553-301  for which a seroresponse rate of 96% six months after vaccination1 was reported. The study will continue to monitor antibody persistence on an annual basis.No safety concerns were identified for the duration of the follow-up study  confirming the safety profile observed in previous studies.Juan Carlos Jaramillo M.D.  Chief Medical Officer of Valneva  said  â€œWe are excited about these twelve-month data which are in line with what we saw from our previous read out at month 6  and strengthen the possibilities of inducing a long-lasting antibody response with our chikungunya vaccine candidate. We are looking forward to completing the BLA rolling submission to the FDA and potentially to changing peopleâ€™s lives. If our investigational vaccine is approved  we are confident that it can help address this major  growing and unmet public health threat.â€Valneva expects to finalize its BLA submission with the FDA by the end of 2022. Once completed  and if the FDA accepts the filing  the FDA will determine priority review eligibility along with the action due date upon which it will complete its evaluation. The program received FDA Fast Track and Breakthrough Therapy designations in 2018 and 2021  respectively. VLA1553 was also granted PRIority MEdicine (PRIME) designation by the EMA in 2020. Valneva currently plans to make additional regulatory submissions for VLA1553 in 2023. Valneva also initiated a Phase 3 trial in adolescents conducted in Brazil by Instituto Butantan to support the label extension in this age group following a potential initial regulatory approval.About ChikungunyaChikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV)  a Togaviridae virus  transmitted by Aedes mosquitoes. Chikungunya virus often causes sudden large outbreaks with high attack rates  affecting one-third to three-quarters of the population in areas where the virus is circulating. There are no preventive vaccines or effective treatments available and  as such  chikungunya is considered to be a major public health threat. As of September 2020  there were more than 3 million reported cases in the Americas4 and the economic impact is considered to be significant. The medical and economic burden is expected to grow as the CHIKV primary mosquito vectors continue to spread geographically. Infection leads to symptomatic disease in up to 97% of humans after three to seven days following the mosquito bite. While mortality with CHIKV is low  morbidity is high. Clinical symptoms include acute onset of fever  debilitating joint and muscle pain  headache  nausea  rash and chronic arthralgia. It is estimated that over three quarters of the worldâ€™s population live in areas at-risk of CHIKV transmission5. High risk areas of infection are places where chikungunya virus-carrying mosquitos are currently endemic  including the Americas  parts of Africa  and Southeast Asia.About VLA1553VLA1553 is a live-attenuated  single dose vaccine candidate targeting the chikungunya virus  which has spread to over 100 countries. It has been designed by deleting a part of the chikungunya virus genome.VLA1553 would expand Valnevaâ€™s existing commercial vaccines portfolio and as such  Valneva intends to commercialize this vaccine  if approved  leveraging its existing manufacturing and commercial operations. The global market for vaccines against chikungunya is estimated to exceed $500 million annually by 20326.To make VLA1553 more accessible to Low and Middle Income Countries (LMIC)  Valneva and Instituto Butantan in Brazil signed an agreement in January 2021 for the development  manufacturing and marketing of VLA15537. The collaboration falls within the framework of the agreement signed between CEPI and Valneva in July 20198  which provides funding of up to $23.4 million with support from the European Unionâ€™s Horizon 2020 program.About Phase 3 trial VLA1553-303VLA1553-303 is a single-arm  open label Phase 3 trial evaluating antibody persistence in 363 participants aged 18 years or above who were immunized with VLA1553 during the pivotal trial VLA1553-301. The primary objective of the trial is to evaluate the persistence of antibodies annually from 1 to 5 years after the single immunization with VLA1553. Study VLA1553-303 collected long-term safety by following-up any Adverse Event of Special Interest (AESI) from the preceding study and collecting new-onset SAE. When participants joined the follow-up study  no AESI was ongoing.Additional information  including a detailed description of the trial design  eligibility criteria and investigator sites  is available at ClinicalTrials.gov (Identifier: NCT04546724).About Valneva SEValneva is a specialty vaccine company focused on the development  production and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. Valneva has leveraged its expertise and capabilities both to commercialize three vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic  including candidates against Lyme disease and the chikungunya virus.Media & Investors ContactsLaÃ«titia Bachelot-FontaineVP Global Communications & European Investor RelationsM +33 (0)6 4516 7099laetitia.bachelot-fontaine@valneva.comJoshua Drumm  PhDVP Global Investor RelationsM +001 917 815 4520joshua.drumm@valneva.comForward-Looking StatementsThis press release contains certain forward-looking statements relating to the business of Valneva  including with respect to the progress  timing  results and completion of research  development  clinical trials  and regulatory review of VLA1553. In addition  even if the actual results or development of Valneva are consistent with the forward-looking statements contained in this press release  those results or developments of Valneva may not be sustained in the future. In some cases  you can identify forward-looking statements by words such as ""could "" ""should "" ""may "" ""expects "" ""anticipates "" ""believes "" ""intends "" ""estimates "" ""aims "" ""targets "" or similar words. These forward-looking statements are based largely on the current expectations of Valneva as of the date of this press release and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results  performance or achievements to be materially different from any future results  performance or achievement expressed or implied by these forward-looking statements. In particular  the expectations of Valneva could be affected by  among other things  uncertainties involved in the development and manufacture of vaccines  unexpected clinical trial results  unexpected regulatory actions or delays  competition in general  currency fluctuations  the impact of the global and European credit crisis  and the ability to obtain or maintain patent or other proprietary intellectual property protection. Success in preclinical studies or earlier clinical trials may not be indicative of results in future clinical trials. In light of these risks and uncertainties  there can be no assurance that the forward-looking statements made during this presentation will in fact be realized. Valneva is providing the information in these materials as of this press release  and disclaim any intention or obligation to publicly update or revise any forward-looking statements  whether as a result of new information  future events  or otherwise.1 Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate - Valneva2 A neutralizing antibody titer of â‰¥150 determined by ÂµPRNT 50   i.e. the antibody level agreed with regulators as endpoint under the accelerated approval pathway.3 Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate  Confirms Plans - Valneva4 PAHO/WHO data: Number of reported cases of chikungunya fever in the Americas. https://www.paho.org/data/index.php/en/mnu-topics/chikv-en/550-chikv-weekly-en.html. Last accessed 13 Oct 2020.5 CDC 2022  Puntasecca CJ 20216 VacZine Analytics Chikungunya virus vaccines Global demand analysis. February 20207 Valneva and Instituto Butantan Sign Final Agreement on Single-Shot Chikungunya Vaccine for Low and Middle Income Countries8 CEPI awards up to $23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccineAttachment",neutral,0.01,0.96,0.03,mixed,0.23,0.1,0.68,True,English,"['Positive 12-Month Antibody Persistence Data', 'Single-Shot Chikungunya Vaccine Candidate', 'Valneva', 'Juan Carlos Jaramillo M.D.', 'attenuated, single dose vaccine candidate', 'unmet public health threat', 'potential initial regulatory approval', 'major public health threat', 'three to seven days', 'dedicated antibody persistence trial', 'existing commercial vaccines portfolio', 'CHIKV primary mosquito vectors', 'positive antibody persistence data', 'additional regulatory submissions', 'one-third to three-quarters', 'Biologics License Application', 'U.S. Food', 'action due date', 'Breakthrough Therapy designations', 'sudden large outbreaks', 'high attack rates', 'specialty vaccine company', 'chikungunya vaccine candidate', 'priority review eligibility', 'mosquito-borne viral disease', 'lasting antibody response', 'Chief Medical Officer', 'chikungunya virus-carrying mosquitos', 'antibody persistence profile', '363 healthy adult participants', 'chikungunya virus genome', 'BLA rolling submission', 'High risk areas', 'earlier studies Valneva', 'FDA Fast Track', 'Primary endpoint', 'positive immunogenicity', 'major, growing', 'Phase 3 trial', 'mosquito bite', 'three quarters', 'existing manufacturing', 'commercial operations', 'investigational vaccine', 'safety data', 'twelve-month data', 'single vaccination', 'Antibody levels', 'antibody titers', 'previous studies', 'PRIority MEdicine', 'symptomatic disease', 'safety profile', 'BLA submission', 'preventive vaccines', 'earlier study', 'English French', '99% seroresponse rate', 'safety concern', 'Drug Administration', 'Euronext Paris', 'long-term durability', 'seroresponse threshold', 'older adults', 'younger adults', 'annual basis', 'previous read', 'PRIME) designation', 'Instituto Butantan', 'label extension', 'age group', 'Togaviridae virus', 'Aedes mosquitoes', 'effective treatments', 'economic impact', 'economic burden', 'Clinical symptoms', 'acute onset', 'debilitating joint', 'muscle pain', 'chronic arthralgia', 'CHIKV transmission', 'Southeast Asia', 'global market', 'Phase 3 study', 'pivotal study', 'single-dose vaccination', 'five years', 'Valneva SE', 'follow-up study', '65 years', 'Saint-Herblain', 'France', 'December', 'VLA', 'March', 'subset', 'period', 'results', 'completion', 'vaccination1', 'duration', 'line', 'possibilities', 'people', 'lives', 'filing', 'evaluation', 'program', 'EMA', 'adolescents', 'Brazil', 'population', 'September', '3 million', 'cases', 'Americas4', 'Infection', 'humans', 'mortality', 'morbidity', 'fever', 'headache', 'nausea', 'rash', 'world', 'places', 'parts', 'Africa', '100 countries']",2022-12-05,2022-12-06,globenewswire.com
14218,EuroNext,NewsApi.org,https://finance.yahoo.com/news/voltalia-announces-success-approximately-490-164500316.html,Voltalia announces the success of its approximately 490 million euros capital increase with preferential subscription rights,The gross final amount of the capital increase (including the issue premium) is 489 990 254.40 euros and results in the issuance of 35 765 712 new sharesThe ...,"VoltaliaThe gross final amount of the capital increase (including the issue premium) is 489 990 254.40 euros and results in the issuance of 35 765 712 new sharesThe capital increase has been the subject of a total demand of 40 280 324 shares  i.e. a subscription rate of 112.62% (including 98.71% on an irreducible basis)Voltalia's market capitalisation is 2 350 million euros on an undiluted basis following the creation of 35 765 712 new shares  based on a closing price of 17.92 euros as of 2 December 2022Following their subscriptions  Voltalia Investissement  Voltaliaâ€™s reference shareholder  holds 71.30% 1 of the share capital of Voltalia and Proparco holds 2.50%The free float  on an undiluted basis  amounts to 573 million euros as of 2 December 2022 compared to 427 million euros on the eve of the capital increase and represents 24.40% of the share capital compared to 23.72% before the capital increaseThe net proceeds of the Capital Increase with PSRs are intended to provide the Company with additional means to finance its target of a consolidated capacity in operation or under construction of at least 5.0 GW by 2027  for which the Company considers that the amount of investment required is between 2.5 and 3 billion euros.Voltalia (the ""Company"") announces today the success of its capital increase in cash with preferential subscription rights (â€œPSRâ€) in a gross amount of approximately 490 million euros (the â€œCapital Increase with PSRsâ€). The Capital Increase with PSRs will result in 35 765 712 new shares being issued (the â€œNew Sharesâ€)  at a subscription price of 13.70 euros per share.â€œI sincerely thank  on behalf of all Voltalia employees  the numerous shareholders who have shown their support by participating in this capital increase and contributing to its success. This strong mobilization motivates us even more to commit ourselves to pursue the mission that drives us on a daily basis to improve the global environment by promoting local development. The funds raised will enable us to accelerate our strategic roadmap with a view to achieve the ambitions we have set ourselves for 2027. Faced with the challenges of climate emergency and energy independence which have become crucial in the context of an unprecedented energy crisis in Europe in particular  Voltalia's teams are responding by providing concrete and realistic solutions to build a more sustainable world. This is the cornerstone to our success. â€ says SÃ©bastien Clerc  CEO of Voltalia.***Reasons for the Capital Increase with PSRsThe issue of the New Shares is intended to provide the Company with additional means to finance its target of a consolidated capacity in operation or under construction of at least 5.0 GW by 2027  for which the Company considers that the amount of investment required is between 2.5 and 3 billion euros. In this respect  the Company plans to allocate at least 450 million euros of the funds raised to the construction of its new production capacity by 2027.The balance of the funds raised will be used to finance (i) the Companyâ€™s growth in services in order to reach its objective of operating and maintaining more than 8 GW of power plants on behalf of third parties and (ii) possible targeted acquisitions  in particular to strengthen the Companyâ€™s presence in its new geographical areas in Africa  Latin America or Europe.Results of the Capital Increase with PSRsThe gross amount of the Capital Increase with PSRs (including the issue premium) is 489 990 254.40 euros and results in the issue of 35 765 712 New Shares at a subscription price of 13.70 euros per New Share (i.e. a nominal value of 5.70 euros and an issue premium of 8.00 euros).Following the subscription period which ended 30 November 2022  total demand amounted to 40 280 324 shares  representing a subscription rate of 112.62%.35 304 924 New Shares have been subscribed on an irreducible basis and represent approximately 98.71% of the New Shares to be issued;Demand on a reducible basis represented 4 975 400 New Shares and will therefore only be partially allocated  460 788 New Shares being allocated according to a coefficient of 0.06254025 calculated on the basis of the number of PSRs underlying subscriptions made on an irreducible basis without it resulting in an allocation of fractions of New Shares and without the allocation of more shares than the number of New Shares requested on a reducible basis.Subscription commitments and subscription intentions of the main shareholders of the Company or members of its administrative or management bodies or anyone intending to subscribe to more than 5% of the New SharesAs of the date of the launch of the Capital Increase with PSRs  the Company had subscription commitments (the ""Subscription Commitments"")  on an irreducible basis  for a total amount of 357 454 262.40 euros  representing approximately 72.95% of the Capital Increase with PSRs  based on a subscription price of 13.70 euros per New Share.Voltalia Investissement   which held on 31 October 2022  71.30% of the capital and 82.77% of the voting rights of the Company  has subscribed directly and indirectly to 25 196 682 New Shares for a total amount of 345 194 543.40 euros.The SociÃ©tÃ© de Promotion et de Participation pour la CoopÃ©ration Economique (â€œProparcoâ€)  which held on 31 October 2022  2.50% of the capital and 1.48% of the voting rights of the Company  has subscribed to 894 870 New Shares for a total amount of 12 259 719 euros.In addition  the corporate officers of the Company mentioned below have each subscribed to the Capital Increase with PSRs: Laurence Mulliez  Chairman of the Board of Directors  for an amount of approximately 57 000 euros  The Green Option  director  for an amount of approximately 100 000 euros and SÃ©bastien Clerc  Chief Executive Officer  for an amount of around 190 000 euros.Impact of the Capital Increase with PSRs on the allocation of the share capitalFollowing the Capital Increase  Voltalia's share capital will amount to 747 503 380.80 euros and will consist of 131 140 944 shares with a nominal value of 5.70 euros each. It will break down as follows:After the Capital Increase with PSRs ShareholdingUndiluted basis Diluted basis(1) Number of shares % of capitall Number of voting rights(2) % voting rights Number of shares % of capitall Number of voting rights(2) % voting rights Voltalia Investissement(3)(4) 93 497 077 71.30 % 159 321 642 80.69 % 93 497 077 66.74 % 159 321 642 77.19 % Proparco 3 281 193 2.50 % 3 281 193 1.66 % 3 281 193 2.34 % 3 281 193 1.59 % EBRD 2 129 501 1.62 % 2 129 501 1.08 % 2 129 501 1.52 % 2 129 501 1.03 % Treasury-shares 239 928 0.18 % 239 928 0.12 % 239 928 0.17 % 239 928 0.12 % Free-float 31 993 245 24.40 % 32 471 559 16.45 % 40 945 539 29.23 % 41 423 853 20.07 % Total 131 140 944 100.00 % 197 443 823 100.00 % 140 093 238 100.00 % 206 396 117 100.00 %(1) In the event of the vesting of all the shares allocated under the free share allocation plans and conversion into shares of the Green OCEANEs based on a 1:1 conversion ratio.(2) A double voting right is attributed to all fully paid-up shares for which there is evidence of registered registration for at least two consecutive years in the name of the same shareholder.(3) As of 31 October 2022  99.39% of Voltalia Investissementâ€™s capital was held by the Mulliez family (through AlterBiz (formerly Creadev S.A) and CREA-FIVE SC  holding 99.01% and 0.38% respectively of Voltalia Investissementâ€™s capital)  0.34% by SOPARVOLTALIA  0.24% by SÃ©bastien Clerc  0.007% by Laurence Mulliez and 0.017% by Company employees.(4) Including 2 988 293 shares loaned by Voltalia Investissement under the share loan arrangement set up with the Borrowers as part of the issue of Green OCEANEs (according to the information provided by the Borrowers). The number of shares loaned by Voltalia Investissement (representing 2 173 310 shares as of 15 November 2022) has been increased by a number of shares corresponding to the shares subscribed through the exercise of the PSRs attached to the shares loaned by Voltalia Investissement or synthetically through the acquisition of existing shares  i.e. 814 983 additional loaned shares (representing a total number of loaned shares of 2 988 293).Lock-up commitment of the CompanyAs of the date of approval by the AutoritÃ© des marchÃ©s financiers (â€œAMFâ€) on the prospectus relating to the Capital Increase with PSRs  i.e. 15 November 2022  and for a period expiring 180 calendar days following the settlement-delivery date of the New Shares  subject to certain standard exceptions.Lock-up commitments of Voltalia Investissement and ProparcoAs of the date of approval by the AMF on the prospectus relating to the Capital Increase with PSRs   i.e. 15 November 2022  and for a period expiring 180 calendar days following the settlement-delivery date of the New Shares  subject to certain standard exceptions.Indicative timetableThe settlement-delivery and admission of the New Shares to trading on Euronext Paris (Compartment B) will take place on 7 December 2022. New shares will immediately entitle their holders to receive dividends. They will be immediately fungible with existing shares of the Company  and will be traded on the same line under the ISIN code FR0011995588.The Capital Increase with PSRs was conducted by BNP Paribas and Goldman Sachs Bank Europe SE as structuring agents and global coordinators  lead managers and joint bookrunners  Banco Santander  S.A.  CrÃ©dit Agricole Corporate and Investment Bank and Natixis  as global coordinators  lead managers and joint bookrunners (together  the â€œGlobalCoordinators  Lead Managers and Joint Bookrunnersâ€)  as well as with CIC and Portzamparc as co-lead managers (together with the Global Coordinators  Lead Managers and Joint Bookrunners  the â€œFinancial Institutionsâ€).Information of the publicThe prospectus  which was approved by the AMF on 15 November 2022 under the number 22-447 is composed of (i) the Universal Registration Document filed with the AMF on 2 May 2022 under the number D.22-0410  (ii) an amendment to the Universal Registration Document filed with the AMF on 15 November 2022 under the number D.22-0410-A01  (iii) the securities note (Note dâ€™OpÃ©ration) dated 15 November 2022 and (iv) a summary of the prospectus (included in the securities note).Copies of the prospectus may be obtained free of charge and upon request from the company  84  boulevard de SÃ©bastopol  75003 Paris  France â€“ and from the internet websites of Voltalia (www.voltalia.com) and the AMF (www.amf-france.org).Voltalia draws the publicâ€™s attention to chapter 2  â€œRisk factors and Risk Managementâ€  of the Universal Registration Document filed with the AMF  chapter 5 â€œMain Risks and Trends as of 30 June 2022â€ of the amendment of the Universal Registration Document  and to chapter 2 â€œRisk factors related to the offeringâ€ of the Note dâ€™OpÃ©ration.About Voltalia (www.voltalia.com) Voltalia is an international player in the renewable energy sector. The Group produces and sells electricity generated from wind  solar  hydraulic  biomass and storage facilities that it owns and operates. Voltalia has a generating capacity in operation and under construction of 2.4 GW and a portfolio of projects under development representing a total capacity of 13.6 GW.Voltalia is also a service provider and supports its investor clients in renewable energy projects during all phases  from design to operation and maintenance.As a pioneer in the corporate market  Voltalia provides a global offer to private companies  ranging from the supply of green electricity and energy efficiency services to the local production of their own electricity.With more than 1 450 employees in 20 countries on 4 continents  Voltalia has the capacity to act globally for its customers.Voltalia is listed on the regulated market of Euronext Paris  compartment B (FR0011995588 â€“ VLTSA) and is part of the EnterNext Tech 40  CAC Mid & Small and Euronext Tech Leaders indices. The Group is also included in the GaÃ¯a-Index  an index for socially responsible midcaps. Voltalia shares are PEA eligible  under certain conditions. VoltaliaInvestor Relations: invest@voltalia.comT. +33 (0)1 81 70 37 00 ActifinPress Contact: Loris Daougabelldaougabel@actifin.fr. T. +33 6 59 01 36 64DisclaimerNo communication and no information in respect of Voltaliaâ€™s share capital increase with shareholdersâ€™ preferential subscription rights  may be distributed to the public in any jurisdiction in which such registration or approval is required. No action has been or will be undertaken outside of France in any jurisdiction in which such actions would be required. The issue  the exercise or the sale of preferential subscription rights  and the subscription for or the purchase of new shares or preferential subscription rights may be subject to specific legal or regulatory restrictions in certain jurisdictions. Voltalia assumes no responsibility for any violation of any such restrictions by any person.This announcement is an advertisement and not a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (as amended  the â€œProspectus Regulationâ€).With respect to the member States of the European Economic Area  other than France (each  a â€œRelevant Member Stateâ€)  no action has been or will be undertaken to make an offer to the public of the securities requiring a publication of a prospectus in any relevant member State. As a result  the preferential subscription rights and the new shares may not and will not be offered except in accordance with the exemptions set forth in Article 1(4) of the Prospectus Regulation or under any other circumstances that do not require the publication by Voltalia of a prospectus pursuant to Article 3 of the Prospectus Regulation and/or to applicable regulations of that Relevant Member State e.This press release and the information it contains are being distributed to and are only intended for persons who are (x) outside the United Kingdom or (y) in the United Kingdom who are qualified investors (as defined in the Prospectus Regulation as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) and are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005  as amended  (the â€œOrderâ€)  (ii) high net worth entities and other such persons falling within Article 49(2)(a) to (d) of the Order (â€œhigh net worth companiesâ€  â€œunincorporated associationsâ€  etc.) or (iii) other persons to whom an invitation or inducement to participate in investment activity (within the meaning of Section 21 of the Financial Services and Market Act 2000) may otherwise lawfully be communicated or caused to be communicated (all such persons in (y)(i)  (y)(ii) and (y)(iii) together being referred to as â€œRelevant Personsâ€). Any invitation  offer or agreement to subscribe  purchase or otherwise acquire securities to which this press release relates will only be engaged with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this press release or any of its contents.This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities nor of any offer or solicitation to sell securities in the United States of America. The preferential subscription rights and the new shares of Voltalia have not been and will not be registered under the U.S. Securities Act of 1933  as amended (the â€œU.S. Securities Actâ€)  and may not be offered or sold  directly or indirectly  within the United States of America except pursuant to an exemption from or in a transaction not subject to  the registration requirements of the Securities Act. Voltalia does not intend to register any portion of the proposed offering in the United States of America nor to conduct an offering of securities to the public in the United States of America.The distribution of this document in certain countries may constitute a breach of applicable law. The information contained in this document does not constitute an offer of securities for sale in the United States of America  Canada  Australia or Japan.This press release may not be published  forwarded or distributed  directly or indirectly  in the United States of America  Canada  Australia or Japan.1 Including the shares loaned by Voltalia Investissement under the share loan arrangement set up with BNP Paribas Arbitrage SNC  Goldman Sachs Bank Europe SE and Natixis (the â€œBorrowersâ€) (according to the information provided by the Borrowers) as part of the issue of green bonds convertible into and/or exchangeable for new and/or existing shares issued on 13 January 2021 and supplemented by the issue of fully fungible Green OCEANEs on 29 July 2022 (together  the â€œGreen OCEANEsâ€).Attachment",neutral,0.1,0.9,0.0,mixed,0.67,0.21,0.12,True,English,"['490 million euros capital increase', 'preferential subscription rights', 'Voltalia', 'success', 'SÃ©bastien Clerc', 'possible targeted acquisitions', 'unprecedented energy crisis', 'new geographical areas', 'preferential subscription rights', 'new production capacity', 'gross final amount', 'The Capital Increase', 'PSRs underlying subscriptions', 'energy independence', 'voting rights', 'consolidated capacity', 'gross amount', 'subscription rate', 'subscription price', 'subscription period', 'Subscription commitments', 'subscription intentions', 'total demand', 'market capitalisation', 'closing price', 'reference shareholder', 'free float', 'net proceeds', 'additional means', 'numerous shareholders', 'strong mobilization', 'global environment', 'local development', 'strategic roadmap', 'climate emergency', 'realistic solutions', 'sustainable world', 'power plants', 'third parties', 'Latin America', 'nominal value', 'main shareholders', 'management bodies', '35,765,712 new shares', '35,304,924 New Shares', '4,975,400 New Shares', '460,788 New Shares', 'irreducible basis', 'undiluted basis', 'daily basis', 'total amount', 'share capital', 'issue premium', '350 million euros', '573 million euros', '427 million euros', '3 billion euros', '490 million euros', '450 million euros', 'Voltalia Investissement', 'Voltalia employees', '40,280,324 shares', '489,990,254.40 euros', '17.92 euros', '13.70 euros', '5.70 euros', '8.00 euros', '4,262.40 euros', 'results', 'issuance', 'subject', 'creation', '2 December', 'Proparco', 'Company', 'operation', 'construction', '5.0 GW', 'investment', 'success', 'cash', 'behalf', 'support', 'mission', 'funds', 'view', 'ambitions', 'challenges', 'context', 'Europe', 'teams', 'concrete', 'cornerstone', 'CEO', 'Reasons', 'respect', 'balance', 'growth', 'services', 'order', 'objective', '8 GW', 'presence', 'Africa', 'coefficient', 'number', 'allocation', 'fractions', 'members', 'administrative', 'launch', '31 October', '24.', '2.5', '2027', '112.', '357']",2022-12-05,2022-12-06,finance.yahoo.com
14219,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567706/0/en/Virbac-Declaration-of-the-number-of-shares-and-voting-rights-11-2022.html,Virbac : Declaration of the number of shares and voting rights 11/2022,DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS  Â   Â   Â   Information on the total number of voting rights and of shares......,English FrenchDECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTSInformation on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority â€“ AutoritÃ©des MarchÃ©s Financiers)Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577Date Total number of shares representing the share capital Total number of voting rights November  30 2022 8 458 000 Gross total of voting rights : 12 765 861 Net total* of voting rights : 12 751 087Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.VIRBAC: Shaping the future of animal healthNYSE Euronext - Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRPCorporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.comWebsite: www.virbac.comAttachment,neutral,0.0,1.0,0.0,neutral,0.01,0.98,0.0,True,English,"['voting rights', 'Virbac', 'Declaration', 'number', 'shares', 'French Financial Market Authority', 'animal health NYSE Euronext', 'MarchÃ©s Financiers', 'English French', 'Euronext Paris', 'total number', 'share capital', 'General regulations', 'Compartiment A', 'ISIN code', 'Gross total', 'Net total', 'Code ISIN', 'Corporate Finance', 'voting rights', 'DECLARATION', 'THE', 'SHARES', 'Information', 'Article', 'place', 'Date', 'VIRBAC', 'future', 'MNEMO', 'VIRP', 'tel.', 'Email', 'finances', 'Website', 'Attachment']",2022-12-05,2022-12-06,globenewswire.com
14220,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567046/0/en/Exor-N-V-Periodic-Report-on-the-Buyback-Program.html,Exor N.V.: Periodic Report on the Buyback Program,EXOR N.V. (AMS: EXO) (â€œExorâ€ or the â€œCompanyâ€) announces that  under the second tranche of the share buyback program of up to â‚¬250 million announced on 29 July 2022 (the â€œsecond trancheâ€)  the Company has completed the following transactions on Euronext Amsteâ€¦,EXOR N.V. (AMS: EXO) (â€œExorâ€ or the â€œCompanyâ€) announces that  under the second tranche of the share buyback program of up to â‚¬250 million announced on 29 July 2022 (the â€œsecond trancheâ€)  the Company has completed the following transactions on Euronext Amsterdam:Trading Date Number of ordinary shares purchased Average price per share excluding fees (â‚¬) Total consideration excluding fees (â‚¬) 1 December 2022 7 413 76.4983 567 081.90 2 December 2022 30 539 76.1906 2 326 784.73 TOTAL 37 952 2 893 866.63After these purchases  the total invested amount under the second tranche is approximately â‚¬116.6 million for a total amount of 1 766 419 ordinary shares purchased.As of 2 December 2022  the Company held in total 12 563 600 ordinary shares in treasury (5.21% of total ordinary issued share capital).A comprehensive overview of the transactions carried out under the share buyback program  as well as the details of the above transactions  are available on Exorâ€™s corporate website under the Share Buyback section.Attachment,neutral,0.01,0.99,0.0,neutral,0.0,0.99,0.0,True,English,"['Exor N.V.', 'Periodic Report', 'Buyback Program', 'Trading Date Number', 'share buyback program', 'Share Buyback section', 'EXOR N.V.', 'share capital', 'second tranche', 'Euronext Amsterdam', 'ordinary shares', 'Average price', 'comprehensive overview', 'corporate website', 'Total consideration', 'total ordinary', 'following transactions', 'total amount', 'Company', '29 July', 'fees', '1 December', 'purchases', '2 December', 'treasury', 'details', 'Attachment', '12']",2022-12-05,2022-12-06,globenewswire.com
14221,EuroNext,NewsApi.org,https://finance.yahoo.com/news/quadient-sa-solid-q3-performance-164500582.html,Quadient SA - Solid Q3 performance thanks to robust subscription-related revenue growth and despite delays in parcel locker projects in the US,Solid Q3 performance thanks to robust subscription-related revenue growth and despite delays in parcel locker projects in the US Group revenue of â‚¬793...,QUADIENTSolid Q3 performance thanks to robust subscription-related revenue growth and despite delays in parcel locker projects in the USGroup revenue of â‚¬ 79 3 million in 9M 2022  up 5.6 % on a reported basis and 0.8% 1 organically compared to 9M 2021.G rowth in subscription-related revenue reached 3 .0 % on an organic basis  further demonstrating the strength of the recurring business model.Revenue for Q3 2022 was up 8.8% on a reported basis and up 1.0%1 on an organic basis to â‚¬270 million at Group level  a small increase against the organic growth trend achieved in H1 2022.At Major Operations level:Intelligent Communication Automation cloud software revenue was up 5.2% organically in the 9M 2022  supported by a strong 17.2% increase in subscription-related revenue. Annual Recurring Revenue growth stood at +22% on an annualized organic basis  at the end of the period.Mail-Related Solutions continues to prove its resilience with a limited organic decline of -0.6% in Q3  bringing the 9M performance to -0.4% organic change.Parcel Locker Solutions revenue was flat in Q3 2022  at -0.2% on an organic basis. Positive contribution from existing contract deployments offset delays in some retail deals and locker installations in the residential sector  both in the US. Revenue for the 9M 2022 was down -1.8% organically.Strong Q4 expectations reiterated across Solutions  not fully offsetting the weak Q3 US lockers performanceOn a reported basis  Group FY 2022 r evenue and current EBIT 2 are expected to grow over last year level benefiting from a favourable forex contribution thanks to the Groupâ€™s significant and growing US presence.O rganic growth in revenue for the FY 2022 is now expected at above 1% 3   compared to above 2% previously 4 . Whilst the Group maintains its expectations for a strong Q4 performance across Solutions  a weaker Q3 from Parcel Lockers and the uncertain level of backlog reduction in Q4 (backlog level is up over +40% compared to 9M 2021) have led to a cautious approach to the full year outlook.FY 2022 current EBIT2 guidance4 is now expected at a low to mid-single digit year-on-year organic decline compared to a previous guidance of a low to mid-single digit organic growth. H2 2022 EBIT margin is still expected to show a significant improvement against H1 2022 level  however  lower than expected Q3 organic revenue organic growth has also led to an updated EBIT4 guidance as it carries a direct impact on the operating profitability level.Story continuesParis  5 December 2022 Quadient (Euronext Paris: QDT)  a leader in business solutions for meaningful customer connections through digital and physical channels  announces today its 2022 third quarter and nine-month consolidated sales (period ended on 31 October 2022).Geoffrey Godet  Chief Executive Officer of Quadient  stated: â€œWith strong growth in subscription-related revenue and a very attractive level in Annual Recurring Revenue  we are pleased with the Q3 performance of our Software business as this further confirms the strength of our product offering. The solid performance of our SaaS platform is complemented by a seventh consecutive quarter of resilience for our Mail-Related Solutions  which posted a marginal organic decline. Parcel Locker Solutions  which has been impacted by US projects postponement to 2023 with retailers  remains very dynamic with strong bookings achieved in Q3. Given the more challenging macro environment  it is important to stress the relevance of our offer and the resilience of our recurring business model. All our Solutions enable organizations to achieve significant time and costs savings while providing their customers with a superior experience. I am proud of the integrated and balanced portfolio of solutions we have built and confident in our ability to deliver a strong level of organic growth in Q4.â€SOLID GROWTH ON A REPORTED BASIS  ORGANIC TREND IN LINE WITH H1Group sales stood at â‚¬793 million in the 9M 2022. On a reported basis  Group sales went up 5.6% compared to 9M 2021  including a positive currency impact of +6.7% and a negative scope effect of -2.2%. In details  changes of scope are related to the acquisition of Beanworks in March 2021 and the divestment of Automated Packaging Systems in July 2021 as well as the more recent divestments of the Graphic business in the Nordics and the Shipping activities in France (both in June 2022). Group sales were up 0.8% organic basis in the 9M 2022.Consolidated salesIn â‚¬ million 9M 2022 9M 2021 Change Organic change(1) Major Operations 749 689 +8.6% +0.7% Intelligent Communication Automation 166 147 +12.7% +5.2% Mail-Related Solutions 518 481 +7.8% (0.4)% Parcel Locker Solutions 65 62 +4.8% (1.8)% Additional Operations 45 62 (28.5)% +2.0% Group total 793 752 +5.6% +0.8%In â‚¬ million 9M 2022 9M 2021 Change Organic change(1) Major Operations 749 689 +8.6% +0.7% North America 442 378 +17.0% +3.0% Main European countries(a) 267 274 (2.5)% (3.2)% International(b) 40 38 +5.7% +5.2% Additional Operations 45 62 (28.5)% +2.0% Group total 793 752 +5.6% +0.8% (a) Including Austria  Benelux  France  Germany  Ireland  Italy  Switzerland  and the United Kingdom.(b) International includes the activities of Parcel Locker Solutions in Japan and of Intelligent Communication Automation outside of North America and the Main European countries.Major OperationsSales from Major Operations reached â‚¬749 million (94% of total sales) in the 9M 2022  an 8.6% increase on a reported basis and a 0.7% year-over-year organic growth  which represents a small improvement compared to H1 2022. Growth in subscription-related revenue remains solid  at +2.9% on an organic basis in the 9M 2022  representing 71% of the Major Operations sales compared to 70% in 9M 2021  a further confirmation of the recurring nature of Quadientâ€™s business model.Sales in North America (59% of Major Operations) were up 3.0% organically  to â‚¬442 million. Double digit organic increase from Intelligent Communication Automation as well as organic growth from Mail-Related Solutions with strong hardware sales were the main contributors to this positive performance. Parcel Locker Solutions reported an organic decline in the region due to a combination in the US of weaker installation in the residential market impacted by construction delays  some retail deals being postponed into 2023 and the high comparison basis from the completion of the roll-out of a large retail contract in Q1 2021.Main European countries (36% of Major Operations) were down 3.2% organically to â‚¬267 million  mostly driven by a small organic decline in Mail-Related Solutions and  to a lesser extent  by lower revenue from Intelligent Communication Automation software license sales  as the Group continues to shift its business model to SaaS subscriptions. Parcel Locker Solutions benefited from a strong acceleration in organic growth  mostly driven by the ongoing deployment of the recently signed contracts in the region  as well as the initial contribution from the roll-out of the UK open network.Sales from the International segment (5% of Major Operations) were up 5.2% organically to â‚¬40 million  with positive contribution from both Intelligent Communication Automation and Parcel Locker Solutions.Intelligent Communication AutomationSales from Intelligent Communication Automation reached â‚¬166 million in the 9M 2022  up +12.7% on a reported basis and 5.2% organically. The penetration of the SMB segment accelerated in the quarter  with the Account Payable (AP) and Account Receivable (AR) offer remaining very strong  (up c. 65% compared to Q3 2021)  supported by a good level of cross-selling from Mail-Related Solutions sales organization. Performance was also well oriented in the enterprise segment.Growth in subscription-related revenue continued to be solid at +17.8% organically in Q3 2022 after +16.9% in H1 2022. (+17.2% organically in the 9M 2022). Subscription-related revenue now represents 75% of Intelligent Communication Automation sales compared to 67% in the 9M 2021  further evidence of the successful shift in business model  from license sales to SaaS. Licenses sales were consequently down 43.1% organically in the 9M 2022.Annual recurring revenue reached â‚¬179 million at the end of 9M 2022  up from â‚¬145 million at the end of 20215 (a 22% annualized organic increase). Also illustrating the shift in revenue model  the share of SaaS customers reached 79% at the end of the 9M 2022 Lastly  professional services were slightly down organically (-2.8%) due to the evolution in product mix.Mail-Related SolutionsMail-Related Solutions sales stood at â‚¬518 million in the 9M 2022  up 7.8% on a reported basis and only down -0.4% organically compared to the 9M 2021 despite a relatively high comparison basis (+2.8% organic growth in 9M 2021 compared to 9M 2020). The resilient trend seen in recent quarters continues for Mail-Related Solutions supported by the positive organic contribution from North America  while decline from the Main European countries remained limited.Of note  the strong performance continued in hardware sales (+3.5% organic growth in the 9M 2022) despite the very demanding comparison basis (+17.6% in the 9M 2021) and some supply chain issues which drove delays in product deliveries and led to a high level of backlog at the end of the period (over +20% compared to 9M 2021). Innovation  leading to positive product placement and continuous upgrade of the installed base  as well as the benefit from price increases were the main drivers behind this remarkable performance.Subscription-related revenue (71% of total sales) proved resilient with a limited organic decline of -1.9% in the 9M 2022. This performance was largely explained by the resilience of the installed base and the largely indexed multi-year contracts associated with it  whilst volume-based revenue remain steady.Parcel Locker SolutionsParcel Locker Solutions sales stood at â‚¬65 million in the 9M 2022  a 4.8% increase on a reported basis and a -1.8% organic decline compared to the 9M 2021.Volatility in lockers hardware sales remains high with a -14.2% organic decline in Q3 2022. This follows a strong Q2 up 25.1% on an organic basis and a very weak Q1  down -47.7% organically  due to the high comparison base linked to the final phase of the deployment of a large North American retail contract in Q1 2021. Overall  hardware sales were down -18.0% organically in the 9M 2022. The weaker Q3 performance was due to fewer installations in the period  mostly explained by longer lead-time for new constructions in the residential sector in the US impacting the delivery of the lockers. Growth was also impacted by the postponement of some US retail projects to 2023.Subscription-related revenues were up 8.7% organically thanks to the continuous roll-out of existing contracts  especially in Europe with accelerating trends in France and the UK  while the usage rate continues to trend higher  reaching 57% at the end of the period. Subscription-related revenue accounted for 61% of total revenue in the 9M 2022. Total number of installed lockers surpassed 17 300 at the end of the period.Whilst some retail deals in the US are being delayed into 2023  the attractiveness of the business model (automation of the first and last mile delivery) remains unchanged both in terms of cost savings and environmental benefits  as evidenced by the continuous high level of booking leading to a significant increase of over +65% in the backlog at the end of October 2022 compared to a year ago. Two third of this backlog relating to an increased mix of new builds impacted by increased construction lead times versus existing building. Therefore  a catch up in installations is expected in 2023 and 2024.Q4 performance is expected to show a significant year-over-year improvement supported by the deployment of existing contracts and the contribution of recent deals signed.Additional OperationsRevenue from Additional Operations stood at â‚¬45 million in the 9M 2022  up 2.0% year-over-year on an organic basis but down 28.5% on a reported basis. This decline is mainly due to the divestment of Automated Packaging Systems in 2021 and the prorata temporis impact of the divestments of the Graphics activities in the Nordic countries and of the Shipping Solutions which both took place in June 2022. Additional Operations accounted for less than 6% of total sales in the 9M 2022.Q3 2022 SALESConsolidated sales stood at â‚¬270 million in the third quarter of 2022  up 8.8% on a reported basis and 1.0% on an organic basis compared to the third quarter of 2021. Subscription-related revenue organic growth in Q3 was up +2.8%  confirming the solid trend seen year-to-date.Major Operations sales stood at â‚¬257 million in the third quarter of 2022  up 0.9% organically compared to the third quarter of 2021. North America enjoyed a solid 4.2% organic growth in the quarter  with positive contribution from both Intelligent Communication Automation growing at a double-digit pace and Mail-Related Solutions posting organic growth. International increased slightly at +0.5% organically while Main European Countries posted a contained -3.5% organic decline mostly due to a weaker contribution from Mail-Related Solutions.Intelligent Communication Automation sales were up 6.3% organically to â‚¬58 million  the double-digit organic increase in subscription-related revenue more than offsetting the still sharp decline in license. Mail-Related Solutions sales remained resilient  at â‚¬176 million  only down by -0.6% on an organic basis despite supply chain issues. Parcel Locker Solutions sales stood at â‚¬22 million in the third quarter of 2022  a -0.2% organic change compared to Q3 2021  mainly due to longer lead time for new constructions in the residential sector in the US impacting lockers installations. Delays in some retail deals in the US are also having a negative impact on the Solution organic growth in the short term.Additional Operations sales stood at â‚¬13 million in the third quarter of 2022  down by -19.4% on a reported basis due to the changes in scope  but up 2.7% on an organic basis.STRONG Q4 EXPECTATIONS REITERATED ACROSS SOLUTIONS  NOT FULLY OFFSETTING THE WEAK Q3 US LOCKERS PERFORMANCEOn a reported basis  Group FY 2022 revenue and current EBIT are expected to grow over last year level benefiting from a favourable forex contribution thanks to the Groupâ€™s significant and growing US presence.2022 Guidance updated4The Group maintains its expectations for both a strong Q4 performance across Solutions and a step up in profitability in H2 2022 compared to H1 2022 . Intelligent Communication Automation delivered a solid Q3 performance in terms of subscription-related revenue growth and the positive trend is expected to continue  supported by strong Annual Recurring Revenue level. After another solid quarter for Mail-Related Solutions  innovation and new product launches continue to drive solid demand and therefore the Group expects this positive trend to continue in Q4. After a disappointing Q3 for Parcel Locker Solutions in the US  the deployment of existing contracts and the contribution of recent deals are expected to support a return to strong growth. Considering the weaker Q3 from Parcel Lockers and the uncertain level of backlog reduction in Q4  and despite unchanged expectations for a strong Q4 across Solutions  the Group now expects full-year 2022 organic sales growth at over 1% compared to 2% previously.H2 2022 current EBIT2 margin is still expected to show a significant improvement against H1 2022 level thanks toi) further price increases and more favorable supply chain costs comparison basisii) higher profitability from the growing installed base for both the SaaS activity and parcel lockers  andiii) still high profitability of Mail-Related Solutions.However  lower than expected Q3 organic revenue growth and the impact from salary inflation and investments into new product launches weighing on margins as seen in H1 2022  are leading to a more cautious approach for the operating profitability of the Group. Consequently  Group current EBIT2 is now expected to decline organically year-on-year by a low to mid-single digit  compared to a low to mid-single digit organic growth previously.2021-2023 outlook confirmedThe Group confirmed the 2021-2023 outlook with both sales and current EBIT6 organic growth CAGR over the period i.e.  a minimum 3% organic sales growth CAGR and a minimum mid-single digit organic growth CAGR of current EBIT before acquisition-related expenses.Q3 BUSINESS HIGHLIGHTSYayPay by Quadient Listed a Technology Leader in the 2022 SPARK Matrix for Accounts Receivable ApplicationsOn 26 October 2022  Quadient announced that its cloud-based solution YayPay by Quadient was listed as a 2022 Technology Leader by Quadrant Knowledge Solutions in the SPARK Matrixâ„¢ analysis of the global accounts receivable applications market.The 2022 Quadrant Knowledge Solutions SPARK Matrix: Accounts Receivable Applications includes a detailed analysis of global market dynamics  major trends  vendor landscape and competitive positioning. The study provides competitive analysis and ranking of the leading accounts receivable applications vendors in the form of its SPARK Matrix. It gives strategic information for users to evaluate different vendor capabilities  competitive differentiation and market position.Quadient Launches Advanced Compact Folder Inserter and Cloud-based Document Integrity Mailroom SoftwareOn 17 October 2022  Quadient announced the global launch of the DS-77 iQ  Quadientâ€™s new compact modular folder inserter solution  and docsecure by Quadient mailroom software  the only fully cloud-based  closed-loop solution that tracks document integrity at every step  including proof that each mail piece has been properly processed.Quadient Recognized for its Corporate Social Responsibility Program with a 2022 Tech Cares Award from TrustRadiusOn 10 October 2022  Quadient announced that TrustRadius  the most trusted research and review platform  has recognized Quadient with a 2022 Tech Cares Award. This third-annual award celebrates companies that have gone above and beyond to provide impactful corporate social responsibility (CSR) programs for their employees and surrounding communities.Quadientâ€™s corporate social responsibility (CSR) strategy is built around five pillars: People  Solutions  Ethics & Compliance  Environment and Philanthropy. These pillars are aligned with the UN Global Compact principles that Quadient committed to respect  support and promote by joining the initiative in 2021. Becoming a signatory member also implies taking action to advance the UN Sustainable Development Goals (SDGs)  eight of which Quadient is already committed to.Quadient Launches SaaS Electronic Invoice Presentment and Payment Solution for Small and Medium-Sized BusinessesOn 5 October 2022  Quadient announced the release of Quadient Impress Invoice  a software-as-a-service (SaaS) that securely and compliantly automates the preparation and delivery of invoices. Impress Invoice features built-in electronic invoice presentment  invoice delivery and facilitates payment of those invoices  so businesses get paid faster while offering customers added convenience and improved satisfaction. Impress Invoice is available in the US and UK and will launch in France  Germany and other European countries by the end of the year.POST-CLOSING EVENTSRelais Colis Installs 200 to 300 Quadient Parcel Lockers in Carrefour Retail StoresOn 1 December 2022  Quadient announced that Relais Colis  a key player in the French out-of-home parcel delivery market  is installing 200 to 300 Quadient smart lockers in Carrefour retail stores. Relais Colis has shared the announcement below  also available on their website (in French).Top 250 Ranking of French Software Companies Places Quadient Fifth in â€˜Horizontal Publishersâ€™ CategoryOn 25 November 2022  Quadient announced it has been ranked fifth in the EY and Numeum 2022 Top 250 list of French software companies in the Horizontal Publishers (cross-industry) category  as well as fifteenth in the overall ranking.Esker and Quadient to Develop Electronic Invoicing Platform  to Partner with French GovernmentOn 21 November 2022  Esker and Quadient announced that their years-long collaboration will take on a new dimension by partnering with the French governmentâ€™s upcoming Partner Dematerialization Platform (PDP).Quadient and Esker have been working together for more than seven years through their joint subsidiary NCS  a strategic partnership that allows Quadient to leverage Esker's technology expertise for automating and digitizing customer and supplier invoices. The new direction NCS is taking strengthens this collaboration and ensures that businesses of all sizes experience a smooth and secure transition to compliance with upcoming French tax regulations  according to the defined timetable  whether invoices are received or transmitted by mail  email in PDF format  portal  EDI or another channel.Quadient launches Parcel Pending smart lockers in Ireland to support on-going modernisation of the residential property industryOn 8 November 2022  Quadient announced the launch of Parcel Pending by Quadient in Ireland. By providing secure  self-service smart parcel lockers to businesses across the country  together with a dedicated support centre and response and repair team  Quadient will help the Irish economy capitalise on the property boom by simplifying parcel delivery and improving residentsâ€™ experience.With the Banking & Payments Federation Ireland (BPFI) expecting 50 000 new homes to be built across 2022 and 2023  Quadient will help property developers and property management organisations transform parcel pickup: providing a secure location for residentsâ€™ parcel deliveries with 24/7 access; in turn freeing up time for building management to deal with other tasks; and reducing the physical and environmental footprint of parcel delivery.To know more about Quadientâ€™s newsflow  previous press releases are available on our website at the following address: https://invest.quadient.com/en-US/press-releases.CONFERENCE CALL & WEBCASTQuadient will host a conference call and webcast today at 6:00 pm Paris time (5:00 pm London time).To join the webcast  click on the following link: Webcast.To join the conference call  please use one of the following phone numbers:â–ª France: +33 (0) 1 70 37 71 66;â–ª United States: +1 212 999 6659;â–ª United Kingdom (standard international): +44 (0) 33 0551 0200.Password: QuadientA replay of the webcast will also be available on Quadientâ€™s Investor Relations website for 12 months.CALENDAR27 March 2023 : FY 2022 results and Q4 2022 sales release (after close of trading on the Euronext Paris regulated market).***About QuadientÂ®Quadient is the driving force behind the worldâ€™s most meaningful customer experiences. By focusing on three key solution areas  Intelligent Communication Automation  Parcel Locker Solutions and Mail-Related Solutions  Quadient helps simplify the connection between people and what matters. Quadient supports hundreds of thousands of customers worldwide in their quest to create relevant  personalized connections and achieve customer experience excellence. Quadient is listed in compartment B of Euronext Paris (QDT) and is part of the SBF 120Â®  CACÂ® Mid 60 and EnterNextÂ® Tech 40 indices.For more information about Quadient  visit https://invest.quadient.com/ContactsCatherine Hubert-Dorel  Quadient+33 (0)1 45 36 61 39c.hubert-dorel@quadient.comfinancial-communication@quadient.comCaroline Baude  Quadient+33 (0)1 45 36 31 82c.baude@quadient.com OPRG FinancialIsabelle Laurent / Fabrice Baron+33 (0)1 53 32 61 51 /+33 (0)1 53 32 61 27isabelle.laurent@oprgfinancial.frfabrice.baron@oprgfinancial.frAppendicesChange in Q3 2022 salesIn â‚¬ million Q3 2022 Q3 2021 Change Organic change(1) Major Operations 257 232 +10.8% +0.9% Intelligent Communication Automation 58 51 +15.0% +6.3% Mail-Related Solutions 176 160 +9.8% (0.6)% Parcel Locker Solutions 22 21 +7.8% (0.2)% Additional Operations 13 16 (19.4)% +2.7% Group total 270 248 +8.8% +1.0%In â‚¬ million Q3 2022 Q3 2021 Change Organic change(1) Major Operations 257 232 +10.8% +0.9% North America 155 128 +21.7% +4.2% Main European countries(a) 88 91 (3.1)% (3.5)% International(b) 13 13 +0.1% +0.5% Additional Operations 13 16 (19.4)% +2.7% Group total 270 248 +8.8% +1.0% (a) Including Austria  Benelux  France  Germany  Ireland  Italy  Switzerland and the United Kingdom.(b) International includes the activities of Parcel Locker Solutions in Japan and of Customer Experience Management outside of North America and the Main European countries.1 9M 2022 sales are compared to 9M 2021 sales at constant exchange rates (â‚¬53 million positive currency impact over the period) to which is added  prorata temporis  revenue from Beanworks and to which is deducted  prorata temporis  revenue from Automated Packaging Systems  Graphic business in the Nordics and the Shipping activities in France  for a consolidated amount of â‚¬-18 million.Q3 2022 sales are compared to Q3 2021 sales at constant exchange rates (â‚¬23 million positive currency impact over the period) to which is deducted  prorata temporis  revenue from Automated Packaging Systems  Graphic business in the Nordics and the Shipping activities in France  for a consolidated amount of â‚¬-3 million.2 Current operational result before acquisition-related fees.3 Compared to FY 2021 sales at constant exchange rates to which is added  prorata temporis  revenue from Beanworks (acquired in March 2021) and to which is deducted  prorata temporis  revenue from Automated Packaging Systems (divested in July 2021)  Graphic business in the Nordics and the Shipping activities in France (divested in June 2022)  accounting for a consolidated amount of â‚¬-21 million.4 FY 2022 guidance last published in Quadient press release - 2022 half-year results and second quarter sales  September 26  20225 9M 2022 ARR benefited from a â‚¬10.2m positive forex impact compared to FY 2021.6 On the basis of 2020 current operating income before acquisition-related expenses excluding Parcel Pendingâ€™s earn-out reversal i.e.  â‚¬145 million  with a scope effect resulting in a â‚¬140 million proforma.Attachment,neutral,0.31,0.68,0.01,mixed,0.61,0.17,0.21,True,English,"['robust subscription-related revenue growth', 'Solid Q3 performance', 'parcel locker projects', 'Quadient SA', 'delays', 'Intelligent Communication Automation cloud software revenue', 'weak Q3 US lockers performance', 'Q3 organic revenue organic growth', 'mid-single digit organic growth', 'low to mid-single digit', 'FY 2022 current EBIT2 guidance4', 'Annual Recurring Revenue growth', 'robust subscription-related revenue growth', 'Parcel Locker Solutions revenue', 'O rganic growth', 'parcel locker projects', 'existing contract deployments', 'full year outlook', 'meaningful customer connections', 'Chief Executive Officer', 'challenging macro environment', 'Automated Packaging Systems', 'Main European countries', 'limited organic decline', 'year organic decline', 'marginal organic decline', 'organic growth trend', 'recurring business model', 'growing US presence', 'US projects postponement', 'favourable forex contribution', 'H2 2022 EBIT margin', 'seventh consecutive quarter', 'last year level', 'operating profitability level', 'positive currency impact', 'negative scope effect', 'nine-month consolidated sales', 'Solid Q3 performance', 'annualized organic basis', '2021 Change Organic change', 'strong Q4 performance', 'Major Operations level', 'Parcel Lockers', 'Software business', 'Strong Q4 expectations', 'H1 Group sales', 'strong growth', 'SOLID GROWTH', 'ORGANIC TREND', 'solid performance', 'Positive contribution', 'locker installations', 'strong level', 'Group revenue', 'weaker Q3', 'direct impact', '2022 third quarter', 'business solutions', 'Graphic business', 'strong 17.2% increase', 'uncertain level', 'backlog level', 'H1 2022 level', 'attractive level', 'strong bookings', 'Additional Operations', 'Group level', 'Group FY', 'G rowth', 'small increase', 'Mail-Related Solutions', 'retail deals', 'residential sector', 'r evenue', 'backlog reduction', 'cautious approach', 'previous guidance', 'EBIT4 guidance', 'physical channels', 'Geoffrey Godet', 'product offering', 'SaaS platform', 'costs savings', 'superior experience', 'balanced portfolio', 'recent divestments', 'Shipping activities', 'North America', '9M performance', 'significant improvement', 'significant time', 'REPORTED BASIS', 'Euronext Paris', 'Q3.', 'Q4.', '9M 2022', 'QUADIENT', 'delays', 'strength', 'period', 'resilience', 'updated', 'Story', '5 December', 'QDT', 'leader', 'digital', '31 October', 'retailers', 'relevance', 'organizations', 'customers', 'integrated', 'details', 'changes', 'acquisition', 'Beanworks', 'March', 'July', 'Nordics', 'France', 'June', 'â‚¬']",2022-12-05,2022-12-06,finance.yahoo.com
14222,EuroNext,NewsApi.org,https://finance.yahoo.com/news/valneva-reports-positive-12-month-060000162.html,Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate,Primary endpoint met with 99% seroresponse rate 12 months after single-dose vaccinationAntibody levels remained stable from month 6 to month 12No safety...,"VALNEVAPrimary endpoint met with 99% seroresponse rate 12 months after single-dose vaccinationAntibody levels remained stable from month 6 to month 12No safety concern identified during follow-up  confirming the safety profile observed in earlier studiesValneva currently on track to complete rolling submission for Biologics License Application (BLA) with U.S. Food and Drug Administration (FDA) by end of 2022Saint-Herblain (France)  December 5  2022 â€“ Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  a specialty vaccine company  today reported positive antibody persistence data twelve months after vaccination with a single dose of its chikungunya vaccine candidate  VLA1553.Following positive immunogenicity and safety data for Phase 3 study VLA1553-301 in March 20221  Valneva set up a dedicated antibody persistence trial (VLA1553-303) to monitor a subset of participants for a period of at least five years and confirm the anticipated long-term durability of the antibody response after a single vaccination.The antibody persistence trial enrolled 363 healthy adult participants and followed them from month 6 after vaccination to month 12. 99% of participants retained neutralizing antibody titers above the seroresponse threshold of 1502 12 months after the single-dose vaccination. These antibody levels confirm the antibody persistence profile observed in an earlier study3. The antibody persistence was similar in older adults aged â‰¥65 years  who retained neutralizing antibody titers comparable to younger adults throughout the follow-up. These results follow completion of the pivotal study VLA1553-301  for which a seroresponse rate of 96% six months after vaccination1 was reported. The study will continue to monitor antibody persistence on an annual basis.No safety concerns were identified for the duration of the follow-up study  confirming the safety profile observed in previous studies.Juan Carlos Jaramillo M.D.  Chief Medical Officer of Valneva  said  â€œWe are excited about these twelve-month data which are in line with what we saw from our previous read out at month 6  and strengthen the possibilities of inducing a long-lasting antibody response with our chikungunya vaccine candidate. We are looking forward to completing the BLA rolling submission to the FDA and potentially to changing peopleâ€™s lives. If our investigational vaccine is approved  we are confident that it can help address this major  growing and unmet public health threat.â€Story continuesValneva expects to finalize its BLA submission with the FDA by the end of 2022. Once completed  and if the FDA accepts the filing  the FDA will determine priority review eligibility along with the action due date upon which it will complete its evaluation. The program received FDA Fast Track and Breakthrough Therapy designations in 2018 and 2021  respectively. VLA1553 was also granted PRIority MEdicine (PRIME) designation by the EMA in 2020. Valneva currently plans to make additional regulatory submissions for VLA1553 in 2023. Valneva also initiated a Phase 3 trial in adolescents conducted in Brazil by Instituto Butantan to support the label extension in this age group following a potential initial regulatory approval.About ChikungunyaChikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV)  a Togaviridae virus  transmitted by Aedes mosquitoes. Chikungunya virus often causes sudden large outbreaks with high attack rates  affecting one-third to three-quarters of the population in areas where the virus is circulating. There are no preventive vaccines or effective treatments available and  as such  chikungunya is considered to be a major public health threat. As of September 2020  there were more than 3 million reported cases in the Americas4 and the economic impact is considered to be significant. The medical and economic burden is expected to grow as the CHIKV primary mosquito vectors continue to spread geographically. Infection leads to symptomatic disease in up to 97% of humans after three to seven days following the mosquito bite. While mortality with CHIKV is low  morbidity is high. Clinical symptoms include acute onset of fever  debilitating joint and muscle pain  headache  nausea  rash and chronic arthralgia. It is estimated that over three quarters of the worldâ€™s population live in areas at-risk of CHIKV transmission5. High risk areas of infection are places where chikungunya virus-carrying mosquitos are currently endemic  including the Americas  parts of Africa  and Southeast Asia.About VLA1553VLA1553 is a live-attenuated  single dose vaccine candidate targeting the chikungunya virus  which has spread to over 100 countries. It has been designed by deleting a part of the chikungunya virus genome.VLA1553 would expand Valnevaâ€™s existing commercial vaccines portfolio and as such  Valneva intends to commercialize this vaccine  if approved  leveraging its existing manufacturing and commercial operations. The global market for vaccines against chikungunya is estimated to exceed $500 million annually by 20326.To make VLA1553 more accessible to Low and Middle Income Countries (LMIC)  Valneva and Instituto Butantan in Brazil signed an agreement in January 2021 for the development  manufacturing and marketing of VLA15537. The collaboration falls within the framework of the agreement signed between CEPI and Valneva in July 20198  which provides funding of up to $23.4 million with support from the European Unionâ€™s Horizon 2020 program.About Phase 3 trial VLA1553-303VLA1553-303 is a single-arm  open label Phase 3 trial evaluating antibody persistence in 363 participants aged 18 years or above who were immunized with VLA1553 during the pivotal trial VLA1553-301. The primary objective of the trial is to evaluate the persistence of antibodies annually from 1 to 5 years after the single immunization with VLA1553. Study VLA1553-303 collected long-term safety by following-up any Adverse Event of Special Interest (AESI) from the preceding study and collecting new-onset SAE. When participants joined the follow-up study  no AESI was ongoing.Additional information  including a detailed description of the trial design  eligibility criteria and investigator sites  is available at ClinicalTrials.gov (Identifier: NCT04546724).About Valneva SEValneva is a specialty vaccine company focused on the development  production and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. Valneva has leveraged its expertise and capabilities both to commercialize three vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic  including candidates against Lyme disease and the chikungunya virus.Media & Investors ContactsLaÃ«titia Bachelot-FontaineVP Global Communications & European Investor RelationsM +33 (0)6 4516 7099laetitia.bachelot-fontaine@valneva.comJoshua Drumm  PhDVP Global Investor RelationsM +001 917 815 4520joshua.drumm@valneva.comForward-Looking StatementsThis press release contains certain forward-looking statements relating to the business of Valneva  including with respect to the progress  timing  results and completion of research  development  clinical trials  and regulatory review of VLA1553. In addition  even if the actual results or development of Valneva are consistent with the forward-looking statements contained in this press release  those results or developments of Valneva may not be sustained in the future. In some cases  you can identify forward-looking statements by words such as ""could "" ""should "" ""may "" ""expects "" ""anticipates "" ""believes "" ""intends "" ""estimates "" ""aims "" ""targets "" or similar words. These forward-looking statements are based largely on the current expectations of Valneva as of the date of this press release and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results  performance or achievements to be materially different from any future results  performance or achievement expressed or implied by these forward-looking statements. In particular  the expectations of Valneva could be affected by  among other things  uncertainties involved in the development and manufacture of vaccines  unexpected clinical trial results  unexpected regulatory actions or delays  competition in general  currency fluctuations  the impact of the global and European credit crisis  and the ability to obtain or maintain patent or other proprietary intellectual property protection. Success in preclinical studies or earlier clinical trials may not be indicative of results in future clinical trials. In light of these risks and uncertainties  there can be no assurance that the forward-looking statements made during this presentation will in fact be realized. Valneva is providing the information in these materials as of this press release  and disclaim any intention or obligation to publicly update or revise any forward-looking statements  whether as a result of new information  future events  or otherwise.1 Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate - Valneva2 A neutralizing antibody titer of â‰¥150 determined by ÂµPRNT 50   i.e. the antibody level agreed with regulators as endpoint under the accelerated approval pathway.3 Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate  Confirms Plans - Valneva4 PAHO/WHO data: Number of reported cases of chikungunya fever in the Americas. https://www.paho.org/data/index.php/en/mnu-topics/chikv-en/550-chikv-weekly-en.html. Last accessed 13 Oct 2020.5 CDC 2022  Puntasecca CJ 20216 VacZine Analytics Chikungunya virus vaccines Global demand analysis. February 20207 Valneva and Instituto Butantan Sign Final Agreement on Single-Shot Chikungunya Vaccine for Low and Middle Income Countries8 CEPI awards up to $23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccineAttachment",neutral,0.01,0.96,0.03,mixed,0.24,0.11,0.64,True,English,"['Positive 12-Month Antibody Persistence Data', 'Single-Shot Chikungunya Vaccine Candidate', 'Valneva', 'Juan Carlos Jaramillo M.D.', 'attenuated, single dose vaccine candidate', 'unmet public health threat', 'potential initial regulatory approval', 'major public health threat', 'three to seven days', 'dedicated antibody persistence trial', 'existing commercial vaccines portfolio', 'CHIKV primary mosquito vectors', 'positive antibody persistence data', 'additional regulatory submissions', 'one-third to three-quarters', 'Biologics License Application', 'U.S. Food', 'action due date', 'Breakthrough Therapy designations', 'sudden large outbreaks', 'high attack rates', 'specialty vaccine company', 'chikungunya vaccine candidate', 'priority review eligibility', 'mosquito-borne viral disease', 'lasting antibody response', 'Chief Medical Officer', 'chikungunya virus-carrying mosquitos', 'antibody persistence profile', '363 healthy adult participants', 'chikungunya virus genome', 'BLA rolling submission', 'High risk areas', 'earlier studies Valneva', 'FDA Fast Track', 'Primary endpoint', 'positive immunogenicity', 'major, growing', 'Phase 3 trial', 'mosquito bite', 'three quarters', 'existing manufacturing', 'commercial operations', 'investigational vaccine', 'safety data', 'twelve-month data', 'single vaccination', 'Antibody levels', 'antibody titers', 'previous studies', 'PRIority MEdicine', 'symptomatic disease', 'safety profile', 'BLA submission', 'preventive vaccines', 'earlier study', '99% seroresponse rate', 'safety concern', 'Drug Administration', 'Euronext Paris', 'long-term durability', 'seroresponse threshold', 'older adults', 'younger adults', 'annual basis', 'previous read', 'PRIME) designation', 'Instituto Butantan', 'label extension', 'age group', 'Togaviridae virus', 'Aedes mosquitoes', 'effective treatments', 'economic impact', 'economic burden', 'Clinical symptoms', 'acute onset', 'debilitating joint', 'muscle pain', 'chronic arthralgia', 'CHIKV transmission', 'Southeast Asia', 'global market', 'Phase 3 study', 'pivotal study', 'single-dose vaccination', 'five years', 'Valneva SE', 'follow-up study', '65 years', 'Saint-Herblain', 'France', 'December', 'VLA', 'March', 'subset', 'period', 'results', 'completion', 'vaccination1', 'duration', 'line', 'possibilities', 'people', 'lives', 'Story', 'filing', 'evaluation', 'program', 'EMA', 'adolescents', 'Brazil', 'population', 'September', '3 million', 'cases', 'Americas4', 'Infection', 'humans', 'mortality', 'morbidity', 'fever', 'headache', 'nausea', 'rash', 'world', 'places', 'parts', 'Africa', '100 countries']",2022-12-05,2022-12-06,finance.yahoo.com
14223,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567660/0/en/FL-Entertainment-enters-into-liquidity-agreement-with-Kepler-Cheuvreux.html,FL Entertainment: enters into liquidity agreement with Kepler Cheuvreux,Press Release  Paris â€“ December 05th  2022  FL Entertainment N.V. enters into liquidity agreement with Kepler Cheuvreux  As of 05/12/2022  FL...,"Press ReleaseParis â€“ December 05th  2022FL Entertainment N.V. enters into liquidity agreement with Kepler CheuvreuxAs of 05/12/2022  FL Entertainment N.V. (""FLE"") has entrusted Kepler Cheuvreux S.A. with the implementation of a liquidity agreement to ensure liquidity and foster regular trading for FLE shares (ISIN Code NL0015000X07) on Euronext Amsterdam  within the limit of FLEâ€™s authorizations granted by the shareholdersâ€˜ meeting dated June 30  2022.This agreement has an initial period ending on December 31  2022 and is automatically renewable for successive 12-month periods.For the implementation of the liquidity agreement  the following resources were allocated by FLE to the liquidity account: a maximum amount of â‚¬1 000 000.The liquidity agreement may be terminated at any time by FLE or with a notice period by Kepler Cheuvreux S.A. under the conditions stipulated in the liquidity agreement. The execution of the liquidity agreement may also be suspended under the conditions set forth in the agreement.FLE will publish the trades under the liquidity agreement on a weekly basis on its website  available at https://fl-entertainment.com/investor-relations/.This press release contains or may contain information about FL Entertainment N.V. within the meaning of Article 7(1) to (4) of EU Regulation No 596/2014.AgendaFY 2022 results: 16 March 2023Investor RelationsCaroline Cohen â€“ Phone: +33 1 44 95 23 34 â€“ c.cohen@flentertainment.comPress RelationsAnne-France Malrieu - afmalrieu@image7.frAbout FL EntertainmentFounded by StÃ©phane Courbit  a 30-year entertainment industry pioneer and entrepreneur  FL Entertainment Group is a global leader in multimedia content and gambling  combining the strengths of Banijay  the worldâ€™s largest independent producer distributor  with Betclic Everest Group  the fastest-growing online sports betting platform in Europe. In 2021  FL Entertainment recorded through Banijay and Betclic Everest Group  a combined revenue  and adjusted EBITDA  of â‚¬3.5bn and â‚¬609m respectively. FL Entertainment listed on Euronext Amsterdam in July 2022.ISIN: NL0015000X07 - Bloomberg: FLE NA - Reuters: FLE.ASRegulated information related to this press release is available on the website:https://fl-entertainment.com/investor-relations/https://fl-entertainment.com/Attachment",neutral,0.02,0.98,0.0,neutral,0.02,0.98,0.0,True,English,"['FL Entertainment', 'liquidity agreement', 'Kepler Cheuvreux', 'growing online sports betting platform', 'largest independent producer distributor', 'Kepler Cheuvreux S.A.', '30-year entertainment industry pioneer', 'FL Entertainment N.V.', 'successive 12-month periods', 'StÃ©phane Courbit', 'Betclic Everest Group', 'FL Entertainment Group', 'Press Release', 'regular trading', 'Euronext Amsterdam', 'shareholdersâ€˜ meeting', 'initial period', 'following resources', 'maximum amount', 'notice period', 'weekly basis', 'EU Regulation', 'FY 2022 results', 'Investor Relations', 'Press Relations', 'Anne-France Malrieu', 'global leader', 'multimedia content', 'combined revenue', 'adjusted EBITDA', 'liquidity account', 'liquidity agreement', 'ISIN Code', 'Caroline Cohen', 'Regulated information', 'FLE shares', 'FLE NA', 'FLE.AS', 'Paris', 'December', '05/12', 'implementation', 'limit', 'authorizations', 'conditions', 'execution', 'trades', 'website', 'investor-relations', 'meaning', 'Article', 'Agenda', '16 March', 'Phone', 'image', 'strengths', 'Banijay', 'world', 'Europe', 'July', 'Bloomberg', 'Reuters', 'Attachment']",2022-12-05,2022-12-06,globenewswire.com
14224,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221205005453/en/Acticor-Biotech-Receives-European-Medicines-Agency-EMA-Endorsement-on-Key-Parameters-of-ACTISAVE-Its-Pivotal-Phase-IIIII-Study-for-Registration-in-Stroke,Acticor Biotech Receives European Medicines Agency (EMA) Endorsement on Key Parameters of ACTISAVE  Its Pivotal Phase II/III Study for Registration in Stroke,PARIS--(BUSINESS WIRE)--Regulatory News: Acticor Biotech  (ISIN: FR0014005OJ5 - ALACT) (Paris:ALACT)  a clinical stage biopharmaceutical company developing glenzocimab  an innovative drug for the treatment of cardiovascular emergencies  has discussed with theâ€¦,"PARIS--(BUSINESS WIRE)--Regulatory News:Acticor Biotech  (ISIN: FR0014005OJ5 - ALACT) (Paris:ALACT)  a clinical stage biopharmaceutical company developing glenzocimab  an innovative drug for the treatment of cardiovascular emergencies  has discussed with the European Medicines Agency (EMA) the design of its pivotal Phase II/III study to support a potential future marketing authorization application (MAA) for its first-in-class drug  glenzocimab.The discussion meeting took place remotely in October 2022  and Acticor Biotech provided a list of questions concerning the non-clinical development and the study design of the ACTISAVE study.The final advice given by the Committee for Medicinal Product for Human use (CHMP) based on the questions and supporting discussion was very positive. The Agency endorsed the strategy of an adaptive design and validated the choice of two dual primary endpoints: the modified Rankin Scale as an ordinal scale in 7 categories from 0 to 6 and the binary endpoint defined as severe disability or death  i.e.  mRS 4-6 (versus mRS 0-3).Other key features of the study design were also endorsed  such as the two futility interim analyses proposed with their go/no go rules  the prespecified analysis in the promising subgroup of patients with thrombectomy and the adaptive reassessment of the sample size at the second futility analysis. Although CHMP recommendations were issued to further detail some analyses  the statistical methodology was therefore endorsed on its general principles.In addition  the CHMP agreed that reproductive and developmental toxicity studies are not requested to support a future MAA  considering glenzocimab profile and safety results on previous nonclinical studies.As reminder  the positive results of the ACTIMIS phase 1b/2a clinical trial evaluating glenzocimab in combination with the reference treatment (thrombolysis with or without thrombectomy) in patients presenting with acute ischemic stroke (AIS) demonstrated glenzocimab very favorable safety profile by meeting the main criterion of the trial as well as by showing a significant reduction in the number of intracerebral hemorrhages and mortality in the group treated with glenzocimab.Glenzocimab was granted PRIME designation in July 2022  and frequent interactions with the EMA will be planned under the PRIME scheme to optimize the development plan and facilitate quicker access for patients of the drug candidate. To date  the ACTISAVE study has enrolled more than 180 patients. A first futility analysis is planned after 200-300 patients will have been recruited  treated  and monitored for 90 days to confirm safety and ascertain that preliminary results are aligned with the initial trial assumptions.Dr. Yannick PLETAN  Chief Medical Officer of Acticor Biotech comments: â€œIt is presumably the first time that such an adaptive protocol is developed and regulatorily endorsed in acute ischemic stroke. It testifies to the urgent need to develop innovative designs to support the rapid advent of novel solutions to cure that terrible condition. Weâ€™re very proud that glenzocimab can benefit from this recognition.â€Pr Jean-Marie GROUIN  Expert Statistician  added: â€œThe adaptive design proposed in ACTISAVE study optimizes the chances of proving glenzocimab efficacy for the benefit of patients who suffer from this dramatic condition.â€Laurie Jullien  Head of Regulatory Affairs of Acticor Biotech concluded: â€œThis new interaction with the EMA paves the way of a reinforced dialogue to build an efficient development up to the marketing authorization application. We look forward to having additional consultations in 2023 under the PRIME scheme and discuss further our proposed registration strategy. â€œAbout ACTISAVEACTISAVE (NCT05070260) is a multinational  adaptive  multicenter  randomized  double-blind  placebo-controlled  parallel-group Phase 2/3 study evaluating the safety and efficacy of a single dose of glenzocimab used in combination with standard of care (thrombolysis +/- thrombectomy) for acute ischemic stroke.About ACTICOR BIOTECHActicor Biotech is a clinical stage biopharmaceutical company  a spin-off from INSERM (the French National Institute of Health and Medical Research)  which is aiming to develop an innovative treatment for cardiovascular emergencies  including ischemic stroke.Acticor Biotech is developing glenzocimab (ACT017)  a humanized monoclonal antibody (mAb) fragment directed against a novel target of major interest  platelet glycoprotein VI (GPVI). Glenzocimab inhibits platelet binding to the thrombus without affecting physiological hemostasis  thereby limiting the bleeding risk  particularly in the brain.In May 2022  Acticor Biotech presented positive results from its Phase 1b/2a study  ACTIMIS  at the ESOC  confirming the safety profile and showing a reduction in mortality and intracerebral hemorrhage in the glenzocimab-treated group in patients with stroke. The efficacy of glenzocimab is now being evaluated in an international Phase 2/3 study  ACTISAVE  which will include 1 000 patients. In July 2022  Acticor Biotech was granted ""PRIME"" status by the European Medicines Agency (EMA) for glenzocimab in the treatment of stroke. This designation will allow the company to strengthen its interactions and obtain early dialogues with regulatory authorities.Acticor Biotech is supported by a panel of European and international investors (Karista  Go Capital  Newton Biocapital  CMS Medical Venture Investment (HK) Limited  A&B (HK) Limited  Mirae Asset Capital  Anaxago  Primer Capital  Mediolanum farmaceutici and the Armesa foundation). Acticor Biotech is listed on Euronext Growth Paris since November 2021 (ISIN: FR0014005OJ5 â€“ ALACT).For more information  visit: www.acticor-biotech.comDisclaimerThis press release contains certain forward-looking statements concerning Acticor Biotech and its business. Such forward-looking statements are based on assumptions that Acticor Biotech considers to be reasonable. However  there can be no assurance that such forward-looking statements will be verified  which statements are subject to numerous risks  including the risks set forth in the Document de rÃ©fÃ©rence registration document as approved by the AutoritÃ© des marchÃ©s financiers under number R. 22-011 on 26 April 2022 and to the development of economic conditions  financial markets and the markets in which Acticor Biotech operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Acticor Biotech or not currently considered material by Acticor Biotech. The occurrence of all or part of such risks could cause actual results  financial conditions  performance or achievements of Acticor Biotech to be materially different from such forward-looking statements.1 an ordinal scale in 7 categories from 0 to 6 to measure the degree of disability of a stroke patient",neutral,0.0,1.0,0.0,mixed,0.33,0.07,0.59,True,English,"['Pivotal Phase II/III Study', 'European Medicines Agency', 'Acticor Biotech', 'Key Parameters', 'EMA', 'Endorsement', 'ACTISAVE', 'Registration', 'Stroke', 'multinational, adaptive, multicenter, randomized, double-blind, placebo-controlled, parallel-group Phase 2/3 study', 'potential future marketing authorization application', 'international Phase 2/3 study', 'ACTIMIS phase 1b/2a clinical trial', 'pivotal Phase II/III study', 'two dual primary endpoints', 'clinical stage biopharmaceutical company', 'two futility interim analyses', 'Phase 1b/2a study', 'Other key features', 'go/no go rules', 'second futility analysis', 'developmental toxicity studies', 'previous nonclinical studies', 'initial trial assumptions', 'Dr. Yannick PLETAN', 'Pr Jean-Marie GROUIN', 'French National Institute', 'humanized monoclonal antibody', 'European Medicines Agency', 'Chief Medical Officer', 'acute ischemic stroke', 'first futility analysis', 'platelet glycoprotein VI', 'favorable safety profile', 'clinical development', 'adaptive reassessment', 'adaptive protocol', 'adaptive design', 'study design', 'future MAA', 'ACTISAVE study', 'prespecified analysis', 'The Agency', 'Medical Research', 'BUSINESS WIRE', 'Regulatory News', 'Acticor Biotech', 'innovative drug', 'cardiovascular emergencies', 'class drug', 'discussion meeting', 'final advice', 'Medicinal Product', 'Human use', 'supporting discussion', 'Rankin Scale', 'ordinal scale', 'binary endpoint', 'severe disability', 'promising subgroup', 'sample size', 'statistical methodology', 'general principles', 'positive results', 'main criterion', 'intracerebral hemorrhages', 'PRIME designation', 'frequent interactions', 'PRIME scheme', 'development plan', 'quicker access', 'drug candidate', 'preliminary results', 'first time', 'urgent need', 'innovative designs', 'rapid advent', 'novel solutions', 'terrible condition', 'Expert Statistician', 'dramatic condition', 'Laurie Jullien', 'Regulatory Affairs', 'new interaction', 'efficient development', 'additional consultations', 'single dose', 'novel target', 'major interest', 'bleeding risk', 'safety results', 'reference treatment', 'innovative treatment', 'significant reduction', 'registration strategy', 'CHMP recommendations', '200-300 patients', '180 patients', '1,000 patients', 'PARIS', 'ALACT', 'EMA', 'October', 'list', 'questions', 'Committee', 'choice', '7 categories', 'death', 'mRS', 'thrombectomy', 'reproductive', 'reminder', 'combination', 'thrombolysis', 'AIS', 'number', 'mortality', 'Glenzocimab', 'July', '90 days', 'recognition', 'chances', 'efficacy', 'benefit', 'Head', 'way', 'dialogue', 'standard', 'care', 'spin-off', 'INSERM', 'Health', 'ACT01', 'fragment', 'GPVI', 'thrombus', 'hemostasis', 'brain', 'May', 'ESOC']",2022-12-05,2022-12-06,businesswire.com
14225,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567685/0/en/VALNEVA-Declaration-of-shares-and-voting-rights-November-30-2022.html,VALNEVA - Declaration of shares and voting rights: November 30  2022,VALNEVA  Declaration of shares and voting rightsNovember 30  2022......,English FrenchVALNEVADeclaration of shares and voting rightsNovember 30  2022__________________________________________________________________________________________Company name: VALNEVARegistered office: 6 rue Alain Bombard  44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment ADeclaration date: December 5  2022Number of sharescomposing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**138 354 982including: 138 334 468 ordinary shares with a par value of â‚¬0.15 each; and20 514 preferred shares convertible into ordinary shares  with a par value of â‚¬0.15 each 160 911 607 Double voting rights granted on 3 475 ordinary shares November 25 & 26  2022 160 787 285___________________________* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations  this number is calculated on the basis of all shares to which voting rights are attached  including those for which voting rights have been suspended.** Net (or exercisable at a General Meeting) voting rights.Attachment,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['voting rights', 'Declaration', 'shares', 'November', '6 rue Alain Bombard', 'AMF General Regulations', 'Double voting rights', 'Theoretical voting rights', 'Valneva Total number', 'General Meeting', 'English French', 'Company name', 'Registered office', 'Regulated market', 'Euronext Paris', 'Compartment A', 'share capital', 'par value', 'threshold crossings', '138,334,468 ordinary shares', '20,514 preferred shares', '3,475 ordinary shares', 'Declaration date', 'change Date', '44800 Saint-Herblain', 'France', 'December', 'Description', 'November', 'basis', 'accordance', 'Article', 'Attachment']",2022-12-05,2022-12-06,globenewswire.com
14226,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567031/0/en/CGG-Announces-New-Integrated-Multi-Client-Data-Project-in-Southeast-Arizona-to-Support-Mining-Industry.html,CGG Announces New Integrated Multi-Client Data Project in Southeast Arizona to Support Mining Industry,Paris  France â€“ December 5  2022   CGG  a global technology and Earth sciences leader  has announced a new multi-client data project in Southeast...,English FrenchParis  France â€“ December 5  2022CGG  a global technology and Earth sciences leader  has announced a new multi-client data project in Southeast Arizona focusing on exploration and development in the mining industry. The project  supported by industry funding and available to license now  will begin immediately  with final products scheduled for delivery through CGGâ€™s proprietary GeoVerseâ„¢ platform.Dechun Lin  EVP  Earth Data  CGG  said: â€œOur Southeast Arizona data project represents a significant step forward in our strategy to provide integrated data solutions for the mining industry and is an innovative and effective model to improve data access in critical mining regions.â€As part of this project  CGG will acquire over 270 000 line-kilometers of new airborne multi-physics data  including aeromagnetic  radiometric and airborne gravity data. CGGâ€™s extensive team of subsurface experts and data scientists will integrate this data set with 50 000 km2 of satellite imagery  multispectral data  and all available data from a broad spectrum of wells and geological data sources  to deliver a single comprehensive  consistent and cross-disciplinary data set to support innovative methods of exploration.For more info about CGGâ€™s Southeast Arizona multi-client project  contact: SEArizona@cgg.comAbout CGGCGG (www.cgg.com) is a global technology and HPC leader that provides data  products  services and solutions in Earth science  data science  sensing and monitoring. Our unique portfolio supports our clients in efficiently and responsibly solving complex digital  energy transition  natural resource  environmental  and infrastructure challenges for a more sustainable future. CGG employs around 3 300 people worldwide and is listed on the Euronext Paris SA (ISIN: 0013181864).ContactsGroup Communications & Investor RelationsChristophe BarniniTel: + 33 1 64 47 38 11E-Mail: christophe.barnini@cgg.comAttachment,neutral,0.02,0.98,0.0,neutral,0.02,0.97,0.0,True,English,"['New Integrated Multi-Client Data Project', 'Southeast Arizona', 'Mining Industry', 'CGG', 'complex digital, energy transition', 'new airborne multi-physics data', 'new multi-client data project', 'Southeast Arizona multi-client project', 'Southeast Arizona data project', 'airborne gravity data', 'proprietary GeoVerseâ„¢ platform', 'single comprehensive, consistent', 'Contacts Group Communications', 'geological data sources', 'critical mining regions', 'cross-disciplinary data set', 'Euronext Paris SA', 'Earth sciences leader', 'integrated data solutions', 'Earth Data', 'data access', 'data scientists', 'multispectral data', 'available data', 'data science', 'HPC leader', 'mining industry', 'English French', 'global technology', 'industry funding', 'Dechun Lin', 'significant step', 'effective model', 'extensive team', 'subsurface experts', 'satellite imagery', 'broad spectrum', 'unique portfolio', 'natural resource', 'infrastructure challenges', 'sustainable future', 'Investor Relations', 'final products', 'innovative methods', 'Christophe Barnini', 'France', 'December', 'CGG', 'exploration', 'development', 'delivery', 'EVP', 'strategy', 'part', '270,000 line-kilometers', 'radiometric', '50,000 km2', 'wells', 'info', 'SEArizona', 'services', 'sensing', 'monitoring', 'clients', 'environmental', '3,300 people', 'Attachment']",2022-12-05,2022-12-06,globenewswire.com
14227,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567384/0/en/Tarkett-Information-on-the-total-number-of-voting-rights-and-shares-in-Tarkett-s-share-capital-as-of-November-30-2022.html,Tarkett - Information on the total number of voting rights and shares in Tarkettâ€™s share capital as of November 30  2022,PARIS  FRANCE  December 5  2022 - Information on the total number of voting rights and shares in Tarkettâ€™s share capital as of November 30  2022 ...,English FrenchPARIS  FRANCE  December 5  2022 - Information on the total number of voting rights and shares in Tarkettâ€™s share capital as of November 30  2022(Article L233-8-II of the French Commercial Code andArticle 223-16 of the General Regulation of the AutoritÃ© des marchÃ©s financiers)Date Total number of shares in the share capital Total number of voting rights As of November 30  202265 550 281Number of theoretical voting rights:65 811 231 Number of exercisable voting rights:65 701 921** After deduction of the treasury shares without voting rights.***Investor Relations Contactinvestors@tarkett.comMedia contactsTarkett - communication@tarkett.comBrunswick - tarkett@brunswickgroup.com - Tel.: +33 (0) 1 53 96 83 83About TarkettWith a history of 140 years  Tarkett is a worldwide leader in innovative flooring and sports surface solutions  with net sales of â‚¬ 2.8 billion in 2021. Offering a wide range of products including vinyl  linoleum  rubber  carpet  wood  laminate  artificial turf and athletics tracks  the Group serves customers in over 100 countries across the globe. Tarkett has 12 000 employees and 34 industrial sites  and sells 1.3 million square meters of flooring every day  for hospitals  schools  housing  hotels  offices  stores and sports fields. Committed to change the game with circular economy and to reducing its carbon footprint  the Group has implemented an eco-innovation strategy based on Cradle to CradleÂ® principles  fully aligned with its Tarkett Human-Conscious DesignÂ® approach. Tarkett is listed on Euronext Paris (compartment B  ISIN: FR0004188670  ticker: TKTT). www.tarkett-group.comAttachment,neutral,0.0,1.0,0.0,negative,0.0,0.37,0.63,True,English,"['total number', 'voting rights', 'share capital', 'Tarkett', 'Information', 'shares', 'November', 'Tarkett Human-Conscious DesignÂ® approach', 'marchÃ©s financiers', 'Investor Relations Contact', '1.3 million square meters', 'French Commercial Code', 'sports surface solutions', 'theoretical voting rights', 'exercisable voting rights', 'Media contacts Tarkett', 'English French', 'sports fields', 'share capital', 'General Regulation', 'worldwide leader', 'net sales', 'wide range', 'artificial turf', 'athletics tracks', '34 industrial sites', 'circular economy', 'carbon footprint', 'eco-innovation strategy', 'compartment B', 'total number', 'innovative flooring', 'CradleÂ® principles', 'Euronext Paris', 'treasury shares', 'FRANCE', 'December', 'Information', 'November', 'Article', 'Date', 'deduction', 'communication', 'Brunswick', 'Tel.', 'history', '140 years', 'products', 'vinyl', 'linoleum', 'rubber', 'carpet', 'wood', 'laminate', 'Group', 'customers', '100 countries', 'globe', '12,000 employees', 'hospitals', 'schools', 'housing', 'hotels', 'offices', 'stores', 'game', 'ISIN', 'ticker', 'TKTT', 'Attachment']",2022-12-05,2022-12-06,globenewswire.com
14228,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567022/0/en/ForFarmers-N-V-ForFarmers-convenes-Extraordinary-General-Meeting-of-Shareholders-on-17-January-2023.html,ForFarmers N.V.: ForFarmers convenes Extraordinary General Meeting of Shareholders on 17 January  2023,Lochem  5 December  2022Â     ForFarmers convenes Extraordinary General Meeting of Shareholders on 17 January  2023Â Â ForFarmers N.V. announces that......,English DutchLochem  5 December  2022ForFarmers convenes Extraordinary General Meeting of Shareholders on 17 January  2023ForFarmers N.V. announces that Extraordinary General Meeting of Shareholders will be held (as a virtual meeting) on Tuesday 17 January  2023  starting at 10.00 am (CET) in relation to the appointment of Theo Spierings as member of the Executive Board (CEO). The convocation announcement and the agenda and explanatory notes to the agenda are available via the corporate website of ForFarmers (www.forfarmersgroup.eu/en) under Investors / General Meeting of Shareholders.This press release contains information that qualifies as inside information within the meaning of Article 7 paragraph 1 of the EU Market Abuse Regulation.Note to the editor / For additional information:Caroline Vogelzang  Director Investor RelationsM: 0031 6 10 94 91 61E: caroline.vogelzang@forfarmers.euCompany profileForFarmers N.V. (â€˜ForFarmersâ€™  Lochem  the Netherlands) is an internationally operating feed company that offers total feed solutions for conventional and organic livestock farming. ForFarmers gives its very best â€œFor the Future of Farmingâ€: for the continuity of farming and for a financially secure sector that will continue to serve society for generations to come in a sustainable way. By working side-by-side with farmers ForFarmers delivers real benefits: better returns  healthier livestock and greater efficiency. This is achieved by offering tailored and Total Feed solutions and a targeted approach with specialist and expert support.With sales of around 10 million tonnes of feed  ForFarmers is market leader in Europe. ForFarmers has approximately 2 500 employees and is active in the Netherlands  Belgium  Germany  Poland and the United Kingdom. In 2021  revenues amounted to approximately â‚¬2.7 billion. ForFarmers N.V. is listed at Euronext Amsterdam.ForFarmers N.V.  Postbus 91  7240 AB Lochem  T: +31 (0)573 28 88 00info@forfarmers.eu  www.forfarmersgroup.eu/en.,neutral,0.01,0.99,0.0,mixed,0.49,0.14,0.38,True,English,"['Extraordinary General Meeting', 'ForFarmers N.V.', 'Shareholders', '17 January', 'EU Market Abuse Regulation', 'Director Investor Relations', 'total feed solutions', 'Extraordinary General Meeting', 'operating feed company', 'ForFarmers N.V.', 'organic livestock farming', 'market leader', 'virtual meeting', 'Company profile', 'healthier livestock', 'English Dutch', 'Theo Spierings', 'Executive Board', 'convocation announcement', 'explanatory notes', 'corporate website', 'press release', 'Article 7 paragraph', 'secure sector', 'sustainable way', 'real benefits', 'greater efficiency', 'targeted approach', 'expert support', '10 million tonnes', 'United Kingdom', 'Euronext Amsterdam', 'inside information', 'additional information', '7240 AB Lochem', 'Caroline Vogelzang', '5 December', 'Shareholders', '17 January', 'Tuesday', 'CET', 'appointment', 'member', 'CEO', 'agenda', 'Investors', 'meaning', 'editor', 'Netherlands', 'conventional', 'Future', 'continuity', 'society', 'generations', 'returns', 'tailored', 'specialist', 'sales', 'Europe', '2,500 employees', 'Belgium', 'Germany', 'Poland', 'revenues', 'Postbus', '10.00']",2022-12-05,2022-12-06,globenewswire.com
14229,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567427/0/en/Dassault-Syst%C3%A8mes-declaration-of-the-number-of-outstanding-shares-and-voting-rights-as-of-November-30-2022.html,Dassault SystÃ¨mes: declaration of the number of outstanding shares and voting rights as of November 30  2022,Press ReleaseVELIZY-VILLACOUBLAY  France â€” December 5  2022  Declaration of the number of outstanding shares and voting rights as of November 30  2022 ......,English FrenchPress ReleaseVELIZY-VILLACOUBLAY  France â€” December 5  2022Declaration of the number of outstanding shares andvoting rights as of November 30  2022Dassault SystÃ¨mes (Euronext Paris: FR0014003TT8  DSY.PA) today announced below the total number of its outstanding shares and voting rights as of November 30  2022  according to articles 223-16 and 221-3 of the General Regulation of the AutoritÃ© des marchÃ©s financiers.Number of outstanding shares: 1 334 891 109Number of voting rights*: 2 033 581 125*The total number of voting rights is calculated on the basis of the total number of outstanding shares  even if the voting rights attached thereto are suspended  pursuant to Article 223-11 of the General Regulation of the AutoritÃ© des marchÃ©s financiers relating to the method for calculating the percentages of holdings in shares and in voting rights. We invite our shareholders to refer to this article should they need to declare crossing of thresholds.Declarations related to crossing of threshold must be sent to:Dassault SystÃ¨mes  Investors Relations Service  10  rue Marcel Dassault  CS 40501  78946 VÃ©lizy-Villacoublay Cedex (France). E-mail address: Investors@3ds.com###ABOUT DASSAULT SYSTÃˆMESDassault SystÃ¨mes  the 3DEXPERIENCE Company  is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications  our customers push the boundaries of innovation  learning and production to achieve a more sustainable world for patients  citizens  and consumers. Dassault SystÃ¨mes brings value to more than 300 000 customers of all sizes  in all industries  in more than 140 countries. For more information  visit www.3ds.comDassault SystÃ¨mes Investor Relationsâ€™ ContactsFranÃ§ois-JosÃ© BORDONADO / BÃ©atrix MARTINEZinvestors@3ds.com+33 (0)1 61 62 69 24USA & Canada: callie.gauzer@3ds.comÂ© Dassault SystÃ¨mes. All rights reserved. 3DEXPERIENCE  the Compass icon  the 3DS logo  CATIA  BIOVIA  GEOVIA  SOLIDWORKS  3DVIA  ENOVIA  NETVIBES  MEDIDATA  CENTRIC PLM  3DEXCITE  SIMULIA  DELMIA  and IFWE are commercial trademarks or registered trademarks of Dassault SystÃ¨mes  a French â€œsociÃ©tÃ© europÃ©enneâ€ (Versailles Commercial Register # B 322 306 440)  or its subsidiaries in the United States and/or other countries.Attachment,neutral,0.01,0.99,0.0,neutral,0.02,0.97,0.0,True,English,"['Dassault SystÃ¨mes', 'outstanding shares', 'voting rights', 'declaration', 'number', 'November', 'French â€œsociÃ©tÃ© europÃ©enne', 'Dassault SystÃ¨mes Investor Relations', 'collaborative 3D virtual environments', 'des marchÃ©s financiers', 'virtual twin experiences', 'rue Marcel Dassault', 'Investors Relations Service', 'VÃ©lizy-Villacoublay Cedex', 'FranÃ§ois-JosÃ© BORDONADO', 'BÃ©atrix MARTINEZ', 'Versailles Commercial Register', 'English French', 'commercial trademarks', 'Press Release', 'Euronext Paris', 'General Regulation', 'mail address', 'human progress', 'sustainable innovations', 'real world', 'sustainable world', 'Compass icon', '3DS logo', 'CENTRIC PLM', 'registered trademarks', 'United States', 'voting rights', 'outstanding shares', '3DEXPERIENCE Company', '3DEXPERIENCE platform', 'total number', 'other countries', '140 countries', 'VELIZY-VILLACOUBLAY', 'France', 'December', 'Declaration', 'November', 'DSY', 'articles', 'basis', 'method', 'percentages', 'holdings', 'shareholders', 'crossing', 'thresholds', 'CS', 'catalyst', 'business', 'people', 'applications', 'customers', 'boundaries', 'learning', 'production', 'patients', 'citizens', 'consumers', 'value', 'sizes', 'industries', 'information', 'Contacts', 'USA', 'Canada', 'gauzer', 'CATIA', 'BIOVIA', 'GEOVIA', 'SOLIDWORKS', '3DVIA', 'ENOVIA', 'NETVIBES', 'MEDIDATA', '3DEXCITE', 'SIMULIA', 'DELMIA', 'IFWE', 'subsidiaries', 'Attachment', 'Â©']",2022-12-05,2022-12-06,globenewswire.com
14230,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567732/0/en/VGP-NV-Disclosure-in-accordance-with-the-Law-of-2-May-2007-Transparency-law-Transparency-notification-by-Mrs-Griet-Van-Malderen.html,VGP NV: Disclosure in accordance with the Law of 2 May 2007 - Transparency law - Transparency notification by Mrs. Griet Van Malderen,Press ReleaseRegulated InformationAntwerp  5Â DecemberÂ 2022â€“ 07:00 p.m. CET    VGP NV has received a transparency notification dated 1 December 2022 that...,English DutchPress ReleaseRegulated InformationAntwerp  5 December 2022â€“ 07:00 p.m. CETVGP NV has received a transparency notification dated 1 December 2022 that by virtue of the new shares issued by VGP NV following the capital increase which occurred on 29 November 2022  that LVM & Family NV and Mrs. Griet Van Malderen now hold 4.39% of the voting rights of VGP NV. Therefore  their voting rights have crossed the threshold of 3%.The notification dated 1December 2022 contains the following information:Reason for notification:Passive threshold crossingAn acquisition or disposal of voting securities or voting rightsNotification by:A parent undertaking or a controlling person.Persons subject to the notification requirement:LVM & Family NV  Spinnerijstraat 12  9240 ZeleGriet Van MalderenDate on which the threshold is crossed:30 November 2022.Threshold that is crossed:3%Denominator:39 611 782Notified details:Previous notification After the transaction Number of voting rights Number of voting rights % of voting rights LVM & Family NV (previously Vadebo France NV) 655 738 1 475 410 3.72% Griet Van Malderen 118 000 265 500 0.67% Total 773 738 1 740 910 4.39%Chain of controlled undertakings through which the holding is effectively held:LVM & Family NV (previously Vadebo France NV) is exclusively controlled by Mrs. Griet Van Malderen.ABOUT VGPVGP is a pan-European owner  manager and developer of high-quality logistics and semi-industrial real estate. VGP operates a fully integrated business model with capabilities and longstanding expertise across the value chain. Founded in 1998 as a Belgian family-owned real estate developer in the Czech Republic  VGP has a staff of circa 380 FTEs today and operates in 19 European countries directly and through several 50:50 joint ventures. As of June 2022  the Gross Asset Value of VGP  including the joint ventures at 100%  amounted to â‚¬ 6.53 billion and the company had a Net Asset Value (EPRA NTA) of â‚¬ 2.34 billion. VGP is listed on Euronext Brussels. (ISIN: BE0003878957).For more information  please visit: http://www.vgpparks.euAttachment,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['Mrs. Griet Van Malderen', 'VGP NV', 'Transparency notification', 'Transparency law', 'Disclosure', 'accordance', '2 May', 'English Dutch Press Release Regulated Information', 'Belgian family-owned real estate developer', 'Mrs. Griet Van Malderen', 'semi-industrial real estate', 'integrated business model', 'Gross Asset Value', 'Net Asset Value', 'Vadebo France NV', 'several 50:50 joint ventures', 'Passive threshold crossing', 'following information', 'Family NV', 'value chain', 'new shares', 'capital increase', 'voting rights', 'voting securities', 'parent undertaking', 'controlling person', 'controlled undertakings', 'pan-European owner', 'high-quality logistics', 'longstanding expertise', 'Czech Republic', '19 European countries', 'EPRA NTA', 'Euronext Brussels', 'VGP NV', 'transparency notification', 'notification requirement', 'Previous notification', 'transaction Number', 'Antwerp', '5 December', 'CET', 'virtue', '29 November', 'LVM', '1December', 'Reason', 'acquisition', 'disposal', 'Persons', 'Spinnerijstraat', '9240 Zele', 'Date', 'Denominator', 'details', 'holding', 'manager', 'capabilities', 'staff', '380 FTEs', 'June', 'company', 'ISIN', 'vgpparks', 'Attachment', '07:00', '30']",2022-12-05,2022-12-06,globenewswire.com
14231,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567733/0/en/VGP-NV-Disclosure-in-accordance-with-the-Law-of-2-May-2007-Transparency-law-Transparency-notification-by-Mr-Jan-Van-Geet.html,VGP NV: Disclosure in accordance with the Law of 2 May 2007 - Transparency law - Transparency notification by Mr Jan Van Geet,Press ReleaseRegulated InformationAntwerp  5 December 2022 â€“ 07:00 p.m. CET    VGP NV has received a transparency notification dated 1 December 2022...,English DutchPress ReleaseRegulated InformationAntwerp  5 December 2022 â€“ 07:00 p.m. CETVGP NV has received a transparency notification dated 1 December 2022 that by virtue of the new shares issued by VGP NV following the capital increase which occurred on 29 November 2022  that (i) Little Rock SA now holds 23.08% of the voting rights of VGP NV  (ii) Alsgard SA now holds 13.69% of the voting rights of VGP NV  and (iii) Tomanvi SCA now holds 2.81% of the voting rights of VGP NV and that therefore together  Jan Van Geet Little Rock SA  Alsgard SA and Tomanvi SCA now hold 39.58% of the voting rights of VGP NV.The notification dated 1 December 2022 contains the following information:Reason for notification:Passive threshold crossingAn acquisition or disposal of voting securities or voting rightsNotification by:A parent undertaking or a controlling person.Persons subject to the notification requirement:Jan Van GeetLittle Rock SA  25 Boulevard Prince Henri  L-1724 Luxembourg  LuxemburgAlsgard SA  25 Boulevard Prince Henri  L-1724 Luxembourg  LuxemburgTomanvi SCA  25 Boulevard Prince Henri  L-1724 Luxembourg  LuxemburgDate on which the threshold is crossed:30 November 2022Threshold that is crossed:40%Denominator:39 611 782Notified details:Previous notification After the transaction Number of voting rights Number of voting rights % of voting rights Jan Van Geet 0 0 0.00% Little Rock SA 7 936 102 9 143 997 23.08% Alsgard SA 4 819 828 5 422 306 13.69% Tomanvi SCA 484 205 1 113 919 2.81% Total 13 240 135 15 680 222 39.58%Chain of controlled undertakings through which the holding is effectively held:Little Rock SA (previously JVG Invest SA)  Alsgard SA and Tomanvi SCA are exclusively controlled by Mr Jan Van Geet.ABOUT VGPVGP is a pan-European owner  manager and developer of high-quality logistics and semi-industrial real estate. VGP operates a fully integrated business model with capabilities and longstanding expertise across the value chain. Founded in 1998 as a Belgian family-owned real estate developer in the Czech Republic  VGP has a staff of circa 380 FTEs today and operates in 19 European countries directly and through several 50:50 joint ventures. As of June 2022  the Gross Asset Value of VGP  including the joint ventures at 100%  amounted to â‚¬ 6.53 billion and the company had a Net Asset Value (EPRA NTA) of â‚¬ 2.34 billion. VGP is listed on Euronext Brussels. (ISIN: BE0003878957).For more information  please visit: http://www.vgpparks.euAttachment,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['Mr Jan Van Geet', 'VGP NV', 'Transparency notification', 'Transparency law', 'Disclosure', 'accordance', '2 May', 'Jan Van Geet Little Rock SA', 'Belgian family-owned real estate developer', 'Mr Jan Van Geet', 'Press Release Regulated Information', 'semi-industrial real estate', '25 Boulevard Prince Henri', 'integrated business model', 'JVG Invest SA', 'Gross Asset Value', 'Net Asset Value', 'several 50:50 joint ventures', 'Passive threshold crossing', 'voting rights Number', 'Luxemburg Tomanvi SCA', 'Alsgard SA', 'transaction Number', 'following information', 'value chain', 'voting securities', 'English Dutch', 'new shares', 'capital increase', 'parent undertaking', 'controlling person', 'controlled undertakings', 'pan-European owner', 'high-quality logistics', 'longstanding expertise', 'Czech Republic', '19 European countries', 'EPRA NTA', 'Euronext Brussels', 'VGP NV', 'transparency notification', 'notification requirement', 'Previous notification', 'Antwerp', '5 December', 'CET', 'virtue', '29 November', '1 December', 'Reason', 'acquisition', 'disposal', 'Persons', '24 Luxembourg', 'Date', '30 November', 'Denominator', 'details', 'holding', 'manager', 'capabilities', 'staff', 'circa', '380 FTEs', 'June', 'company', 'ISIN', 'vgpparks', 'Attachment', '07:00']",2022-12-05,2022-12-06,globenewswire.com
14232,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567658/0/en/Update-on-share-repurchase-program-KBC-Ancora-until-02-December-2022.html,Update on share repurchase program KBC Ancora until 02 December 2022,Regulated information  inside information  Leuven  05 December 2022 (17:40 CET)  Update on share repurchase program KBC Ancora until 02 December 2022 ...,English Dutch FrenchRegulated information  inside information  Leuven  05 December 2022 (17:40 CET)Update on share repurchase program KBC Ancora until 02 December 2022As part of the EUR 50 million share repurchase program  as confirmed on 20 May 2022  KBC Ancora has announced that it bought back a total of 27 755 shares in the period from 28 November 2022 to 02 December 2022.The following transactions were carried out during the period in question:Transaction date Number of shares Average price (EUR) Lowest price (EUR) Highest price (EUR) Total amount (EUR) Mon 28 November 2022 6 005 39.16 38.92 39.52 235 181.02 Tue 29 November 2022 5 000 39.19 38.68 39.42 195 937.50 Wed 30 November 2022 5 500 39.44 39.20 39.64 216 938.70 Thu 1 December 2022 7 000 39.48 39.10 39.82 276 383.10 Fri 2 December 2022 4 250 40.26 39.22 40.88 171 121.58 TOTAL(period concerned) 27 755 39.47 38.68 40.88 1 095 561.90 TOTAL (overall repurchase program) 838 993 35.19 31.68 40.88 29 524 579.51All transactions were carried out in the central order book of Euronext Brussels.Since the start of the share repurchase program on 10 June 2022  KBC Ancora has bought back 838 993 of its own shares  or 1.07% of the total number of shares issued (i.e. 78 301 314)  for an average price of 35.19 euros per share and for a total amount of 29 524 580 euros. KBC Ancora has currently implemented 59.05% of the repurchase program.The repurchase program runs within the limits of the share repurchase authorization granted by the Extraordinary General Meeting of Shareholders on 30 October 2020.---------------------------------KBC Ancora is a listed company that holds 18.6% of the shares in KBC Group. Together with Cera  MRBB and the Other Permanent Shareholders  it ensures shareholder stability and the ongoing development of the KBC Group. As core shareholders of KBC Group  they have concluded a shareholdersâ€™ agreement to this end.Financial calendar:27 January 2023 Interim financial report (1H)1 September 2023 Annual press release for the financial year 2022/202327 October 2023 Annual General Meeting of ShareholdersThis press release is available in Dutch  French and English on the website www.kbcancora.be.KBC Ancora Investor Relations & Press contact: Jan BergmansTel. +32 (0)16 27 96 72email: jan.bergmans@kbcancora.be or mailbox@kbcancora.beAttachment,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['share repurchase program', 'KBC Ancora', 'Update', '02 December', 'EUR 50 million share repurchase program', 'KBC Ancora Investor Relations', 'central order book', 'Extraordinary General Meeting', 'Annual General Meeting', 'share repurchase authorization', 'Interim financial report', 'Annual press release', 'Other Permanent Shareholders', 'English Dutch French', 'Financial calendar', 'financial year', 'Press contact', 'KBC Group', 'Transaction date', 'Average price', 'Lowest price', 'Highest price', 'Euronext Brussels', 'listed company', 'shareholder stability', 'ongoing development', 'Jan Bergmans', 'jan.bergmans', 'core shareholders', 'shareholdersâ€™ agreement', 'Total amount', 'Regulated information', 'following transactions', 'total number', 'Leuven', '05 December', 'Update', '02 December', 'part', '20 May', '27,755 shares', 'period', '28 November', 'question', 'Mon', 'Wed', '30 November', 'start', '10 June', '35.19 euros', '29,524,580 euros', 'limits', '30 October', 'Cera', 'MRBB', '27 January', '1 September', '27 October', 'website', 'Tel.', 'email', 'kbcancora', 'mailbox', 'Attachment']",2022-12-05,2022-12-06,globenewswire.com
14233,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567659/0/en/Press-release-Biocartis-Group-NV-Mandatory-Conversion-Bondholder-Notification.html,Press release Biocartis Group NV: Mandatory Conversion Bondholder Notification,PRESS RELEASE:Â REGULATED INFORMATION5 December 2022  17:40 CET  Mandatory Conversion Bondholder Notification  Capitalised terms not otherwise defined...,"English DutchPRESS RELEASE: REGULATED INFORMATION5 December 2022  17:40 CETMandatory Conversion Bondholder NotificationCapitalised terms not otherwise defined in this notice shall have the meaning given to them in the Terms and Conditions of the Bonds.Mechelen  Belgium  5 December 2022 â€“ This announcement constitutes a notice (the â€œMandatory Conversion Bondholder Notificationâ€) in accordance with  respectively  Condition 5(m)(v) of the terms and conditions of the 4.00% convertible bonds due 2024/2027 (the ""Existing Convertible Bonds"") (ISIN BE0002651322) and Condition 6(b)(v) of the terms and conditions of the 4.50% new second lien secured convertible bonds due 2024/2026 (the ""New Convertible Bonds"") (together  the ""Terms and Conditions of the Bonds"") (ISIN BE6338582206) issued by Biocartis Group NV (the ""Company"" or ""Biocartis"")  an innovative molecular diagnostics company (Euronext Brussels: BCART).The Company today announces  that the Recapitalisation Transactions (as such term is defined in the Terms and Conditions of the Bonds) have completed on Friday  2 December 2022 (the â€œRecapitalisation Transactions Completion Dateâ€).In accordance with the Terms and Conditions of the Bonds  the occurrence of the Recapitalisation Transactions Completion Date results in a number of consequences for the holders of the Existing Convertible Bonds and/or the New Convertible Bonds  including (but not limited to):the automatic extension of the Final Maturity Dates of such Bonds to 9 November 2026 (in the case of the New Convertible Bonds) and 9 November 2027 (in the case of the Existing Convertible Bonds);the start of the Bondholder Conversion Option Period for the New Convertible Bonds from the Mandatory Conversion Date (as defined in the terms and conditions of the New Convertible Bonds) of Friday  16 December 2022. In accordance with Condition 6(b)(v) of the terms and conditions of the New Convertible Bonds  the Company informs the Bondholders that the lowest price per Share at which Shares were sold to investors in the Required Topco Equity Offering was EUR 0.75 per Share. Accordingly  the initial ""Bondholder Conversion Option Conversion Price"" (as defined in the terms and conditions of the New Convertible Bonds) is EUR 1.125 per Share; andthe Mandatory Conversion of 10% of the principal amount outstanding under each of the Existing Convertible Bonds and the New Convertible Bonds. For the Mandatory Conversion of the Existing Convertible Bonds the Conversion Price in effect on the Conversion Date is EUR 12.8913 per Share; the Mandatory Conversion Price for the New Convertible Bonds is EUR 12.8913 per Share as well.The aforementioned Mandatory Conversion will occur 10 Brussels business days after the Recapitalisation Transactions Completion Date. Accordingly  the Mandatory Conversion Date (in the case of the New Convertible Bonds) and the Conversion Date (in the case of the Existing Convertible Bonds) (both as defined in the Terms and Conditions of the Bonds) is Friday  16 December 2022.In accordance with the Terms and Conditions of the Bonds  the Bondholders are required to complete the following formalities in order to obtain delivery of the shares issued pursuant to the aforementioned Mandatory Conversion:a duly completed and signed Mandatory Conversion Investor Notice needs to be provided by the Bondholder to the Agent (copying such other persons as indicated in the form of the Mandatory Conversion Investor Notice) by 17:00 CET on the Cut-Off Date on Friday  9 December 2022 . In order to complete the Mandatory Conversion Investor Notice  a Bondholder may need to contact the financial institution at which the Bonds are held to its order  for assistance in providing the required securities and bank account details; andneeds to be provided by the Bondholder to the Agent (copying such other persons as indicated in the form of the Mandatory Conversion Investor Notice) by 17:00 CET on the Cut-Off Date on . In order to complete the Mandatory Conversion Investor Notice  a Bondholder may need to contact the financial institution at which the Bonds are held to its order  for assistance in providing the required securities and bank account details; and the Bondholder must request the financial institution at which the Bonds are held to its order to provide the Agent with proof that the Bonds   as specified in the submitted Mandatory Conversion Investor Notice  are held to its order or under its control and blocked by it . This proof must either be a certificate of blocking from the financial institution at which the Bonds are held  or a proof by the recognized account holder of the NBB-SSS Clearing System at which the Bonds are held  delivered by swift messaging directly to the Agent. Such proof must reach the Agent at the latest by 17:00 CET on Monday  12 December 2022.A copy of the current form of the ""Mandatory Conversion Investor Notice"" can be obtained from the Agent (via its specified office or via regulations@belfius.be) or directly from the Company (via rdegrave@biocartis.com).Failure to comply with the formalities by the applicable deadlines will result in the relevant shares being sold by the Share Settlement Agent and the proceeds (if any  after deducting a.o. the costs of such procedure) being distributed rateably to the relevant Bondholders. In view thereof  the Company encourages the Bondholders that have not yet been in contact with the Company in the context of the Recapitalisation Transactions to contact the Company urgently.The Terms and Conditions of the Bonds can be consulted  subject to applicable legal restrictions  on https://investors.biocartis.com/en/convertible-bonds .--- END ---More information:Renate DegraveHead of Corporate Communications & Investor Relations Biocartise-mail rdegrave@biocartis.comtel +32 15 631 729mobile +32 471 53 60 64About BiocartisWith its revolutionary and proprietary Idyllaâ„¢ platform  Biocartis (Euronext Brussels: BCART) aspires to enable personalized medicine for patients around the world through universal access to molecular testing  by making molecular testing actionable  convenient  fast and suitable for any lab. The Idyllaâ„¢ platform is a fully automated sample-to-result  real-time PCR (Polymerase Chain Reaction) based system designed to offer in-house access to accurate molecular information in a minimum amount of time for faster  informed treatment decisions. Idyllaâ„¢'s continuously expanding menu of molecular diagnostic tests address key unmet clinical needs  with a focus in oncology. This is the fastest growing segment of the molecular diagnostics market worldwide. Today  Biocartis offers tests supporting melanoma  colorectal  lung and liver cancer  as well as for COVID-19  Flu  RSV and sepsis. For more information  visit www.biocartis.com or follow Biocartis on Twitter @Biocartis_   Facebook or LinkedIn.Biocartis and Idyllaâ„¢ are registered trademarks in Europe  the United States and other countries. The Biocartis and Idyllaâ„¢ trademark and logo are used trademarks owned by Biocartis. Please refer to the product labeling for applicable intended uses for each individual Biocartis product.This press release is not for distribution  directly or indirectly  in any jurisdiction where to do so would be unlawful. Any persons reading this press release should inform themselves of and observe any such restrictions. Biocartis takes no responsibility for any violation of any such restrictions by any person. This press release does not constitute an offer or invitation for the sale or purchase of securities in any jurisdiction. No securities of Biocartis may be offered or sold in the United States of America absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933  as amended.Important informationThis announcement is not a prospectus for the purposes of Regulation 2017/1129  as amended (together with any applicable implementing measures in any Member State of the European Economic Area  the â€œProspectus Regulationâ€) or the Prospectus Regulation as it forms part of UK domestic law by virtue of the UK European Union (Withdrawal) Act 2018 and as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019 (each as amended) (the ""UK Prospectus Regulation"").THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION  DIRECTLY OR INDIRECTLY  IN THE UNITED STATES OF AMERICA  AUSTRALIA  CANADA  JAPAN  SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW.THIS ANNOUNCEMENT IS FOR GENERAL INFORMATION ONLY AND DOES NOT FORM PART OF ANY OFFER TO SELL OR PURCHASE  OR THE SOLICITATION OF ANY OFFER TO SELL OR PURCHASE  ANY NEW BONDS  OUTSTANDING BONDS OR OTHER SECURITIES. THE DISTRIBUTION OF THIS ANNOUNCEMENT AND THE OFFER  SALE AND PURCHASE OF THE NEW BONDS  NEW TERM LOANS OR THE OUTSTANDING BONDS DESCRIBED IN THIS ANNOUNCEMENT IN CERTAIN JURISDICTIONS MAY BE RESTRICTED BY LAW. ANY PERSONS READING THIS ANNOUNCEMENT SHOULD INFORM THEMSELVES OF AND OBSERVE ANY SUCH RESTRICTIONS.There shall be no offer  solicitation  sale or purchase or exchange of the Existing Convertible Bonds or the New Convertible Bonds in any jurisdiction in which such offer  solicitation  sale  or purchase would be unlawful prior to registration  exemption from registration or qualification under the securities laws of any such jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933  as amended from time to time (the ""U.S. Securities Act"") or the securities laws of any state of the United States  and may not be offered or sold in the United States unless these securities are registered under the U.S. Securities Act  or an exemption from the registration requirements of the U.S. Securities Act is available.Biocartis has not registered  and does not intend to register  any portion of the offering of the securities concerned in the United States  and does not intend to conduct a public offering of securities in the United States. This communication is only addressed to and directed at persons in member states of the European Economic Area (each a ""Member States"") and in the United Kingdom who are ""qualified investors"" within the meaning of Article 2(e) of the Prospectus Regulation and of the UK Prospectus Regulation  respectively (""Qualified Investors""). This communication is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the ""Order"") or (iii) high net worth companies  and other persons to whom it may lawfully be communicated  falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as ""relevant persons""). The securities referred to herein are only available to  and any invitation  offer or agreement to subscribe  purchase or otherwise acquire such securities will be engaged in only with  relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. This announcement cannot be used as a basis for any investment agreement or decision. Biocartis is not liable if the aforementioned restrictions are not complied with by any person.",neutral,0.0,1.0,0.0,negative,0.0,0.0,1.0,True,English,"['Mandatory Conversion Bondholder Notification', 'Biocartis Group NV', 'Press release', '4.50% new second lien secured convertible bonds', 'Bondholder Conversion Option Conversion Price', 'Bondholder Conversion Option Period', 'Mandatory Conversion Investor Notice', 'Recapitalisation Transactions Completion Date', 'innovative molecular diagnostics company', 'Mandatory Conversion Bondholder Notification', 'Mandatory Conversion Price', 'Mandatory Conversion Date', 'Final Maturity Dates', 'Topco Equity Offering', 'NBB-SSS Clearing System', 'bank account details', 'New Convertible Bonds', 'Biocartis Group NV', 'Existing Convertible Bonds', 'lowest price', '4.00% convertible bonds', 'Cut-Off Date', 'account holder', 'English Dutch', 'PRESS RELEASE', 'REGULATED INFORMATION', 'Euronext Brussels', 'automatic extension', 'principal amount', 'Brussels business', 'following formalities', 'other persons', 'financial institution', 'swift messaging', 'The Company', 'current form', 'Such proof', 'Capitalised terms', '5 December', 'CET', 'meaning', 'Conditions', 'Mechelen', 'Belgium', 'announcement', 'accordance', 'ISIN', 'BCART', 'Friday', '2 December', 'number', 'consequences', 'holders', '9 November', 'case', 'start', 'Share', 'investors', 'effect', 'order', 'delivery', 'Agent', 'assistance', 'required', 'securities', 'control', 'certificate', 'blocking', 'Monday', 'copy', 'office', 'regulations', 'rdegrave', 'Failure']",2022-12-05,2022-12-06,globenewswire.com
14234,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567033/0/en/BGHL-EUR-NAV-s.html,BGHL (EUR): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED      Ordinary Shares      The Directors of Boussard & Gavaudan...,"BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 02 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5420 Â£ 24.1925 Estimated MTD return 0.06 % 0.09 % Estimated YTD return -5.68 % -4.40 % Estimated ITD return 175.42 % 141.92 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.40 N/A Premium/discount to estimated NAV -18.67 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.33 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 240.7411 Class GBP A Shares (estimated) Â£ 129.0392The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.For further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.2,0.8,True,English,"['BGHL', 'EUR', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares Number', 'The Class B Euro Shares', 'GAVAUDAN HOLDING LIMITED Ordinary Shares', 'BGHL Ordinary Shares Euro Shares', 'Class GBP A Shares', 'A N/A Average Price', 'N/A Sterling Shares Amsterdam', 'London Stock Exchange plc', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Sterling Shares Shares', 'Euro Shares Amsterdam', 'A N/A Range', 'US Investment Company Act', 'expert financial advice', 'Guernsey Policy Council', 'collective investment scheme', 'UK Listing Authority', 'other professional advice', 'BG Fund ICAV', 'Gavaudan Investment Management', 'closed-ended investment company', 'US Securities Act', 'investment manager fees', 'N/A Shares', 'BG Fund NAV', 'The Shares', 'Dutch Authority', 'Emmanuel Gavaudan', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Financial Markets', 'The Directors', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'following information', 'further information', 'information purposes', 'main market', 'United States', 'Market information', 'necessary approval', 'future results', 'listed securities', 'LSE) Market', 'BOUSSARD', 'business', '02 Dec', 'returns', 'AEX', 'Transactions', 'treasury', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-05,2022-12-06,globenewswire.com
14235,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567032/0/en/BGHL-GBP-NAV-s.html,BGHL (GBP): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED      Ordinary Shares      The Directors of Boussard & Gavaudan...,"BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 02 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5420 Â£ 24.1925 Estimated MTD return 0.06 % 0.09 % Estimated YTD return -5.68 % -4.40 % Estimated ITD return 175.42 % 141.92 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.40 N/A Premium/discount to estimated NAV -18.67 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.33 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 240.7411 Class GBP A Shares (estimated) Â£ 129.0392The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.For further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.2,0.8,True,English,"['BGHL', 'GBP', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares Number', 'The Class B Euro Shares', 'GAVAUDAN HOLDING LIMITED Ordinary Shares', 'BGHL Ordinary Shares Euro Shares', 'Class GBP A Shares', 'A N/A Average Price', 'N/A Sterling Shares Amsterdam', 'London Stock Exchange plc', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Sterling Shares Shares', 'Euro Shares Amsterdam', 'A N/A Range', 'US Investment Company Act', 'expert financial advice', 'Guernsey Policy Council', 'collective investment scheme', 'UK Listing Authority', 'other professional advice', 'BG Fund ICAV', 'Gavaudan Investment Management', 'closed-ended investment company', 'US Securities Act', 'investment manager fees', 'N/A Shares', 'BG Fund NAV', 'The Shares', 'Dutch Authority', 'Emmanuel Gavaudan', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Financial Markets', 'The Directors', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'following information', 'further information', 'information purposes', 'main market', 'United States', 'Market information', 'necessary approval', 'future results', 'listed securities', 'LSE) Market', 'BOUSSARD', 'business', '02 Dec', 'returns', 'AEX', 'Transactions', 'treasury', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-05,2022-12-06,globenewswire.com
14236,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567385/0/en/Atos-opens-New-Global-Delivery-Center-in-Cairo.html,Atos opens New Global Delivery Center in Cairo,Press Release  Atos opens New Global Delivery Center in Cairo  Prime Minister along with the Minister of Communications & IT witness signing...,English FrenchPress ReleaseAtos opens New Global Delivery Center in CairoPrime Minister along with the Minister of Communications & IT witness signing agreement between Atos and Egyptâ€™s ITIDA to expand Atosâ€™ operations in EgyptThe new GDC provides cutting-edge  best-in-class digital services to clients across the globeCairo  Egypt - December 5  2022 - Atos today announces the opening of its new Global Delivery Center (GDC) facility in Cairo  Egypt concluded in a formal signing ceremony together with the Egyptian Prime Minister  Mr. Mostafa Kamal Madbouly  and Egyptâ€™s Minister of Communications and Information Technology  Dr. Amr Talaat.With this new GDC  Atos reinforces its presence in the Middle East and Africa and its commitment to both regional and global clients. This new GDC will boost its offshore delivery capability in addition to enabling it to explore business prospects from the wider region.Egypt produces 100 000 IT graduates each year  with a diverse  gender-balanced workforce. Over 80% of its young working population are fluent in languages such as Arabic  English  French and German. Egypt was also ranked the 4th most pandemic-resilient country  solidifying its position as one of the worldâ€™s best delivery locations1.Leveraging Egyptâ€™s diverse and skilled workforce and strong support from the Ministry of Communications and IT  Atos aims to provide cutting-edge  best-in-class digital services to its clients across the globe. It offers a full range of services  including digital workplace  application development  automated testing  project management  analytics and database  mainframe  server and infrastructure support to its clients with competitive pricing.Dr. Amr Talaat  Egyptâ€™s Minister of Communications and Information Technology endorsed the agreement inked with Atos which comes amongst several agreements with 29 multinational companies  creating over 34 thousand jobs directed towards exports through 35 global delivery centers with export value worth USD 1 billion annually. â€œThese agreements reflect Egyptâ€™s conducive business environment and multinationalsâ€™ confidence in our qualified local talent â€ Talaat commented.H.E. Talaat underlined Egyptâ€™s potential to become the next big hub for digital and high-end services  thanks to the constant efforts made to boost Egyptâ€™s competitiveness in the offshoring industry. â€œWith its unique central location at the crossroads between 3 continents  Egypt delivers a resilient high-quality digital infrastructure  and provides a supportive legislative framework catching up with the global rapid growth â€ he continued. â€œOur plentiful supply of tech talent is all set and ready at a competitive cost  with proven experience in business services delivery for global firms to more than 100 countries with 20 different languages â€ Talaat affirmed.Amr Mahfouz  CEO of ITIDA  said: â€œWe're thrilled to reach an agreement with Atos  helping ITIDA achieve its strategic goals of the ambitious Digital Egypt strategy for the offshoring industry (2022-2026)  that aims at multiplying the exports revenues from the offshoring sector  while creating more domestic jobs for our skilled pool of talent.â€â€œITIDA is working diligently to leverage the current geopolitical situation that led to major challenges across key delivery locations  while simultaneously monitoring the global shortage of talents. We invest heavily in building the digital and soft skills of our large talent pool  with a strategic focus on developing the countryâ€™s capabilities in the high-value services  including engineering  research & development (ER&D)  embedded software  and electronic design â€ Mahfouz added.The diversity of the IT and business services provided in Egypt  along with its cost competitiveness  and government support  encourage global enterprises to launch and expand their global operations reinforcing the countryâ€™s reputation as a favorable  reliable IT offshoring destination and business services hub.Sven Hesterman  Head of Global Delivery Centers Atos  said â€œWe are proud and excited to open a new Global Delivery Centre in Egypt  adding our network of award-winning centres around the world. The talented and diverse workforce in Egypt is an excellent addition to the thousands of dedicated colleagues we have in our centres around the world  serving our customers on a daily basis.â€BÃ©rÃ©nice Chassagne  Head of Growing Markets at Atos  said â€œEgypt is an excellent location for a new Atos GDC  not only because of its strategic geographic location and good infrastructure  but also its robust language capabilities and diverse culture. It is strategically located to provide our customers with all the benefits of scale and flexibility. The decision to open a new Global Delivery Center in the city of Cairo reinforces our commitment to growing markets as one of our key elements in ensuring optimized and high-quality delivery to our clientsâ€.Now with 350 IT professionals  Atos in Egypt plans to hire another 1 000 employees over the next 12 months with an emphasis on local talent. Atos will continue its investment in premise extension  training and skill set development and recruitment of local resources.***About AtosAtos is a global leader in digital transformation with 112 000 employees and annual revenue of c. â‚¬ 11 billion. European number one in cybersecurity  cloud and high performance computing  the Group provides tailored end-to-end solutions for all industries in 71 countries. A pioneer in decarbonization services and products  Atos is committed to a secure and decarbonized digital for its clients. Atos is a SE (Societas Europaea) and listed on Euronext Paris.The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge  education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world  the Group enables its customers and employees  and members of societies at large to live  work and develop sustainably  in a safe and secure information space.Press contactLaura Fau | laura.fau@atos.net | +33 6 73 64 04 18 | @ laurajanefau1 itida - IT Industry Development IndustryAttachment,neutral,0.0,0.99,0.0,mixed,0.65,0.22,0.14,True,English,"['New Global Delivery Center', 'Atos', 'Cairo', 'new Global Delivery Center (GDC) facility', 'favorable, reliable IT offshoring destination', 'Mr. Mostafa Kamal Madbouly', 'BÃ©rÃ©nice Chassagne', 'new Global Delivery Centre', 'resilient high-quality digital infrastructure', 'ambitious Digital Egypt strategy', '35 global delivery centers', 'offshore delivery capability', 'best delivery locations', 'global rapid growth', 'formal signing ceremony', 'young working population', 'supportive legislative framework', 'current geopolitical situation', 'key delivery locations', 'unique central location', 'conducive business environment', 'next big hub', 'business services delivery', 'H.E. Talaat', 'strategic geographic location', 'robust language capabilities', 'Dr. Amr Talaat', 'business services hub', 'new Atos GDC', 'qualified local talent', 'large talent pool', 'diverse, gender-balanced workforce', 'Egyptian Prime Minister', 'class digital services', 'high-quality delivery', 'new GDC', 'global firms', 'global shortage', 'global enterprises', 'global operations', 'offshoring industry', 'offshoring sector', 'infrastructure support', 'excellent location', 'good infrastructure', 'business prospects', 'skilled pool', 'key elements', 'next 12 months', 'digital workplace', 'skilled workforce', 'strategic goals', 'strategic focus', 'diverse workforce', 'global clients', 'high-end services', 'high-value services', 'IT witness', '100,000 IT graduates', 'Amr Mahfouz', '350 IT professionals', 'Press Release', 'Information Technology', 'Middle East', 'wider region', 'strong support', 'full range', 'automated testing', 'project management', 'competitive pricing', '29 multinational companies', '34 thousand jobs', 'export value', 'multinationalsâ€™ confidence', 'constant efforts', 'plentiful supply', 'competitive cost', 'proven experience', 'domestic jobs', 'major challenges', 'soft skills', 'ER&D', 'embedded software', 'electronic design', 'government support', 'Sven Hesterman', 'dedicated colleagues', 'daily basis', 'Growing Markets', 'diverse culture', 'application development', 'several agreements', '20 different languages', 'exports revenues', 'cost competitiveness', 'award-winning centres', 'excellent addition', 'pandemic-resilient country', 'Atosâ€™ operations', 'English French', 'Cairo', 'Communications', 'ITIDA', 'The', 'globe', 'December', 'opening', 'presence', 'Africa', 'commitment', 'regional', 'Arabic', 'German', 'position', 'world', 'Ministry', 'analytics', 'database', 'mainframe', 'server', 'potential', 'crossroads', '3 continents', '100 countries', 'CEO', 'talents', 'engineering', 'research', 'diversity', 'reputation', 'Head', 'network', 'talented', 'thousands', 'customers', 'benefits', 'scale', 'flexibility', 'decision', 'city', 'optimized', '1,000 employees', 'emphasis']",2022-12-05,2022-12-06,globenewswire.com
14237,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567667/0/en/Voltalia-announces-the-success-of-its-approximately-490-million-euros-capital-increase-with-preferential-subscription-rights.html,Voltalia announces the success of its approximately 490 million euros capital increase with preferential subscription rights,"Voltalia (the ""Company"") announces today the success of its capital increase in cash with preferential subscription rights (â€œPSRâ€) in a gross amount of approximately 490 million euros (the â€œCapital Increase with PSRsâ€). The Capital Increase with PSRs will resâ€¦","English FrenchThe gross final amount of the capital increase (including the issue premium) is 489 990 254.40 euros and results in the issuance of 35 765 712 new sharesThe capital increase has been the subject of a total demand of 40 280 324 shares  i.e. a subscription rate of 112.62% (including 98.71% on an irreducible basis)Voltalia's market capitalisation is 2 350 million euros on an undiluted basis following the creation of 35 765 712 new shares  based on a closing price of 17.92 euros as of 2 December 2022Following their subscriptions  Voltalia Investissement  Voltaliaâ€™s reference shareholder  holds 71.30% 1 of the share capital of Voltalia and Proparco holds 2.50%of the share capital of Voltalia and Proparco holds 2.50% The free float  on an undiluted basis  amounts to 573 million euros as of 2 December 2022 compared to 427 million euros on the eve of the capital increase and represents 24.40% of the share capital compared to 23.72% before the capital increaseThe net proceeds of the Capital Increase with PSRs are intended to provide the Company with additional means to finance its target of a consolidated capacity in operation or under construction of at least 5.0 GW by 2027  for which the Company considers that the amount of investment required is between 2.5 and 3 billion euros.Voltalia (the ""Company"") announces today the success of its capital increase in cash with preferential subscription rights (â€œPSRâ€) in a gross amount of approximately 490 million euros (the â€œCapital Increase with PSRsâ€). The Capital Increase with PSRs will result in 35 765 712 new shares being issued (the â€œNew Sharesâ€)  at a subscription price of 13.70 euros per share.â€œI sincerely thank  on behalf of all Voltalia employees  the numerous shareholders who have shown their support by participating in this capital increase and contributing to its success. This strong mobilization motivates us even more to commit ourselves to pursue the mission that drives us on a daily basis to improve the global environment by promoting local development. The funds raised will enable us to accelerate our strategic roadmap with a view to achieve the ambitions we have set ourselves for 2027. Faced with the challenges of climate emergency and energy independence which have become crucial in the context of an unprecedented energy crisis in Europe in particular  Voltalia's teams are responding by providing concrete and realistic solutions to build a more sustainable world. This is the cornerstone to our success. â€ says SÃ©bastien Clerc  CEO of Voltalia.***Reasons for the Capital Increase with PSRsThe issue of the New Shares is intended to provide the Company with additional means to finance its target of a consolidated capacity in operation or under construction of at least 5.0 GW by 2027  for which the Company considers that the amount of investment required is between 2.5 and 3 billion euros. In this respect  the Company plans to allocate at least 450 million euros of the funds raised to the construction of its new production capacity by 2027.The balance of the funds raised will be used to finance (i) the Companyâ€™s growth in services in order to reach its objective of operating and maintaining more than 8 GW of power plants on behalf of third parties and (ii) possible targeted acquisitions  in particular to strengthen the Companyâ€™s presence in its new geographical areas in Africa  Latin America or Europe.Results of the Capital Increase with PSRsThe gross amount of the Capital Increase with PSRs (including the issue premium) is 489 990 254.40 euros and results in the issue of 35 765 712 New Shares at a subscription price of 13.70 euros per New Share (i.e. a nominal value of 5.70 euros and an issue premium of 8.00 euros).Following the subscription period which ended 30 November 2022  total demand amounted to 40 280 324 shares  representing a subscription rate of 112.62%.35 304 924 New Shares have been subscribed on an irreducible basis and represent approximately 98.71% of the New Shares to be issued;Demand on a reducible basis represented 4 975 400 New Shares and will therefore only be partially allocated  460 788 New Shares being allocated according to a coefficient of 0.06254025 calculated on the basis of the number of PSRs underlying subscriptions made on an irreducible basis without it resulting in an allocation of fractions of New Shares and without the allocation of more shares than the number of New Shares requested on a reducible basis.Subscription commitments and subscription intentions of the main shareholders of the Company or members of its administrative or management bodies or anyone intending to subscribe to more than 5% of the New SharesAs of the date of the launch of the Capital Increase with PSRs  the Company had subscription commitments (the ""Subscription Commitments"")  on an irreducible basis  for a total amount of 357 454 262.40 euros  representing approximately 72.95% of the Capital Increase with PSRs  based on a subscription price of 13.70 euros per New Share.Voltalia Investissement   which held on 31 October 2022  71.30% of the capital and 82.77% of the voting rights of the Company  has subscribed directly and indirectly to 25 196 682 New Shares for a total amount of 345 194 543.40 euros.which held on 31 October 2022  71.30% of the capital and 82.77% of the voting rights of the Company  has subscribed directly and indirectly to 25 196 682 New Shares for a total amount of 345 194 543.40 euros. The SociÃ©tÃ© de Promotion et de Participation pour la CoopÃ©ration Economique (â€œProparcoâ€)  which held on 31 October 2022  2.50% of the capital and 1.48% of the voting rights of the Company  has subscribed to 894 870 New Shares for a total amount of 12 259 719 euros.In addition  the corporate officers of the Company mentioned below have each subscribed to the Capital Increase with PSRs: Laurence Mulliez  Chairman of the Board of Directors  for an amount of approximately 57 000 euros  The Green Option  director  for an amount of approximately 100 000 euros and SÃ©bastien Clerc  Chief Executive Officer  for an amount of around 190 000 euros.Impact of the Capital Increase with PSRs on the allocation of the share capitalFollowing the Capital Increase  Voltalia's share capital will amount to 747 503 380.80 euros and will consist of 131 140 944 shares with a nominal value of 5.70 euros each. It will break down as follows:After the Capital Increase with PSRs ShareholdingUndiluted basis Diluted basis(1) Number of shares % of capitall Number of voting rights(2) % voting rights Number of shares % of capitall Number of voting rights(2) % voting rights Voltalia Investissement(3)(4) 93 497 077 71.30 % 159 321 642 80.69 % 93 497 077 66.74 % 159 321 642 77.19 % Proparco 3 281 193 2.50 % 3 281 193 1.66 % 3 281 193 2.34 % 3 281 193 1.59 % EBRD 2 129 501 1.62 % 2 129 501 1.08 % 2 129 501 1.52 % 2 129 501 1.03 % Treasury-shares 239 928 0.18 % 239 928 0.12 % 239 928 0.17 % 239 928 0.12 % Free-float 31 993 245 24.40 % 32 471 559 16.45 % 40 945 539 29.23 % 41 423 853 20.07 % Total 131 140 944 100.00 % 197 443 823 100.00 % 140 093 238 100.00 % 206 396 117 100.00 %(1) In the event of the vesting of all the shares allocated under the free share allocation plans and conversion into shares of the Green OCEANEs based on a 1:1 conversion ratio.(2) A double voting right is attributed to all fully paid-up shares for which there is evidence of registered registration for at least two consecutive years in the name of the same shareholder.(3) As of 31 October 2022  99.39% of Voltalia Investissementâ€™s capital was held by the Mulliez family (through AlterBiz (formerly Creadev S.A) and CREA-FIVE SC  holding 99.01% and 0.38% respectively of Voltalia Investissementâ€™s capital)  0.34% by SOPARVOLTALIA  0.24% by SÃ©bastien Clerc  0.007% by Laurence Mulliez and 0.017% by Company employees.(4) Including 2 988 293 shares loaned by Voltalia Investissement under the share loan arrangement set up with the Borrowers as part of the issue of Green OCEANEs (according to the information provided by the Borrowers). The number of shares loaned by Voltalia Investissement (representing 2 173 310 shares as of 15 November 2022) has been increased by a number of shares corresponding to the shares subscribed through the exercise of the PSRs attached to the shares loaned by Voltalia Investissement or synthetically through the acquisition of existing shares  i.e. 814 983 additional loaned shares (representing a total number of loaned shares of 2 988 293).Lock-up commitment of the CompanyAs of the date of approval by the AutoritÃ© des marchÃ©s financiers (â€œAMFâ€) on the prospectus relating to the Capital Increase with PSRs  i.e. 15 November 2022  and for a period expiring 180 calendar days following the settlement-delivery date of the New Shares  subject to certain standard exceptions.Lock-up commitments of Voltalia Investissement and ProparcoAs of the date of approval by the AMF on the prospectus relating to the Capital Increase with PSRs   i.e. 15 November 2022  and for a period expiring 180 calendar days following the settlement-delivery date of the New Shares  subject to certain standard exceptions.Indicative timetableThe settlement-delivery and admission of the New Shares to trading on Euronext Paris (Compartment B) will take place on 7 December 2022. New shares will immediately entitle their holders to receive dividends. They will be immediately fungible with existing shares of the Company  and will be traded on the same line under the ISIN code FR0011995588.The Capital Increase with PSRs was conducted by BNP Paribas and Goldman Sachs Bank Europe SE as structuring agents and global coordinators  lead managers and joint bookrunners  Banco Santander  S.A.  CrÃ©dit Agricole Corporate and Investment Bank and Natixis  as global coordinators  lead managers and joint bookrunners (together  the â€œGlobalCoordinators  Lead Managers and Joint Bookrunnersâ€)  as well as with CIC and Portzamparc as co-lead managers (together with the Global Coordinators  Lead Managers and Joint Bookrunners  the â€œFinancial Institutionsâ€).Information of the publicThe prospectus  which was approved by the AMF on 15 November 2022 under the number 22-447 is composed of (i) the Universal Registration Document filed with the AMF on 2 May 2022 under the number D.22-0410  (ii) an amendment to the Universal Registration Document filed with the AMF on 15 November 2022 under the number D.22-0410-A01  (iii) the securities note (Note dâ€™OpÃ©ration) dated 15 November 2022 and (iv) a summary of the prospectus (included in the securities note).Copies of the prospectus may be obtained free of charge and upon request from the company  84  boulevard de SÃ©bastopol  75003 Paris  France â€“ and from the internet websites of Voltalia (www.voltalia.com) and the AMF (www.amf-france.org).Voltalia draws the publicâ€™s attention to chapter 2  â€œRisk factors and Risk Managementâ€  of the Universal Registration Document filed with the AMF  chapter 5 â€œMain Risks and Trends as of 30 June 2022â€ of the amendment of the Universal Registration Document  and to chapter 2 â€œRisk factors related to the offeringâ€ of the Note dâ€™OpÃ©ration.About Voltalia (www.voltalia.com) Voltalia is an international player in the renewable energy sector. The Group produces and sells electricity generated from wind  solar  hydraulic  biomass and storage facilities that it owns and operates. Voltalia has a generating capacity in operation and under construction of 2.4 GW and a portfolio of projects under development representing a total capacity of 13.6 GW.Voltalia is also a service provider and supports its investor clients in renewable energy projects during all phases  from design to operation and maintenance.As a pioneer in the corporate market  Voltalia provides a global offer to private companies  ranging from the supply of green electricity and energy efficiency services to the local production of their own electricity.With more than 1 450 employees in 20 countries on 4 continents  Voltalia has the capacity to act globally for its customers.Voltalia is listed on the regulated market of Euronext Paris  compartment B (FR0011995588 â€“ VLTSA) and is part of the EnterNext Tech 40  CAC Mid & Small and Euronext Tech Leaders indices. The Group is also included in the GaÃ¯a-Index  an index for socially responsible midcaps. Voltalia shares are PEA eligible  under certain conditions. VoltaliaInvestor Relations: invest@voltalia.comT. +33 (0)1 81 70 37 00 ActifinPress Contact: Loris Daougabelldaougabel@actifin.fr. T. +33 6 59 01 36 64DisclaimerNo communication and no information in respect of Voltaliaâ€™s share capital increase with shareholdersâ€™ preferential subscription rights  may be distributed to the public in any jurisdiction in which such registration or approval is required. No action has been or will be undertaken outside of France in any jurisdiction in which such actions would be required. The issue  the exercise or the sale of preferential subscription rights  and the subscription for or the purchase of new shares or preferential subscription rights may be subject to specific legal or regulatory restrictions in certain jurisdictions. Voltalia assumes no responsibility for any violation of any such restrictions by any person.This announcement is an advertisement and not a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (as amended  the â€œProspectus Regulationâ€).With respect to the member States of the European Economic Area  other than France (each  a â€œRelevant Member Stateâ€)  no action has been or will be undertaken to make an offer to the public of the securities requiring a publication of a prospectus in any relevant member State. As a result  the preferential subscription rights and the new shares may not and will not be offered except in accordance with the exemptions set forth in Article 1(4) of the Prospectus Regulation or under any other circumstances that do not require the publication by Voltalia of a prospectus pursuant to Article 3 of the Prospectus Regulation and/or to applicable regulations of that Relevant Member State e.This press release and the information it contains are being distributed to and are only intended for persons who are (x) outside the United Kingdom or (y) in the United Kingdom who are qualified investors (as defined in the Prospectus Regulation as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) and are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005  as amended  (the â€œOrderâ€)  (ii) high net worth entities and other such persons falling within Article 49(2)(a) to (d) of the Order (â€œhigh net worth companiesâ€  â€œunincorporated associationsâ€  etc.) or (iii) other persons to whom an invitation or inducement to participate in investment activity (within the meaning of Section 21 of the Financial Services and Market Act 2000) may otherwise lawfully be communicated or caused to be communicated (all such persons in (y)(i)  (y)(ii) and (y)(iii) together being referred to as â€œRelevant Personsâ€). Any invitation  offer or agreement to subscribe  purchase or otherwise acquire securities to which this press release relates will only be engaged with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this press release or any of its contents.This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities nor of any offer or solicitation to sell securities in the United States of America. The preferential subscription rights and the new shares of Voltalia have not been and will not be registered under the U.S. Securities Act of 1933  as amended (the â€œU.S. Securities Actâ€)  and may not be offered or sold  directly or indirectly  within the United States of America except pursuant to an exemption from or in a transaction not subject to  the registration requirements of the Securities Act. Voltalia does not intend to register any portion of the proposed offering in the United States of America nor to conduct an offering of securities to the public in the United States of America.The distribution of this document in certain countries may constitute a breach of applicable law. The information contained in this document does not constitute an offer of securities for sale in the United States of America  Canada  Australia or Japan.This press release may not be published  forwarded or distributed  directly or indirectly  in the United States of America  Canada  Australia or Japan.1 Including the shares loaned by Voltalia Investissement under the share loan arrangement set up with BNP Paribas Arbitrage SNC  Goldman Sachs Bank Europe SE and Natixis (the â€œBorrowersâ€) (according to the information provided by the Borrowers) as part of the issue of green bonds convertible into and/or exchangeable for new and/or existing shares issued on 13 January 2021 and supplemented by the issue of fully fungible Green OCEANEs on 29 July 2022 (together  the â€œGreen OCEANEsâ€).Attachment",neutral,0.1,0.9,0.0,mixed,0.67,0.21,0.12,True,English,"['490 million euros capital increase', 'preferential subscription rights', 'Voltalia', 'success', 'SÃ©bastien Clerc', 'possible targeted acquisitions', 'unprecedented energy crisis', 'new geographical areas', 'preferential subscription rights', 'new production capacity', 'gross final amount', 'The Capital Increase', 'PSRs underlying subscriptions', 'energy independence', 'consolidated capacity', 'gross amount', 'subscription rate', 'subscription price', 'subscription period', 'Subscription commitments', 'subscription intentions', 'English French', 'total demand', 'market capitalisation', 'closing price', 'reference shareholder', 'free float', 'net proceeds', 'additional means', 'numerous shareholders', 'strong mobilization', 'global environment', 'local development', 'strategic roadmap', 'climate emergency', 'realistic solutions', 'sustainable world', 'power plants', 'third parties', 'Latin America', 'nominal value', 'main shareholders', 'management bodies', 'New Share', 'irreducible basis', 'undiluted basis', 'daily basis', 'share capital', 'total amount', 'issue premium', '350 million euros', '573 million euros', '427 million euros', '3 billion euros', '490 million euros', '450 million euros', 'Voltalia Investissement', 'Voltalia employees', '40,280,324 shares', '489,990,254.40 euros', '17.92 euros', '13.70 euros', '5.70 euros', '8.00 euros', '4,262.40 euros', 'results', 'issuance', 'subject', 'creation', '2 December', 'Proparco', 'Company', 'operation', 'construction', '5.0 GW', 'investment', 'success', 'cash', 'behalf', 'support', 'mission', 'funds', 'view', 'ambitions', 'challenges', 'context', 'Europe', 'teams', 'concrete', 'cornerstone', 'CEO', 'Reasons', 'respect', 'balance', 'growth', 'services', 'order', 'objective', '8 GW', 'presence', 'Africa', 'coefficient', 'number', 'allocation', 'fractions', 'members', 'administrative', 'launch', '31 Octobe', '24.', '2.5', '2027', '112.', '357']",2022-12-05,2022-12-06,globenewswire.com
14238,EuroNext,NewsApi.org,https://www.prnewswire.com/news-releases/broadridge-appoints-martin-koopman-as-chief-product-officer-301694095.html,Broadridge Appoints Martin Koopman as Chief Product Officer,NEW YORK  Dec. 5  2022 /PRNewswire/ -- Broadridge Financial Solutions  Inc. (NYSE: BR)  a global Fintech leader  is pleased to announce the appointment of Martin Koopman as Chief Product Officer  effective January 1  2023. In this role  Martin will lead the Pâ€¦,"NEW YORK  Dec. 5  2022 /PRNewswire/ -- Broadridge Financial Solutions  Inc. (NYSE: BR)  a global Fintech leader  is pleased to announce the appointment of Martin Koopman as Chief Product Officer  effective January 1  2023.Broadridge Appoints Martin Koopman as Chief Product OfficerIn this role  Martin will lead the Product Management team working across all business units to collectively drive Broadridge's delivery of world-class SaaS and other service offerings to leading financial services clients. He will be responsible for Broadridge's enterprise product vision and strategy  building enterprise-wide platforms to benefit Broadridge clients  empowering product management teams  and accelerating innovation in partnership with our technology teams.""Martin has a proven record of driving product innovation both at Broadridge and at previous companies "" said Tim Gokey  Chief Executive of Broadridge. ""His vision and proven ability to execute will be invaluable as we become the foremost SaaS provider to the financial services industry.""""I'm excited to lead our efforts as we scale to become the leading global FinTech serving Governance  Capital Markets  and Wealth and Investment Management "" said Martin Koopman  Chief Product Officer of Broadridge. ""I look forward to working with our clients and our talented product management and technology associates to ensure that we continue to deliver world-class solutions for our clients.""In his new role  Martin will report directly to CEO Tim Gokey. Martin joined Broadridge in 2014 as Head of Strategy for Broadridge's Investor Communication Services business. In 2017  he was named President  Bank Broker-Dealer (BBD)  where he helped steer that business through a period of double-digit growth and innovation. Martin oversaw the successful launch of 70+ product initiatives  including the Shareholder Rights Directive solution in Europe with 300+ new clients; retail shareholder tools  including the ProxyVote app  proxyvote.com and external APIs. Martin has 23 years of industry experience across both investor communications and capital markets/institutional trading  and he has held positions at NYSE Euronext  Boston Consulting Group  and Itiviti/Orc Software after its acquisition of Cameron Systems  which he co-founded.About BroadridgeBroadridge Financial Solutions (NYSE: BR)  a global Fintech leader with more than $5 billion in revenues  provides the critical infrastructure that powers investing  corporate governance and communications to enable better financial lives. We deliver technology-driven solutions that drive business transformation for banks  broker-dealers  asset and wealth managers and public companies. Broadridge's infrastructure serves as a global communications hub enabling corporate governance by linking thousands of public companies and mutual funds to tens of millions of individual and institutional investors around the world. Our technology and operations platforms underpin the daily trading of more than U.S. $9 trillion of equities  fixed income  and other securities globally. A certified Great Place to WorkÂ®  Broadridge is part of the S&P 500Â® Index  employing over 14 000 associates in 21 countries.For more information about us please visit broadridge.com .Investors:W. Edings ThibaultInvestor Relations[email protected]Media:Gregg RosenbergCorporate Communications[email protected]SOURCE Broadridge Financial Solutions  Inc.",neutral,0.01,0.99,0.0,positive,0.79,0.2,0.0,True,English,"['Chief Product Officer', 'Martin Koopman', 'Broadridge', 'leading global FinTech serving Governance', 'Shareholder Rights Directive solution', 'Investor Communication Services business', 'SOURCE Broadridge Financial Solutions', 'global Fintech leader', 'retail shareholder tools', 'Boston Consulting Group', 'W. Edings Thibault', '70+ product initiatives', 'financial services industry', 'Chief Product Officer', 'Product Management team', 'talented product management', 'other service offerings', 'foremost SaaS provider', 'global communications hub', 'S&P 500Â® Index', 'financial services clients', 'CEO Tim Gokey', 'enterprise product vision', '300+ new clients', 'corporate governance', 'financial lives', 'world-class solutions', 'technology-driven solutions', 'Chief Executive', 'Investment Management', 'investor communications', 'Investor Relations', 'world-class SaaS', 'industry experience', 'U.S.', 'other securities', 'NEW YORK', 'business units', 'business transformation', 'product innovation', 'technology teams', 'enterprise-wide platforms', 'previous companies', 'Capital Markets', 'Bank Broker', 'double-digit growth', 'successful launch', 'external APIs', 'institutional trading', 'Itiviti/Orc Software', 'Cameron Systems', 'public companies', 'mutual funds', 'operations platforms', 'daily trading', 'fixed income', 'Great Place', 'Gregg Rosenberg', 'Corporate Communications', 'new role', 'Broadridge clients', 'ProxyVote app', 'NYSE Euronext', 'critical infrastructure', 'wealth managers', 'institutional investors', 'Martin Koopman', 'technology associates', '14,000 associates', 'Dec.', 'PRNewswire', 'Inc.', 'appointment', 'delivery', 'strategy', 'partnership', 'record', 'proven', 'ability', 'efforts', 'Head', 'Dealer', 'BBD', 'period', 'Europe', '23 years', 'positions', 'acquisition', 'revenues', 'investing', 'banks', 'asset', 'thousands', 'tens', 'millions', 'individual', 'equities', '21 countries', 'information', 'Media']",2022-12-05,2022-12-06,prnewswire.com
14239,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/05/2567668/0/en/Quadient-SA-Solid-Q3-performance-thanks-to-robust-subscription-related-revenue-growth-and-despite-delays-in-parcel-locker-projects-in-the-US.html,Quadient SA - Solid Q3 performance thanks to robust subscription-related revenue growth and despite delays in parcel locker projects in the US,Solid Q3 performance thanks to robust subscription-related revenue growth and despite delays in parcel locker projects in the US  Group revenue of......,English FrenchSolid Q3 performance thanks to robust subscription-related revenue growth and despite delays in parcel locker projects in the USGroup revenue of â‚¬ 79 3 million in 9M 2022  up 5.6 % on a reported basis and 0.8% 1 organically compared to 9M 2021.and 0.8% organically compared to 9M 2021. G rowth in subscription-related revenue reached 3 .0 % on an organic basis  further demonstrating the strength of the recurring business model.on an organic basis  further demonstrating the strength of the recurring business model. Revenue for Q3 2022 was up 8.8% on a reported basis and up 1.0%1 on an organic basis to â‚¬270 million at Group level  a small increase against the organic growth trend achieved in H1 2022.At Major Operations level:Intelligent Communication Automation cloud software revenue was up 5.2% organically in the 9M 2022  supported by a strong 17.2% increase in subscription-related revenue. Annual Recurring Revenue growth stood at +22% on an annualized organic basis  at the end of the period.in subscription-related revenue. basis  at the end of the period. Mail-Related Solutions continues to prove its resilience with a limited organic decline of -0.6% in Q3  bringing the 9M performance to -0.4% organic change.of -0.6% in Q3  bringing the 9M performance to -0.4% organic change. Parcel Locker Solutions revenue was flat in Q3 2022  at -0.2% on an organic basis. Positive contribution from existing contract deployments offset delays in some retail deals and locker installations in the residential sector  both in the US. Revenue for the 9M 2022 was down -1.8% organically.Strong Q4 expectations reiterated across Solutions  not fully offsetting the weak Q3 US lockers performanceOn a reported basis  Group FY 2022 r evenue and current EBIT 2 are expected to grow over last year level benefiting from a favourable forex contribution thanks to the Groupâ€™s significant and growing US presence.over last year level benefiting from a favourable forex contribution thanks to the Groupâ€™s significant and growing US presence. O rganic growth in revenue for the FY 2022 is now expected at above 1% 3   compared to above 2% previously 4 . Whilst the Group maintains its expectations for a strong Q4 performance across Solutions  a weaker Q3 from Parcel Lockers and the uncertain level of backlog reduction in Q4 (backlog level is up over +40% compared to 9M 2021) have led to a cautious approach to the full year outlook.Whilst the Group maintains its expectations for a strong Q4 performance across Solutions  a weaker Q3 from Parcel Lockers and the uncertain level of backlog reduction in Q4 (backlog level is up over +40% compared to 9M 2021) have led to a cautious approach to the full year outlook. FY 2022 current EBIT2 guidance4 is now expected at a low to mid-single digit year-on-year organic decline compared to a previous guidance of a low to mid-single digit organic growth. H2 2022 EBIT margin is still expected to show a significant improvement against H1 2022 level  however  lower than expected Q3 organic revenue organic growth has also led to an updated EBIT4 guidance as it carries a direct impact on the operating profitability level.Paris  5 December 2022 Quadient (Euronext Paris: QDT)  a leader in business solutions for meaningful customer connections through digital and physical channels  announces today its 2022 third quarter and nine-month consolidated sales (period ended on 31 October 2022).Geoffrey Godet  Chief Executive Officer of Quadient  stated: â€œWith strong growth in subscription-related revenue and a very attractive level in Annual Recurring Revenue  we are pleased with the Q3 performance of our Software business as this further confirms the strength of our product offering. The solid performance of our SaaS platform is complemented by a seventh consecutive quarter of resilience for our Mail-Related Solutions  which posted a marginal organic decline. Parcel Locker Solutions  which has been impacted by US projects postponement to 2023 with retailers  remains very dynamic with strong bookings achieved in Q3. Given the more challenging macro environment  it is important to stress the relevance of our offer and the resilience of our recurring business model. All our Solutions enable organizations to achieve significant time and costs savings while providing their customers with a superior experience. I am proud of the integrated and balanced portfolio of solutions we have built and confident in our ability to deliver a strong level of organic growth in Q4.â€SOLID GROWTH ON A REPORTED BASIS  ORGANIC TREND IN LINE WITH H1Group sales stood at â‚¬793 million in the 9M 2022. On a reported basis  Group sales went up 5.6% compared to 9M 2021  including a positive currency impact of +6.7% and a negative scope effect of -2.2%. In details  changes of scope are related to the acquisition of Beanworks in March 2021 and the divestment of Automated Packaging Systems in July 2021 as well as the more recent divestments of the Graphic business in the Nordics and the Shipping activities in France (both in June 2022). Group sales were up 0.8% organic basis in the 9M 2022.Consolidated salesIn â‚¬ million 9M 2022 9M 2021 Change Organic change(1) Major Operations 749 689 +8.6% +0.7% Intelligent Communication Automation 166 147 +12.7% +5.2% Mail-Related Solutions 518 481 +7.8% (0.4)% Parcel Locker Solutions 65 62 +4.8% (1.8)% Additional Operations 45 62 (28.5)% +2.0% Group total 793 752 +5.6% +0.8%In â‚¬ million 9M 2022 9M 2021 Change Organic change(1) Major Operations 749 689 +8.6% +0.7% North America 442 378 +17.0% +3.0% Main European countries(a) 267 274 (2.5)% (3.2)% International(b) 40 38 +5.7% +5.2% Additional Operations 45 62 (28.5)% +2.0% Group total 793 752 +5.6% +0.8% (a) Including Austria  Benelux  France  Germany  Ireland  Italy  Switzerland  and the United Kingdom.(b) International includes the activities of Parcel Locker Solutions in Japan and of Intelligent Communication Automation outside of North America and the Main European countries.Major OperationsSales from Major Operations reached â‚¬749 million (94% of total sales) in the 9M 2022  an 8.6% increase on a reported basis and a 0.7% year-over-year organic growth  which represents a small improvement compared to H1 2022. Growth in subscription-related revenue remains solid  at +2.9% on an organic basis in the 9M 2022  representing 71% of the Major Operations sales compared to 70% in 9M 2021  a further confirmation of the recurring nature of Quadientâ€™s business model.Sales in North America (59% of Major Operations) were up 3.0% organically  to â‚¬442 million. Double digit organic increase from Intelligent Communication Automation as well as organic growth from Mail-Related Solutions with strong hardware sales were the main contributors to this positive performance. Parcel Locker Solutions reported an organic decline in the region due to a combination in the US of weaker installation in the residential market impacted by construction delays  some retail deals being postponed into 2023 and the high comparison basis from the completion of the roll-out of a large retail contract in Q1 2021.Main European countries (36% of Major Operations) were down 3.2% organically to â‚¬267 million  mostly driven by a small organic decline in Mail-Related Solutions and  to a lesser extent  by lower revenue from Intelligent Communication Automation software license sales  as the Group continues to shift its business model to SaaS subscriptions. Parcel Locker Solutions benefited from a strong acceleration in organic growth  mostly driven by the ongoing deployment of the recently signed contracts in the region  as well as the initial contribution from the roll-out of the UK open network.Sales from the International segment (5% of Major Operations) were up 5.2% organically to â‚¬40 million  with positive contribution from both Intelligent Communication Automation and Parcel Locker Solutions.Intelligent Communication AutomationSales from Intelligent Communication Automation reached â‚¬166 million in the 9M 2022  up +12.7% on a reported basis and 5.2% organically. The penetration of the SMB segment accelerated in the quarter  with the Account Payable (AP) and Account Receivable (AR) offer remaining very strong  (up c. 65% compared to Q3 2021)  supported by a good level of cross-selling from Mail-Related Solutions sales organization. Performance was also well oriented in the enterprise segment.Growth in subscription-related revenue continued to be solid at +17.8% organically in Q3 2022 after +16.9% in H1 2022. (+17.2% organically in the 9M 2022). Subscription-related revenue now represents 75% of Intelligent Communication Automation sales compared to 67% in the 9M 2021  further evidence of the successful shift in business model  from license sales to SaaS. Licenses sales were consequently down 43.1% organically in the 9M 2022.Annual recurring revenue reached â‚¬179 million at the end of 9M 2022  up from â‚¬145 million at the end of 20215 (a 22% annualized organic increase). Also illustrating the shift in revenue model  the share of SaaS customers reached 79% at the end of the 9M 2022 Lastly  professional services were slightly down organically (-2.8%) due to the evolution in product mix.Mail-Related SolutionsMail-Related Solutions sales stood at â‚¬518 million in the 9M 2022  up 7.8% on a reported basis and only down -0.4% organically compared to the 9M 2021 despite a relatively high comparison basis (+2.8% organic growth in 9M 2021 compared to 9M 2020). The resilient trend seen in recent quarters continues for Mail-Related Solutions supported by the positive organic contribution from North America  while decline from the Main European countries remained limited.Of note  the strong performance continued in hardware sales (+3.5% organic growth in the 9M 2022) despite the very demanding comparison basis (+17.6% in the 9M 2021) and some supply chain issues which drove delays in product deliveries and led to a high level of backlog at the end of the period (over +20% compared to 9M 2021). Innovation  leading to positive product placement and continuous upgrade of the installed base  as well as the benefit from price increases were the main drivers behind this remarkable performance.Subscription-related revenue (71% of total sales) proved resilient with a limited organic decline of -1.9% in the 9M 2022. This performance was largely explained by the resilience of the installed base and the largely indexed multi-year contracts associated with it  whilst volume-based revenue remain steady.Parcel Locker SolutionsParcel Locker Solutions sales stood at â‚¬65 million in the 9M 2022  a 4.8% increase on a reported basis and a -1.8% organic decline compared to the 9M 2021.Volatility in lockers hardware sales remains high with a -14.2% organic decline in Q3 2022. This follows a strong Q2 up 25.1% on an organic basis and a very weak Q1  down -47.7% organically  due to the high comparison base linked to the final phase of the deployment of a large North American retail contract in Q1 2021. Overall  hardware sales were down -18.0% organically in the 9M 2022. The weaker Q3 performance was due to fewer installations in the period  mostly explained by longer lead-time for new constructions in the residential sector in the US impacting the delivery of the lockers. Growth was also impacted by the postponement of some US retail projects to 2023.Subscription-related revenues were up 8.7% organically thanks to the continuous roll-out of existing contracts  especially in Europe with accelerating trends in France and the UK  while the usage rate continues to trend higher  reaching 57% at the end of the period. Subscription-related revenue accounted for 61% of total revenue in the 9M 2022. Total number of installed lockers surpassed 17 300 at the end of the period.Whilst some retail deals in the US are being delayed into 2023  the attractiveness of the business model (automation of the first and last mile delivery) remains unchanged both in terms of cost savings and environmental benefits  as evidenced by the continuous high level of booking leading to a significant increase of over +65% in the backlog at the end of October 2022 compared to a year ago. Two third of this backlog relating to an increased mix of new builds impacted by increased construction lead times versus existing building. Therefore  a catch up in installations is expected in 2023 and 2024.Q4 performance is expected to show a significant year-over-year improvement supported by the deployment of existing contracts and the contribution of recent deals signed.Additional OperationsRevenue from Additional Operations stood at â‚¬45 million in the 9M 2022  up 2.0% year-over-year on an organic basis but down 28.5% on a reported basis. This decline is mainly due to the divestment of Automated Packaging Systems in 2021 and the prorata temporis impact of the divestments of the Graphics activities in the Nordic countries and of the Shipping Solutions which both took place in June 2022. Additional Operations accounted for less than 6% of total sales in the 9M 2022.Q3 2022 SALESConsolidated sales stood at â‚¬270 million in the third quarter of 2022  up 8.8% on a reported basis and 1.0% on an organic basis compared to the third quarter of 2021. Subscription-related revenue organic growth in Q3 was up +2.8%  confirming the solid trend seen year-to-date.Major Operations sales stood at â‚¬257 million in the third quarter of 2022  up 0.9% organically compared to the third quarter of 2021. North America enjoyed a solid 4.2% organic growth in the quarter  with positive contribution from both Intelligent Communication Automation growing at a double-digit pace and Mail-Related Solutions posting organic growth. International increased slightly at +0.5% organically while Main European Countries posted a contained -3.5% organic decline mostly due to a weaker contribution from Mail-Related Solutions.Intelligent Communication Automation sales were up 6.3% organically to â‚¬58 million  the double-digit organic increase in subscription-related revenue more than offsetting the still sharp decline in license. Mail-Related Solutions sales remained resilient  at â‚¬176 million  only down by -0.6% on an organic basis despite supply chain issues. Parcel Locker Solutions sales stood at â‚¬22 million in the third quarter of 2022  a -0.2% organic change compared to Q3 2021  mainly due to longer lead time for new constructions in the residential sector in the US impacting lockers installations. Delays in some retail deals in the US are also having a negative impact on the Solution organic growth in the short term.Additional Operations sales stood at â‚¬13 million in the third quarter of 2022  down by -19.4% on a reported basis due to the changes in scope  but up 2.7% on an organic basis.STRONG Q4 EXPECTATIONS REITERATED ACROSS SOLUTIONS  NOT FULLY OFFSETTING THE WEAK Q3 US LOCKERS PERFORMANCEOn a reported basis  Group FY 2022 revenue and current EBIT are expected to grow over last year level benefiting from a favourable forex contribution thanks to the Groupâ€™s significant and growing US presence.2022 Guidance updated4The Group maintains its expectations for both a strong Q4 performance across Solutions and a step up in profitability in H2 2022 compared to H1 2022 . Intelligent Communication Automation delivered a solid Q3 performance in terms of subscription-related revenue growth and the positive trend is expected to continue  supported by strong Annual Recurring Revenue level. After another solid quarter for Mail-Related Solutions  innovation and new product launches continue to drive solid demand and therefore the Group expects this positive trend to continue in Q4. After a disappointing Q3 for Parcel Locker Solutions in the US  the deployment of existing contracts and the contribution of recent deals are expected to support a return to strong growth. Considering the weaker Q3 from Parcel Lockers and the uncertain level of backlog reduction in Q4  and despite unchanged expectations for a strong Q4 across Solutions  the Group now expects full-year 2022 organic sales growth at over 1% compared to 2% previously.and a . Intelligent Communication Automation delivered a solid Q3 performance in terms of subscription-related revenue growth and the positive trend is expected to continue  supported by strong Annual Recurring Revenue level. After another solid quarter for Mail-Related Solutions  innovation and new product launches continue to drive solid demand and therefore the Group expects this positive trend to continue in Q4. After a disappointing Q3 for Parcel Locker Solutions in the US  the deployment of existing contracts and the contribution of recent deals are expected to support a return to strong growth. Considering the weaker Q3 from Parcel Lockers and the uncertain level of backlog reduction in Q4  and despite unchanged expectations for a strong Q4 across Solutions  the Group now expects full-year 2022 organic sales growth at over 1% compared to 2% previously. H2 2022 current EBIT2 margin is still expected to show a significant improvement against H1 2022 level thanks toi) further price increases and more favorable supply chain costs comparison basisii) higher profitability from the growing installed base for both the SaaS activity and parcel lockers  andiii) still high profitability of Mail-Related Solutions.However  lower than expected Q3 organic revenue growth and the impact from salary inflation and investments into new product launches weighing on margins as seen in H1 2022  are leading to a more cautious approach for the operating profitability of the Group. Consequently  Group current EBIT2 is now expected to decline organically year-on-year by a low to mid-single digit  compared to a low to mid-single digit organic growth previously.2021-2023 outlook confirmedThe Group confirmed the 2021-2023 outlook with both sales and current EBIT6 organic growth CAGR over the period i.e.  a minimum 3% organic sales growth CAGR and a minimum mid-single digit organic growth CAGR of current EBIT before acquisition-related expenses.Q3 BUSINESS HIGHLIGHTSYayPay by Quadient Listed a Technology Leader in the 2022 SPARK Matrix for Accounts Receivable ApplicationsOn 26 October 2022  Quadient announced that its cloud-based solution YayPay by Quadient was listed as a 2022 Technology Leader by Quadrant Knowledge Solutions in the SPARK Matrixâ„¢ analysis of the global accounts receivable applications market.The 2022 Quadrant Knowledge Solutions SPARK Matrix: Accounts Receivable Applications includes a detailed analysis of global market dynamics  major trends  vendor landscape and competitive positioning. The study provides competitive analysis and ranking of the leading accounts receivable applications vendors in the form of its SPARK Matrix. It gives strategic information for users to evaluate different vendor capabilities  competitive differentiation and market position.Quadient Launches Advanced Compact Folder Inserter and Cloud-based Document Integrity Mailroom SoftwareOn 17 October 2022  Quadient announced the global launch of the DS-77 iQ  Quadientâ€™s new compact modular folder inserter solution  and docsecure by Quadient mailroom software  the only fully cloud-based  closed-loop solution that tracks document integrity at every step  including proof that each mail piece has been properly processed.Quadient Recognized for its Corporate Social Responsibility Program with a 2022 Tech Cares Award from TrustRadiusOn 10 October 2022  Quadient announced that TrustRadius  the most trusted research and review platform  has recognized Quadient with a 2022 Tech Cares Award. This third-annual award celebrates companies that have gone above and beyond to provide impactful corporate social responsibility (CSR) programs for their employees and surrounding communities.Quadientâ€™s corporate social responsibility (CSR) strategy is built around five pillars: People  Solutions  Ethics & Compliance  Environment and Philanthropy. These pillars are aligned with the UN Global Compact principles that Quadient committed to respect  support and promote by joining the initiative in 2021. Becoming a signatory member also implies taking action to advance the UN Sustainable Development Goals (SDGs)  eight of which Quadient is already committed to.Quadient Launches SaaS Electronic Invoice Presentment and Payment Solution for Small and Medium-Sized BusinessesOn 5 October 2022  Quadient announced the release of Quadient Impress Invoice  a software-as-a-service (SaaS) that securely and compliantly automates the preparation and delivery of invoices. Impress Invoice features built-in electronic invoice presentment  invoice delivery and facilitates payment of those invoices  so businesses get paid faster while offering customers added convenience and improved satisfaction. Impress Invoice is available in the US and UK and will launch in France  Germany and other European countries by the end of the year.POST-CLOSING EVENTSRelais Colis Installs 200 to 300 Quadient Parcel Lockers in Carrefour Retail StoresOn 1 December 2022  Quadient announced that Relais Colis  a key player in the French out-of-home parcel delivery market  is installing 200 to 300 Quadient smart lockers in Carrefour retail stores. Relais Colis has shared the announcement below  also available on their website (in French).Top 250 Ranking of French Software Companies Places Quadient Fifth in â€˜Horizontal Publishersâ€™ CategoryOn 25 November 2022  Quadient announced it has been ranked fifth in the EY and Numeum 2022 Top 250 list of French software companies in the Horizontal Publishers (cross-industry) category  as well as fifteenth in the overall ranking.Esker and Quadient to Develop Electronic Invoicing Platform  to Partner with French GovernmentOn 21 November 2022  Esker and Quadient announced that their years-long collaboration will take on a new dimension by partnering with the French governmentâ€™s upcoming Partner Dematerialization Platform (PDP).Quadient and Esker have been working together for more than seven years through their joint subsidiary NCS  a strategic partnership that allows Quadient to leverage Esker's technology expertise for automating and digitizing customer and supplier invoices. The new direction NCS is taking strengthens this collaboration and ensures that businesses of all sizes experience a smooth and secure transition to compliance with upcoming French tax regulations  according to the defined timetable  whether invoices are received or transmitted by mail  email in PDF format  portal  EDI or another channel.Quadient launches Parcel Pending smart lockers in Ireland to support on-going modernisation of the residential property industryOn 8 November 2022  Quadient announced the launch of Parcel Pending by Quadient in Ireland. By providing secure  self-service smart parcel lockers to businesses across the country  together with a dedicated support centre and response and repair team  Quadient will help the Irish economy capitalise on the property boom by simplifying parcel delivery and improving residentsâ€™ experience.With the Banking & Payments Federation Ireland (BPFI) expecting 50 000 new homes to be built across 2022 and 2023  Quadient will help property developers and property management organisations transform parcel pickup: providing a secure location for residentsâ€™ parcel deliveries with 24/7 access; in turn freeing up time for building management to deal with other tasks; and reducing the physical and environmental footprint of parcel delivery.To know more about Quadientâ€™s newsflow  previous press releases are available on our website at the following address: https://invest.quadient.com/en-US/press-releases.CONFERENCE CALL & WEBCASTQuadient will host a conference call and webcast today at 6:00 pm Paris time (5:00 pm London time).To join the webcast  click on the following link: Webcast.To join the conference call  please use one of the following phone numbers:â–ª France: +33 (0) 1 70 37 71 66;â–ª United States: +1 212 999 6659;â–ª United Kingdom (standard international): +44 (0) 33 0551 0200.Password: QuadientA replay of the webcast will also be available on Quadientâ€™s Investor Relations website for 12 months.CALENDAR27 March 2023 : FY 2022 results and Q4 2022 sales release (after close of trading on the Euronext Paris regulated market).***About QuadientÂ®Quadient is the driving force behind the worldâ€™s most meaningful customer experiences. By focusing on three key solution areas  Intelligent Communication Automation  Parcel Locker Solutions and Mail-Related Solutions  Quadient helps simplify the connection between people and what matters. Quadient supports hundreds of thousands of customers worldwide in their quest to create relevant  personalized connections and achieve customer experience excellence. Quadient is listed in compartment B of Euronext Paris (QDT) and is part of the SBF 120Â®  CACÂ® Mid 60 and EnterNextÂ® Tech 40 indices.For more information about Quadient  visit https://invest.quadient.com/ContactsCatherine Hubert-Dorel  Quadient+33 (0)1 45 36 61 39c.hubert-dorel@quadient.comfinancial-communication@quadient.comCaroline Baude  Quadient+33 (0)1 45 36 31 82c.baude@quadient.com OPRG FinancialIsabelle Laurent / Fabrice Baron+33 (0)1 53 32 61 51 /+33 (0)1 53 32 61 27isabelle.laurent@oprgfinancial.frfabrice.baron@oprgfinancial.frAppendicesChange in Q3 2022 salesIn â‚¬ million Q3 2022 Q3 2021 Change Organic change(1) Major Operations 257 232 +10.8% +0.9% Intelligent Communication Automation 58 51 +15.0% +6.3% Mail-Related Solutions 176 160 +9.8% (0.6)% Parcel Locker Solutions 22 21 +7.8% (0.2)% Additional Operations 13 16 (19.4)% +2.7% Group total 270 248 +8.8% +1.0%In â‚¬ million Q3 2022 Q3 2021 Change Organic change(1) Major Operations 257 232 +10.8% +0.9% North America 155 128 +21.7% +4.2% Main European countries(a) 88 91 (3.1)% (3.5)% International(b) 13 13 +0.1% +0.5% Additional Operations 13 16 (19.4)% +2.7% Group total 270 248 +8.8% +1.0% (a) Including Austria  Benelux  France  Germany  Ireland  Italy  Switzerland and the United Kingdom.(b) International includes the activities of Parcel Locker Solutions in Japan and of Customer Experience Management outside of North America and the Main European countries.1 9M 2022 sales are compared to 9M 2021 sales at constant exchange rates (â‚¬53 million positive currency impact over the period) to which is added  prorata temporis  revenue from Beanworks and to which is deducted  prorata temporis  revenue from Automated Packaging Systems  Graphic business in the Nordics and the Shipping activities in France  for a consolidated amount of â‚¬-18 million.Q3 2022 sales are compared to Q3 2021 sales at constant exchange rates (â‚¬23 million positive currency impact over the period) to which is deducted  prorata temporis  revenue from Automated Packaging Systems  Graphic business in the Nordics and the Shipping activities in France  for a consolidated amount of â‚¬-3 million.2 Current operational result before acquisition-related fees.3 Compared to FY 2021 sales at constant exchange rates to which is added  prorata temporis  revenue from Beanworks (acquired in March 2021) and to which is deducted  prorata temporis  revenue from Automated Packaging Systems (divested in July 2021)  Graphic business in the Nordics and the Shipping activities in France (divested in June 2022)  accounting for a consolidated amount of â‚¬-21 million.4 FY 2022 guidance last published in Quadient press release - 2022 half-year results and second quarter sales  September 26  20225 9M 2022 ARR benefited from a â‚¬10.2m positive forex impact compared to FY 2021.6 On the basis of 2020 current operating income before acquisition-related expenses excluding Parcel Pendingâ€™s earn-out reversal i.e.  â‚¬145 million  with a scope effect resulting in a â‚¬140 million proforma.Attachment,neutral,0.31,0.68,0.01,mixed,0.67,0.02,0.31,True,English,"['robust subscription-related revenue growth', 'Solid Q3 performance', 'parcel locker projects', 'Quadient SA', 'delays', 'Intelligent Communication Automation cloud software revenue', 'low to mid-single digit organic growth', 'weak Q3 US lockers performance', 'Q3 organic revenue organic growth', 'FY 2022 current EBIT2 guidance4', 'Annual Recurring Revenue growth', 'robust subscription-related revenue growth', 'Parcel Locker Solutions revenue', 'O rganic growth', 'existing contract deployments', 'meaningful customer connections', 'Chief Executive Officer', 'challenging macro environment', 'Automated Packaging Systems', 'organic growth trend', 'parcel locker projects', 'recurring business model', 'limited organic decline', 'favourable forex contribution', 'growing US presence', 'nine-month consolidated sales', 'marginal organic decline', 'US projects postponement', 'H2 2022 EBIT margin', 'seventh consecutive quarter', 'full year outlook', 'Major Operations level', 'operating profitability level', 'positive currency impact', 'negative scope effect', 'annualized organic basis', 'Solid Q3 performance', 'strong Q4 performance', 'last year level', 'Software business', 'H1 Group sales', 'Strong Q4 expectations', 'strong growth', 'Parcel Lockers', 'SOLID GROWTH', 'ORGANIC TREND', 'Positive contribution', 'solid performance', 'locker installations', 'strong level', 'direct impact', '2022 third quarter', 'Graphic business', 'Group revenue', 'weaker Q3', 'strong 17.2% increase', 'strong bookings', 'business solutions', 'uncertain level', 'backlog level', 'H1 2022 level', 'attractive level', 'English French', 'G rowth', 'small increase', 'retail deals', 'residential sector', 'Group FY', 'backlog reduction', 'cautious approach', 'previous guidance', 'EBIT4 guidance', 'physical channels', 'Geoffrey Godet', 'product offering', 'SaaS platform', 'costs savings', 'superior experience', 'balanced portfolio', 'recent divestments', 'Shipping activities', 'Group level', '9M performance', 'Mail-Related Solutions', 'REPORTED BASIS', 'significant improvement', 'Euronext Paris', 'significant time', 'Q3.', 'Q4.', '9M 2022', 'delays', 'strength', 'period', 'resilience', '5 December', 'Quadient', 'QDT', 'leader', 'digital', '31 October', 'retailers', 'relevance', 'organizations', 'customers', 'integrated', 'details', 'changes', 'acquisition', 'Beanworks', 'March', 'July', 'Nordics', 'France']",2022-12-05,2022-12-06,globenewswire.com
14240,EuroNext,NewsApi.org,https://www.irishtimes.com/business/2022/12/05/irelands-top-firms-focusing-more-on-esg-issues/,Irelandâ€™s top firms focusing more on ESG issues,Spencer Stuart report shows ESG increasingly important for listed firms,Irelandâ€™s biggest companies are increasingly prioritising environmental  social and governance (ESG) issues  recognising it as a key performance indicator  a new study has indicated.According to US recruitment firm Spencer Stuart  some 40 per cent of top Iseq-listed companies now have specifically dedicated ESG or sustainability committees.The 2022 Ireland Spencer Stuart Board Index analyses board governance practices in the Iseq 20 index  which comprises the 20 largest companies trading on the Euronext Dublin exchange by trading volume and market capitalisation.It found that 50 per cent of Iseq 20 companies now included ESG metrics in remuneration policies for executive directors  while a further 15 per cent of companies have indicated they would be revising their policies to include ESG metrics by the end of this year.READ MOREThe study also found that two-thirds of these companies now have an executive specifically dedicated to leading sustainability. Of the eight boards with an ESG or sustainability committee  five were newly-established in 2021 or early 2022.â€œWhile ESG has been an established part of the board agenda for a while  the year-on-year changes in the data reflect a significant growth in the efforts being made to address ESG  and specifically sustainability at a board level â€ said Spencer Stuartâ€™s managing partner Ruth Curran.â€œCritically  weâ€™re seeing that awareness and understanding of sustainability issues is now a core competency for boards â€ she said.â€œ Companies are bringing fresh talent into both their executive and non-executive director roles and linking executive remuneration to delivery in this area. This is a trend we expect to continue in the coming years. This will be critical to delivering genuine ESG impact.â€The report also highlighted an increase in the appointment of new directors  reflecting what it described as â€œthe refresh in board approaches in the past 12 monthsâ€. It said 85 per cent of Iseq 20 companies appointed at least one new director to the board during the survey period  a notable increase from the 55 per cent of boards recording a new director a year earlier.In terms of broader board diversification  the proportion of women directors across the Iseq 20 rose by 10 per cent from last year. Women  it said  now represented 33 per cent of all board members  with each board in the Iseq 20 having at least one woman  and 55 per cent of boards having at least 30 per cent women.,neutral,0.05,0.95,0.0,neutral,0.05,0.92,0.03,True,English,"['top firms', 'ESG issues', 'Ireland', '2022 Ireland Spencer Stuart Board Index', 'key performance indicator', 'US recruitment firm', 'Euronext Dublin exchange', 'broader board diversification', 'top Iseq-listed companies', 'genuine ESG impact', 'executive director roles', 'one new director', 'board governance practices', '30 per cent women', 'Iseq 20 index', 'one woman', 'board agenda', 'board level', 'board approaches', 'board members', '40 per cent', '50 per cent', '15 per cent', 'new directors', '85 per cent', '55 per cent', '33 per cent', 'trading volume', 'market capitalisation', 'established part', 'significant growth', 'managing partner', 'Ruth Curran', 'core competency', 'fresh talent', 'coming years', 'past 12 months', 'survey period', 'women directors', 'executive directors', 'executive remuneration', 'biggest companies', 'new study', '20 largest companies', 'year changes', 'last year', 'ESG) issues', 'ESG metrics', 'sustainability committees', 'sustainability issues', 'remuneration policies', 'notable increase', 'Iseq 20 companies', 'eight boards', 'social', 'The', 'READ', 'two-thirds', 'data', 'efforts', 'awareness', 'understanding', 'delivery', 'area', 'trend', 'report', 'appointment', 'refresh', 'terms', 'proportion', '10']",2022-12-05,2022-12-06,irishtimes.com
14242,EuroNext,NewsApi.org,https://www.uppermichiganssource.com/prnewswire/2022/12/05/broadridge-appoints-martin-koopman-chief-product-officer/,Broadridge Appoints Martin Koopman as Chief Product Officer,,"NEW YORK  Dec. 5  2022 /PRNewswire/ -- Broadridge Financial Solutions  Inc. (NYSE: BR)  a global Fintech leader  is pleased to announce the appointment of Martin Koopman as Chief Product Officer  effective January 1  2023.In this role  Martin will lead the Product Management team working across all business units to collectively drive Broadridge's delivery of world-class SaaS and other service offerings to leading financial services clients. He will be responsible for Broadridge's enterprise product vision and strategy  building enterprise-wide platforms to benefit Broadridge clients  empowering product management teams  and accelerating innovation in partnership with our technology teams.""Martin has a proven record of driving product innovation both at Broadridge and at previous companies "" said Tim Gokey  Chief Executive of Broadridge. ""His vision and proven ability to execute will be invaluable as we become the foremost SaaS provider to the financial services industry.""""I'm excited to lead our efforts as we scale to become the leading global FinTech serving Governance  Capital Markets  and Wealth and Investment Management "" said Martin Koopman  Chief Product Officer of Broadridge. ""I look forward to working with our clients and our talented product management and technology associates to ensure that we continue to deliver world-class solutions for our clients.""In his new role  Martin will report directly to CEO Tim Gokey. Martin joined Broadridge in 2014 as Head of Strategy for Broadridge's Investor Communication Services business. In 2017  he was named President  Bank Broker-Dealer (BBD)  where he helped steer that business through a period of double-digit growth and innovation. Martin oversaw the successful launch of 70+ product initiatives  including the Shareholder Rights Directive solution in Europe with 300+ new clients; retail shareholder tools  including the ProxyVote app  proxyvote.com and external APIs. Martin has 23 years of industry experience across both investor communications and capital markets/institutional trading  and he has held positions at NYSE Euronext  Boston Consulting Group  and Itiviti/Orc Software after its acquisition of Cameron Systems  which he co-founded.About BroadridgeBroadridge Financial Solutions (NYSE: BR)  a global Fintech leader with more than $5 billion in revenues  provides the critical infrastructure that powers investing  corporate governance and communications to enable better financial lives. We deliver technology-driven solutions that drive business transformation for banks  broker-dealers  asset and wealth managers and public companies. Broadridge's infrastructure serves as a global communications hub enabling corporate governance by linking thousands of public companies and mutual funds to tens of millions of individual and institutional investors around the world. Our technology and operations platforms underpin the daily trading of more than U.S. $9 trillion of equities  fixed income  and other securities globally. A certified Great Place to WorkÂ®  Broadridge is part of the S&P 500Â® Index  employing over 14 000 associates in 21 countries.For more information about us please visit broadridge.com .Investors:W. Edings ThibaultInvestor Relationsbroadridgeir@broadridge.comMedia:Gregg RosenbergCorporate CommunicationsGregg.rosenberg@broadridge.comBroadridge Appoints Martin Koopman as Chief Product Officer (PRNewswire)Broadridge Logo. (PRNewsFoto/Broadridge Financial Solutions) (PRNewswire)View original content to download multimedia:SOURCE Broadridge Financial Solutions  Inc.",neutral,0.01,0.99,0.0,positive,0.56,0.43,0.01,True,English,"['Chief Product Officer', 'Martin Koopman', 'Broadridge', 'leading global FinTech serving Governance', 'Shareholder Rights Directive solution', 'Investor Communication Services business', 'SOURCE Broadridge Financial Solutions', 'global Fintech leader', 'retail shareholder tools', 'Boston Consulting Group', 'W. Edings Thibault', '70+ product initiatives', 'financial services industry', 'Chief Product Officer', 'Product Management team', 'talented product management', 'other service offerings', 'foremost SaaS provider', 'global communications hub', 'S&P 500Â® Index', 'financial services clients', 'CEO Tim Gokey', 'capital markets/institutional trading', 'enterprise product vision', '300+ new clients', 'corporate governance', 'financial lives', 'world-class solutions', 'technology-driven solutions', 'Chief Executive', 'Investment Management', 'investor communications', 'Investor Relations', 'world-class SaaS', 'industry experience', 'daily trading', 'U.S.', 'other securities', 'NEW YORK', 'business units', 'business transformation', 'product innovation', 'technology teams', 'enterprise-wide platforms', 'previous companies', 'double-digit growth', 'successful launch', 'external APIs', 'Itiviti/Orc Software', 'Cameron Systems', 'public companies', 'mutual funds', 'operations platforms', 'fixed income', 'Great Place', 'Gregg Rosenberg', 'Corporate Communications', 'Gregg.rosenberg', 'original content', 'new role', 'Broadridge clients', 'Broadridge Logo', 'ProxyVote app', 'NYSE Euronext', 'critical infrastructure', 'wealth managers', 'institutional investors', 'Martin Koopman', 'technology associates', '14,000 associates', 'Dec.', 'PRNewswire', 'Inc.', 'appointment', 'delivery', 'strategy', 'partnership', 'record', 'proven', 'ability', 'efforts', 'Head', 'Broker', 'Dealer', 'BBD', 'period', 'Europe', '23 years', 'positions', 'acquisition', 'revenues', 'investing', 'banks', 'asset', 'thousands', 'tens', 'millions', 'individual', 'equities', '21 countries', 'information', 'Media', 'PRNewsFoto', '9']",2022-12-05,2022-12-06,uppermichiganssource.com
14256,Euroclear,NewsApi.org,https://finance.yahoo.com/news/canadian-private-placement-proposed-uk-070000248.html,Canadian Private Placement and Proposed UK Placing to Accelerate Exploration and Development at Ortoire,"Touchstone Exploration Inc. (""Touchstone"" or the ""Company"") (TSX:TXP)(LSE:TXP) announces that the Company launched a private placement in Canada (the...","THIS ANNOUNCEMENT (INCLUDING THE APPENDICES) AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR RELEASE  PUBLICATION OR DISTRIBUTION  IN WHOLE OR IN PART  DIRECTLY OR INDIRECTLY  IN OR INTO THE UNITED STATES  AUSTRALIA  NEW ZEALAND  JAPAN  THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY  SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY NEW COMMON SHARES OF TOUCHSTONE EXPLORATION INC. IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL.THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018  AS AMENDED (""MAR""). IN ADDITION  MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED IN â€THIS ANNOUNCEMENT  WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH â€INSIDE INFORMATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT  THIS INSIDE â€INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL â€THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.â€TOUCHSTONE EXPLORATION INC.CANADIAN PRIVATE PLACEMENT AND PROPOSED UK PLACING TO ACCELERATE EXPLORATION AND DEVELOPMENT AT ORTOIRECALGARY  AB / ACCESSWIRE / December 6  2022 / Touchstone Exploration Inc. (""Touchstone"" or the ""Company"") (TSX:TXP)(LSE:TXP) announces that the Company launched a private placement in Canada (the ""Canadian Private Placement"") at 5 p.m. EST on December 5  2022 to raise a minimum of C$7.5 million (approximately US$5.5 million and Â£4.5 million) up to a maximum of C$10 million (approximately US$7.4 million and Â£6.1 million) at a price of C$0.90 (approximately 54.5 pence) per Common Share (as defined below) of no par value (the ""Canadian Placement Shares"").Touchstone Exploration  Inc.   Tuesday  December 6  2022  Press release pictureThe Company further announces a proposed placing in the UK (the ""UK Placing"") to raise approximately US$5.5 million (approximately Â£4.5 million and C$7.4 million) through the issue of Common Shares (as defined below) of no par value (the ""UK Placing Shares"") with institutional and other investors in the United Kingdom at a price of 54.5 pence per UK Placing Share (approximately C$0.90) (the ""Placing Price"").Story continuesThe Canadian Private Placement and the UK Placing (collectively  the ""Fundraise"") are expected to raise aggregate gross proceeds of between US$11 million (approximately Â£9 million and C$14.9 million) and US$13 million (approximately Â£10.6 million and C$17.5 million) to allow Touchstone to accelerate its Ortoire exploration and development program.In the event of excess demand  the Company reserves the right to increase the size of the UK Placing and/or the Placing Price. The UK Placing is being completed by way of an accelerated book building process (the ""Bookbuild"") and UK Placees (as defined below) will be subscribing for Common Shares pursuant to the terms and conditions set out in the Appendix to this announcement. Shore Capital and Canaccord (each as defined below) are acting as Joint Bookrunners in connection with the UK Placing.The Bookbuild in respect of the Canadian Private Placement and the UK Placing is expected to close on or around 3.00 p.m. London Time (10.00 a.m. EST) on December 6  2022 but the timing of the closing of the Bookbuild for the UK Placing is at the absolute discretion of the Joint Bookrunners and the Company.Background to the Fundraise and Use of ProceedsIn recent years  the Company has been focusing on its successful exploration and development program on the Ortoire block  onshore in the Republic of Trinidad and Tobago (Touchstone 80% working interest)  which has identified significant natural gas discoveries at the Coho and Cascadura projects and an oil discovery at Royston.Touchstone recently completed the development of its facility at Coho and announced initial natural gas production on October 10  2022  with the Coho-1 well delivering average net natural gas sales of 7.3 MMcf/d (approximately 1 212 boe/d) over 19 operational days in October.On August 16  2022  the Company received a Certificate of Environmental Clearance (""CEC"") to conduct development operations within the Cascadura area of the Ortoire block from the Trinidad and Tobago Environmental Management Authority. The CEC approved the construction of a multi-well surface production facility with a designed production capacity of 200 MMcf/d of natural gas  5 000 bbls/d of associated liquids and 200 bbls/d of produced water  with a storage capacity of 8 800 barrels of liquids on the Cascadura A wellsite. In addition to the facility  the CEC includes the drilling of up to eight wells on two additional well pads (Cascadura B and C) and the establishment of associated pipelines and infrastructure within the Ortoire block.Construction of the Cascadura surface facility and associated infrastructure required to bring production online from the two existing Cascadura wells is in progress. Once production at Cascadura is online  which the Company anticipates will be by the end of the first quarter of 2023  initial gross aggregate natural gas and associated liquids production from the Cascadura-1ST1 and Cascadura Deep-1 wells  based on previous well tests  has been forecasted at approximately 11 500 boe/d (9 200 boe/d net).In addition to the development of the Cascadura facility  the Company has a portfolio of further exploration and development drilling targets at the Ortoire block. In order to allow the Company to continue to accelerate these prospective exploration  development and production opportunities while the Company's cash balance and cash flows from operations are being allocated towards the Cascadura facility construction  Touchstone is seeking to complete the Canadian Private Placement and the UK Placing in order to side track Royston-1ST1 to drill and test the intermediate and subthrust sheets of the Herrera Formation. Net proceeds will also be applied to bring forward the drilling and potential completion of the Cascadura-2 development well.The funds raised will strengthen the Company's balance sheet and the Company also intends to use a portion of the net proceeds for working capital purposes as it continues constructing the Cascadura facility.Details of the UK PlacingThe UK Placing is being completed within the Company's existing share issuance authorities. Shore Capital and Corporate Limited and Shore Capital Stockbrokers Limited (together  ""Shore Capital"") and Canaccord Genuity Limited (""Canaccord"") (Shore Capital and Canaccord together  the ""Joint Bookrunners"") will be conducting an accelerated book building process  in respect of the UK Placing. The book will open with immediate effect. Shore Capital and Canaccord have entered into an agreement with Touchstone (the ""Placing Agreement"") under which  subject to the conditions set out therein  Shore Capital and Canaccord will agree to use their respective reasonable endeavours to procure subscribers for the UK Placing Shares at the Placing Price. The UK Placing is subject to the terms and conditions set out in the Appendix to this announcement  including the completion of the Canadian Private Placement. Members of the public are not entitled to participate in the UK Placing. The Placing Price represents a 13.5 percent discount to 63 pence  being the closing price of the Common Shares on the AIM market of the London Stock Exchange (""AIM"") on December 5  2022.The UK Placing Shares will  when issued  be credited as fully paid and will rank pari passu in all respects with Touchstone's existing issued common shares of no par value each (""Common Shares""). The number of UK Placing Shares to be allotted and issued by the Company pursuant to the UK Placing will be determined at the close of the Bookbuild. It is envisaged that the Bookbuild will close no later than 3.00 p.m. (London Time) on December 6  2022 but the timing of the closing of the Bookbuild and allocations are at the absolute discretion of the Joint Bookrunners and the Company. Details of the final number of UK Placing Shares and the Placing Price will be announced as soon as practicable after the closing of the Bookbuild. The UK Placing is not being underwritten. The UK Placing is conditional upon the completion of the Canadian Private Placement and the admission to trading and settlement of the Canadian Placement Shares. The Placing Price for UK Placees (as defined below) pursuant to the UK Placing has been translated at a fixed exchange rate of Â£1.00 to C$1.65 such that it will be the same price in pounds sterling equivalent as for placees participating in the Canadian Private Placement.Details of the Canadian Private PlacementThe Canadian Private Placement is separate to and is being managed distinctly from the UK Placing. UK investors are not entitled to participate in the Canadian Private Placement. The placement of the Canadian Placement Shares in Canada is not conditional upon the completion of the UK Placing nor on the admission to trading and settlement of the UK Placing Shares.Admission and SettlementApplication will be made for the Canadian Placement Shares and the UK Placing Shares to be admitted to trading on AIM (""Admission"") and the Toronto Stock Exchange (the ""TSX""). It is expected that Admission will take place at or around 8.00 a.m. (London time) on December 14  2022 (or such later date as may be agreed between the Company  Shore Capital and Canaccord). The UK Placing is conditional upon  inter alia  the completion of the Canadian Private Placement and Admission becoming effective. The UK Placing is also conditional upon the Placing Agreement not being terminated in accordance with its terms.UK Placing Shares issued in connection with the UK Placing will be subject to a four-month and one day restricted hold period which will prevent such UK Placing Shares from being resold in Canada  through a Canadian exchange or otherwise  during the restricted period without an exemption from the Canadian prospectus requirement. Any such UK Placing Shares will otherwise be freely transferable.This announcement should be read in its entirety. In particular  you should read and understand the Appendix and the information provided in the ""Important Notice to Investors"" section of this announcement.Touchstone Exploration Inc.Touchstone Exploration Inc. is a Calgary  Alberta based company engaged in the business of acquiring interests in petroleum and natural gas rights and the exploration  development  production and sale of petroleum and natural gas. Touchstone is currently active in onshore properties located in the Republic of Trinidad and Tobago. The Company's Common Shares are traded on the Toronto Stock Exchange and the AIM market of the London Stock Exchange under the symbol ""TXP"".For further information about Touchstone  please visit our website at www.touchstoneexploration.com or contact:Touchstone Exploration Inc.Mr. Paul Baay  President and Chief Executive Officer Tel: +1 (403) 750-4487Mr. Scott Budau  Chief Financial OfficerShore Capital (Nominated Advisor and Joint Broker)Daniel Bush / Toby Gibbs / Iain Sexton Tel: +44 (0) 207 408 4090Canaccord (Joint Broker)Adam James / Gordon HamiltonSam Lucas / Darren Furby Tel: +44 (0) 207 523 8000Camarco (Financial PR)Billy Clegg / Emily Hall / Lily Pettifar Tel: +44 (0) 203 781 8330AdvisoriesExchange RateFor reference purposes in this announcement  one British pound has been converted into United States dollars at a rate of 1.00 to US$1.22 and Canadian dollars at a rate of 1.00 to C$1.65.Forward-looking StatementsCertain information provided in this announcement may constitute forward-looking statements and information (collectively  ""forward-looking statements"") within the meaning of applicable securities laws. Such forward-looking statements include  without limitation  forecasts  estimates  expectations and objectives for future operations that are subject to assumptions  risks and uncertainties  many of which are beyond the control of the Company. Forward-looking statements are statements that are not historical facts and are generally  but not always  identified by the words ""expects""  ""plans""  ""anticipates""  ""believes""  ""intends""  ""estimates""  ""projects""  ""potential"" and similar expressions  or are events or conditions that ""will""  ""would""  ""may""  ""could"" or ""should"" occur or be achieved.Forward-looking statements in this announcement include  but are not limited to  those in respect of the UK Placing and the Canadian Private Placement  including the size  pricing and timing thereof  the type of securities being offered thereunder  the investors participating therein  the intended use of proceeds therefrom (including with respect to future exploration  development and production activities and the locations thereof)  the conditions and approvals required and applications being filed in connection therewith  the expected construction of the Cascadura facility and timing thereof  and the expectation of bringing exploration wells to production and the forecasted production rates derived from previous well production tests. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable  undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions  by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Certain of these risks are set out in more detail in the Company's December 31  2021 Annual Information Form dated March 25  2022 which has been filed on SEDAR and can be accessed at www.sedar.com. The forward-looking statements contained in this announcement are made as of the date hereof  and except as may be required by applicable securities laws  the Company assumes no obligation nor intent to update publicly or revise any forward-looking statements made herein or otherwise  whether as a result of new information  future events or otherwise.Oil and Gas MeasuresWhere applicable  natural gas has been converted to barrels of oil equivalent based on six thousand cubic feet to one barrel of oil. The barrel of oil equivalent rate is based on an energy equivalent conversion method primarily applicable at the burner tip  and given that the value ratio based on the current price of crude oil as compared to natural gas is significantly different than the energy equivalency of the 6:1 conversion ratio  utilizing the 6:1 conversion ratio may be misleading as an indication of value.Abbreviationsbbls/d barrels per dayboe barrels of oil equivalentboe/d barrels of oil equivalent per dayMMcf/d million cubic feet per dayNGL(s) natural gas liquidsImportant Notice to InvestorsMembers of the public are not eligible to take part in the UK Placing. This announcement (including the Appendix) and the terms and conditions set out herein are for information purposes only and are directed only at persons whose ordinary activities involve them acquiring  holding  managing and disposing of investments (as principal or agent) for the purposes of their business and who have professional experience in matters relating to investments and are: (A) if in a member state of the European Economic Area (the ""EEA"")  persons who are qualified investors (""Qualified Investors"")  being persons falling within the meaning of Article 2(e) of the Prospectus Regulation (EU) 2017/1129; (""EU Prospectus Regulation"") or (B) if in the United Kingdom  qualified investors as defined under Article 2(e) of the UK version of the Prospectus Regulation (EU) 2017/1129  which forms part of the domestic law by virtue of European Union (Withdrawal) Act 2018  as amended  (""UK Prospectus Regulation"") who are also (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005  as amended (the ""Order""); or (ii) high net worth companies  unincorporated associations and other persons falling within Article 49(2)(a) to (d) of the Order; or (C) persons to whom it may otherwise by lawfully communicated (all such persons referred to in (A)  (B) and (C) above together being referred to as ""Relevant Persons""). No prospectus  offering document or admission document will be made available in connection with the matters contained in this announcement.This announcement and any other documentation that may be delivered directly to certain persons in connection with the UK Placing may constitute offering documents as defined under applicable securities laws in certain jurisdictions. Otherwise  no prospectus  offering document or admission document will be made available in connection with the matters contained in this announcement.This announcement  including the terms and conditions set out in the Appendix  must not be acted on or relied on by persons who are not Relevant Persons. Persons distributing this announcement must satisfy themselves that it is lawful to do so. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. This announcement does not itself constitute an offer for sale or subscription of any securities in the Company. Persons distributing this announcement must satisfy themselves that is lawful to do so. This announcement is for information only and does not constitute an offer to sell  or a solicitation of an offer to buy or otherwise acquire  any securities in any jurisdiction in which it is unlawful to do so.Persons needing advice should consult an independent financial adviser.Persons (including  without limitation  nominees and trustees) who have a contractual or other legal obligation to forward a copy of this announcement should seek appropriate advice before taking any action.Neither this announcement nor any copy of it may be taken or transmitted  published or distributed  directly or indirectly  in whole or in part  in  into or from the United States of America (including its territories and possessions  any state of the United States of America (the ""United States"" or the ""US""))  Australia  New Zealand  Japan or the Republic of South Africa or transmitted  distributed to  or sent by  any national or resident or citizen of any such countries or any other jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction (each a ""Restricted Jurisdiction""). Any failure to comply with this restriction may constitute a violation of securities laws in the Restricted Jurisdictions.This announcement is not being distributed by  nor has it been approved for the purposes of section 21 of the Financial Services and Markets Act 2000  as amended (""FSMA"") by  Shore Capital  Canaccord or any other person authorised under FSMA. This announcement is being distributed and communicated to persons in the United Kingdom only in circumstances in which section 21(1) of FSMA does not apply or otherwise falls within a relevant exemption. No prospectus will be made available in connection with the matters contained in this announcement and all offers of the UK Placing Shares will be made pursuant to an exemption under the EU Prospectus Regulation and the UK Prospectus Regulation from the requirement to produce a prospectus. Persons needing advice should consult an independent financial adviser.Persons (including without limitation  nominees and trustees) who have a contractual right or other legal obligations to forward a copy of this announcement should seek appropriate advice before taking any action.This announcement does not constitute  or form part of  any offer or invitation to sell or issue  or any solicitation of any offer to purchase or subscribe for any shares or other securities in Canada or the Restricted Jurisdictions. The UK Placing and the distribution of this announcement and other information in connection with the UK Placing in certain jurisdictions may be restricted by law and persons into whose possession this announcement and any document or other information referred to herein comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.No action has been taken by the Company  Shore Capital  Canaccord or any of their respective directors  officers  partners  agents  employees or affiliates that would permit an offer of the UK Placing Shares or possession or distribution of this announcement or any other publicity material relating to such UK Placing Shares in any jurisdiction where action for that purpose is required. Persons receiving this announcement are required to inform themselves about and to observe any such restrictions.The UK Placing Shares referred to in this announcement have not been and will not be registered under the United States Securities Act of 1933  as amended (the ""US Securities Act"") or under the securities laws of any state or other jurisdiction of the United States  and may not be offered  sold or transferred within the United States except pursuant to an exemption from  or in a transaction not subject to  the registration requirements of the US Securities Act. The UK Placing Shares have not been and will not be approved or disapproved by the US Securities and Exchange Commission  any state securities commission or other regulatory authority in the United States  nor have any of the foregoing authorities passed upon or endorsed the merits of the UK Placing or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.This announcement has been issued by and is the sole responsibility of the Company. The information contained in this announcement is for background purposes only and does not purport to be full or complete and shall not constitute an offer to sell or issue or the solicitation of an offer to buy  subscribe for or otherwise acquire securities in any jurisdiction in which any such offer or solicitation would be unlawful. Any failure to comply with this restriction may constitute a violation of the securities laws of such jurisdictions.No reliance may or should be placed for any purposes whatsoever on the information contained in this announcement or its accuracy  completeness or fairness. The information in this announcement is subject to change. The Company does not undertake to provide the recipient of this announcement with any additional information  or to update this announcement or to correct any inaccuracies  and the distribution of this announcement shall not be deemed to be any form of commitment on the part of the Company to proceed with the UK Placing or any transaction or arrangement referred to in this announcement.Any indication in this announcement of the price at which the Common Shares have been bought or sold in the past cannot be relied upon as a guide to future performance. Persons needing advice should consult an independent financial adviser. No statement in this announcement is intended to be a profit forecast and no statement in this announcement should be interpreted to mean that earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings per share of the Company.Shore Capital and Corporate Limited (""SCC"") is nominated advisor to the Company. SCC  which is authorised and regulated by the Financial Conduct Authority (""FCA"")  is acting exclusively for the Company and no one else in connection with the proposed UK Placing and will not be acting for any other person or otherwise responsible to any person other than the Company for providing the protections afforded to clients of SCC or for advising any other person in respect of the UK Placing.Shore Capital Stockbrokers Limited (""SCS"") has been appointed as broker to the Company in respect of the UK Placing. SCS  which is authorised and regulated by the FCA  is acting exclusively for the Company and no one else in connection with the proposed UK Placing and will not be acting for any other person or otherwise responsible to any person other than the Company for providing the protections afforded to clients of SCS or for advising any other person in respect of the UK Placing.Canaccord is authorised and regulated by the FCA and is acting exclusively for the Company and no one else in connection with the proposed UK Placing and will not be acting for any other person or otherwise responsible to any person other than the Company for providing the protections afforded to clients of Canaccord or for advising any other person in respect of the UK Placing.No representation or warranty  express or implied  is or will be made as to  or in relation to  and no responsibility or liability is or will be accepted by Shore Capital  Canaccord or by any of their affiliates or their affiliates' agents  directors  officers and employees  respectively  as to  or in relation to  the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers  and any liability therefor is expressly disclaimed.By participating in the Bookbuild and the UK Placing  each person who is invited to and who chooses to participate in the UK Placing (each a ""UK Placee"") by making an oral and legally binding offer to acquire UK Placing Shares will be deemed to have read and understood this announcement in its entirety  to be participating  making an offer and acquiring UK Placing Shares on the terms and conditions contained in the Appendix to this announcement and to be providing the representations  warranties  indemnities  acknowledgements and undertakings contained in the Appendix to this announcement.This announcement does not constitute a recommendation concerning any investor's options with respect to the UK Placing. The price of the UK Placing Shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the UK Placing Shares. Past performance is no guide to future performance. The contents of this announcement are not to be construed as legal  business  financial or tax advice. Each investor or prospective investor should consult his  her or its own legal adviser  business adviser  financial adviser or tax adviser for legal  financial  business or tax advice.Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in  or forms part of  this announcement.This announcement contains inside information for the purposes of MAR. Upon publication of this announcement  the inside information is now considered to be in the public domain for the purposes of MAR. The person responsible for arranging release of this information on behalf of the Company is Paul Baay.Information to Distributors - UK Product Governance RequirementsSolely for the purposes of the product governance requirements of Chapter 3 of the FCA Handbook Product Intervention and Product Governance Sourcebook (the ""UK MiFIR Product Governance Requirements"")  and disclaiming all and any liability  whether arising in tort  contract or otherwise  which any ""manufacturer"" (for the purposes of the UK MiFIR Product Governance Requirements) may otherwise have with respect thereto  the UK Placing Shares have been subject to a product approval process  which has determined that the UK Placing Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties  as respectively defined in paragraphs 3.5 and 3.6 of COBS; and (ii) eligible for distribution through all permitted distribution channels (the ""Target Market Assessment"").Notwithstanding the Target Market Assessment  distributors should note that: the price of the UK Placing Shares may decline and investors could lose all or part of their investment; the UK Placing Shares offer no guaranteed income and no capital protection; and an investment in the UK Placing Shares is compatible only with investors who do not need a guaranteed income or capital protection  who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to any contractual  legal or regulatory selling restrictions in relation to the UK Placing. Furthermore  it is noted that  in relation to the UK Placing  notwithstanding the Target Market Assessment  Shore Capital and Canaccord will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt  the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of Chapters 9A or 10A respectively of COBS; or (b) a recommendation to any investor or group of investors to invest in  or purchase  or take any other action whatsoever with respect to the UK Placing Shares.Each distributor is responsible for undertaking its own target market assessment in respect of the UK Placing Shares and determining appropriate distribution channels.APPENDIX - TERMS AND CONDITIONS OF THE UK PLACINGIMPORTANT INFORMATION FOR INVITED UK PLACEES ONLY REGARDING THE UK PLACINGMEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE UK PLACING. THIS ANNOUNCEMENT  INCLUDING THIS APPENDIX (TOGETHER  THE ""ANNOUNCEMENT"")  AND THE INFORMATION IN IT IS RESTRICTED AND IS NOT FOR PUBLICATION  RELEASE OR DISTRIBUTION  DIRECTLY OR INDIRECTLY  IN WHOLE OR IN PART  IN OR INTO OR FROM THE UNITED STATES  AUSTRALIA  NEW ZEALAND  JAPAN  THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL (EACH A ""RESTRICTED JURISDICTION"").THIS ANNOUNCEMENT (INCLUDING THIS APPENDIX) AND THE TERMS AND CONDITIONS SET OUT HEREIN (TOGETHER  THIS ""ANNOUNCEMENT"") ARE FOR INFORMATION PURPOSES ONLY AND ARE DIRECTED ONLY AT PERSONS WHOSE ORDINARY ACTIVITIES INVOLVE THEM IN ACQUIRING  HOLDING  MANAGING AND DISPOSING OF INVESTMENTS (AS PRINCIPAL OR AGENT) FOR THE PURPOSES OF THEIR BUSINESS AND WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS AND ARE: (A) IF IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA (THE ""EEA"")  PERSONS WHO ARE QUALIFIED INVESTORS WITHIN THE MEANING OF ARTICLE 2(E) OF REGULATION (EU) 2017/1129 (THE ""EU PROSPECTUS REGULATION"") (""EU QUALIFIED INVESTORS""); OR (B) IF IN THE UNITED KINGDOM  QUALIFIED INVESTORS WITHIN THE MEANING OF ARTICLE 2(E) OF THE UK VERSION OF REGULATION (EU) 2017/1129 AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018  AS AMENDED (THE ""UK PROSPECTUS REGULATION"") WHO ARE (I) PERSONS WHO FALL WITHIN THE DEFINITION OF ""INVESTMENT PROFESSIONALS"" IN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005  AS AMENDED (THE ""ORDER"")  OR (II) PERSONS WHO ARE HIGH NET WORTH COMPANIES  UNINCORPORATED ASSOCIATION"" OR PARTNERSHIPS OR TRUSTEES OF HIGH VALUE TRUSTS AS DESCRIBED IN ARTICLE 49(2)(A) TO (D) OF THE ORDER (""UK QUALIFIED INVESTORS""); OR (C) OTHERWISE  PERSONS TO WHOM IT MAY OTHERWISE BE LAWFUL TO COMMUNICATE IT TO (EACH SUCH PERSONS IN (A)  (B) AND (C) REFERRED TO AS ""RELEVANT PERSONS""). NO OTHER PERSON SHOULD ACT OR RELY ON THIS ANNOUNCEMENT. BY ACCEPTING THE TERMS OF THIS ANNOUNCEMENT  YOU REPRESENT AND AGREE THAT YOU ARE A RELEVANT PERSON. THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. PERSONS DISTRIBUTING THIS ANNOUNCEMENT MUST SATISFY THEMSELVES THAT IT IS LAWFUL TO DO SO. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT AND THE TERMS AND CONDITIONS SET OUT HEREIN RELATE IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS.This Announcement does not constitute or form part of any offer to sell  or any solicitation of an offer to buy  securities in the United States. The UK Placing Shares have not been and will not be registered under the U.S. Securities Act of 1933  as amended (the ""US Securities Act"")  or under the securities laws of any state or other jurisdiction of the United States and may not be offered  sold  resold or delivered  directly or indirectly  in or into the United States absent registration except pursuant to an exemption from or in a transaction not subject to the registration requirements of the US Securities Act. No public offering of the UK Placing Shares is being made in the United States. The UK Placing Shares are being offered and sold outside the United States in offshore transactions  as defined in  and in compliance with  Regulation S under the US Securities Act. Persons receiving this Announcement (including custodians  nominees and trustees) must not forward  distribute  mail or otherwise transmit it in or into the United States or use the United States mails  directly or indirectly  in connection with the UK Placing.This Announcement does not constitute an offer to sell or issue or a solicitation of an offer to buy or subscribe for UK Placing Shares in any jurisdiction including  without limitation  the Restricted Jurisdictions or any other jurisdiction in which such offer or solicitation is or may be unlawful. This Announcement and the information contained in it is not for publication or distribution  directly or indirectly  to persons in a Restricted Jurisdiction unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction.No prospectus has been lodged with or registered by the Australian Securities and Investments Commission or the Japanese Ministry of Finance or the South African Reserve Bank; and the UK Placing Shares have not been  nor will they be  registered under or offered in compliance with the securities laws of any state  province or territory of Australia  Japan or the Republic of South Africa. Accordingly  the UK Placing Shares may not (unless an exemption under the relevant securities laws is applicable) be offered  sold  resold or delivered  directly or indirectly  in or into Australia  Japan  the Republic of South Africa or any other jurisdiction in which such offer  sale  resale or delivery would be unlawful.By participating in the UK Placing  each person who is invited to and who chooses to participate in the UK Placing (a ""UK Placee"") by making or accepting an oral offer to subscribe for UK Placing Shares is deemed to have read and understood this Announcement in its entirety (including this Appendix) and to be providing the representations  warranties  undertakings  agreements and acknowledgements contained in this Appendix to the Company  Shore Capital and Canaccord.Persons (including  without limitation  nominees and trustees) who have a contractual or other legal obligation to forward a copy of this Appendix or this Announcement of which it forms part should seek appropriate advice before taking any action.These terms and conditions apply to persons making an offer to acquire UK Placing Shares that were offered the UK Placing Shares. They do not apply to the Canadian Private Placement. Each UK Placee will be deemed to have read and understood this Announcement (including this Appendix) and hereby agrees with Shore Capital  Canaccord and the Company to be bound by these terms and conditions as being the terms and conditions upon which UK Placing Shares will be issued or acquired. A UK Placee shall  without limitation  become so bound if Shore Capital or Canaccord confirms to such UK Placee its allocation of UK Placing Shares.Upon being notified of its allocation of UK Placing Shares  a UK Placee shall be contractually committed to acquire the number of UK Placing Shares allocated to it at the Placing Price and  to the fullest extent permitted by law  will be deemed to have agreed not to exercise any rights to rescind or terminate or otherwise withdraw from such commitment.EACH UK PLACEE SHOULD CONSULT WITH ITS OWN ADVISERS AS TO THE LEGAL  REGULATORY  TAX  BUSINESS AND RELATED ASPECTS OF A SUBSCRIPTION OF UK PLACING SHARES. THE PRICE OF SHARES AND THE INCOME FROM THEM (IF ANY) MAY GO DOWN AS WELL AS UP AND INVESTORS MAY NOT GET BACK THE FULL AMOUNT INVESTED ON DISPOSAL OF SHARES.BookbuildFollowing this Announcement  the Joint Bookrunners will today commence an accelerated book building process in respect of the UK Placing (the ""Bookbuild"") to determine demand for participation in the UK Placing by UK Placees. This Appendix gives details of the terms and conditions of  and the mechanics of participation in  the UK Placing. No commissions will be paid to UK Placees or by UK Placees in respect of any UK Placing Shares. Members of the public are not entitled to participate.The Joint Bookrunners shall be entitled to effect the UK Placing by such alternative method to the Bookbuild as they may  in consultation with the Company  determine.Details of the Placing Agreement and the UK Placing SharesThe Company has today entered into a placing agreement (the ""Placing Agreement"") with Shore Capital and Corporate Limited and Shore Capital Stockbrokers Limited (together  ""Shore Capital"") and Canaccord Genuity Limited (""Canaccord""). Pursuant to the Placing Agreement  Shore Capital and Canaccord have  subject to the terms set out in such agreement  agreed to use reasonable endeavours  as agent of the Company  to procure UK Placees for the UK Placing Shares (the "" UK Placing"").The UK Placing Shares will  when issued  be subject to the articles of incorporation of the Company  be credited as fully paid and will rank pari passu in all respects with each other and with the existing Common Shares in the Company  including the right to receive all dividends and other distributions declared  made or paid in respect of the Common Shares after the date of issue of the UK Placing Shares. The UK Placing Shares will be issued free of any encumbrance  lien  claim  charge  equity and third-party right.Application for AdmissionApplication will be made for the UK Placing Shares and the Canadian Placement Shares to be admitted to trading on the AIM market of the London Stock Exchange (""AIM"") (""Admission"") and the Toronto Stock Exchange (the ""TSX""). It is expected that Admission will become effective and that dealings in the UK Placing Shares and Canadian Placement Shares will commence on December 14  2022 (or such later date as Shore Capital  Canaccord and the Company may agree in writing). In any event  the latest date for Admission is December 31  2022 (the ""Long Stop Date"") (or such later date as Shore Capital  Canaccord and the Company may agree in writing).Principal Terms of the UK Placing for UK PlaceesThis Appendix gives UK Placees details of the terms and conditions of  and the mechanics of participation in  the UK Placing.Shore Capital and Canaccord are acting as agents of the Company in connection with the UK Placing on the terms and subject to the conditions of the Placing Agreement. Participation in the UK Placing will only be available to persons who may lawfully be  and are  invited by Shore Capital or Canaccord to participate. Shore Capital  Canaccord and any of their affiliates are entitled to participate in the UK Placing as principal. To bid in the Bookbuild  prospective UK Placees should communicate their bid by telephone or email to their usual sales contact at Shore Capital or Canaccord. Each bid should state the number of UK Placing Shares which the prospective Placee wishes to subscribe for at the Placing Price. Bids may be scaled down by Shore Capital on the basis referred to in paragraph 5 below. The price per Placing Share (the ""Placing Price"") is a price of 54.5 pence and is payable to the Joint Bookrunners (as agent for the Company) by all Placees. The Bookbuild closing time is at the discretion of the Joint Bookrunners and the Bookbuild is expected to close in short order. Shore Capital and Canaccord may  in agreement with the Company  accept bids received after the Bookbuild has closed. Shore Capital and Canaccord may choose to accept bids  either in whole or in part  on the basis of allocations determined at their discretion (in agreement with the Company) and may scale down any bids for this purpose on such basis as they may determine. The final number of UK Placing Shares to be issued in the UK Placing and the final Placing Price will be determined following conclusion of the Bookbuild and will be communicated through a further announcement by or on behalf of the Company through a Regulatory Information Service. The Company  Shore Capital and Canaccord reserve the right: (i) to scale back the number of UK Placing Shares to be subscribed for by any UK Placee in the event of the UK Placing being over-subscribed; and (ii) not to accept offers for UK Placing Shares or to accept such offers in part rather than in full. The Company reserves the right to reduce the amount to be raised pursuant to the UK Placing  in agreement with Shore Capital and Canaccord. A bid in the Bookbuild will be made on the terms and subject to the conditions in this Appendix and will be legally binding on the UK Placee on behalf of which it is made and  except with Shore Capital's and Canaccord's consent  will not be capable of variation or revocation after the time at which it is submitted. Each prospective UK Placee's allocations of UK Placing Shares will be determined by Shore Capital and Canaccord in accordance with the principles of allocation discussed between Shore Capital  Canaccord and the Company and will be confirmed orally to UK Placees by Shore Capital or Canaccord  and each UK Placee's allocation and commitment will be evidenced by a contract note issued to such UK Placee by Shore Capital or Canaccord  the form of which will be dispatched to each UK Placee as soon as possible after its allocation of UK Placing Shares has been confirmed orally to it by Shore Capital or Canaccord. The terms of this Appendix will be deemed incorporated in that contract note. Shore Capital's or Canaccord's oral confirmation of an allocation of UK Placing Shares will give rise to an irrevocable  legally binding commitment by that person (who at that point becomes a UK Placee )  in favour of Shore Capital or Canaccord and the Company  under which it agrees to acquire the number of UK Placing Shares allocated to it on the terms and subject to the conditions set out in this Appendix and in accordance with the Company's articles of incorporation and each UK Placee will be deemed to have read and understood this announcement (including this Appendix) in its entirety. Each UK Placee's allocation and commitment to subscribe for UK Placing Shares will be made on the terms and subject to the conditions in this Appendix and will be legally binding on the UK Placee on behalf of which it is made and  except with Shore Capital's and Canaccord's consent  will not be capable of variation or revocation after the time at which it is submitted. Each UK Placee will have an immediate  separate  irrevocable and binding obligation  owed to Shore Capital and/or Canaccord  as agent for the Company  to pay to it (or as it may direct) in cleared funds an amount equal to the product of the Placing Price and the number of UK Placing Shares such UK Placee has agreed to acquire and the Company has agreed to allot and issue to that UK Placee. Except as required by law or regulation  no press release or other announcement will be made by Shore Capital  Canaccord or the Company using the name of any UK Placee (or its agent)  in its capacity as UK Placee (or agent)  other than with such UK Placee's prior written consent. Irrespective of the time at which a UK Placee's allocation(s) pursuant to the UK Placing is/are confirmed  settlement for all UK Placing Shares to be acquired pursuant to the UK Placing by UK Placees will be required to be made at the same time  on the basis explained below under ""Registration and Settlement"". All obligations under the UK Placing will be subject to fulfilment of the conditions referred to below under ""Conditions of the UK Placing"" and to the Placing not being terminated on the basis referred to below under ""Right to Terminate under the Placing Agreement"". By participating in the UK Placing  each UK Placee agrees that its rights and obligations in respect of the UK Placing will terminate only in the circumstances described below and will not be capable of rescission or termination by the UK Placee. To the fullest extent permissible by law and the applicable rules of the Financial Conduct Authority  none of: (a) Shore Capital  (b) Canaccord  (c) the Company  nor (d) any of their affiliates  agents  directors  officers  consultants or employees nor (e) to the extent not contained within (a)  (b)  (c) or (d)  any person connected with Shore Capital  Canaccord or the Company as defined in the Financial Services and Markets Act 2000 ((d) and (e) being together ""Affiliates"" and individually an ""Affiliate"") shall have any liability (including to the extent permissible by law  any fiduciary duties) to UK Placees or to any other person whether acting on behalf of a UK Placee or otherwise. In particular  none of Shore Capital  Canaccord  the Company nor any of their Affiliates shall have any liability (including  to the extent permissible by law  any fiduciary duties) in respect of Shore Capital or Canaccord's conduct of the UK Placing or of such alternative method of effecting the UK Placing as Shore Capital  Canaccord and the Company may agree. Nothing in this Appendix shall be effective to limit or exclude any liability for fraud or which  by law or regulation  cannot otherwise be so limited or excluded.Conditions of the UK PlacingThe UK Placing is conditional upon the Placing Agreement becoming unconditional and not having been terminated in accordance with its terms.The obligations of Shore Capital and Canaccord under the Placing Agreement are conditional  inter alia  on:the warranties on the part of the Company contained in the Placing Agreement being true and accurate on and as of the date of the Placing Agreement and on Admission; the fulfilment by the Company in all material respects of its obligations under the Placing Agreement to the extent that such obligations fail to be performed prior to Admission; the Company delivering  by no later than 3.00 p.m. (London time) on the dealing day immediately prior to the expected date of Admission (but dated the day of such Admission)  to Shore Capital and Canaccord a certificate confirming  inter alia  that none of the warranties given by the Company in the Placing Agreement were untrue  inaccurate or misleading in any material respect when made or would cease to be true and accurate or would become misleading in any material respect were it to be repeated by reference to the facts and circumstances subsisting as at immediately prior to such Admission; receipt of the conditional acceptance of the TSX of the UK Placing and Canadian Private Placement in accordance with Part VI of the TSX Company Manual subject to the fulfilment of certain requirements of the TSX; the completion of the Canadian Private Placement; the obligations of Shore Capital and Canaccord not having been terminated pursuant to the Placing Agreement and the Placing Agreement otherwise becoming unconditional; and Admission occurring not later than 8.00 a.m. (London time) on or around December  14  2022 (or such later date as the Company  Shore Capital and Canaccord may agree  in any event being no later than the Long Stop Date).If (a) any of the conditions contained in the Placing Agreement  including those described above  are not fulfilled (or to the extent permitted under the Placing Agreement  waived by Shore Capital and Canaccord) by the relevant time or date specified in the Placing Agreement (or such later time or date as Shore Capital and Canaccord may notify to the Company)  or (b) the Placing Agreement is terminated in the circumstances specified below  the UK Placing will not proceed and each UK Placee's rights and obligations hereunder shall cease and terminate at such time and each UK Placee agrees that no claim may be made by or on behalf of a UK Placee (or any person on whose behalf the UK Placee is acting) in respect thereof. Neither Shore Capital  Canaccord  the Company nor any of their respective Affiliates shall have any liability to any UK Placee (or to any other person whether acting on behalf of a UK Placee or otherwise) in respect of any decision they may make as to whether or not to waive or to extend the time and/or date for the satisfaction of any condition in the Placing Agreement or in respect of the UK Placing generally. UK Placees will have no rights against Shore Capital  Canaccord  the Company or any of their respective members  directors or employees under the Placing Agreement pursuant to the Contracts (Rights of Third Parties) Act 1999 (as amended) or otherwise.Shore Capital and Canaccord may waive compliance by the Company with certain of the Company's obligations in relation to the conditions in the Placing Agreement. Any such extension or waiver will not affect UK Placees' commitments as set out in this Announcement.By participating in the UK Placing  each UK Placee agrees that its rights and obligations hereunder terminate only in the circumstances described below under ""Right to Terminate under the Placing Agreement"" and will not be capable of rescission or termination by the UK Placee.No commissions will be paid to UK Placees or by UK Placees in respect of any UK Placing Shares.â€Right to Terminate under the Placing AgreementShore Capital and Canaccord may  at any time before Admission  terminate their obligations under the Placing Agreement by giving notice to the Company in certain circumstances  including if they become aware that  inter alia:any of the warranties in the Placing Agreement was untrue  inaccurate or misleading  in each case  when given on the date of the Placing Agreement and/or that any of the warranties has ceased or is likely at Admission to be untrue  inaccurate or misleading; any statement contained in this Announcement  or certain of the other documents delivered in relation to theUK Placing  is or has become untrue  incorrect or misleading in each case in any respect; the Company has failed in any material respect to comply with its â€obligations under the Placing Agreement  MAR  FSMA  the AIM Rules  or the â€AIM Mining  Oil & Gas Companies Note in respect of the Placing or â€Admission and which is material in the context of the UK Placing and/or â€Admission; a material adverse change in the financial position or prospects of the â€Group (taken as a whole) has occurred or appears likely to occur; or any one of a number of force majeure events specified in the Placing Agreement occurs and such events would in the reasonable opinion of Shore Capital and Canaccord be likely to materially prejudice the outcome of the UK Placing  and that it is  as a result of such matter  inappropriate to proceed with the UK Placing.By participating in the UK Placing  each UK Placee agrees with Shore Capital and Canaccord that the exercise by Shore Capital and Canaccord of any right of termination or any other right or other discretion under the Placing Agreement shall be within the absolute discretion of Shore Capital and Canaccord and that Shore Capital and Canaccord need not make any reference to the UK Placees in this regard and that  to the fullest extent permitted by law  neither Shore Capital nor Canaccord shall have any liability whatsoever to the UK Placees in connection with any such exercise.No Admission Document or ProspectusThe UK Placing Shares are being offered to a limited number of specifically invited persons only and have not been nor will be offered in such a way as to require the publication of an admission document or prospectus in the United Kingdom or any equivalent document in any other jurisdiction. No offering document  admission document or prospectus has been or will be submitted to be approved by the Financial Conduct Authority or the London Stock Exchange in relation to theUK Placing and no such offering document  admission document or prospectus is required to be published and commitments made by UK Placees will be made solely on the basis of the information contained in this Announcement and any information previously published by or on behalf of the Company by notification to a Regulatory Information Service (""Publicly Available Information"") (save that in the case of Publicly Available Information  a UK Placee's right to rely on that information is limited to the right that such UK Placee would have as a matter of law in the absence of this paragraph). Each UK Placee  by accepting a participation in the UK Placing  agrees that the content of this Announcement is exclusively the responsibility of the Company and confirms to Shore Capital  Canaccord and the Company that it has neither received nor relied on any other information (other than the Publicly Available Information)  representation  warranty or statement made by or on behalf of the Company or Shore Capital or Canaccord (other than the amount of the relevant UK Placing participation in the oral confirmation given to UK Placees and the trade confirmation referred to below)  any of their Affiliates or any persons acting on their behalf and none of Shore Capital  Canaccord or the Company nor any of their Affiliates nor any persons acting on their behalf will be liable for the decision of any UK Placee to participate in the UK Placing based on any other information  representation  warranty or statement which the UK Placee may have obtained or received (regardless of whether or not such information  representation  warranty or statement was given or made by or on behalf of any such persons)  and if given or made  such information  representation  warranty or statement must not be relied upon as having been authorised by Shore Capital  Canaccord  the Company or their respective officers  directors  employees or agents.By participating in the UK Placing  each UK Placee acknowledges to and agrees with Shore Capital and Canaccord for themselves and as agents for the Company that  except in relation to the information contained in this Announcement  it has relied on its own investigation of the business  financial or other position of the Company in deciding to participate in the UK Placing. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation. None of the Company  Shore Capital or Canaccord are making any undertaking or warranty to any UK Placee regarding the legality of an investment in the UK Placing Shares by such UK Placee under any legal  investment or similar laws or regulations. Each UK Placee should not consider any information in this Announcement to be legal  tax or business advice. Each UK Placee should consult its own solicitor  tax adviser and financial adviser for independent legal  tax and financial advice regarding an investment in the UK Placing Shares.Registration and SettlementUK Placees will receive their UK Placing Shares (ISIN: CA89156L1085) following Admission within the system administered by Euroclear UK & Ireland (""CREST"")  subject to certain exceptions. Shore Capital and/or Canaccord reserve the right to require settlement for and delivery of the UK Placing Shares to UK Placees in certificated form or by such other means that they deem necessary if delivery or settlement is not possible or practicable within the CREST system within the timetable set out in this Announcement or would not be consistent with the regulatory requirements in the UK Placee's jurisdiction. Each UK Placee will be deemed to agree that it will do all things necessary to ensure that delivery and payment is completed as directed by Shore Capital or Canaccord in accordance with the standing CREST settlement instructions which they have in place with Shore Capital or Canaccord.In order to enable UK Placees to settle their securities through CREST  the Company has appointed Link Market Services Trustees Limited to act as a depositary (the ""Depositary"") to hold the Common Shares and issue dematerialised depositary interests representing the underlying Common Shares (""Depositary Interests""). The Depositary will hold the Common Shares on trust for the relevant shareholders and this trust relationship is documented in a deed poll executed by the Depositary on 22 March 2021 (the ""Deed Poll""). The Deed Poll set(s) out the procedure for holders of Depositary Interests to vote at general meetings of Touchstone and to exercise other procedural shareholder rights  which will be transferred to the Depositary with the Common Shares.The Depositary Interests will be independent English securities and will be held on a register maintained by the Depositary. The Depositary Interests will have the same security code and ISIN number as the underlying Common Shares which they represent and will not require a separate admission to AIM.Each UK Placee allocated UK Placing Shares in the UK Placing will be sent a trade confirmation stating the number of UK Placing Shares allocated to it  the Placing Price  the aggregate amount owed by such UK Placee to Shore Capital or Canaccord and settlement instructions.Interest is chargeable daily on payments not received from UK Placees on the due date in accordance with the arrangements set out above at the rate of two percentage points above the base rate of Barclays Bank Plc.Each UK Placee is deemed to agree that if it does not comply with these payment obligations: (i) the Company may release itself (if it decides in its absolute discretion to do so) and will be released from all obligations it may have to issue any such UK Placing Shares to such UK Placee or at its direction which are then unissued; (ii) the Company may exercise all rights of lien  forfeiture and set-off over and in respect of any such UK Placing Shares to the fullest extent permitted under its articles of incorporation or otherwise by law and to the extent that such UK Placee then has any interest in or rights in respect of any such UK Placing Shares; (iii) the Company  Shore Capital or Canaccord may sell (and each of them is irrevocably authorised by such UK Placee to do so) all or any of such UK Placing Shares on such UK Placee's behalf and then retain from the proceeds  for the account and benefit of the Company or  where applicable  Shore Capital and/or Canaccord: (a) any amount up to the total amount due to it as  or in respect of  subscription monies  or as interest on such monies  for any UK Placing Shares; (b) any amount required to cover any stamp duty or stamp duty reserve tax (together with any interest or penalties) arising on the sale of such UK Placing Shares on such UK Placee's behalf; and (c) any amount required to cover dealing costs and/or commissions necessarily or reasonably incurred by it in respect of such sale; and (iv) such UK Placee shall remain liable to the Company and to Shore Capital and/or Canaccord (as applicable) for the full amount of any losses and of any costs which it may suffer or incur as a result of it: (a) not receiving payment in full for such UK Placing Shares by the required time; and/or (b) the sale of any such UK Placing Shares to any other person at whatever price and on whatever terms are actually obtained for such sale by or for it. By communicating a bid for UK Placing Shares  each UK Placee confers on Shore Capital  Canaccord and the Company such authorities and powers necessary to carry out any such sale and agrees to ratify and confirm all actions which Shore Capital  Canaccord and/or the Company lawfully takes in pursuance of such sale. Legal and/or beneficial title in and to any UK Placing Shares shall not pass to the relevant UK Placee until it has fully complied with its obligations hereunder.If UK Placing Shares are to be delivered to a custodian or settlement agent  the UK Placee should ensure that the trade confirmation is copied and delivered immediately to the relevant person within that organisation.Insofar as UK Placing Shares are registered in the UK Placee's name or that of its nominee or in the name of any person for whom the UK Placee is contracting as agent or that of a nominee for such person  such UK Placing Shares will  subject as provided below  be so registered free from any liability to stamp duty or stamp duty reserve tax. If there are any circumstances in which any other stamp duty or stamp duty reserve tax is payable in respect of the issue of the UK Placing Shares  none of Shore Capital  Canaccord or the Company shall be responsible for the payment thereof. UK Placees (or any nominee or other agent acting on behalf of a UK Placee) will not be entitled to receive any fee or commission in connection with the UK Placing.It is expected that settlement will be on 14 December 2022 on a delivery versus payment basis in accordance with the instructions given to the Joint Bookrunners.Resale RestrictionsThe certificates representing the UK Placing Shares or the ownership statement issued under a direct registration system or other electronic book-entry system shall bear a restrictive legend in the following form (and with the necessary information inserted) in accordance with applicable Canadian securities laws and the policies of the TSX indicating that the resale of such securities is restricted:""UNLESS PERMITTED UNDER SECURITIES LEGISLATION  THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY IN CANADA BEFORE 15 APRIL 2022.""""The securities represented by this certificate are listed on the Toronto Stock Exchange (""TSX""); however  the said securities cannot be traded through the facilities of TSX since they are not freely transferable  and consequently any certificate representing such securities is not ""good delivery"" in settlement of transactions on TSX.""Representations and WarrantiesBy participating in the UK Placing  each UK Placee (and any person acting on such UK Placee's behalf):represents and warrants that it has read and understood this Announcement in its entirety (including this Appendix) and acknowledges that its participation in the UK Placing will be governed by the terms  conditions  representations  warranties  acknowledgements  agreements and undertakings as referred to and included in this Announcement (including this Appendix) and undertakes not to redistribute or duplicate this Announcement; acknowledges that no prospectus  admission document or offering document has been or will be prepared in connection with the UK Placing and that it has not received and will not receive a prospectus  admission document or other offering document in connection with the UK Placing or the UK Placing Shares; agrees to indemnify on an after-tax basis and hold harmless each of the Company  Shore Capital  Canaccord their respective Affiliates and any person acting on their behalf from any and all costs  claims  liabilities and expenses (including legal fees and expenses) arising out of or in connection with any breach of the representations  warranties  acknowledgements  agreements and undertakings in this Announcement and further agrees that the provisions of this Announcement shall survive after completion of the UK Placing; acknowledges that the UK Placing Shares will be admitted to trading on AIM  and the Company is therefore required to publish certain business and financial information in accordance with the AIM Rules for Companies  which includes a description of the nature of the Company's business and the Company's most recent balance sheet and profit and loss account and the Company's announcements and circulars published in the past 12 months and the Company's admission document (collectively  the ""Exchange Information"")  and that it is able to obtain or access such information without undue difficulty and has read and understood the Exchange Information; acknowledges that its obligations are irrevocable and legally binding and shall not be capable of rescission or termination by it in any circumstances; agrees that it has no rights against Shore Capital  Canaccord or the Company  or any of their respective officers  directors or employees  under the Placing Agreement pursuant to the Contracts (Rights of Third Parties Act) 1999; acknowledges that neither Shore Capital nor Canaccord nor any of their Affiliates nor any person acting on their behalf has provided  and will not provide it with  any material or information regarding the UK Placing Shares or the Company; nor has it requested that Shore Capital  Canaccord or any of their Affiliates or any person acting on their behalf to provide it with any such material or information; acknowledges that the content of this Announcement is exclusively the responsibility of the Company and that neither Shore Capital nor Canaccord nor any of their Affiliates nor any person acting on their behalf will be responsible for or shall have any liability for any information  representation or statement relating to the Company contained in this Announcement or any information previously published by or on behalf of the Company and neither Shore Capital nor Canaccord any of their Affiliates nor any person acting on their behalf will be liable for any UK Placee's decision to participate in the UK Placing based on any information  representation or statement contained in this Announcement or otherwise; represents  warrants and agrees that the only information on which it is entitled to rely and on which such UK Placee has relied in committing to subscribe for the UK Placing Shares is the information contained in this Announcement and any Exchange Information and any Publicly Available Information (save that in the case of Exchange Information and Publicly Available Information  a UK Placee's right to rely on that information is limited to the right that such UK Placee would have as a matter of law in the absence of this paragraph)  such information being all that it deems necessary to make an investment decision in respect of the UK Placing Shares and that it has made its own assessment of  and has not relied on any other information given  or representation or statement made at any time  by any person concerning the Company  the UK Placing Shares or the UK Placing. It agrees that none of the Company  Shore Capital or Canaccord  nor any of their respective officers  agents  employees or affiliates will have any liability for any other information or representation. It irrevocably and unconditionally waives any rights it may have in respect of any other information or representation and has relied on its own investigation with respect to  the UK Placing Shares  the UK Placing and the Company in connection with its decision to subscribe for the UK Placing Shares; acknowledges that it is not relying on any investigation that Shore Capital  Canaccord or any of their Affiliates or any person acting on their behalf may have conducted with respect to the UK Placing Shares or the Company and no person is authorised in connection with the UK Placing to give any information or make any representation to it  express or implied  with respect thereto other than as contained in this Announcement and  if given or made  any information or representation must not be relied upon as having been authorised by Shore Capital  Canaccord or the Company; represents and warrants that it has knowledge and experience in financial  business and international investment matters as is required to evaluate the merits and risks of subscribing for the UK Placing Shares. It further represents and warrants that it is experienced in investing in securities of this nature and is aware that it may be required to bear  and is able to bear  the economic risk of  and is able to sustain  a complete loss in connection with the UK Placing. It also represents and warrants that it has had sufficient time to consider and has conducted its own investigation with respect to the offer and subscription for the UK Placing Shares  including the tax  legal and other economic considerations and has relied upon its own examination and due diligence of the Company and its affiliates taken as a whole  and the terms of the UK Placing  including the merits and risks involved; represents and warrants that it has neither received nor relied on any confidential price sensitive information concerning the Company which has not subsequently been made public in making its investment decision to participate in the UK Placing and is not purchasing the UK Placing Shares on the basis of material non-public information or inside information (as defined under the Market Abuse Regulation (EU 596/2014) as it forms part of the UK law by virtue of the European Union (Withdrawal) Act 2018 (""MAR"") or any price sensitive information for the purposes of Rule 11 of the AIM Rules for Companies; agrees that these terms and conditions represent the whole and only agreement between it  Shore Capital  Canaccord and the Company in relation to its participation in the UK Placing and supersedes any previous agreement between any of such parties in relation to such participation. Accordingly  each UK Placee  in accepting its participation in the UK Placing  acknowledges that it has not relied on any information which is contained in any research reports prepared by Shore Capital  Canaccord  any of their Affiliates or any person acting on their behalf and understands that (i) neither Shore Capital nor Canaccord  nor any of their Affiliates nor any person acting on their behalf has or shall have any liability for public information or any representation; (ii) neither Shore Capital nor Canaccord nor the Company  nor any of their Affiliates  nor any person acting on their behalf has or shall have any liability for any additional information that has otherwise been made available to such UK Placee   whether at the date of publication  the date of this Announcement or otherwise; and that (iii) none of Shore Capital  Canaccord or the Company  nor any of their Affiliates  nor any person acting on their behalf makes any representation or warranty  express or implied  as to the truth  accuracy or completeness of such information  whether at the date of publication  the date of this Announcement or otherwise; represents and warrants that (i) it is entitled to acquire the UK Placing Shares under the laws and regulations of all relevant jurisdictions which apply to it; (ii) it has fully observed such laws and regulations and obtained all such governmental and other guarantees and other consents and authorities which may be required thereunder and complied with all necessary formalities; (iii) it has all necessary capacity and authority  and is entitled  to commit to participation in the UK Placing and to perform its obligations in relation thereto and will honour such obligations  and to make the representations and agreements contained on this Appendix; (iv) it has paid any issue  transfer or other taxes due in connection with its participation in the UK Placing in any territory; and (v) it has not taken any action which will or may result in the Company  Shore Capital  Canaccord  any of their respective Affiliates or any person acting on their behalf being in breach of the legal and/or regulatory requirements of any territory in connection with the UK Placing; acknowledges that a communication that the UK Placing or the book is ""covered"" (i.e.  indicated demand from investors in the book equals or exceeds the amount of the securities being offered) is not any indication or assurance that the book will remain covered or that the UK Placing and securities will be fully distributed by Shore Capital and Canaccord. Each Joint Bookrunner reserves the right to take up a portion of the securities in the UK Placing as a principal position at any stage at its sole discretion  among other things  to take account of the Company's objectives and/or its allocation policies; represents and warrants that it understands that: (i) the UK Placing Shares have not been and will not be registered under the US Securities Act or with any state or other jurisdiction of the United States  nor approved or disapproved by the US Securities and Exchange Commission  any state securities commission in the United States or any other United States regulatory authority; and (ii) it will not offer  sell or deliver  directly or indirectly  any UK Placing Shares in or into the United States other than pursuant to an effective registration under the US Securities Act or in a transaction exempt from  or not subject to  the registration requirements thereunder and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and may only be acquired in ""offshore transactions"" as defined in and pursuant to Regulation S under the US Securities Act or in transactions exempt from or not subject to the registration requirements of the US Securities Act; represents and warrants that its acquisition of the UK Placing Shares has been or will be made in an ""offshore transaction"" as defined in and pursuant to Regulation S under the US Securities Act; represents and warrants that it will not offer or sell  directly or indirectly  any of the UK Placing Shares in the United States except in accordance with Regulation S or pursuant to an exemption from  or in a transaction not subject to  the registration requirements of the US Securities Act; represents and warrants that it will observe the resale restrictions set out in further detail in the section entitled ""Resale Restrictions"" above in this Appendix; represents and warrants that it is subscribing for the UK Placing Shares for investment purposes  and not with a view to offer  resell  or distribute within the meaning of US securities law; represents and warrants that it understands that the Company is relying on an exemption from the requirements to provide it with a prospectus and to sell the UK Placing Shares through a person or company registered to sell securities under the Securities Act  RSA 2000. C S-4 (the ""Alberta Securities Act"") and  as a consequence of acquiring UK Placing Shares pursuant to this exemption  certain protections  rights and remedies provided under the Alberta Securities Act  including statutory rights of rescission or damages  will not be available to it; represents and warrants that if it is a financial intermediary  as that term is used in Article 5(1) of the UK Prospectus Regulation  that the UK Placing Shares subscribed for by it in the UK Placing will not be subscribed for on a non-discretionary basis on behalf of  nor will they be subscribed for with a view to their offer or resale to  persons in a member state of the EEA other than EU Qualified Investors or the United Kingdom other than UK Qualified Persons  or in circumstances in which the prior consent of the Joint Bookrunners has been given to the proposed offer or resales; represents and warrants that it has not offered or sold and will not offer or sell any UK Placing Shares to the public in the United Kingdom or any member state of the European Economic Area except in circumstances falling within Article 1(4) of the UK Prospectus Regulation which do not result in any requirement for the publication of a prospectus pursuant to Article 3 of the UK Prospectus Regulation; represents and warrants that it has only communicated or caused to be communicated and will only communicate or cause to be communicated any invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) relating to the UK Placing Shares in circumstances in which it is permitted to do so pursuant to section 21 of FSMA and it acknowledges and agrees that this Announcement has not been approved by either Shore Capital or Canaccord in their capacities as authorised persons under section 21 of FSMA and it may not therefore be subject to the controls which would apply if it was made or approved as financial promotion by an authorised person; represents and warrants that it is aware of and has complied and will comply with all applicable provisions of FSMA with respect to anything done by it in relation to the UK Placing Shares in  from  or otherwise involving the United Kingdom; if in the United Kingdom  unless otherwise agreed by the Joint Bookrunners  it is a ""professional client"" or an ""eligible counterparty"" within the meaning of Chapter 3 of the FCA's Conduct of Business Sourcebook and it is purchasing UK Placing Shares for investment only and not with a view to resale or distribution; represents and warrants that it is aware of and has complied with its obligations in connection with money laundering and terrorist financing under the Criminal Justice Act 1993  MAR  the Proceeds of Crime Act 2002 (as amended)  the Terrorism Act 2000  the Terrorism Act 2006  the Anti-terrorism Crime and Security Act 2001  the Money Laundering  Terrorist Financing and Transfer of Funds (Information on the Payer) Regulations 2017 (as amended) and related or similar rules  regulations or guidelines  issued  administered or enforced by any government agency having jurisdiction in respect thereof (the ""Regulations"") and the Money Laundering Sourcebook of the FCA and  if it is making payment on behalf of a third party  that satisfactory evidence has been obtained and recorded by it to verify the identity of the third party as required by the Regulations; if in the United Kingdom  represents and warrants that it is a person falling within (a) Article 19(5) of the Order or (b) a person falling within Article 49(2)(a) to (d) of the Order and undertakes that it will acquire  hold  manage and dispose of any UK Placing Shares that are allocated to it for the purposes of its business; if in the United Kingdom  represents and warrants that it is a qualified investor as defined in Article 2(e) of the UK Prospectus Regulation  acting as principal or in circumstances to which section 86(2) of FSMA applies; represents and warrants that its participation in the UK Placing is not being made pursuant to an agreement or understanding (whether formal or informal) with another person or persons or to obtain or consolidate control of the Company (as further defined in the City Code on Takeovers and Mergers and in the Canadian National Instrument 62-104 - Take-Over Bids and Issuer Bids); undertakes that it (and any person acting on its behalf) will pay for the UK Placing Shares acquired by it in accordance with this Announcement on the due time and date set out in this Announcement or any trade confirmation issued pursuant to this Announcement against delivery of such UK Placing Shares to it  failing which the relevant UK Placing Shares may be placed with other UK Placees or sold as Shore Capital  Canaccord or the Company may  in their absolute discretion  determine and it will remain liable for any shortfall below the net proceeds of such sale and the placing proceeds of such UK Placing Shares and may be required to bear any costs  commissions  stamp duty or stamp duty reserve tax (together with any interest or penalties due pursuant to the terms set out or referred to in this Announcement) which may arise upon the sale of such UK Placee's UK Placing Shares on its behalf; if it has received any confidential price sensitive information about the Company in advance of the UK Placing (including inside information as defined under MAR and price sensitive information under Rule 11 of the AIM Rules for Companies)  it warrants that it has received such information within the marketing soundings regime provided for in article 11 of MAR and associated delegated regulations and has not: (a) dealt in the securities of the Company; (b) encouraged or required another person to deal in the securities of the Company; or (c) disclosed such information to any person  prior to the information being made publicly available; acknowledges that none of Shore Capital  Canaccord nor the Company  nor any of their Affiliates nor any person acting on their behalf is making any recommendations to it or advising it regarding the suitability or merits of any transaction it may enter into in connection with the UK Placing  and acknowledges that none of Shore Capital  Canaccord nor the Company  nor any of their Affiliates nor any person acting on their behalf has any duties or responsibilities to it for providing advice in relation to the UK Placing or in respect of any representations  warranties  undertakings or indemnities contained in the Placing Agreement or for the exercise or performance of any of Shore Capital's  Canaccord's or the Company's rights and obligations thereunder  including any right to waive or vary any condition or exercise any termination right contained therein; undertakes that (i) the person whom it specifies for registration as holder of the UK Placing Shares will be (a) the UK Placee or (b) the UK Placee's nominee  as the case may be  (ii) none of Shore Capital  Canaccord nor the Company will be responsible for any liability to stamp duty or stamp duty reserve tax resulting from a failure to observe this requirement and (iii) the UK Placee and any person acting on its behalf agrees to acquire the UK Placing Shares on the basis that the UK Placing Shares will be issued to the CREST stock account of Shore Capital or Canaccord which will hold them as settlement agent as nominee for the UK Placee until settlement in accordance with its standing settlement instructions with payment for the UK Placing Shares being made simultaneously upon receipt of the UK Placing Shares in the UK Placee's stock account on a delivery versus payment basis; acknowledges that any agreements entered into by it pursuant to these terms and conditions  and any non-contractual obligations arising out of or in connection with such agreements  shall be governed by and construed in accordance with the laws of England and Wales and it submits (on behalf of itself and on behalf of any person on whose behalf it is acting) to the exclusive jurisdiction of the courts of England and Wales as regards any claim  dispute or matter arising out of any such contract; acknowledges that it irrevocably appoints any director of Shore Capital or Canaccord as its agent for the purposes of executing and delivering to the Company and/or its registrars any documents on its behalf necessary to enable it to be registered as the holder of any of the UK Placing Shares agreed to be taken up by it under theUK Placing; represents and warrants that (unless otherwise agreed with Shore Capital and Canaccord) it is not   and any person who it is acting on behalf of is not  and at the time the UK Placing Shares are subscribed will not be  a resident of any Restricted Jurisdiction and acknowledges and agrees that the UK Placing Shares have not been and will not be registered nor will a prospectus be cleared in respect of the UK Placing Shares under the securities legislation of any Restricted Jurisdiction and  subject to certain exceptions  the UK Placing Shares may not be offered  sold  taken up  renounced  delivered or transferred  directly or indirectly  within any Restricted Jurisdiction; represents and warrants that any person who confirms to Shore Capital or Canaccord on behalf of a UK Placee an agreement to subscribe for UK Placing Shares and/or who authorises Shore Capital and Canaccord to notify the UK Placee's name to the Company's registrar  has authority to do so on behalf of the UK Placee; acknowledges that the agreement to settle each UK Placee's allocation of UK Placing Shares (and/or the allocation of a person for whom it is contracting as agent) free of stamp duty and stamp duty reserve tax depends on the settlement relating only to an acquisition by it and/or such person direct from the Company of the UK Placing Shares in question. Such agreement assumes that the UK Placing Shares are not being acquired in connection with arrangements to issue depositary receipts or to issue or transfer the UK Placing Shares into a clearance service. If there were any such arrangements  or the settlement related to other dealing in the UK Placing Shares  stamp duty or stamp duty reserve tax may be payable  for which none of the Company  Shore Capital nor Canaccord will be responsible. If this is the case  the UK Placee should take its own advice and notify Shore Capital or Canaccord accordingly; represents and warrants that it  or the person specified by it for registration as a holder of the UK Placing Shares  will be liable for any stamp duty and all other stamp  issue  securities  transfer  registration  documentary or other duties or taxes (including any interest  fines or penalties relating thereto)  if any  payable on acquisition of any of the UK Placing Shares or the agreement to subscribe for the UK Placing Shares and acknowledges and agrees that none of Shore Capital  Canaccord  the Company  any of their respective Affiliates or any person acting on behalf of them will be responsible for any liability to stamp duty or stamp duty reserve tax resulting from a failure to observe this requirement. Each UK Placee and any person acting on behalf of such UK Placee agrees to participate in the UK Placing  and agrees to indemnify the Company  Shore Capital and Canaccord on an after-tax basis in respect of the same  on the basis that the UK Placing Shares will be allotted to the CREST stock account of Shore Capital or Canaccord who will hold them as nominee on behalf of such UK Placee until settlement in accordance with its standing settlement instructions; represents and warrants that it will not make any offer to the public of those UK Placing Shares to be subscribed for by it for the purposes of the Prospectus Regulation Rules made by the FCA pursuant to Prospectus Regulation Rules Instrument 2019 (FCA 2019/80); represents and warrants it will not distribute any document relating to the UK Placing Shares and it will be acquiring the UK Placing Shares for its own account as principal or for a discretionary account or accounts (as to which it has the authority to make the statements set out herein) for investment purposes only and it does not have any contract  understanding or arrangement with any person to sell  pledge  transfer or grant a participation therein to such person or any third person with respect of any UK Placing Shares; save that if it is a private client stockbroker or fund manager it confirms that in purchasing the UK Placing Shares it is acting under the terms of one or more discretionary mandates granted to it by private clients and it is not acting on an execution only basis or under specific instructions to purchase the UK Placing Shares for the account of any third party; acknowledges that the UK Placing Shares will be issued subject to the terms and conditions set out in this Announcement (including this Appendix); acknowledges that when a UK Placee or any person acting on behalf of the UK Placee is dealing with Shore Capital or Canaccord  any money held in an account with Shore Capital or Canaccord on behalf of the UK Placee and/or any person acting on behalf of the UK Placee will not be treated as client money within the meaning of the relevant rules and regulations of the FCA. The UK Placee acknowledges that the money will not be subject to the protections conferred by the client money rules; as a consequence  this money will not be segregated from Shore Capital's nor Canaccord's money in accordance with the client money rules and will be used by Shore Capital and Canaccord in the course of their businesses; and the UK Placee will rank only as a general creditor of Shore Capital or Canaccord (as the case may be); acknowledges and understands that the Company  Shore Capital  Canaccord and others will rely upon the truth and accuracy of the foregoing representations  warranties  agreements  undertakings and acknowledgements; acknowledges that no prospectus  admission document or other offering document has been or will be prepared in connection with the UK Placing and it has not received and will not receive a prospectus  admission document or other offering document in connection with the Placing or the UK Placing Shares; acknowledges that time is of the essence as regard its obligations in respect of its participation in the UK Placing under these terms and conditions; acknowledges that the basis of allocation will be determined by Shore Capital and Canaccord at their absolute discretion in consultation with the Company. The right is reserved to reject in whole or in part and/or scale back any participation in the UK Placing; irrevocably authorises the Company  Shore Capital and Canaccord to produce this Announcement pursuant to  in connection with  or as maybe required by any applicable law or regulation  administrative or legal proceeding or official inquiry with respect to the matters set forth in this Announcement; and acknowledges that its commitment to subscribe for UK Placing Shares on the terms set out in this Announcement will continue notwithstanding any amendment that may in future be made to the terms of the UK Placing and that UK Placees will have no right to be consulted or require that their consent be obtained with respect to the Company's conduct of the UK Placing.The acknowledgements  agreements  undertakings  representations and warranties referred to above are given to each of the Company  Shore Capital and Canaccord (for their own benefit and  where relevant  the benefit of their respective Affiliates and any person acting on their behalf) and are irrevocable. The provisions of this Appendix may be waived  varied or modified as regards specific UK Placees or on a general basis by Shore Capital  Canaccord and/or the Company.No claim shall be made against the Company  Shore Capital  Canaccord or any of their respective Affiliates or any other person acting on behalf of any of such persons by a UK Placee to recover any damage  cost  charge or expense which it may suffer or incur by reason of or arising from the carrying out by it of the work to be done by it pursuant to this Announcement or the performance of its obligations pursuant to this Announcement or otherwise in connection with the UK Placing.No UK stamp duty or stamp duty reserve tax should be payable to the extent that the UK Placing Shares are issued or transferred (as the case may be) into CREST to  or to the nominee of  a UK Placee who holds those shares beneficially (and not as agent or nominee for any other person) within the CREST system and registered in the name of such UK Placee or such UK Placee's nominee.Any arrangements to issue or transfer the UK Placing Shares into a depositary receipts system or a clearance service or to hold the UK Placing Shares as agent or nominee of a person to whom a depositary receipt may be issued or who will hold the UK Placing Shares in a clearance service  or any arrangements subsequently to transfer the UK Placing Shares  may give rise to stamp duty and/or stamp duty reserve tax  for which neither the Company nor Shore Capital nor Canaccord will be responsible and the UK Placee to whom (or on behalf of whom  or in respect of the person for whom it is participating in the UK Placing as an agent or nominee) the allocation  allotment  issue or delivery of UK Placing Shares has given rise to such stamp duty or stamp duty reserve tax undertakes to pay such stamp duty or stamp duty reserve tax forthwith and to indemnify on an after-tax basis and to hold harmless the Company  Shore Capital and Canaccord in the event that the Company or Shore Capital incurs any such liability to stamp duty or stamp duty reserve tax.In addition  UK Placees should note that they will be liable for any capital duty  stamp duty and all other stamp  issue  securities  transfer  registration  documentary or other duties or taxes (including any interest  fines or penalties relating thereto) payable outside the UK by them or any other person on the acquisition by them of any UK Placing Shares or the agreement by them to acquire any UK Placing Shares.All times and dates in this Announcement may be subject to amendment. Shore Capital or Canaccord will notify the UK Placees and any person acting on behalf of the UK Placees of any such changes.This Announcement has been issued by the Company and is the sole responsibility of the Company. Each UK Placee  and any person acting on behalf of the UK Placee  acknowledges that neither Shore Capital nor Canaccord owe any fiduciary or other duties to any UK Placee in respect of any representations  warranties  undertakings or indemnities in the Placing Agreement. Each UK Placee and any person acting on behalf of the UK Placee acknowledges and agrees that Shore Capital or Canaccord  or any of their Affiliates may  at their absolute discretion  agree to become a UK Placee in respect of some or all of the UK Placing Shares.The rights and remedies of Shore Capital  Canaccord and the Company under these terms and conditions are in addition to any rights and remedies which would otherwise be available to each of them and the exercise or partial exercise or partial exercise of one will not prevent the exercise of others.Each UK Placee may be asked to disclose in writing or orally to Shore Capital or Canaccord:(a) if he is an individual  his nationality; or(b) if he is a discretionary fund manager  the jurisdiction in which the funds are managed or owned.SOURCE: Touchstone Exploration  Inc.View source version on accesswire.com:https://www.accesswire.com/730357/Canadian-Private-Placement-and-Proposed-UK-Placing-to-Accelerate-Exploration-and-Development-at-Ortoire",neutral,0.06,0.94,0.0,mixed,0.18,0.11,0.7,True,English,"['Canadian Private Placement', 'UK Placing', 'Exploration', 'Development', 'Ortoire', 'average net natural gas sales', 'two additional well pads', 'significant natural gas discoveries', 'Tobago Environmental Management Authority', 'initial natural gas production', 'multi-well surface production facility', 'The Canadian Private Placement', 'book building process', 'Canadian Placement Shares', 'MARKET ABUSE REGULATION', 'Cascadura A wellsite', 'Cascadura surface facility', 'Press release picture', 'aggregate gross proceeds', 'Touchstone 80% working interest', 'PROPOSED UK PLACING', 'NEW COMMON SHARES', 'TOUCHSTONE EXPLORATION INC', 'UK Placing Shares', 'The UK Placing', 'production capacity', 'Environmental Clearance', 'NEW ZEALAND', 'MARKET SOUNDINGS', 'Cascadura projects', 'Cascadura area', 'Cascadura B', 'UK LAW', 'UK Placees', 'successful exploration', 'UNITED STATES', 'SOUTH AFRICA', 'EUROPEAN UNION', 'WITHDRAWAL) ACT', 'par value', 'other investors', 'United Kingdom', 'excess demand', 'Shore Capital', 'Joint Bookrunners', 'London Time', 'absolute discretion', 'recent years', 'oil discovery', '19 operational days', 'storage capacity', 'eight wells', 'Ortoire exploration', 'INSIDE INFORMATION', 'INSIDE \u200eINFORMATION', 'Ortoire block', 'Placing Price', 'associated pipelines', 'development program', 'development operations', 'OTHER JURISDICTION', 'CERTAIN PERSONS', 'infrastructure requi', 'INFORMATION PURPOSES', 'The Bookbuild', 'The CEC', 'associated liquids', 'The Company', 'ANNOUNCEMENT', 'APPENDICES', 'DISTRIBUTION', 'WHOLE', 'PART', 'AUSTRALIA', 'JAPAN', 'REPUBLIC', 'OFFER', 'SELL', 'SOLICITATION', 'BUY', 'OTHERWISE', 'SUCH', 'VIRTUE', 'RESPECT', 'MATTERS', 'RESULT', 'AWARE', 'DOMAIN', 'POSSESSION', 'ACCELERATE', 'CALGARY', 'ACCESSWIRE', 'December', 'Canada', 'minimum', 'maximum', '54.5 pence', 'Tuesday', 'issue', 'institutional', 'Story', 'Fundraise', 'event', 'right', 'size', 'way', 'terms', 'conditions', 'Appendix', 'Canaccord', 'connection', 'timing', 'closing', 'Trinidad', 'Coho', 'Royston', 'October', '7.3 MMcf', '1,212 boe', 'August', 'Certificate', 'construction', '200 MMcf', '5,000 bbls', '200 bbls', 'water', '8,800 barrels', 'drilling', 'establishment', '3.00']",2022-12-06,2022-12-06,finance.yahoo.com
14257,Euroclear,Twitter API,Twitter,Full Stack Developer (Front-end)  Euroclear Finland Oy  Helsinki https://t.co/GjGCGdmlrH #ohjelmointi #it #rekry https://t.co/r7b7dplmzD,nan,Full Stack Developer (Front-end)  Euroclear Finland Oy  Helsinki https://t.co/GjGCGdmlrH #ohjelmointi #it #rekry https://t.co/r7b7dplmzD,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['Full Stack Developer', 'Euroclear Finland', 'end', 'Helsinki', 'GjGCGdmlrH', 'Full Stack Developer', 'Euroclear Finland', 'end', 'Helsinki', 'GjGCGdmlrH']",2022-12-06,2022-12-06,Unknown
14258,Deutsche Boerse,NewsApi.org,https://www.moneycontrol.com/news/world/porsche-will-join-germanys-blue-chip-index-deutsche-boerse-9655581.html,Porsche will join Germany#39;s blue-chip index: Deutsche Boerse,Porsche AG will replace sportswear maker Puma on the DAX stock index on Dec. 19 while Puma will move down to the MDAX index  it said.,Porsche (Image: Porsche)German sportscar maker Porsche AG will join the blue-chip index  just over two months after its market debut  exchange operator Deutsche Boerse said on Monday.Porsche AG will replace sportswear maker Puma on the DAX stock index on Dec. 19 while Puma will move down to the MDAX index  it said.Shares in Porsche have gained around 30% since their listing in Germany in late September. The carmaker quickly overtook its former parent Volkswagen - which holds 75% minus one ordinary share of Porsche AG's total share capital - as Europe's most valuable carmaker.Both Volkswagen and its majority owner Porsche SE are on the DAX index as well.Deutsche Boerse periodically reassesses the composition of the index using trading data to measure market value and trading volume as a basis for deciding which companies to include.Last year  the index was expanded to 40 companies from 30 in its biggest overhaul in history.Bioenergy company Verbio will also join the mid-cap MDAX index  while real estate firm Deutsche Wohnen and battery maker Varta (VAR1.DE) will be demoted to the small-cap SDAX.,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['blue-chip index', 'Deutsche Boerse', 'Porsche', 'Germany', '75% minus one ordinary share', 'total share capital', 'real estate firm', 'German sportscar maker', 'battery maker Varta', 'former parent Volkswagen', 'DAX stock index', 'mid-cap MDAX index', 'sportswear maker', 'blue-chip index', 'market debut', 'exchange operator', 'Deutsche Boerse', 'late September', 'majority owner', 'trading data', 'market value', 'trading volume', 'biggest overhaul', 'Bioenergy company', 'Deutsche Wohnen', 'VAR1.DE', 'small-cap SDAX', 'Porsche AG', 'Porsche SE', 'valuable carmaker', 'Image', 'Monday', 'Puma', 'Dec.', 'Shares', 'listing', 'Germany', 'Europe', 'composition', 'basis', 'companies', 'history', 'Verbio']",2022-12-06,2022-12-06,moneycontrol.com
14259,Deutsche Boerse,NewsApi.org,https://biztoc.com/x/cbd0ffc0ddecc543,Porsche to replace Puma on Germanyâ€™s DAX index,Porsche AG P911  The DAX contains the countryâ€™s top 40 major blue-chip companies. Puma PUM  The composition is reviewed every three months and selection is based on free float market capitalization  Deutsche Boerse said. The next review of the DAX is scheduleâ€¦,Porsche AGP911 The DAX contains the countryâ€™s top 40 major blue-chip companies.PumaPUM The composition is reviewed every three months and selection is based on free float market capitalization  Deutsche Boerse said.The next review of the DAX is scheduled to take place on March 3  Deutsche Boerse said.Write to Pierre Bertrand at pierre.bertrand@wsj.comThis story appeared first on marketwatch.com   2022-12-06.,neutral,0.0,1.0,0.0,neutral,0.02,0.98,0.0,True,English,"['DAX index', 'Porsche', 'Puma', 'Germany', 'top 40 major blue-chip companies', 'free float market capitalization', 'Porsche AG', 'Deutsche Boerse', 'next review', 'marketwatch.com', 'The DAX', 'Pierre Bertrand', 'country', 'Puma', 'composition', 'selection', 'place', 'March', 'story']",2022-12-06,2022-12-06,biztoc.com
14260,Deutsche Boerse,NewsApi.org,https://biztoc.com/x/32ad19c53d0cf1ec,Porsche up on DAX promotion; Puma shrugs off exclusion By Investing.com,By Geoffrey Smith Investing.com -- Porsche (ETR:P911_p) preferred stock edged back up toward a record high in early trade in Frankfurt on Tuesday  after market operator Deutsche Boerse said it will join the benchmark DAX index later this month. The sports carâ€¦,By Geoffrey SmithInvesting.com -- Porsche (ETR:P911_p) preferred stock edged back up toward a record high in early trade in Frankfurt on Tuesday  after market operator Deutsche Boerse said it will join the benchmark DAX index later this month.The sports car maker has enjoyed a strong start to life as a separately listed company  despite the headwinds from the surge in energy costs at its factories and lingering problems with supply chains. It's risen nearly 30% since being spun off by its parent company Volkswagen (ETR:VOWG_p) at the end of September  with investors happy to pay a premium price for a company that has enjoyed historically high profit margins.With a market value of over 88 billion euros (â‚¬1=$1.0495)  Porsche is now worth more than Mercedes Benz (ETR:MBGn) and is worth twice as much as Ferrari (NYSE:RACE)  against which it was benchmarked during the IPO process.The change in the index will come into force on December 19th  Deutsche Boerse said. The DAX's compositionâ€¦This story appeared first on investing.com   2022-12-06.,neutral,0.03,0.97,0.0,mixed,0.44,0.09,0.47,True,English,"['DAX promotion', 'Porsche', 'Puma', 'exclusion', 'Investing', 'sports car maker', 'high profit margins', 'benchmark DAX index', 'record high', 'The DAX', 'Geoffrey Smith', 'preferred stock', 'early trade', 'market operator', 'Deutsche Boerse', 'strong start', 'energy costs', 'lingering problems', 'supply chains', 'premium price', 'market value', '88 billion euros', 'Mercedes Benz', 'IPO process', 'Investing.com', 'parent company', 'Porsche', 'Frankfurt', 'Tuesday', 'life', 'headwinds', 'surge', 'factories', 'Volkswagen', 'VOWG_p', 'end', 'September', 'investors', 'MBGn', 'Ferrari', 'NYSE', 'RACE', 'change', 'force', 'December', 'composition', 'story']",2022-12-06,2022-12-06,biztoc.com
14261,Deutsche Boerse,NewsApi.org,https://biztoc.com/x/ca02c0aea12f7a5e,Porsche will join Germany's blue-chip index,BERLIN (Reuters) - German sportscar maker Porsche AG will join the blue-chip index  just over two months after its market debut  exchange operator Deutsche Boerse (ETR:DB1Gn) said on Monday. Add a Comment Are you sure you want to block %USER_NAME%? By doing sâ€¦,BERLIN (Reuters) - German sportscar maker Porsche AG will join the blue-chip index  just over two months after its market debut  exchange operator Deutsche Boerse (ETR:DB1Gn) said on Monday.Add a CommentAre you sure you want to block %USER_NAME%?By doing so  you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.Since youâ€™ve just unblocked this person  you must wait 48 hours before renewing the block.This story appeared first on investing.com   2022-12-05.,neutral,0.0,1.0,0.0,neutral,0.02,0.95,0.03,True,English,"['blue-chip index', 'Porsche', 'Germany', 'German sportscar maker', 'Porsche AG', 'blue-chip index', 'market debut', 'exchange operator', 'Deutsche Boerse', 'Investing.com', 'Reuters', 'ETR', 'DB1Gn', 'Monday', 'Comment', 'posts', 'person', 'block', 'story']",2022-12-05,2022-12-06,biztoc.com
14262,Deutsche Boerse,NewsApi.org,https://biztoc.com/x/567ba895afd33a74,The rise and fall of Wirecard By Reuters,(Reuters) - Payments company Wirecard collapsed in 2020 in Germany's biggest post-war fraud scandal. A trial will start in Munich on Thursday  with former Chief Executive Markus Braun facing charges. Braun denies wrongdoing. The following timeline summarises â€¦,(Reuters) - Payments company Wirecard collapsed in 2020 in Germany's biggest post-war fraud scandal. A trial will start in Munich on Thursday  with former Chief Executive Markus Braun facing charges. Braun denies wrongdoing.The following timeline summarises the developments that led to the collapse of the company  as well as key moments since:1999: Wirecard is founded in Munich.2002: Markus Braun  previously a KPMG consultant  takes over as chief executive.2005: Wirecard is listed on the Deutsche Boerse (ETR:DB1Gn) Frankfurt (Frankfurt Stock Exchange)  Prime Standard segment.2006: Consolidation of Wirecard Bank AG.2007: Wirecard Asia Pacific established.2010: Jan Marsalek appointed Chief Operating Officer at Wirecard.2016: A negative report by short sellers Zatarra Research alleges fraudulent activity at Wirecard  claiming that senior executives have committed money laundering offences  as well as defrauding Mastercard (NYSE:MA) and Visa (NYSE:V).2018: Wirecard joins the DAXâ€¦This story appeared first on investing.com   2022-12-06.,neutral,0.0,0.99,0.0,negative,0.0,0.12,0.88,True,English,"['rise', 'fall', 'Wirecard', 'Reuters', 'former Chief Executive Markus Braun', 'biggest post-war fraud scandal', 'Chief Operating Officer', 'Prime Standard segment', 'money laundering offences', 'Frankfurt Stock Exchange', 'Wirecard Bank AG', 'Wirecard Asia Pacific', 'following timeline', 'key moments', 'KPMG consultant', 'Deutsche Boerse', 'Jan Marsalek', 'negative report', 'short sellers', 'Zatarra Research', 'fraudulent activity', 'senior executives', 'Payments company', 'Reuters', 'Germany', 'trial', 'Munich', 'Thursday', 'charges', 'wrongdoing', 'developments', 'collapse', 'DB1Gn', 'Consolidation', 'Mastercard', 'NYSE', 'Visa', 'DAX', 'story', 'investing.']",2022-12-06,2022-12-06,biztoc.com
14263,Deutsche Boerse,NewsApi.org,https://www.fxempire.com/news/article/the-rise-and-fall-of-wirecard-1220791,The rise and fall of Wirecard,(Reuters) -   Payments company Wirecard collapsed in 2020 in Germany&#039;s biggest post-war fraud scandal. A trial will start in Munich on Thursday  with former Chief Executive Markus Braun facing charges. Braun denies wrongdoing.,1999: Wirecard is founded in Munich.2002: Markus Braun  previously a KPMG consultant  takes over as chief executive.2005: Wirecard is listed on the Deutsche Boerse Frankfurt (Frankfurt Stock Exchange)  Prime Standard segment.2006: Consolidation of Wirecard Bank AG.2007: Wirecard Asia Pacific established.2010: Jan Marsalek appointed Chief Operating Officer at Wirecard.2016: A negative report by short sellers Zatarra Research alleges fraudulent activity at Wirecard  claiming that senior executives have committed money laundering offences  as well as defrauding Mastercard and Visa.2018: Wirecard joins the DAX blue-chip market index  making it officially one of the 30 most valuable German companies listed on the Frankfurt Stock Exchange.2019Jan. 30: Wirecard denies a report in the Financial Times that a companyâ€™s executive had used forged and backdated contracts in a string of suspicious transactions that raised questions about the integrity of the companyâ€™s accounting practice.Feb. 19: BaFin informs the finance ministry that it has ordered an inquiry into Wirecardâ€™s accounting  and is banning short-selling in the companyâ€™s stock.March 28: Wirecard sues the FT over a series of investigative reports that it said made use of  and misrepresented  business secrets.Oct. 21: The company hires KPMG to conduct an independent audit to address allegations by the FT that its finance team had sought to inflate reported sales and profits.2020Apr. 28: An independent investigation by auditor KPMG finds that Wirecard did not provide sufficient documentation to address all allegations of accounting irregularities made by the Financial Times.May 25: Publication of final 2019 results is postponed for a third time.June 18: Auditor EY refuses to sign off Wirecardâ€™s 2019 accounts as it was unable to confirm the existence of 1.9 billion euros ($1.99 billion) in cash balances on trust accounts  representing around a quarter of its balance sheet.June 19: Wirecardâ€™s CEO Markus Braun quits as firmâ€™s search for missing cash hits a dead end in the Philippines and it scrambles to secure a financial lifeline from its banks.June 22: Wirecard says that the 1.9 billion euros it booked in its accounts likely never existed.June 22: The finance ministry examines giving Wirecard loan from state bank KfW  documents seen by Reuters show.June 23: Wirecardâ€™s former boss Braun is released on bail after being arrested on suspicion of falsifying the companyâ€™s accounts.June 25: Wirecard files for insolvency  owing creditors almost $4 billion after disclosing a gaping hole in its books.June 29: A Munich court appoints Michael Jaffe to manage the insolvency of Wirecard.July 1: Police and public prosecutors raid Wirecardâ€™s headquarters in Munich and four properties in German and Austria as they widen their investigation into the company.July 2: The head of Germanyâ€™s financial watchdog calls the accounting scandal at Wirecard â€œa massive criminal actâ€.July 6: German prosecutors arrest the head of a Dubai-based subsidiary of Wirecard.July 9: German state prosecutors start investigating individuals at Wirecard for suspected money laundering.July 16: The former head of a Dubai-based subsidiary of Wirecard admits wrongdoing to prosecutors for his role in a multi-billion-euro fraud.July 22: German prosecutors arrest three former top executives of Wirecard  including Braun  saying they suspected them of masterminding a criminal racket to fake the companyâ€™s accounts and defraud creditors of billions of euros.Sept. 1: German lawmakers launch a parliamentary inquiry into Wirecard.2021Jan. 29: Felix Hufeld  president of German financial watchdog BaFin  steps down.Feb. 2: Olaf Scholz  then German finance minister and vice-chancellor  announces he is giving BaFin more powers to spot and investigate misconduct at companies it supervises.Feb. 24: The head of Germanyâ€™s accounting watchdog steps down.April 22: Scholz denies any responsibility for the Wirecard fraud.April 23: Then chancellor Angela Merkel rejects criticism of her lobbying for Wirecard in China months before it collapsed  saying she had no reason to suspect the firm of criminality.June 5: Authorities in the Philippines plan to sue some Wirecard executives.2022Jan. 14: German prosecutors file first charges in Wirecard fraud  the Financial Times reports.Sept. 21: A Munich district court said it had admitted charges against former Wirecard executives  paving way for a trial.($1 = 0.9530 euros)(Reporting by Tommy Lund  Jagoda Darlak  Bartosz Dabrowski  Linda Pasquini  Tristan Chabba  Anastasiia Kozlova  John Oâ€™Donnell. Editing by Jane Merriman),neutral,0.0,0.99,0.01,negative,0.0,0.04,0.96,True,English,"['rise', 'fall', 'Wirecard', 'DAX blue-chip market index', 'three former top executives', '30 most valuable German companies', 'German financial watchdog BaFin', 'Deutsche Boerse Frankfurt', 'Prime Standard segment', 'state bank KfW', 'chancellor Angela Merkel', 'John Oâ€™Donnell', 'Chief Operating Officer', 'Frankfurt Stock Exchange', 'former boss Braun', 'money laundering offences', 'German finance minister', 'CEO Markus Braun', 'German state prosecutors', 'Financial Times reports', 'Wirecard Bank AG', 'Wirecard Asia Pacific', 'Munich district court', 'former Wirecard executives', 'senior executives', 'German prosecutors', 'German lawmakers', 'investigative reports', 'financial lifeline', 'accounting watchdog', 'finance ministry', 'finance team', 'Munich court', 'former head', 'chief executive', 'short sellers', 'Zatarra Research', 'fraudulent activity', 'suspicious transactions', 'business secrets', 'independent audit', 'sufficient documentation', 'final 2019 results', 'third time', 'cash balances', 'balance sheet', 'missing cash', 'dead end', 'Reuters show', 'gaping hole', 'Michael Jaffe', 'public prosecutors', 'four properties', 'massive criminal', 'Dubai-based subsidiary', 'multi-billion-euro fraud', 'criminal racket', 'Felix Hufeld', 'Tommy Lund', 'Jagoda Darlak', 'Bartosz Dabrowski', 'Linda Pasquini', 'Tristan Chabba', 'Anastasiia Kozlova', 'Jane Merriman', 'accounting practice', 'accounting irregularities', 'accounting scandal', 'negative report', 'independent investigation', 'Auditor EY', '1.9 billion euros', 'parliamentary inquiry', 'Olaf Scholz', 'first charges', 'KPMG consultant', 'Wirecard loan', 'Wirecard fraud', 'Jan Marsalek', 'trust accounts', '0.9530 euros', 'Jan.', '2019 accounts', 'Consolidation', 'Mastercard', 'Visa', 'company', 'contracts', 'string', 'questions', 'integrity', 'Feb.', 'short-selling', 'FT', 'series', 'use', 'Oct.', 'allegations', 'sales', 'profits', 'Apr.', 'Publication', 'June', 'existence', 'quarter', 'firm', 'Philippines', 'banks', 'documents', 'bail', 'suspicion', 'insolvency', 'creditors', 'books', 'July', 'Police', 'Austria', 'Germany', 'individuals', 'wrongdoing', 'role', 'billions', 'Sept.', 'president', 'vice-chancellor', 'powers', 'misconduct', 'April', 'responsibility', 'criticism', 'lobbying', 'China', 'reason', 'criminality', 'Authorities', 'way', 'trial', 'Editing']",2022-12-06,2022-12-06,fxempire.com
14264,Deutsche Boerse,NewsApi.org,https://www.marketwatch.com/story/porsche-ag-to-replace-puma-on-germany-s-dax-index-271670309049,Dow Jones Newswires: Porsche to replace Puma on Germanyâ€™s DAX index,Puma has been moved to Germany's MDAX index which tracks the 50 largest companies which follow the DAX.,Porsche AG P911  -0.66%   the German sports-car maker  has replaced clothing brand Puma SE on Germanyâ€™s DAX index effective Dec. 19  Deutsche Boerse AG said late Monday.The DAX contains the countryâ€™s top 40 major blue-chip companies.Puma PUM  -0.88% has been moved to Germanyâ€™s MDAX index which tracks the 50 largest companies which follow the DAX.The composition is reviewed every three months and selection is based on free float market capitalization  Deutsche Boerse said.The next review of the DAX is scheduled to take place on March 3  Deutsche Boerse said.Write to Pierre Bertrand at pierre.bertrand@wsj.com,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['Dow Jones Newswires', 'DAX index', 'Porsche', 'Puma', 'Germany', 'free float market capitalization', 'top 40 major blue-chip companies', 'German sports-car maker', 'Deutsche Boerse AG', '50 largest companies', 'Porsche AG', 'clothing brand', 'Puma SE', 'Puma PUM', 'MDAX index', 'next review', 'The DAX', 'Pierre Bertrand', 'Germany', 'country', 'composition', 'selection', 'place', 'March']",2022-12-06,2022-12-06,marketwatch.com
14265,Deutsche Boerse,Bing API,https://www.creativereview.co.uk/photography-annual-2022-mohamed-bourouissa-peripherique/,Mohamed Bourouissa: PÃ©riphÃ©rique,Algeria-born French photographer and Deutsche BÃ¶rse award-winner Mohamed Bourouissaâ€™s series PÃ©riphÃ©rique was shot between 2005 and 2008,Algeria-born French photographer and Deutsche BÃ¶rse award-winner Mohamed Bourouissaâ€™s series PÃ©riphÃ©rique was shot between 2005 and 2008  and this book is the first full presentation of the series  aiming to contextualise his images of people living in the â€˜banlieuesâ€™ of Paris.The photographer took an unusual approach to documenting life for the marginalised people living in the outskirts of the French capital: instead of shooting real life  he chose to â€œappropriate the codes of history paintingâ€ by staging scenes with his friends and acquaintances in places where they once used to hang out.When the images were shot in the mid-2000s  it was against a backdrop of unprecedented riots against social inequality in the banlieues; the new edition looks back on that original context â€œin light of still-prescient social  economic and political issuesâ€  according to the publisher.mohamedbourouissa.com,neutral,0.01,0.99,0.0,negative,0.05,0.09,0.86,True,English,"['PÃ©riphÃ©rique', 'Mohamed Bourouissa', 'Deutsche BÃ¶rse award-winner', 'PÃ©riphÃ©rique', 'first full presentation', 'prescient social, economic', 'Algeria-born French photographer', 'French capital', 'social inequality', 'Mohamed Bourouissa', 'unusual approach', 'history painting', 'unprecedented riots', 'new edition', 'original context', 'political issues', 'marginalised people', 'real life', 'series', 'book', 'images', 'banlieues', 'Paris', 'outskirts', 'codes', 'scenes', 'friends', 'acquaintances', 'places', 'mid-2000s', 'backdrop', 'light', 'publisher']",2022-01-06,2022-12-06,creativereview.co.uk
14266,Deutsche Boerse,Bing API,https://www.marketwatch.com/story/porsche-ag-to-replace-puma-on-germany-s-dax-index-271670309049?mod=hp_minor_pos26,Porsche to replace Puma on Germanyâ€™s DAX index,The DAX contains the countryâ€™s top 40 major blue-chip companies. Puma PUM  -0.99% has been moved to Germanyâ€™s MDAX index which tracks the 50 largest companies which follow the DAX. The composition is reviewed every three months and selection is based on free float market capitalization ,Porsche AG P911  -0.66%   the German sports-car maker  has replaced clothing brand Puma SE on Germanyâ€™s DAX index effective Dec. 19  Deutsche Boerse AG said late Monday.The DAX contains the countryâ€™s top 40 major blue-chip companies.Puma PUM  -0.88% has been moved to Germanyâ€™s MDAX index which tracks the 50 largest companies which follow the DAX.The composition is reviewed every three months and selection is based on free float market capitalization  Deutsche Boerse said.The next review of the DAX is scheduled to take place on March 3  Deutsche Boerse said.Write to Pierre Bertrand at pierre.bertrand@wsj.com,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['DAX index', 'Porsche', 'Puma', 'Germany', 'free float market capitalization', 'top 40 major blue-chip companies', 'German sports-car maker', 'Deutsche Boerse AG', '50 largest companies', 'Porsche AG', 'clothing brand', 'Puma SE', 'Puma PUM', 'MDAX index', 'next review', 'The DAX', 'Pierre Bertrand', 'Germany', 'country', 'composition', 'selection', 'place', 'March']",2022-12-06,2022-12-06,marketwatch.com
14267,Deutsche Boerse,Bing API,https://www.marketwatch.com/story/porsche-ag-to-replace-puma-on-germany-s-dax-index-271670309049,Porsche AG to Replace Puma on Germany's DAX Index,By Pierre Bertrand Porsche AG  the German sports-car maker  has replaced clothing brand Puma SE on Germany's DAX index effective Dec. 19  Deutsche Boerse,Porsche AG P911  -0.66%   the German sports-car maker  has replaced clothing brand Puma SE on Germanyâ€™s DAX index effective Dec. 19  Deutsche Boerse AG said late Monday.The DAX contains the countryâ€™s top 40 major blue-chip companies.Puma PUM  -0.88% has been moved to Germanyâ€™s MDAX index which tracks the 50 largest companies which follow the DAX.The composition is reviewed every three months and selection is based on free float market capitalization  Deutsche Boerse said.The next review of the DAX is scheduled to take place on March 3  Deutsche Boerse said.Write to Pierre Bertrand at pierre.bertrand@wsj.com,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['Porsche AG', 'DAX Index', 'Puma', 'Germany', 'free float market capitalization', 'top 40 major blue-chip companies', 'German sports-car maker', 'Deutsche Boerse AG', '50 largest companies', 'Porsche AG', 'clothing brand', 'Puma SE', 'Puma PUM', 'MDAX index', 'next review', 'The DAX', 'Pierre Bertrand', 'Germany', 'country', 'composition', 'selection', 'place', 'March']",2022-12-06,2022-12-06,marketwatch.com
14268,Deutsche Boerse,Bing API,https://www.reuters.com/business/finance/rise-fall-wirecard-2022-12-06/,The rise and fall of Wirecard,Payments company Wirecard collapsed in 2020 in Germany's biggest post-war fraud scandal. A trial will start in Munich on Thursday  with former Chief Executive Markus Braun facing charges. Braun denies wrongdoing.,"[1/2] Wirecard's former boss Markus Braun looks on  ahead of his testifying before a German parliamentary committee in Berlin  Germany  November 19  2020. REUTERS/Fabrizio Bensch/PoolDec 6 (Reuters) - Payments company Wirecard collapsed in 2020 in Germany's biggest post-war fraud scandal. A trial will start in Munich on Thursday  with former Chief Executive Markus Braun facing charges. Braun denies wrongdoing.The following timeline summarises the developments that led to the collapse of the company  as well as key moments since:1999: Wirecard is founded in Munich.2002: Markus Braun  previously a KPMG consultant  takes over as chief executive.2005: Wirecard is listed on the Deutsche Boerse Frankfurt (Frankfurt Stock Exchange)  Prime Standard segment.2006: Consolidation of Wirecard Bank AG.2007: Wirecard Asia Pacific established.2010: Jan Marsalek appointed Chief Operating Officer at Wirecard.2016: A negative report by short sellers Zatarra Research alleges fraudulent activity at Wirecard  claiming that senior executives have committed money laundering offences  as well as defrauding Mastercard and Visa.2018: Wirecard joins the DAX blue-chip market index  making it officially one of the 30 most valuable German companies listed on the Frankfurt Stock Exchange.2019Jan. 30: Wirecard denies a report in the Financial Times that a company's executive had used forged and backdated contracts in a string of suspicious transactions that raised questions about the integrity of the company's accounting practice.Feb. 19: BaFin informs the finance ministry that it has ordered an inquiry into Wirecard's accounting  and is banning short-selling in the company's stock.March 28: Wirecard sues the FT over a series of investigative reports that it said made use of  and misrepresented  business secrets.Oct. 21: The company hires KPMG to conduct an independent audit to address allegations by the FT that its finance team had sought to inflate reported sales and profits.2020Apr. 28: An independent investigation by auditor KPMG finds that Wirecard did not provide sufficient documentation to address all allegations of accounting irregularities made by the Financial Times.May 25: Publication of final 2019 results is postponed for a third time.June 18: Auditor EY refuses to sign off Wirecard's 2019 accounts as it was unable to confirm the existence of 1.9 billion euros ($1.99 billion) in cash balances on trust accounts  representing around a quarter of its balance sheet.June 19: Wirecard's CEO Markus Braun quits as firm's search for missing cash hits a dead end in the Philippines and it scrambles to secure a financial lifeline from its banks.June 22: Wirecard says that the 1.9 billion euros it booked in its accounts likely never existed.June 22: The finance ministry examines giving Wirecard loan from state bank KfW  documents seen by Reuters show.June 23: Wirecard's former boss Braun is released on bail after being arrested on suspicion of falsifying the company's accounts.June 25: Wirecard files for insolvency  owing creditors almost $4 billion after disclosing a gaping hole in its books.June 29: A Munich court appoints Michael Jaffe to manage the insolvency of Wirecard.July 1: Police and public prosecutors raid Wirecard's headquarters in Munich and four properties in German and Austria as they widen their investigation into the company.July 2: The head of Germany's financial watchdog calls the accounting scandal at Wirecard ""a massive criminal act"".July 6: German prosecutors arrest the head of a Dubai-based subsidiary of Wirecard.July 9: German state prosecutors start investigating individuals at Wirecard for suspected money laundering.July 16: The former head of a Dubai-based subsidiary of Wirecard admits wrongdoing to prosecutors for his role in a multi-billion-euro fraud.July 22: German prosecutors arrest three former top executives of Wirecard  including Braun  saying they suspected them of masterminding a criminal racket to fake the company's accounts and defraud creditors of billions of euros.Sept. 1: German lawmakers launch a parliamentary inquiry into Wirecard.2021Jan. 29: Felix Hufeld  president of German financial watchdog BaFin  steps down.Feb. 2: Olaf Scholz  then German finance minister and vice-chancellor  announces he is giving BaFin more powers to spot and investigate misconduct at companies it supervises.Feb. 24: The head of Germany's accounting watchdog steps down.April 22: Scholz denies any responsibility for the Wirecard fraud.April 23: Then chancellor Angela Merkel rejects criticism of her lobbying for Wirecard in China months before it collapsed  saying she had no reason to suspect the firm of criminality.June 5: Authorities in the Philippines plan to sue some Wirecard executives.2022Jan. 14: German prosecutors file first charges in Wirecard fraud  the Financial Times reports.Sept. 21: A Munich district court said it had admitted charges against former Wirecard executives  paving way for a trial.($1 = 0.9530 euros)Reporting by Tommy Lund  Jagoda Darlak  Bartosz Dabrowski  Linda Pasquini  Tristan Chabba  Anastasiia Kozlova  John O'Donnell. Editing by Jane MerrimanOur Standards: The Thomson Reuters Trust Principles.",neutral,0.0,0.99,0.01,negative,0.0,0.06,0.93,True,English,"['rise', 'fall', 'Wirecard', 'DAX blue-chip market index', 'former Chief Executive Markus Braun', 'three former top executives', 'biggest post-war fraud scandal', 'former boss Markus Braun', '30 most valuable German companies', 'German financial watchdog BaFin', 'former boss Braun', 'Chief Operating Officer', 'CEO Markus Braun', 'Deutsche Boerse Frankfurt', 'Prime Standard segment', 'state bank KfW', 'chancellor Angela Merkel', 'massive criminal act', 'Frankfurt Stock Exchange', 'German parliamentary committee', 'money laundering offences', 'German finance minister', 'German state prosecutors', 'former Wirecard executives', 'Wirecard Bank AG', 'Wirecard Asia Pacific', 'Financial Times reports', 'Munich district court', 'accounting scandal', 'senior executives', 'former head', 'German prosecutors', 'German lawmakers', 'investigative reports', 'financial lifeline', 'multi-billion-euro fraud', 'criminal racket', 'accounting watchdog', 'finance ministry', 'finance team', 'Munich court', 'Fabrizio Bensch/Pool', 'following timeline', 'key moments', 'short sellers', 'Zatarra Research', 'fraudulent activity', 'suspicious transactions', 'business secrets', 'independent audit', 'sufficient documentation', 'final 2019 results', 'third time', 'cash balances', 'balance sheet', 'missing cash', 'dead end', 'gaping hole', 'Michael Jaffe', 'public prosecutors', 'four properties', 'Dubai-based subsidiary', 'parliamentary inquiry', 'Felix Hufeld', 'Wirecard fraud', 'accounting practice', 'accounting irregularities', 'negative report', 'independent investigation', 'Auditor EY', '1.9 billion euros', 'Olaf Scholz', 'Wirecard loan', 'Wirecard files', 'KPMG consultant', 'Reuters show', 'first charges', 'Jan Marsalek', 'trust accounts', 'Payments company', '0.9530 euros', 'Jan.', '2019 accounts', 'testifying', 'Berlin', 'Germany', 'Dec', 'trial', 'Thursday', 'wrongdoing', 'developments', 'collapse', 'Consolidation', 'Mastercard', 'Visa', 'contracts', 'string', 'questions', 'integrity', 'Feb.', 'short-selling', 'March', 'FT', 'series', 'use', 'Oct.', 'allegations', 'sales', 'profits', 'Apr.', 'May', 'Publication', 'June', 'existence', 'quarter', 'firm', 'Philippines', 'banks', 'documents', 'bail', 'suspicion', 'insolvency', 'creditors', 'books', 'July', 'Police', 'Austria', 'individuals', 'role', 'billions', 'Sept.', 'president', 'vice-chancellor', 'powers', 'misconduct', 'April', 'responsibility', 'criticism', 'lobbying', 'China', 'reason', 'criminality', 'Authorities', 'way', 'Reporting', 'Tom']",2022-12-06,2022-12-06,reuters.com
14269,Deutsche Boerse,Bing API,https://finance.yahoo.com/news/porsche-dax-promotion-puma-shrugs-033954868.html,Porsche up on DAX promotion; Puma shrugs off exclusion,Porsche is now worth more than Mercedes Benz (ETR:MBGn) and is worth twice as much as Ferrari (NYSE:RACE)  against which it was benchmarked during the IPO process. The change in the index will come into force on December 19th ,By Geoffrey SmithInvesting.com -- Porsche (ETR:P911_p) preferred stock edged back up toward a record high in early trade in Frankfurt on Tuesday  after market operator Deutsche Boerse said it will join the benchmark DAX index later this month.The sports car maker has enjoyed a strong start to life as a separately listed company  despite the headwinds from the surge in energy costs at its factories and lingering problems with supply chains. It's risen nearly 30% since being spun off by its parent company Volkswagen (ETR:VOWG_p) at the end of September  with investors happy to pay a premium price for a company that has enjoyed historically high profit margins.With a market value of over 88 billion euros (â‚¬1=$1.0495)  Porsche is now worth more than Mercedes Benz (ETR:MBGn) and is worth twice as much as Ferrari (NYSE:RACE)  against which it was benchmarked during the IPO process.The change in the index will come into force on December 19th  Deutsche Boerse said. The DAX's composition is reviewed every three months and selection is based on free float market capitalization.Porsche will replace sportswear maker Puma (ETR:PUMG)  which has had a wretched time this year due to a sudden slowdown in demand as the pandemic-era boom in athletic wear faded sharply. Puma stock is down by over 50% and to make matters worse  it recently lost its chief executive BjÃ¸rn Gulden to cross-town rival Adidas (ETR:ADSGN).As such  the rebalancing will tilt the benchmark index of Europe's largest economy even further back toward the automotive sector. In addition to Porsche  Volkswagen and its rivals Mercedes-Benz and BMW (ETR:BMWG)  the index also includes Daimler Truck Holding (ETR:DTGGe)  tiremaker Continental (ETR:CONG) and Porsche Automobil Holding (ETR:PSHG_p)  the vehicle through which the descendants of founder Ferdinand Porsche control both the sports car maker and its parent.The next review of the DAX is scheduled to take place on March 3  Deutsche Boerse said.Story continuesBy 03:40 ET (08:40 GMT)  Porsche stock was up 1.1%  while Puma stock was up 1.0%.Related ArticlesPorsche up on DAX promotion; Puma shrugs off exclusionUK watchdog moots tougher checks on financial marketingStocks slip  dollar up as data challenges Fed pause hopes,neutral,0.05,0.9,0.04,mixed,0.22,0.05,0.73,True,English,"['DAX promotion', 'Porsche', 'Puma', 'exclusion', 'chief executive BjÃ¸rn Gulden', 'free float market capitalization', 'Daimler Truck Holding', 'sports car maker', 'high profit margins', 'Porsche Automobil Holding', 'founder Ferdinand Porsche', 'benchmark DAX index', 'market operator', 'market value', 'sportswear maker', 'record high', 'benchmark index', 'Geoffrey Smith', 'Investing.com', 'preferred stock', 'early trade', 'Deutsche Boerse', 'strong start', 'energy costs', 'lingering problems', 'supply chains', 'premium price', '88 billion euros', 'Mercedes Benz', 'IPO process', 'The DAX', 'wretched time', 'sudden slowdown', 'pandemic-era boom', 'athletic wear', 'town rival', 'largest economy', 'automotive sector', 'next review', 'DAX promotion', 'UK watchdog', 'tougher checks', 'financial marketing', 'data challenges', 'Porsche stock', 'Puma stock', 'ETR:CONG', 'parent company', 'Frankfurt', 'Tuesday', 'life', 'headwinds', 'surge', 'factories', 'Volkswagen', 'VOWG_p', 'end', 'September', 'investors', 'MBGn', 'Ferrari', 'NYSE', 'RACE', 'change', 'force', 'December', 'composition', 'selection', 'PUMG', 'demand', 'matters', 'Adidas', 'ADSGN', 'rebalancing', 'Europe', 'addition', 'rivals', 'Mercedes-Benz', 'BMW', 'tiremaker', 'Continental', 'PSHG_p', 'vehicle', 'place', 'March', 'Story', '08:40 GMT', 'Articles', 'exclusion', 'Stocks', 'Fed', '03:40']",2022-12-06,2022-12-06,finance.yahoo.com
14270,Deutsche Boerse,Bing API,https://www.moneycontrol.com/news/world/porsche-will-join-germanys-blue-chip-index-deutsche-boerse-9655581.html,Porsche will join Germany's blue-chip index: Deutsche Boerse,Porsche AG will replace sportswear maker Puma on the DAX stock index on Dec. 19 while Puma will move down to the MDAX index  it said.,Porsche (Image: Porsche)German sportscar maker Porsche AG will join the blue-chip index  just over two months after its market debut  exchange operator Deutsche Boerse said on Monday.Porsche AG will replace sportswear maker Puma on the DAX stock index on Dec. 19 while Puma will move down to the MDAX index  it said.Shares in Porsche have gained around 30% since their listing in Germany in late September. The carmaker quickly overtook its former parent Volkswagen - which holds 75% minus one ordinary share of Porsche AG's total share capital - as Europe's most valuable carmaker.Both Volkswagen and its majority owner Porsche SE are on the DAX index as well.Deutsche Boerse periodically reassesses the composition of the index using trading data to measure market value and trading volume as a basis for deciding which companies to include.Last year  the index was expanded to 40 companies from 30 in its biggest overhaul in history.Bioenergy company Verbio will also join the mid-cap MDAX index  while real estate firm Deutsche Wohnen and battery maker Varta (VAR1.DE) will be demoted to the small-cap SDAX.,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['blue-chip index', 'Deutsche Boerse', 'Porsche', 'Germany', '75% minus one ordinary share', 'total share capital', 'real estate firm', 'German sportscar maker', 'battery maker Varta', 'former parent Volkswagen', 'DAX stock index', 'mid-cap MDAX index', 'sportswear maker', 'blue-chip index', 'market debut', 'exchange operator', 'Deutsche Boerse', 'late September', 'majority owner', 'trading data', 'market value', 'trading volume', 'biggest overhaul', 'Bioenergy company', 'Deutsche Wohnen', 'VAR1.DE', 'small-cap SDAX', 'Porsche AG', 'Porsche SE', 'valuable carmaker', 'Image', 'Monday', 'Puma', 'Dec.', 'Shares', 'listing', 'Germany', 'Europe', 'composition', 'basis', 'companies', 'history', 'Verbio']",2022-12-06,2022-12-06,moneycontrol.com
14271,Deutsche Boerse,Twitter API,Twitter,Now available through @DeutscheBoerse Group Market Data + Services distribution network: Kaiko's real-time crypto pâ€¦ https://t.co/ZTve1sipDJ,nan,Now available through @DeutscheBoerse Group Market Data + Services distribution network: Kaiko's real-time crypto pâ€¦ https://t.co/ZTve1sipDJ,neutral,0.07,0.92,0.01,neutral,0.07,0.92,0.01,True,English,"['real-time crypto p', 'Kaiko', 'ZTve1sipDJ', 'real-time crypto p', 'Kaiko', 'ZTve1sipDJ']",2022-12-06,2022-12-06,Unknown
14272,Deutsche Boerse,Twitter API,Twitter,Porsche will join Germany's blue-chip index - Deutsche BoerseğŸ“… More daily news and analysis available on Blue Suiâ€¦ https://t.co/Dej3GIZ3K9,nan,Porsche will join Germany's blue-chip index - Deutsche BoerseğŸ“… More daily news and analysis available on Blue Suiâ€¦ https://t.co/Dej3GIZ3K9,neutral,0.06,0.93,0.01,neutral,0.06,0.93,0.01,True,English,"['blue-chip index', 'Deutsche Boerse', 'daily news', 'Blue Sui', 'Porsche', 'Germany', 'More', 'analysis', 'Dej3GIZ3K9', 'blue-chip index', 'Deutsche Boerse', 'daily news', 'Blue Sui', 'Porsche', 'Germany', 'More', 'analysis', 'Dej3GIZ3K9']",2022-12-06,2022-12-06,Unknown
14273,Deutsche Boerse,Twitter API,Twitter,There will be changes in SDAX as well: @Varta_AG  @Deutsche_Wohnen  #Elmos und @ADVAOpticalNews will replaceâ€¦ https://t.co/eHrgphiqzG,nan,There will be changes in SDAX as well: @Varta_AG  @Deutsche_Wohnen  #Elmos und @ADVAOpticalNews will replaceâ€¦ https://t.co/eHrgphiqzG,neutral,0.09,0.89,0.02,neutral,0.09,0.89,0.02,True,English,"['changes', 'SDAX', 'changes', 'SDAX']",2022-12-06,2022-12-06,Unknown
14274,Deutsche Boerse,Twitter API,Twitter,Porsche will join Germany's blue-chip index - Deutsche Boerse#Ainvest #Ainvest_Wire #precious #business #Trendingâ€¦ https://t.co/OZStTrxYEo,nan,Porsche will join Germany's blue-chip index - Deutsche Boerse#Ainvest #Ainvest_Wire #precious #business #Trendingâ€¦ https://t.co/OZStTrxYEo,neutral,0.03,0.96,0.01,neutral,0.03,0.96,0.01,True,English,"['blue-chip index', 'Deutsche Boerse', 'Porsche', 'Germany', 'Ainvest_Wire', 'business', 'OZStTrxYEo', 'blue-chip index', 'Deutsche Boerse', 'Porsche', 'Germany', 'Ainvest_Wire', 'business', 'OZStTrxYEo']",2022-12-06,2022-12-06,Unknown
14275,Deutsche Boerse,Twitter API,Twitter,âš ï¸ Porsche will join Germany's blue-chip index - Deutsche Boerse- Full story via Reuters at https://t.co/TekYV0Nq8J,nan,âš ï¸ Porsche will join Germany's blue-chip index - Deutsche Boerse- Full story via Reuters at https://t.co/TekYV0Nq8J,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['blue-chip index', 'Deutsche Boerse', 'Full story', 'Porsche', 'Germany', 'Reuters', 'TekYV0Nq8J', 'blue-chip index', 'Deutsche Boerse', 'Full story', 'Porsche', 'Germany', 'Reuters', 'TekYV0Nq8J']",2022-12-06,2022-12-06,Unknown
14276,Deutsche Boerse,Twitter API,Twitter,#Porsche will join Germany's blue-chip index - Deutsche Boerse https://t.co/qkgDoO50Ce,nan,#Porsche will join Germany's blue-chip index - Deutsche Boerse https://t.co/qkgDoO50Ce,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['blue-chip index', 'Deutsche Boerse', 'Germany', 'qkgDoO50Ce', 'blue-chip index', 'Deutsche Boerse', 'Germany', 'qkgDoO50Ce']",2022-12-05,2022-12-06,Unknown
14277,Deutsche Boerse,Twitter API,Twitter,âš¡In the #News at 4:32 PMğŸ‘‡ğŸ“°Porsche will join Germany's blue-chip index - Deutsche Boerse,nan,âš¡In the #News at 4:32 PMğŸ‘‡ğŸ“°Porsche will join Germany's blue-chip index - Deutsche Boerse,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['blue-chip index', 'Deutsche Boerse', '4:32 PM', 'Porsche', 'Germany', 'blue-chip index', 'Deutsche Boerse', '4:32 PM', 'Porsche', 'Germany']",2022-12-05,2022-12-06,Unknown
14278,EuroNext,NewsApi.org,https://finance.yahoo.com/news/valneva-hosts-investor-day-york-060000207.html,Valneva Hosts Investor Day in New York City,Live event and webcast TODAY at 10 AM â€“ 12 PM ET Saint-Herblain (France)  December 06  2022 â€“ Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  a specialty...,"VALNEVALive event and webcast TODAY at 10 AM â€“ 12 PM ETSaint-Herblain (France)  December 06  2022 â€“ Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  a specialty vaccine company  is hosting an in-person investor day today in New York City to discuss the Companyâ€™s current vaccine pipeline  commercial products  and future directions. Valnevaâ€™s Chief Executive Officer Thomas Lingelbach  Chief Financial Officer Peter BÃ¼hler  and other members of the Companyâ€™s senior leadership team will highlight Valnevaâ€™s core near- and mid-term value drivers  including its early- and late-stage development pipeline and commercial vaccine business.Presentations will begin at 10am Eastern Time. The event will also be webcast live and archived on the Events and Presentations page in the Investors section of Valnevaâ€™s website. A live Q&A session will follow the formal presentations with opportunity for virtual attendees to participate. To register for the event  please click here .Valneva will highlight its late-stage clinical and select preclinical vaccine candidates:VLA15  a Lyme Borreliosis (Lyme disease) vaccine candidate that is partnered with Pfizer for global development and commercialization  currently enrolling a pivotal Phase 3 studyVLA1553  a chikungunya virus vaccine candidate for which rolling submission of a Biologics License Application (BLA) is nearing completionVLA1554  a proprietary recombinant protein subunit candidate comprised of stabilized pre-fusion F peptide as a potential prophylactic vaccine against the respiratory pathogen human metapneumovirus (hMPV)VLA2112  a recombinant protein subunit candidate comprised of a mix of relevant antigens as a potential second-generation prophylactic vaccine against Epstein-Barr virus (EBV)Valneva will also provide a detailed overview of its current commercial products and the factors driving continued recovery and potential growth of this part of the business as the COVID-19 pandemic slows  followed by a brief financial overview.Story continuesThomas Lingelbach  Chief Executive Officer of Valneva  said  â€œAs we look ahead over the next 12 to 36 months  we anticipate substantial growth for Valneva  driven by the potential commercialization of two additional vaccine products. This key strengthening of our commercial portfolio  combined with initiatives designed to fuel our current and future R&D pipeline  is part of a broader vision to transform Valneva into a globally recognized leader in the vaccines industry. To achieve this vision  we will continue to rely on our core strengths in vaccine development and manufacturing  as well as our experience and track record for bringing new vaccines from discovery and early development to commercialization.â€Select Investor Day Highlights:VLA15  Lyme diseaseVLA15 is the only Lyme vaccine program in advanced clinical development worldwide. It leverages an established mechanism of action against Lyme borreliosis infection by targeting the six most prevalent serotypes of the Borrelia outer surface protein A (OspA). Pre-clinical proof-of-concept studies showed that VLA15 was protective against tick-transmitted Borrelia infection  and in clinical studies in more than 1000 adults and children (age â‰¥5 years)  VLA15 was generally well tolerated and showed strong immunogenicity including anamnestic response to a booster dose twelve months after primary vaccination1. Recently reported antibody persistence results from study VLA15-221 in adults and children further validate the use of the three-dose vaccination schedule  which is also included in the Phase 3 protocols for all participants. Antibody levels remained above baseline six months after completing primary vaccination  and no vaccine-related serious adverse events (SAEs) and no safety concerns were observed in this six-month observational follow up2. Pfizer and Valneva are currently executing the Phase 3 field efficacy study for VLA15 called VALOR (Vaccine Against Lyme for Outdoor Recreationists)3. Enrollment completion is anticipated in the second quarter 2023. Pending successful Phase 3  Pfizer could potentially submit a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) and Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) in 2025.VLA1553  chikungunya virusVLA1553 is a live-attenuated vaccine candidate targeting long-lasting immunity against mosquito-transmitted chikungunya virus infection with a single shot. It is currently the only chikungunya vaccine candidate to successfully complete pivotal Phase 3 studies and the first for which a regulatory filing process has been initiated with the U.S. FDA4. The sponsor of the first chikungunya vaccine approved in the U.S. may be eligible to receive a Priority Review Voucher (PRV)  which Valneva intends to monetize upon receipt. The pivotal Phase 3 study of VLA1553 met its primary efficacy endpoint  with a seroresponse rate (SRR) that exceeded the threshold established with the FDA based on an immunological surrogate of protection  including in older adults (age â‰¥65 years)5. The high SRR was maintained after six months6 and  as recently reported  after twelve months7  further highlighting the potential for long-lasting immunity from a single shot of VLA1553.While completion of the BLA submission is expected by year end  Valneva is focused on pre-commercial and market access preparations. Upon potential approval  the Company expects to market VLA1553 globally across multiple market segments  leveraging its existing commercial infrastructure  which spans North America  Europe  the Nordics and other key territories  as well as its strategic partner in Brazil  Instituto Butantan  who will market in low- and middle-income countries (LMICs) where chikungunya is currently endemic8.The recommendation process is ongoing with the Advisory Committee on Immunization Practices (ACIP)  which governs vaccine policy in the U.S. This is a well-defined process and the ACIP vote on the specific recommendation(s) for VLA1553 is tentatively scheduled for the February 2024 meeting  pending approval by the FDA. In parallel  market access for ACIP-recommended vaccines is improving. Recent passage of the Inflation Reduction Act now requires that the 49 million-and-growing population of Americans enrolled in Medicare Part D be covered without cost sharing for all ACIP-recommended vaccines. This is important as the number of outbound travelers to chikungunya endemic countries is projected to exceed pre-COVID-19 levels by 2025 according to the International Air Transport Association (IATA)9.VLA1554  human metapneumovirusValnevaâ€™s hMPV vaccine program leverages recent advances in the development of vaccines against related Respiratory Syncytial Virus (RSV)  where discovery of the pre-fusion form of the F protein  which mediates viral entry into human cells  led to major recent breakthroughs. Valneva successfully generated a stabilized pre-fusion F protein antigen  which forms the basis of the proprietary vaccine candidate VLA1554. In key pre-clinical studies  low doses of the vaccine candidate generated hMPV-neutralizing responses that protected mice from challenge with hMPV virus. Adjuvant evaluation is currently in progress.VLA2112  Epstein-Barr virusValnevaâ€™s EBV vaccine candidate is based on adjuvanted  subunit viral glycoproteins designed to elicit high titers of EBV-neutralizing antibodies and block EBV infection of both B cells and epithelial cells. Vaneva is utilizing structural information to design potently immunogenic antigens. Evaluation of external and internal antigens is ongoing  with the ultimate vaccine candidate comprised of an adjuvanted combination of antigens that best neutralizes EBV infection.Commercial portfolioValnevaâ€™s current commercial portfolio includes proprietary travelersâ€™ vaccines IXIAROÂ® and DUKORALÂ®  for which Valneva owns global rights  as well as a number of vaccines that Valneva markets on behalf of third parties in select markets  leveraging its commercial infrastructure. Since 2016  Valneva has established a strong track record of adding additional third-party products to its portfolio  most recently adding VBI Vaccinesâ€™ PreHevbriÂ® in 202210. The portfolio also includes VLA2001  the Companyâ€™s vaccine against COVID-19  for which the Company is now solely focused on deploying remaining vaccine inventory. In parallel  the current shelf-life of VLA2001 was recently extended to 18 months and the Company is continuing to work to gradually extend the shelf-life to at least 24 months.Financial OverviewValneva remains well capitalized to execute on its strategic objectives  with â‚¬261 million in cash at the end of September 2022  excluding an additional â‚¬102.9 million in gross proceeds from a recent follow-on Global Offering. The Company reiterates its 2022 financial guidance  which includes total revenues of â‚¬340 million to â‚¬360 million and lowered R&D expenses of â‚¬95 million to â‚¬110 million (previously â‚¬120 million to â‚¬135 million)11.About Valneva SEValneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. Valneva has leveraged its expertise and capabilities both to commercialize three vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic  including candidates against Lyme disease and the chikungunya virus.Media & Investor ContactsLaÃ«titia Bachelot-FontaineVP Global Communications & European Investor RelationsM +33 (0)6 4516 7099laetitia.bachelot-fontaine@valneva.comJoshua Drumm  Ph.D.VP Global Investor RelationsM +001 917 815 4520joshua.drumm@valneva.comValneva Forward-Looking StatementsThis press release contains certain forward-looking statements relating to the business of Valneva  including with respect to its product candidates and estimates for future performance. In addition  even if the actual results or development of Valneva are consistent with the forward-looking statements contained in this press release  those results or developments of Valneva may not be sustained in the future. In some cases  you can identify forward-looking statements by words such as ""could "" ""should "" ""may "" ""expects "" ""anticipates "" ""believes "" ""intends "" ""estimates "" ""aims "" ""targets "" or similar words. These forward-looking statements are based largely on the current expectations of Valneva as of the date of this press release and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results  performance or achievements to be materially different from any future results  performance or achievement expressed or implied by these forward-looking statements. In particular  the expectations of Valneva could be affected by  among other things  uncertainties involved in the development and manufacture of vaccines  unexpected clinical trial results  unexpected regulatory actions or delays  competition in general  currency fluctuations  the impact of the global and European credit crisis  and the ability to obtain or maintain patent or other proprietary intellectual property protection. Success in preclinical studies or earlier clinical trials may not be indicative of results in future clinical trials. In light of these risks and uncertainties  there can be no assurance that the forward-looking statements made during this presentation will in fact be realized. Valneva is providing the information in these materials as of this press release and disclaim any intention or obligation to publicly update or revise any forward-looking statements  whether as a result of new information  future events  or otherwise.1 Valneva and Pfizer Report Further Positive Phase 2 Results  Including Booster Response  for Lyme Disease Vaccine Candidate2 Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate3 https://www.valorlymestudy.com/4 Valneva Initiates Rolling Submission of FDA Biologics License Application for its Single-Shot Chikungunya Vaccine Candidate5 Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate6 Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate7 Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate - Valneva8 Valneva and Instituto Butantan Sign Final Agreement on Single-Shot Chikungunya Vaccine for Low and Middle Income Countries9 https://www.iata.org/10 Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbriÂ®11 Valneva Reports Nine-Month 2022 Results and Provides Corporate UpdatesAttachment",neutral,0.01,0.99,0.0,mixed,0.28,0.11,0.61,True,English,"['New York City', 'Investor Day', 'Valneva', 'Chief Financial Officer Peter BÃ¼hler', 'Borrelia outer surface protein A', 'proprietary recombinant protein subunit candidate', 'six most prevalent serotypes', 'live Q&A session', 'Select Investor Day Highlights', 'vaccine-related serious adverse events', 'future R&D pipeline', 'two additional vaccine products', 'mosquito-transmitted chikungunya virus infection', 'potential second-generation prophylactic vaccine', 'chikungunya virus vaccine candidate', 'Phase 3 field efficacy study', 'Lyme disease) vaccine candidate', 'Chief Executive Officer', 'tick-transmitted Borrelia infection', 'chikungunya vaccine candidate', 'live-attenuated vaccine candidate', 'person investor day', 'brief financial overview', 'potential prophylactic vaccine', 'first chikungunya vaccine', 'preclinical vaccine candidates', 'senior leadership team', 'mid-term value drivers', '10am Eastern Time', 'Biologics License Application', 'pre-fusion F peptide', 'COVID-19 pandemic slows', 'next 12 to 36 months', 'six-month observational follow', 'Marketing Authorisation Application', 'European Medicines Agency', 'regulatory filing process', 'Priority Review Voucher', 'current vaccine pipeline', 'primary efficacy endpoint', 'Lyme vaccine program', 'pivotal Phase 3 study', 'New York City', 'antibody persistence results', 'Lyme borreliosis infection', 'three-dose vaccination schedule', 'U.S. Food', 'late-stage development pipeline', 'pivotal Phase 3 studies', 'specialty vaccine company', 'current commercial products', 'advanced clinical development', 'commercial vaccine business', 'U.S. FDA', 'vaccine development', 'future directions', 'Epstein-Barr virus', 'late-stage clinical', 'Phase 3 protocols', 'successful Phase', 'potential growth', 'clinical studies', 'primary vaccination', 'detailed overview', 'commercial portfolio', 'new vaccines', 'Antibody levels', 'global development', 'early development', 'concept studies', 'Live event', 'potential commercialization', 'Euronext Paris', 'Thomas Lingelbach', 'other members', 'Investors section', 'virtual attendees', 'rolling submission', 'respiratory pathogen', 'human metapneumovirus', 'relevant antigens', 'continued recovery', 'substantial growth', 'key strengthening', 'vaccines industry', 'core strengths', 'track record', 'Pre-clinical proof', 'strong immunogenicity', 'booster dose', 'safety concerns', 'Outdoor Recreationists', 'second quarter', 'Drug Administration', 'long-lasting immunity', 'single shot', 'seroresponse rate', 'immunological surrogate', 'Presentations page', 'formal presentations', 'broader vision', 'Enrollment completion', 'older adults', 'Valneva SE', '1000 adults', 'webcast', '10 AM', 'Saint-Herblain', 'France', 'December', 'VLA', 'website', 'opportunity', 'Pfizer', 'hMPV', 'mix', 'EBV', 'factors', 'part', 'Story', 'initiatives', 'manufacturing', 'experience', 'discovery', 'mechanism', 'action', 'OspA', 'children', 'â‰¥5 years', 'use', 'baseline', 'SAEs', 'MAA', 'EMA', 'sponsor', 'PRV', 'receipt', 'SRR', 'threshold', 'protection']",2022-12-06,2022-12-06,finance.yahoo.com
14279,EuroNext,NewsApi.org,https://finance.yahoo.com/news/vantiva-information-concerning-total-number-153800763.html,Vantiva - Information concerning the total number of voting rights and shares,December 6  2022 Vantiva: Information concerning the total number of voting rights and shares  provided pursuant to Article L. 233-8 II of the French...,VantivaDecember 6  2022Vantiva: Information concerning the total number of voting rights and shares  provided pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the AutoritÃ© des marchÃ©s financiersVantiva Shares(ISIN Code FR0013505062) Date Number of Outstanding Shares Number of Voting Rights November 30  2022355 389 840Number of Theoretical Voting Rights(1): 355 389 840Number of Voting Rights Exercisable at Shareholdersâ€™ meeting(2): 355 389 840(1) Calculated  pursuant to Article 223-11 of the General Regulations of the AutoritÃ© des MarchÃ©s Financiers  based on the total number of outstanding shares to which voting rights are attached  including shares with suspended voting rights.(2) Excluding shares with suspended voting rights.* **About Vantivawww.vantiva.com â€“ Follow us: @Vantiva â€“ www.linkedin.com/company/vantiva/Vantiva shares are on the Euronext Paris exchange (VANTI) and traded in the USA on the OTCQX marketplace (OTCQX: TCLRY).Attachment,neutral,0.0,1.0,0.0,positive,0.93,0.06,0.01,True,English,"['total number', 'voting rights', 'Vantiva', 'Information', 'shares', 'des MarchÃ©s Financiers', 'Euronext Paris exchange', 'French Commercial Code', 'Theoretical Voting Rights', 'ISIN Code', 'General Regulations', 'Shareholdersâ€™ meeting', 'OTCQX marketplace', 'Outstanding Shares', 'total number', 'Date Number', 'Article L.', 'Vantiva Shares', 'Information', 'USA', 'TCLRY', 'Attachment']",2022-12-06,2022-12-06,finance.yahoo.com
14280,EuroNext,NewsApi.org,https://finance.yahoo.com/news/exor-n-v-periodic-report-071000835.html,Exor N.V.: Periodic Report on the Buyback Program,EXOR N.V. (AMS: EXO) (â€œExorâ€ or the â€œCompanyâ€) announces that  under the second tranche of the share buyback program of up to â‚¬250 million announced on 29...,EXOR N.V. (AMS: EXO) (â€œExorâ€ or the â€œCompanyâ€) announces that  under the second tranche of the share buyback program of up to â‚¬250 million announced on 29 July 2022 (the â€œsecond trancheâ€)  the Company has completed the following transactions on Euronext Amsterdam:Trading Date Number of ordinary shares purchased Average price per share excluding fees (â‚¬) Total consideration excluding fees (â‚¬) 1 December 2022 7 413 76.4983 567 081.90 2 December 2022 30 539 76.1906 2 326 784.73 TOTAL 37 952 2 893 866.63After these purchases  the total invested amount under the second tranche is approximately â‚¬116.6 million for a total amount of 1 766 419 ordinary shares purchased.As of 2 December 2022  the Company held in total 12 563 600 ordinary shares in treasury (5.21% of total ordinary issued share capital).A comprehensive overview of the transactions carried out under the share buyback program  as well as the details of the above transactions  are available on Exorâ€™s corporate website under the Share Buyback section.Attachment,neutral,0.01,0.99,0.0,neutral,0.0,0.99,0.0,True,English,"['Exor N.V.', 'Periodic Report', 'Buyback Program', 'Trading Date Number', 'share buyback program', 'Share Buyback section', 'EXOR N.V.', 'share capital', 'second tranche', 'Euronext Amsterdam', 'ordinary shares', 'Average price', 'comprehensive overview', 'corporate website', 'Total consideration', 'total ordinary', 'following transactions', 'total amount', 'Company', '29 July', 'fees', '1 December', 'purchases', '2 December', 'treasury', 'details', 'Attachment', '12']",2022-12-05,2022-12-06,finance.yahoo.com
14281,EuroNext,NewsApi.org,https://finance.yahoo.com/news/global-bioenergies-successful-scale-pomacle-054500574.html,Global Bioenergies - Successful scale-up of Pomacle commercial unit,Successful scale-up of Pomacle commercial unit Evry  06 December 2022 â€“ Global Bioenergies announces the successful scale-up of production at its Pomacle...,GLOBAL BIOENERGIESSuccessful scale-up of Pomacle commercial unitEvry  06 December 2022 â€“ Global Bioenergies announces the successful scale-up of production at its Pomacle commercial unit. All sub-units are now up and running  a few weeks ahead of schedule.Global Bioenergies announces that its first commercial production unit is now fully operational. All units (biological isobutene production  purification  condensation and packaging) have been validated and are now in operation.FrÃ©dÃ©ric Ollivier  Global Bioenergiesâ€™ Chief Technical Officer  said: â€œAn industrial project is invariably an adventure. This is especially so in these troubled times. Nevertheless  we were able to successfully build and commission the unit in very good conditions. We are now producing about 1 tonne of isobutene per week. I would like to congratulate the entire Global Bioenergies team  who made this success possible.â€Global Bioenergies plans to sell purified isobutene for use in cosmetics and high value-added fuel applications that can cover what remains a very high production cost.Global Bioenergies will also convert some of the isobutene produced  via an established chain of tollers  into cosmetic-grade isododecane for sale to major cosmetic companies under the trademark IsonaturaneÂ® 12. The scale-up of this downstream chain was executed in parallel to the start of operations at the Pomacle unit.Daphne Galvez  Global Bioenergiesâ€™ Head of Sales  said: â€œWe will produce IsonaturaneÂ® 12 by campaigns. The first batch  which will be delivered in a few months  has already been sold in full  and our commercial discussions are now focusing on subsequent batches.â€Marc Delcourt  Global Bioenergiesâ€™ Chief Executive Officer  said: â€œThe primary purpose of this unit is to generate revenue. Its second purpose is to pave the way in commercial  technical and regulatory terms for the 2025 launch of a new unit destined to produce 2 000 tonnes of isobutene and derivatives per year.â€Story continuesAbout GLOBAL BIOENERGIESGlobal Bioenergies converts plant-derived resources into compounds used in the cosmetics industry  as well as the energy and materials sectors. After launching the first long-lasting and natural make-up brand LASTÂ® in 2021  Global Bioenergies is now marketing IsonaturaneÂ® 12  its key ingredient  to major cosmetics companies to improve the naturalness of their formulas whilst improving their carbon footprint. In the long run  Global Bioenergies is also aiming at cutting CO 2 emissions in the aviation and road sector and thereby curb global warming. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).Receive information about Global Bioenergies directly by subscribing to our news feed on www.global-bioenergies.comFollow us on LinkedIn: Global BioenergiesContactsGLOBAL BIOENERGIESinvest@global-bioenergies.comPRESS RELATIONSIva Baytchevaibaytcheva@ulysse-communication.comNicolas Danielsndaniels@ulysse-communication.comAttachment,neutral,0.48,0.52,0.0,mixed,0.7,0.07,0.23,True,English,"['Pomacle commercial unit', 'Global Bioenergies', 'Successful scale-up', 'Global Bioenergiesâ€™ Chief Executive Officer', 'Global Bioenergiesâ€™ Chief Technical Officer', 'FrÃ©dÃ©ric Ollivier', 'high value-added fuel applications', 'entire Global Bioenergies team', 'first commercial production unit', 'high production cost', 'major cosmetic companies', 'natural make-up brand', 'Euronext Growth Paris', 'major cosmetics companies', 'Global Bioenergiesâ€™ Head', 'Pomacle commercial unit', 'biological isobutene production', 'commercial, technical', 'Pomacle unit', 'commercial discussions', 'first batch', 'first long-lasting', 'global warming', 'new unit', 'industrial project', 'troubled times', 'good conditions', 'established chain', 'cosmetic-grade isododecane', 'downstream chain', 'Daphne Galvez', 'subsequent batches', 'Marc Delcourt', 'primary purpose', 'second purpose', 'regulatory terms', 'plant-derived resources', 'cosmetics industry', 'materials sectors', 'key ingredient', 'carbon footprint', 'long run', 'road sector', 'news feed', 'PRESS RELATIONS', 'Iva Baytcheva', 'Nicolas Daniels', 'Successful scale-up', 'Evry', 'sub-units', 'schedule', 'purification', 'condensation', 'packaging', 'operation', 'adventure', '1 tonne', 'week', 'use', 'tollers', 'sale', 'trademark', 'Isonaturane', 'parallel', 'start', 'campaigns', 'months', 'revenue', 'way', '2025 launch', '2,000 tonnes', 'derivatives', 'year', 'Story', 'compounds', 'energy', 'LASTÂ®', 'naturalness', 'formulas', '2 emissions', 'aviation', 'ALGBE', 'information', 'LinkedIn', 'Contacts', 'communication', 'ndaniels', 'Attachment', '06']",2022-12-06,2022-12-06,finance.yahoo.com
14282,EuroNext,NewsApi.org,https://finance.yahoo.com/news/dsm-delivery-shares-170100414.html,DSM - delivery of shares,Following the Offering Circular published on 22 November 2022  Royal DSM is required to announce transactions relating to the ordinary shares in its capital ...,This is a press release by Koninklijke DSM N.V. (Royal DSM)  pursuant to the provisions of Sections 13 paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) (the Decree) in connection with the public offer by Danube AG (to be renamed DSM-Firmenich AG) for all the issued and outstanding ordinary shares in the capital of DSM (the Exchange Offer). This press release does not constitute an offer  or any solicitation of any offer  to buy or subscribe for any securities. This press release is not for general release  publication or distribution  in whole or in part  in or into  directly or indirectly  the United States or any other jurisdiction where such release  publication or distribution would violate applicable laws or regulations.HEERLEN  Netherlands  Dec. 6  2022 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022  Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.DSM Logo.Pursuant to commitments entered into prior to issuing the Offering Circular  DSM has in the period from 23 November up to 6 December  2022  delivered 9 090 ordinary shares to employees in view of settling the exercise of an equivalent number of stock options granted under the respective DSM Incentive Plan (the exercise price of 6 750 stock options was â‚¬50.98  whereas the average exercise price of 2 340 stock options was â‚¬97.90). In the same period  DSM has delivered 7 668 ordinary shares in view of the vesting of an equivalent number of share units that have been granted subject to the terms of the respective DSM Incentive Plan. On the date hereof  the total number of issued and outstanding DSM ordinary shares is 173 072 337. As a consequence of the delivery included herein  the number of outstanding DSM ordinary shares increased by 0.0097%.DSMRoyal DSM is a global  purpose-led company in Health  Nutrition & Bioscience  applying science to improve the health of people  animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic  environmental and societal value for all its stakeholders â€“ customers  employees  shareholders  and society at large. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.Or find us on:LinkedIn: http://www.linkedin.com/company/3108Twitter: http://www.twitter.com/DSMFacebook: http://www.facebook.com/DSMcompanyYouTube: http://www.youtube.com/user/dsmcompanyFor more informationDSM Media Relations Gareth Mead tel. +31 (0) 45 5782420 email media.contacts@dsm.com DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 email investor.relations@dsm.comForward-looking statementsThis press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations  estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release  unless required by law. The English language version of the press release is leading.CisionView original content:https://www.prnewswire.co.uk/news-releases/dsm---delivery-of-shares-301696052.html,neutral,0.02,0.98,0.0,mixed,0.2,0.2,0.6,True,English,"['DSM', 'delivery', 'shares', 'DSM Media Relations Gareth Mead', 'DSM Investor Relations Dave Huizing', 'Koninklijke DSM N.V.', 'respective DSM Incentive Plan', 'Dutch public offer rules', 'outstanding DSM ordinary shares', 'Public Takeover Bids', 'outstanding ordinary shares', 'English language version', 'future (financial) performance', 'global, purpose-led company', 'average exercise price', '9,090 ordinary shares', '7,668 ordinary shares', 'Dutch Decree', 'treasury shares', 'actual performance', 'Royal DSM', 'DSM Logo', 'Sections 13 paragraphs', 'biedingen Wft', 'Danube AG', 'Exchange Offer', 'United States', 'other jurisdiction', 'applicable laws', 'Offering Circular', 'stock options', 'brighter lives', 'biggest challenges', 'economic, environmental', 'societal value', 'Euronext Amsterdam', 'current expectations', 'many factors', 'original content', 'press release', 'general release', 'equivalent number', 'total number', 'same period', 'Forward-looking statements', 'Such statements', 'More information', 'share units', 'provisions', 'connection', 'capital', 'solicitation', 'securities', 'publication', 'distribution', 'part', 'regulations', 'HEERLEN', 'Netherlands', 'Dec.', 'PRNewswire', '22 November', 'transactions', 'accordance', 'delivery', 'employees', 'view', 'vesting', 'commitments', '23 November', '6 December', 'terms', 'date', 'consequence', 'Health', 'Nutrition', 'Bioscience', 'people', 'animals', 'planet', 'products', 'solutions', 'world', 'stakeholders', 'customers', 'shareholders', 'society', 'LinkedIn', 'Twitter', 'Facebook', 'DSMcompany', 'YouTube', 'position', 'estimates', 'projections', 'readers', 'risks', 'uncertainties', 'obligation', 'Cision', 'news-releases']",2022-12-06,2022-12-06,finance.yahoo.com
14283,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2568659/0/en/Exor-included-in-the-AEX-Index-at-Euronext.html,Exor included in the AEX Index at Euronext,EXOR N.V. (AMS: EXO) (â€œExorâ€) has been selected for inclusion in the AEX Index after its listing on Euronext Amsterdam on 12 August 2022. This was announced by Euronext Amsterdam today following its December quarterly review. Exor will start trading as part oâ€¦,EXOR N.V. (AMS: EXO) (â€œExorâ€) has been selected for inclusion in the AEX Index after its listing on Euronext Amsterdam on 12 August 2022. This was announced by Euronext Amsterdam today following its December quarterly review. Exor will start trading as part of the AEX Index effective 19 December 2022.The AEX is a leading European index that reflects the performance of the 25 largest companies listed in the Netherlands based on free-float adjusted market capitalization  and is the most widely used indicator of the Dutch stock market.Attachment,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['AEX Index', 'Exor', 'Euronext', 'free-float adjusted market capitalization', 'Dutch stock market', 'leading European index', 'EXOR N.V.', 'AEX Index', 'Euronext Amsterdam', 'quarterly review', 'The AEX', '25 largest companies', 'inclusion', 'listing', '12 August', 'December', 'part', 'performance', 'Netherlands', 'indicator', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14284,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221206005400/en/Unibail-Rodamco-Westfield-Unveils-Landmark-Vision-for-Westfield-Old-Orchard,Unibail-Rodamco-Westfield Unveils Landmark Vision for Westfield Old Orchard,SKOKIE  Ill.--(BUSINESS WIRE)-- #oldorchard--Unibail-Rodamco-Westfield (URW) unveiled a new  landmark vision today for Westfield Old Orchard that will create a North Shore destination unlike anything else in Chicagoland  featuring best-in-class retail  modernâ€¦,A rendering showing the new  landmark vision for Westfield Old Orchard in Skokie  Illinois. The planned mixed-use development will feature best-in-class retail  modern residences  chef-led dining  entertainment  gourmet markets  and upscale health and wellness amenities  all alongside a park and event space designed as the center's focal point and social gathering place. (Photo: Business Wire)A rendering showing the new  landmark vision for Westfield Old Orchard in Skokie  Illinois. The planned mixed-use development will feature best-in-class retail  modern residences  chef-led dining  entertainment  gourmet markets  and upscale health and wellness amenities  all alongside a park and event space designed as the center's focal point and social gathering place. (Photo: Business Wire)A rendering showing the new  landmark vision for Westfield Old Orchard in Skokie  Illinois. The planned mixed-use development will feature best-in-class retail  modern residences  chef-led dining  entertainment  gourmet markets  and upscale health and wellness amenities  all alongside a park and event space designed as the center's focal point and social gathering place. (Photo: Business Wire)A rendering showing the new  landmark vision for Westfield Old Orchard in Skokie  Illinois. The planned mixed-use development will feature best-in-class retail  modern residences  chef-led dining  entertainment  gourmet markets  and upscale health and wellness amenities  all alongside a park and event space designed as the center's focal point and social gathering place. (Photo: Business Wire)SKOKIE  Ill.--(BUSINESS WIRE)--Unibail-Rodamco-Westfield (URW) unveiled a new  landmark vision today for Westfield Old Orchard that will create a North Shore destination unlike anything else in Chicagoland  featuring best-in-class retail  modern residences  chef-led dining  entertainment  gourmet markets  and upscale health and wellness amenities.The development plans also feature a park and event space designed as the centerâ€™s focal point and social gathering place. Under a canopy of native trees and plants  paved pathways will wind through lush landscaping and comfortable seating  leading to an open-air plaza where local events  concerts  farmerâ€™s markets  and festivals can take place.Geoff Mason  executive vice president of operating management and development for URW in the U.S.  said: â€œWestfield Old Orchard already provides an exceptional experience for our customers  local residents  and our office workers. Our bold new vision for the center will dramatically enhance its offering and further establish it as the preeminent live  work  shop  and play destination on the North Shore. By creatively unlocking the potential of the center  this development will bring new life  energy and choices to Old Orchard and provide experiences that are even more engaging and meaningful for the local community.â€Sustainability will be central to the development  with the project serving as an example of URWâ€™s broader strategy to create unique  sustainable places where people connect through meaningful shared experiences. Innovative  sustainable building strategies that incorporate renewable energy  natural materials  biophilic design  and biodiversity will be introduced  enhancing Old Orchardâ€™s contribution to the environmental  social  and economic vitality of Skokie and the North Shore.The multi-phase development began earlier this fall with the modernization of the existing shopping center  starting with enhancements to the common areas as well as the opening of a slate of new restaurants  health and wellness amenities  and luxury retailers â€“ including Bloomies  Bloomingdaleâ€™s new curated shopping concept â€“ and Louis Vuitton  as well as the return of Barnes & Noble  a long-time center favorite.Redevelopment at the center will continue in 2023 with the former Lord & Taylor space. It will be completely reimagined and redesigned  offering new luxury home furnishings  top fashion  and entertainment options to shoppers. Development of the new residences  eateries  wellness facilities  and outdoor amenities is expected to begin in 2024  and will open in phases starting in 2026.Mayor George VanDusen said: â€œFor decades  Westfield Old Orchard has been a key economic and employment driver for Skokie and the region. Westfield and URWâ€™s commitment to significantly invest and transform Old Orchard continues both this important economic growth and the Villageâ€™s long-standing  collaborative partnership with property ownership. The Village Boardâ€™s action earlier this year to designate Old Orchard as one of over 200 Illinois Business Districts has resulted in Westfieldâ€™s financial commitment of over $100 million to transform Old Orchard. I applaud Westfieldâ€™s focus on sustainability with this new vision  as is consistent with the Villageâ€™s recently approved comprehensive Environmental Sustainability Plan. The additional announcements and developments at Old Orchard in the coming year will further strengthen this tremendous community and regional asset.â€More detailed plans for the development will be unveiled in early 2024  and community input will be encouraged.Mason added: â€œWe are at the very start of this project  but already incredibly excited about working with the Village of Skokie and the local community to take one of the most desirable destinations on the North Shore and enhance itâ€”creating a place that can become the residential  commercial  and cultural heart of the community.â€About Unibail-Rodamco-WestfieldUnibail-Rodamco-Westfield is an owner  developer and operator of sustainable  high-quality real estate assets in the most dynamic cities in Europe and the United States.The Group operates 80 shopping centres in 12 countries  including 45 which carry the iconic Westfield brand. These centres attract over 900 million visits annually and provide a unique platform for retailers and brands to connect with consumers. URW also has a portfolio of high-quality offices  10 convention and exhibition venues in Paris  and a â‚¬3 Bn development pipeline of mainly mixed-use assets. Currently  its â‚¬55 Bn portfolio is 87% in retail  6% in offices  5% in convention and exhibition venues  and 2% in services (as at June 30  2022).URW is a committed partner to major cities on urban regeneration projects  through both mixed-use development and the retrofitting of buildings to industry-leading sustainability standards. These commitments are enhanced by the Groupâ€™s Better Places 2030 agenda  which strives to make a positive environmental  social and economic impact on the cities and communities where URW operates.URWâ€™s stapled shares are listed on Euronext Amsterdam and Euronext Paris (Ticker: URW)  with a secondary listing in Australia through Chess Depositary Interests. The Group benefits from a BBB+ rating from Standard & Poorâ€™s and from a Baa2 rating from Moodyâ€™s.For more information  please visit www.urw.com,neutral,0.01,0.99,0.0,positive,0.78,0.22,0.01,True,English,"['Westfield Old Orchard', 'Unibail-Rodamco-Westfield Unveils', 'Landmark Vision', 'Innovative, sustainable building strategies', 'new curated shopping concept', 'comprehensive Environmental Sustainability Plan', 'new luxury home furnishings', 'unique, sustainable places', 'executive vice president', 'Mayor George VanDusen', 'standing, collaborative partnership', 'new, landmark vision', 'bold new vision', 'social gathering place', 'More detailed plans', 'important economic growth', 'meaningful shared experiences', 'existing shopping center', 'The Village Board', 'Westfield Old Orchard', 'time center favorite', 'North Shore destination', '200 Illinois Business Districts', 'luxury retailers', 'new restaurants', 'new residences', 'play destination', 'economic vitality', 'key economic', 'Business Wire', 'development plans', 'class retail', 'modern residences', 'chef-led dining', 'wellness amenities', 'event space', 'focal point', 'native trees', 'lush landscaping', 'comfortable seating', 'open-air plaza', 'local events', 'Geoff Mason', 'operating management', 'U.S.', 'exceptional experience', 'local residents', 'office workers', 'preeminent live', 'local community', 'broader strategy', 'natural materials', 'biophilic design', 'common areas', 'Louis Vuitton', 'former Lord', 'Taylor space', 'top fashion', 'wellness facilities', 'outdoor amenities', 'employment driver', 'property ownership', 'additional announcements', 'coming year', 'tremendous community', 'regional asset', 'gourmet markets', 'upscale health', 'mixed-use development', 'multi-phase development', 'renewable energy', 'financial commitment', 'entertainment options', 'rendering', 'Skokie', 'park', 'Photo', 'Unibail-Rodamco-Westfield', 'URW', 'Chicagoland', 'canopy', 'plants', 'pathways', 'concerts', 'farmer', 'festivals', 'customers', 'offering', 'potential', 'choices', 'project', 'example', 'people', 'biodiversity', 'contribution', 'modernization', 'enhancements', 'opening', 'slate', 'Bloomies', 'Bloomingdale', 'return', 'Barnes', 'Noble', 'long', 'Redevelopment', 'shoppers', 'eateries', 'phases', 'decades', 'action', 'focus', 'developments']",2022-12-06,2022-12-06,businesswire.com
14285,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221205005072/en/Thales-Reinforces-its-Border-Travel-Offer-With-the-New-Multimodal-Biometric-Pod,Thales Reinforces its Border & Travel Offer With the New Multimodal Biometric Pod,PARIS LA DÃ‰FENSE--(BUSINESS WIRE)-- #ThalesIDWallet--The new Thales multimodal biometric pod is an efficient enrolment and identification solution that helps smoothly manage travelersâ€™ border and immigration processes. The combination of â€˜iris & faceâ€™ captureâ€¦,PARIS LA DÃ‰FENSE--(BUSINESS WIRE)--The new Thales multimodal biometric pod is an efficient enrolment and identification solution that helps smoothly manage travelersâ€™ border and immigration processes. The combination of â€˜iris & faceâ€™ capture and recognition capacities enables a fast and secure enrolment and ID verification at borders. The pod features a modern design that perfectly suits the authorityâ€™s needs in highly secure environments.The travel industry and border security agencies have recognized the need to improve efficiency and overall traveler experience at border entry and exit points. For years  biometrics has been used by authorities to simplify traveler experiences at borders  speeding up people enrolment and ID checks such as the eGates or Entry-Exit Systems. With the Thales multimodal biometric pod  borders authorities can easily integrate automation into their processes  without compromising on passenger and employee security or on the confidentiality of the data exchanged as the solution offers â€˜security and privacy by designâ€™ parameters.Featuring a camera and a high-resolution LCD screen  the biometric pod is able to recognise pre-enrolled travelersâ€™ iris and face at a distance of 0.5m and up to 1.5m with excellent accuracy. Boosted by AI  the solution captures dual iris and face in two seconds  leading to swifter operations and visibly shorter wait times . Thales biometric pods can be set at any borders checkpoint (airports  seaports  etc.) managing both the first traveler enrolment upon arrival and quick biometric checks whenever required (upon territory exit  internal flights etc).â€œThe combination of biometric patterns applied to contactless authentication  is a sought-after solution for many stakeholders to address security  operational and convenience challenges. Thales relies on its in-house biometrics  border and smart travel expertise to design  develop and deliver top tier responsible biometric solutions to meet usersâ€™ expectations and authoritiesâ€™ requirementsâ€  said Youzec Kurp  VP Identity and Biometric Solutions at Thales.About ThalesThales (Euronext Paris: HO) is a global leader in advanced technologies  investing in digital and â€œdeep techâ€ innovations â€“ connectivity  big data  artificial intelligence  cybersecurity and quantum technologies â€“ to build a confident future crucial for the development of our societies. The Group provides its customers â€“ businesses  organizations and governments â€“ in the defense  aeronautics  space  transport  and digital identity and security domains with solutions  services and products that help them fulfil their critical role  consideration for the individual being the driving force behind all decisions.Thales has 81 000 employees in 68 countries. In 2021  the Group generated sales of â‚¬16.2 billion.PLEASE VISITThales GroupDigital Identity and SecurityDownload HD photos,neutral,0.01,0.99,0.0,positive,0.84,0.15,0.0,True,English,"['New Multimodal Biometric Pod', 'Travel Offer', 'Thales', 'Border', 'top tier responsible biometric solutions', 'new Thales multimodal biometric pod', 'PARIS LA DÃ‰FENSE', 'high-resolution LCD screen', 'shorter wait times', 'deep techâ€ innovations', 'quick biometric checks', 'overall traveler experience', 'smart travel expertise', 'Thales biometric pods', 'first traveler enrolment', 'border security agencies', 'biometric patterns', 'Euronext Paris', 'traveler experiences', 'travel industry', 'ID checks', 'efficient enrolment', 'secure enrolment', 'people enrolment', 'BUSINESS WIRE', 'travelersâ€™ border', 'recognition capacities', 'ID verification', 'secure environments', 'border entry', 'exit points', 'excellent accuracy', 'two seconds', 'swifter operations', 'territory exit', 'internal flights', 'contactless authentication', 'many stakeholders', 'convenience challenges', 'usersâ€™ expectations', 'Youzec Kurp', 'VP Identity', 'global leader', 'advanced technologies', 'artificial intelligence', 'quantum technologies', 'confident future', 'critical role', 'driving force', 'HD photos', 'employee security', 'security domains', 'Thales Group', 'travelersâ€™ iris', 'dual iris', 'authoritiesâ€™ requirements', 'The Group', 'digital identity', 'immigration processes', 'modern design', 'borders checkpoint', 'house biometrics', 'big data', 'identification solution', 'borders authorities', 'combination', 'face', 'capture', 'fast', 'authority', 'needs', 'efficiency', 'years', 'eGates', 'automation', 'passenger', 'confidentiality', 'privacy', 'parameters', 'camera', 'distance', 'airports', 'seaports', 'arrival', 'operational', 'connectivity', 'cybersecurity', 'development', 'societies', 'customers', 'businesses', 'organizations', 'governments', 'defense', 'aeronautics', 'space', 'transport', 'services', 'products', 'consideration', 'individual', 'decisions', '81,000 employees', '68 countries', 'sales', '0.5']",2022-12-06,2022-12-06,businesswire.com
14286,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2568212/0/en/VEON-Appoints-Group-Diversity-and-Inclusion-Officer.html,VEON Appoints Group Diversity and Inclusion Officer,AMSTERDAM  6 DecemberÂ â€“ VEON Ltd. (NASDAQ and Euronext Amsterdam: VEON)  a global digital operator that provides converged connectivity and...,AMSTERDAM  6 December â€“ VEON Ltd. (NASDAQ and Euronext Amsterdam: VEON)  a global digital operator that provides converged connectivity and online services  announces that it has established the Group Diversity and Inclusion Officer position as it continues to strengthen commitment to diversity and inclusion.Ana  VEONâ€™s current Director Financial Control  will assume the new role effective of 1st of January 2023 in addition to her current responsibilities. In this capacity she will report to Michael Schulz  Group Chief People Officer and continue to report to Serkan Okandan  Group Chief Financial Officer  on the finance and financial control matters.In her new position Ana will champion initiatives across VEONâ€™s markets of operations  chairing VEONâ€™s Diversity & Inclusion Forum and promoting cross-cultural  inclusive and collaborative way of working.â€œDiversity & inclusion is in our DNA as we work across the markets in Eastern Europe  Central and Southern Asia. Anaâ€™s appointment will reinforce our commitment to diversity & inclusion  which is paramount for VEON as an equal opportunities employer â€ said Kaan Terzioglu  CEO of VEON Group. â€œHer exemplary work for VEON during the past seven years  her passion and leadership in creating diverse working environments across the Group  her international background of working in Mexico  USA and Netherlands  leading global teams across the world  make her an ideal fit for the inclusion role.â€â€œI am thrilled with this opportunity to make a difference  join the efforts of our leaders and colleagues across VEON geographies and contribute to the matter that is close to my heart â€ said Ana. â€œVEON is one of the most forward-looking digital operators in the world. Our innovation in services for finance  education  entertainment and healthcare has driven digital inclusion in emerging economies.In my new role  I will focus on leveraging the immensely rich experience of our operating companies such as digital inclusion  supporting female entrepreneurship  and fostering exchange between the countries in which we operate.â€ expressed Ana de Kok-Reyes.About VEONVEON is a digital operator that currently provides converged connectivity and online services to over 200 million customers. Operating across seven countries that are home to more than 8% of the worldâ€™s population  VEON is transforming peopleâ€™s lives  empowering individuals and driving economic growth. Headquartered in Amsterdam  VEON is listed on NASDAQ and Euronext.DisclaimerThis release contains â€œforward-looking statements â€ as the phrase is defined in Section 27A of the U.S. Securities Act of 1933  as amended  and Section 21E of the U.S. Securities Exchange Act of 1934  as amended. Forward-looking statements are not historical facts  and include statements relating to  among other things  our management team and certain diversity and inclusion initiatives. Forward-looking statements are inherently subject to risks and uncertainties  many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update  except as required by U.S. federal securities laws  any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events.Contact Information:VEON GroupGroup Communications DirectorMarina Levinapr@veon.comTUVA PartnersJulian Tannerjulian.tanner@tuvapartners.com,neutral,0.01,0.99,0.0,mixed,0.51,0.1,0.39,True,English,"['Inclusion Officer', 'VEON', 'Group', 'Diversity', 'U.S. federal securities laws', 'U.S. Securities Exchange Act', 'U.S. Securities Act', 'VEON Group Group Communications Director', 'current Director Financial Control', 'Group Chief Financial Officer', 'Group Chief People Officer', 'financial control matters', 'equal opportunities employer', 'diverse working environments', 'past seven years', 'looking digital operators', 'Inclusion Officer position', 'global digital operator', 'Ana de Kok-Reyes', 'current responsibilities', 'new position', 'global teams', 'Group Diversity', 'digital inclusion', 'converged connectivity', 'new role', 'Michael Schulz', 'Serkan Okandan', 'cross-cultural, inclusive', 'collaborative way', 'Eastern Europe', 'Southern Asia', 'Kaan Terzioglu', 'exemplary work', 'international background', 'emerging economies', 'rich experience', 'operating companies', 'female entrepreneurship', '200 million customers', 'seven countries', 'economic growth', 'historical facts', 'other things', 'management team', 'forward-looking statement', 'Contact Information', 'Marina Levina', 'TUVA Partners', 'Inclusion Forum', 'inclusion role', 'online services', 'unanticipated events', 'VEON Ltd.', 'VEON geographies', 'inclusion initiatives', 'Julian Tanner', 'Euronext Amsterdam', 'statements', '6 December', 'NASDAQ', 'commitment', '1st', 'January', 'addition', 'capacity', 'finance', 'markets', 'operations', 'DNA', 'Central', 'appointment', 'CEO', 'passion', 'leadership', 'Mexico', 'USA', 'Netherlands', 'world', 'opportunity', 'difference', 'efforts', 'colleagues', 'heart', 'innovation', 'education', 'entertainment', 'healthcare', 'population', 'lives', 'individuals', 'Disclaimer', 'release', 'phrase', 'Section', 'risks', 'uncertainties', 'accuracy', 'date', 'circumstances']",2022-12-06,2022-12-06,globenewswire.com
14287,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2568591/0/en/Quadient-Named-an-Approved-Cloud-Software-Supplier-on-UK-Government-s-Digital-Marketplace.html,Quadient Named an Approved Cloud Software Supplier on UK Governmentâ€™s Digital Marketplace,Quadient Named an Approved Cloud Software Supplier on UK Governmentâ€™s Digital Marketplace  Paris  December 6  2022  Quadient (Euronext Paris: QDT)  a......,English FrenchQuadient Named an Approved Cloud Software Supplier on UK Governmentâ€™s Digital MarketplaceParis  December 6  2022Quadient (Euronext Paris: QDT)  a leader in helping businesses create meaningful customer connections through digital and physical channels  announced today it has been awarded a place on the UK governmentâ€™s new G Cloud 13 framework  managed by Crown Commercial Service (CCS). G Cloud provides organizations  across both central government and the wider public sector  with an online digital marketplace to procure cloud-based software solutions.The Digital Marketplace also allows organizations to easily procure required services at competitive prices  protecting the public purse.Quadient has been a long-time provider of solutions to the UK central government and wider public sector organizations  having been awarded places on multiple previous framework agreements. G Cloud 13 further builds on these relationships  providing access to Quadientâ€™s broad portfolio of cloud-based software solutions.As part of the successful acceptance to G Cloud 13  organizations can now access seven Quadient cloud-based solutions via the Digital Marketplace  across the applications below:Accounts payable automationAccounts receivable automationMultichannel communicationsCustomer experience managementDocument managementPostal address validationâ€œWe are delighted to have been awarded a place on G Cloud 13  a clear indication of our commitment to supporting UK government and the wider public sector â€ said Craig Spencer  Director of Public Sector Strategy at Quadient UK. â€œG Cloud 13 presents a real opportunity for organizations to access leading-edge SaaS technologies simply and at competitive rates.â€Quadientâ€™s growing software business has more than 12 000 customers worldwide  78% of which rely on the companyâ€™s SaaS solutions. The companyâ€™s Intelligent Communication Automation (ICA) cloud-based platform includes a comprehensive offering for accounts payable (AP) and accounts receivable (AR) automation and management  customer communications management (CCM) and document automation and customer journey mapping (CJM).About QuadientÂ®Quadient is the driving force behind the worldâ€™s most meaningful customer experiences. By focusing on three key solution areas  Intelligent Communication Automation  Parcel Locker Solutions and Mail-Related Solutions  Quadient helps simplify the connection between people and what matters. Quadient supports hundreds of thousands of customers worldwide in their quest to create relevant  personalized connections and achieve customer experience excellence. Quadient is listed in compartment B of Euronext Paris (QDT) and is part of the SBF 120Â®  CACÂ® Mid 60 and EnterNextÂ® Tech 40 indices.For more information about Quadient  visit www.quadient.com.Contacts Joe Scolaro  Quadient Dominic Walsh  Spark Communications Global Press Relations Manager +44 (0)20 7436 0420 +1 203-301-3673 quadient@sparkcomms.co.uk j.scolaro@quadient.comAttachment,neutral,0.0,1.0,0.0,positive,0.84,0.16,0.0,True,English,"['Cloud Software Supplier', 'UK Government', 'Digital Marketplace', 'Spark Communications Global Press Relations Manager', 'multiple previous framework agreements', 'three key solution areas', 'new G Cloud 13 framework', 'seven Quadient cloud-based solutions', 'wider public sector organizations', 'Public Sector Strategy', 'ICA) cloud-based platform', 'meaningful customer connections', 'Crown Commercial Service', 'Postal address validation', 'growing software business', 'customer journey mapping', 'meaningful customer experiences', 'relevant, personalized connections', 'customer experience excellence', 'EnterNextÂ® Tech 40 indices', 'customer communications management', 'cloud-based software solutions', 'Intelligent Communication Automation', 'Parcel Locker Solutions', 'leading-edge SaaS technologies', 'Cloud Software Supplier', 'Customer experience management', 'Contacts Joe Scolaro', 'online digital marketplace', 'The Digital Marketplace', 'Quadient Dominic Walsh', 'Accounts receivable automation', 'Accounts payable automation', 'UK central government', 'Multichannel communications', 'SaaS solutions', 'public purse', 'AR) automation', 'document automation', 'Mail-Related Solutions', 'UK Government', 'Document management', 'English French', 'physical channels', 'required services', 'competitive prices', 'long-time provider', 'broad portfolio', 'successful acceptance', 'clear indication', 'Craig Spencer', 'real opportunity', 'competitive rates', 'comprehensive offering', 'driving force', 'compartment B', 'CACÂ® Mid', 'Euronext Paris', 'Quadient UK', 'QuadientÂ®', 'December', 'QDT', 'leader', 'businesses', 'CCS', 'places', 'relationships', 'access', 'applications', 'commitment', 'Director', '12,000 customers', 'company', 'CCM', 'CJM', 'world', 'people', 'hundreds', 'thousands', 'quest', 'SBF 120Â®', 'information', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14288,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2567902/0/en/Valneva-Hosts-Investor-Day-in-New-York-City.html,Valneva Hosts Investor Day in New York City,Live event and webcast TODAY at 10 AM â€“ 12 PM ET    Saint-Herblain (France)  December 06  2022 â€“ Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  a......,"English FrenchLive event and webcast TODAY at 10 AM â€“ 12 PM ETSaint-Herblain (France)  December 06  2022 â€“ Valneva SE (Nasdaq: VALN; Euronext Paris: VLA)  a specialty vaccine company  is hosting an in-person investor day today in New York City to discuss the Companyâ€™s current vaccine pipeline  commercial products  and future directions. Valnevaâ€™s Chief Executive Officer Thomas Lingelbach  Chief Financial Officer Peter BÃ¼hler  and other members of the Companyâ€™s senior leadership team will highlight Valnevaâ€™s core near- and mid-term value drivers  including its early- and late-stage development pipeline and commercial vaccine business.Presentations will begin at 10am Eastern Time. The event will also be webcast live and archived on the Events and Presentations page in the Investors section of Valnevaâ€™s website. A live Q&A session will follow the formal presentations with opportunity for virtual attendees to participate. To register for the event  please click here .Valneva will highlight its late-stage clinical and select preclinical vaccine candidates:VLA15  a Lyme Borreliosis (Lyme disease) vaccine candidate that is partnered with Pfizer for global development and commercialization  currently enrolling a pivotal Phase 3 studyVLA1553  a chikungunya virus vaccine candidate for which rolling submission of a Biologics License Application (BLA) is nearing completionVLA1554  a proprietary recombinant protein subunit candidate comprised of stabilized pre-fusion F peptide as a potential prophylactic vaccine against the respiratory pathogen human metapneumovirus (hMPV)VLA2112  a recombinant protein subunit candidate comprised of a mix of relevant antigens as a potential second-generation prophylactic vaccine against Epstein-Barr virus (EBV)Valneva will also provide a detailed overview of its current commercial products and the factors driving continued recovery and potential growth of this part of the business as the COVID-19 pandemic slows  followed by a brief financial overview.Thomas Lingelbach  Chief Executive Officer of Valneva  said  â€œAs we look ahead over the next 12 to 36 months  we anticipate substantial growth for Valneva  driven by the potential commercialization of two additional vaccine products. This key strengthening of our commercial portfolio  combined with initiatives designed to fuel our current and future R&D pipeline  is part of a broader vision to transform Valneva into a globally recognized leader in the vaccines industry. To achieve this vision  we will continue to rely on our core strengths in vaccine development and manufacturing  as well as our experience and track record for bringing new vaccines from discovery and early development to commercialization.â€Select Investor Day Highlights:VLA15  Lyme diseaseVLA15 is the only Lyme vaccine program in advanced clinical development worldwide. It leverages an established mechanism of action against Lyme borreliosis infection by targeting the six most prevalent serotypes of the Borrelia outer surface protein A (OspA). Pre-clinical proof-of-concept studies showed that VLA15 was protective against tick-transmitted Borrelia infection  and in clinical studies in more than 1000 adults and children (age â‰¥5 years)  VLA15 was generally well tolerated and showed strong immunogenicity including anamnestic response to a booster dose twelve months after primary vaccination1. Recently reported antibody persistence results from study VLA15-221 in adults and children further validate the use of the three-dose vaccination schedule  which is also included in the Phase 3 protocols for all participants. Antibody levels remained above baseline six months after completing primary vaccination  and no vaccine-related serious adverse events (SAEs) and no safety concerns were observed in this six-month observational follow up2. Pfizer and Valneva are currently executing the Phase 3 field efficacy study for VLA15 called VALOR (Vaccine Against Lyme for Outdoor Recreationists)3. Enrollment completion is anticipated in the second quarter 2023. Pending successful Phase 3  Pfizer could potentially submit a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) and Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) in 2025.VLA1553  chikungunya virusVLA1553 is a live-attenuated vaccine candidate targeting long-lasting immunity against mosquito-transmitted chikungunya virus infection with a single shot. It is currently the only chikungunya vaccine candidate to successfully complete pivotal Phase 3 studies and the first for which a regulatory filing process has been initiated with the U.S. FDA4. The sponsor of the first chikungunya vaccine approved in the U.S. may be eligible to receive a Priority Review Voucher (PRV)  which Valneva intends to monetize upon receipt. The pivotal Phase 3 study of VLA1553 met its primary efficacy endpoint  with a seroresponse rate (SRR) that exceeded the threshold established with the FDA based on an immunological surrogate of protection  including in older adults (age â‰¥65 years)5. The high SRR was maintained after six months6 and  as recently reported  after twelve months7  further highlighting the potential for long-lasting immunity from a single shot of VLA1553.While completion of the BLA submission is expected by year end  Valneva is focused on pre-commercial and market access preparations. Upon potential approval  the Company expects to market VLA1553 globally across multiple market segments  leveraging its existing commercial infrastructure  which spans North America  Europe  the Nordics and other key territories  as well as its strategic partner in Brazil  Instituto Butantan  who will market in low- and middle-income countries (LMICs) where chikungunya is currently endemic8.The recommendation process is ongoing with the Advisory Committee on Immunization Practices (ACIP)  which governs vaccine policy in the U.S. This is a well-defined process and the ACIP vote on the specific recommendation(s) for VLA1553 is tentatively scheduled for the February 2024 meeting  pending approval by the FDA. In parallel  market access for ACIP-recommended vaccines is improving. Recent passage of the Inflation Reduction Act now requires that the 49 million-and-growing population of Americans enrolled in Medicare Part D be covered without cost sharing for all ACIP-recommended vaccines. This is important as the number of outbound travelers to chikungunya endemic countries is projected to exceed pre-COVID-19 levels by 2025 according to the International Air Transport Association (IATA)9.VLA1554  human metapneumovirusValnevaâ€™s hMPV vaccine program leverages recent advances in the development of vaccines against related Respiratory Syncytial Virus (RSV)  where discovery of the pre-fusion form of the F protein  which mediates viral entry into human cells  led to major recent breakthroughs. Valneva successfully generated a stabilized pre-fusion F protein antigen  which forms the basis of the proprietary vaccine candidate VLA1554. In key pre-clinical studies  low doses of the vaccine candidate generated hMPV-neutralizing responses that protected mice from challenge with hMPV virus. Adjuvant evaluation is currently in progress.VLA2112  Epstein-Barr virusValnevaâ€™s EBV vaccine candidate is based on adjuvanted  subunit viral glycoproteins designed to elicit high titers of EBV-neutralizing antibodies and block EBV infection of both B cells and epithelial cells. Vaneva is utilizing structural information to design potently immunogenic antigens. Evaluation of external and internal antigens is ongoing  with the ultimate vaccine candidate comprised of an adjuvanted combination of antigens that best neutralizes EBV infection.Commercial portfolioValnevaâ€™s current commercial portfolio includes proprietary travelersâ€™ vaccines IXIAROÂ® and DUKORALÂ®  for which Valneva owns global rights  as well as a number of vaccines that Valneva markets on behalf of third parties in select markets  leveraging its commercial infrastructure. Since 2016  Valneva has established a strong track record of adding additional third-party products to its portfolio  most recently adding VBI Vaccinesâ€™ PreHevbriÂ® in 202210. The portfolio also includes VLA2001  the Companyâ€™s vaccine against COVID-19  for which the Company is now solely focused on deploying remaining vaccine inventory. In parallel  the current shelf-life of VLA2001 was recently extended to 18 months and the Company is continuing to work to gradually extend the shelf-life to at least 24 months.Financial OverviewValneva remains well capitalized to execute on its strategic objectives  with â‚¬261 million in cash at the end of September 2022  excluding an additional â‚¬102.9 million in gross proceeds from a recent follow-on Global Offering. The Company reiterates its 2022 financial guidance  which includes total revenues of â‚¬340 million to â‚¬360 million and lowered R&D expenses of â‚¬95 million to â‚¬110 million (previously â‚¬120 million to â‚¬135 million)11.About Valneva SEValneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. Valneva has leveraged its expertise and capabilities both to commercialize three vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic  including candidates against Lyme disease and the chikungunya virus.Media & Investor ContactsLaÃ«titia Bachelot-FontaineVP Global Communications & European Investor RelationsM +33 (0)6 4516 7099laetitia.bachelot-fontaine@valneva.comJoshua Drumm  Ph.D.VP Global Investor RelationsM +001 917 815 4520joshua.drumm@valneva.comValneva Forward-Looking StatementsThis press release contains certain forward-looking statements relating to the business of Valneva  including with respect to its product candidates and estimates for future performance. In addition  even if the actual results or development of Valneva are consistent with the forward-looking statements contained in this press release  those results or developments of Valneva may not be sustained in the future. In some cases  you can identify forward-looking statements by words such as ""could "" ""should "" ""may "" ""expects "" ""anticipates "" ""believes "" ""intends "" ""estimates "" ""aims "" ""targets "" or similar words. These forward-looking statements are based largely on the current expectations of Valneva as of the date of this press release and are subject to a number of known and unknown risks and uncertainties and other factors that may cause actual results  performance or achievements to be materially different from any future results  performance or achievement expressed or implied by these forward-looking statements. In particular  the expectations of Valneva could be affected by  among other things  uncertainties involved in the development and manufacture of vaccines  unexpected clinical trial results  unexpected regulatory actions or delays  competition in general  currency fluctuations  the impact of the global and European credit crisis  and the ability to obtain or maintain patent or other proprietary intellectual property protection. Success in preclinical studies or earlier clinical trials may not be indicative of results in future clinical trials. In light of these risks and uncertainties  there can be no assurance that the forward-looking statements made during this presentation will in fact be realized. Valneva is providing the information in these materials as of this press release and disclaim any intention or obligation to publicly update or revise any forward-looking statements  whether as a result of new information  future events  or otherwise.1 Valneva and Pfizer Report Further Positive Phase 2 Results  Including Booster Response  for Lyme Disease Vaccine Candidate2 Valneva and Pfizer Report Six-Month Antibody Persistence Data in Children and Adults for Lyme Disease Vaccine Candidate3 https://www.valorlymestudy.com/4 Valneva Initiates Rolling Submission of FDA Biologics License Application for its Single-Shot Chikungunya Vaccine Candidate5 Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate6 Valneva Successfully Completes Pivotal Phase 3 Trial of Single-Shot Chikungunya Vaccine Candidate7 Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate - Valneva8 Valneva and Instituto Butantan Sign Final Agreement on Single-Shot Chikungunya Vaccine for Low and Middle Income Countries9 https://www.iata.org/10 Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbriÂ®11 Valneva Reports Nine-Month 2022 Results and Provides Corporate UpdatesAttachment",neutral,0.01,0.99,0.0,negative,0.01,0.24,0.75,True,English,"['New York City', 'Investor Day', 'Valneva', 'Chief Financial Officer Peter BÃ¼hler', 'Borrelia outer surface protein A', 'proprietary recombinant protein subunit candidate', 'six most prevalent serotypes', 'live Q&A session', 'Select Investor Day Highlights', 'vaccine-related serious adverse events', 'future R&D pipeline', 'two additional vaccine products', 'mosquito-transmitted chikungunya virus infection', 'potential second-generation prophylactic vaccine', 'chikungunya virus vaccine candidate', 'Phase 3 field efficacy study', 'Lyme disease) vaccine candidate', 'Chief Executive Officer', 'tick-transmitted Borrelia infection', 'chikungunya vaccine candidate', 'live-attenuated vaccine candidate', 'brief financial overview', 'potential prophylactic vaccine', 'first chikungunya vaccine', 'preclinical vaccine candidates', 'senior leadership team', 'mid-term value drivers', '10am Eastern Time', 'Biologics License Application', 'pre-fusion F peptide', 'COVID-19 pandemic slows', 'next 12 to 36 months', 'six-month observational follow', 'Marketing Authorisation Application', 'European Medicines Agency', 'regulatory filing process', 'Priority Review Voucher', 'current vaccine pipeline', 'primary efficacy endpoint', 'Lyme vaccine program', 'pivotal Phase 3 study', 'New York City', 'antibody persistence results', 'Lyme borreliosis infection', 'three-dose vaccination schedule', 'U.S. Food', 'late-stage development pipeline', 'pivotal Phase 3 studies', 'specialty vaccine company', 'current commercial products', 'advanced clinical development', 'commercial vaccine business', 'U.S. FDA', 'vaccine development', 'person investor', 'future directions', 'Epstein-Barr virus', 'late-stage clinical', 'Phase 3 protocols', 'successful Phase', 'potential growth', 'clinical studies', 'primary vaccination', 'detailed overview', 'commercial portfolio', 'new vaccines', 'Antibody levels', 'global development', 'early development', 'concept studies', 'Live event', 'potential commercialization', 'English French', 'Euronext Paris', 'Thomas Lingelbach', 'other members', 'Investors section', 'virtual attendees', 'rolling submission', 'respiratory pathogen', 'human metapneumovirus', 'relevant antigens', 'continued recovery', 'substantial growth', 'key strengthening', 'vaccines industry', 'core strengths', 'track record', 'established mechanism', 'Pre-clinical proof', 'strong immunogenicity', 'anamnestic response', 'booster dose', 'safety concerns', 'Outdoor Recreationists', 'second quarter', 'Drug Administration', 'long-lasting immunity', 'single shot', 'seroresponse rate', 'immunological surrogate', 'Presentations page', 'formal presentations', 'broader vision', 'Enrollment completion', 'older adults', 'Valneva SE', '1000 adults', 'webcast', '10 AM', 'Saint-Herblain', 'France', 'December', 'VLA', 'website', 'opportunity', 'Pfizer', 'hMPV', 'mix', 'EBV', 'factors', 'part', 'initiatives', 'manufacturing', 'experience', 'discovery', 'action', 'OspA', 'children', '5 years', 'use', 'baseline', 'SAEs', 'MAA', 'EMA', 'sponsor', 'PRV', 'receipt', 'SRR', 'threshold', 'protection']",2022-12-06,2022-12-06,globenewswire.com
14289,EuroNext,NewsApi.org,https://www.businesswire.com/news/home/20221206005126/en/Medidata-Launches-New-myMedidata-Native-App-to-Expedite-Study-Start-Up-and-Improve-Patient-Experience,Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience,NEW YORK--(BUSINESS WIRE)--Medidata launched a new patient-centric myMedidata app  designed to provide trial participants with a single login for all remote trial activities.,NEW YORK--(BUSINESS WIRE)--Medidata  a Dassault SystÃ¨mes company  launched a new patient-centric native myMedidata app  designed to provide trial participants with another option for a seamless platform experience and a single login for all their remote trial activities. The app will feature all of the myMedidata patient-centric solutions  with an initial focus on eCOA (electronic clinical outcome assessments). The myMedidata app is available on iOS and Android and can be used both on the patientsâ€™ own devices (BYOD) or via a provisioned device.â€œ Our latest addition to myMedidata brings an innovative app to patients designed in concert with our patient insights team  customer feedback  and the experiences derived from running the worldâ€™s biggest DCTs over the last twenty years â€ said Matt Noble  senior vice president  Medidata Patient Cloud. â€œ Medidata is leveraging its unique insights from sponsors  CROs  sites  and patients to make a meaningful difference in the clinical trial experience.â€Unique to the industry  the myMedidata app is unified with the Medidata Platform  including Rave EDC (electronic data capture)  resulting in an entirely self-sustaining ecosystem where patient input  site based activities  and behind the scenes data management seamlessly operate together.The app is configured using Medidata Designer  a new platform configuration tool  bringing a patient-centered mobile-first workflow builder to the myMedidata app. With Designer  sponsors and CRO partners can build a rich patient experience via intuitive drag and drop screen templates and visual workflow tools  which simultaneously in the background set up a clinical database without the need for any custom code. Designer drastically lowers study build times by employing Medidata and client libraries  including pre-built eCOA instruments  translations  and study configurations.Medidata is a wholly owned subsidiary of Dassault SystÃ¨mes  which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform  from research to commercialization.About MedidataMedidata is leading the digital transformation of life sciences  creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical  biotech  medical device and diagnostics companies  and academic researchers accelerate value  2 000+ customers and partners access the world's most trusted platform for clinical development  commercial  and real-world data. Medidata  a Dassault SystÃ¨mes company (Euronext Paris: FR0014003TT8  DSY.PA)  is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata.About Dassault SystÃ¨mesDassault SystÃ¨mes  the 3DEXPERIENCE Company  is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications  our customers push the boundaries of innovation  learning and production to achieve a more sustainable world for patients  citizens  and consumers. Dassault SystÃ¨mes brings value to more than 300 000 customers of all sizes  in all industries  in more than 140 countries. For more information  visit www.3ds.com3DEXPERIENCE  the Compass icon  the 3DS logo  CATIA  BIOVIA  GEOVIA  SOLIDWORKS  3DVIA  ENOVIA  NETVIBES  MEDIDATA  CENTRIC PLM  3DEXCITE  SIMULIA  DELMIA  and IFWE are commercial trademarks or registered trademarks of Dassault SystÃ¨mes  a French â€œsociÃ©tÃ© europÃ©enneâ€ (Versailles Commercial Register # B 322 306 440)  or its subsidiaries in the United States and/or other countries.,neutral,0.08,0.92,0.0,positive,0.59,0.41,0.0,True,English,"['New myMedidata Native App', 'Patient Experience', 'Study', 'French â€œsociÃ©tÃ© europÃ©enne', 'new patient-centric native myMedidata app', 'patient-centered mobile-first workflow builder', 'collaborative 3D virtual environments', 'electronic clinical outcome assessments', 'new platform configuration tool', 'Dassault SystÃ¨mes company', 'myMedidata patient-centric solutions', 'visual workflow tools', 'last twenty years', 'senior vice president', 'New York City', 'electronic data capture', 'rich patient experience', 'clinical trial experience', 'study build times', 'virtual twin experiences', 'seamless platform experience', 'Versailles Commercial Register', 'patient insights team', 'remote trial activities', 'Medidata Patient Cloud', '3DEXPERIENCE Company', 'clinical database', 'patient input', 'trial participants', 'study configurations', 'trusted platform', 'data management', 'real-world data', '3DEXPERIENCE platform', 'business platform', 'single login', 'initial focus', 'latest addition', 'innovative app', 'customer feedback', 'biggest DCTs', 'Matt Noble', 'unique insights', 'meaningful difference', 'Rave EDC', 'self-sustaining ecosystem', 'intuitive drag', 'screen templates', 'custom code', 'client libraries', 'digital transformation', 'life sciences', 'personalized medicine', 'first end', 'end scientific', 'diagnostics companies', 'academic researchers', 'Euronext Paris', 'human progress', 'sustainable innovations', 'Compass icon', '3DS logo', 'CENTRIC PLM', 'commercial trademarks', 'registered trademarks', 'United States', 'Medidata Platform', 'BUSINESS WIRE', 'CRO partners', 'eCOA instruments', 'medical device', 'other countries', 'real world', 'sustainable world', '2,000+ customers', 'Medidata Designer', '140 countries', '300,000 customers', 'option', 'iOS', 'Android', 'patients', 'devices', 'BYOD', 'concert', 'sponsors', 'CROs', 'sites', 'industry', 'scenes', 'background', 'need', 'translations', 'subsidiary', 'commercialization', 'hope', 'millions', 'evidence', 'value', 'DSY', 'offices', 'catalyst', 'people', 'applications', 'boundaries', 'learning', 'production', 'citizens', 'consumers', 'sizes', 'industries', 'information', 'CATIA', 'BIOVIA', 'GEOVIA', 'SOLIDWORKS', '3DVIA', 'ENOVIA', 'NETVIBES', '3DEXCITE', 'SIMULIA', 'DELMIA', 'IFWE', 'subsidiaries']",2022-12-06,2022-12-06,businesswire.com
14290,EuroNext,NewsApi.org,https://finance.yahoo.com/news/bghl-gbp-nav-063000601.html,BGHL (GBP): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for...,"BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 05 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5304 Â£ 24.1853 Estimated MTD return 0.02 % 0.07 % Estimated YTD return -5.72 % -4.43 % Estimated ITD return 175.30 % 141.85 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.20 N/A Premium/discount to estimated NAV -19.36 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.31 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 240.6741 Class GBP A Shares (estimated) Â£ 129.0041The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.Story continuesFor further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.18,0.81,True,English,"['BGHL', 'GBP', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'GAVAUDAN HOLDING LIMITED Ordinary Shares', 'Class GBP A Shares', 'N/A Sterling Shares Amsterdam', 'London Stock Exchange plc', 'Guernsey Financial Services Commission', 'A N/A Average Price', 'Dutch Financial Supervision Act', 'Sterling Shares Shares', 'Euro Shares Amsterdam', 'US Investment Company Act', 'A N/A Range', 'expert financial advice', 'Guernsey Policy Council', 'collective investment scheme', 'other professional advice', 'BG Fund ICAV', 'Gavaudan Investment Management', 'closed-ended investment company', 'UK Listing Authority', 'US Securities Act', 'investment manager fees', 'N/A Shares', 'BG Fund NAV', 'The Shares', 'Dutch Authority', 'Emmanuel Gavaudan', 'Euronext Amsterdam', 'US persons', 'Financial Markets', 'The Directors', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'United States', 'following information', 'information purposes', 'necessary approval', 'main market', 'future results', 'listed securities', 'Market information', 'BOUSSARD', 'business', 'returns', 'AEX', 'LSE', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'Story', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment', '7']",2022-12-06,2022-12-06,finance.yahoo.com
14291,EuroNext,NewsApi.org,https://finance.yahoo.com/news/bghl-eur-nav-063000776.html,BGHL (EUR): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for...,"BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 05 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5304 Â£ 24.1853 Estimated MTD return 0.02 % 0.07 % Estimated YTD return -5.72 % -4.43 % Estimated ITD return 175.30 % 141.85 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.20 N/A Premium/discount to estimated NAV -19.36 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.31 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 240.6741 Class GBP A Shares (estimated) Â£ 129.0041The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.Story continuesFor further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.18,0.81,True,English,"['BGHL', 'EUR', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'Class GBP A Shares', 'London Stock Exchange plc', 'N/A Sterling Shares Amsterdam', 'Guernsey Financial Services Commission', 'A N/A Average Price', 'Dutch Financial Supervision Act', 'Euro Shares Amsterdam', 'Sterling Shares Shares', 'US Investment Company Act', 'A N/A Range', 'GAVAUDAN HOLDING LIMITED', 'expert financial advice', 'Guernsey Policy Council', 'collective investment scheme', 'other professional advice', 'BG Fund ICAV', 'closed-ended investment company', 'UK Listing Authority', 'US Securities Act', 'Gavaudan Investment Management', 'investment manager fees', 'N/A Shares', 'BG Fund NAV', 'The Shares', 'Dutch Authority', 'Euronext Amsterdam', 'US persons', 'Emmanuel Gavaudan', 'Financial Markets', 'The Directors', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'United States', 'following information', 'information purposes', 'necessary approval', 'main market', 'future results', 'listed securities', 'Market information', 'BOUSSARD', 'business', 'returns', 'AEX', 'LSE', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'Story', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment', '7']",2022-12-06,2022-12-06,finance.yahoo.com
14292,EuroNext,NewsApi.org,https://finance.yahoo.com/news/progress-share-buyback-programme-070000178.html,Progress on share buyback programme,Progress on share buyback programme ING announced today that  in line with the launch of its â‚¬1 5 billion share buyback programme announced on 3 November...,ING GroupProgress on share buyback programmeING announced today that  in line with the launch of its â‚¬1 5 billion share buyback programme announced on 3 November 2022  the company has repurchased 16 492 184 shares during the week of 28 November 2022 up to and including 2 December 2022.The shares were repurchased at an average price of â‚¬11.53 for a total amount of â‚¬190 079 853.26. For detailed information on the daily repurchased shares  individual share purchase transactions and weekly reports  see the ING website at www.ing.com/investorrelations.The total number of shares repurchased under this programme to date 82 968 216 ordinary shares at an average price of â‚¬11.23 for a total consideration of â‚¬931 740 600.70. To date approximately 62.12% of the maximum total value of the share buyback programme has been completed.Note for editorsFor further information on ING  please visit www.ing.com. Frequent news updates can be found in the Newsroom or via the @ING_news Twitter feed. Photos of ING operations  buildings and its executives are available for download at Flickr. ING presentations are available at SlideShare.Press enquiries Investor enquiries Christoph Linke ING Group Investor Relations +31 20 576 5000 +31 20 576 6396 Christoph.Linke@ing.com Investor.Relations@ing.comING PROFILEING is a global financial institution with a strong European base  oï¬€ering banking services through its operating company ING Bank. The purpose of ING Bank is: empowering people to stay a step ahead in life and in business. ING Bankâ€™s more than 58 000 employees oï¬€er retail and wholesale banking services to customers in over 40 countries.ING Group shares are listed on the exchanges of Amsterdam (INGA NA  INGA.AS)  Brussels and on the New York Stock Exchange (ADRs: ING US  ING.N).Sustainability is an integral part of INGâ€™s strategy  evidenced by INGâ€™s leading position in sector benchmarks. ING's Environmental  Social and Governance (ESG) rating by MSCI was aï¬ƒrmed 'AA' in September 2022. As of August 2022  Sustainalytics considers INGâ€™s management of ESG material risk to be â€˜strongâ€™  and in June 2022 ING received an ESG rating of 'strong' from S&P Global Ratings. ING Group shares are also included in major sustainability and ESG index products of leading providers Euronext  STOXX  Morningstar and FTSE Russell.Story continuesIMPORTANT LEGAL INFORMATIONCertain of the statements contained herein are not historical facts  including  without limitation  certain statements made of future expectations and other forward-looking statements that are based on managementâ€™s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results  performance or events to diï¬€er materially from those expressed or implied in such statements. Actual results  performance or events may diï¬€er materially from those in such statements due to a number of factors  including  without limitation: (1) changes in general economic conditions and customer behaviour  in particular economic conditions in INGâ€™s core markets  including changes aï¬€ecting currency exchange rates and the regional and global economic impact of the invasion of Russia into Ukraine and related international response measures (2) eï¬€ects of the Covid-19 pandemic and related response measures  including lockdowns and travel restrictions  on economic conditions in countries in which ING operates  on INGâ€™s business and operations and on INGâ€™s employees  customers and counterparties (3) changes aï¬€ecting interest rate levels (4) any default of a major market participant and related market disruption (5) changes in performance of financial markets  including in Europe and developing markets (6) fiscal uncertainty in Europe and the United States(7) discontinuation of or changes in â€˜benchmarkâ€™ indices (8) inflation and deflation in our principal markets (9) changes in conditions in the credit and capital markets generally  including changes in borrower and counterparty creditworthiness (10) failures of banks falling under the scope of state compensation schemes (11) non-compliance with or changes in laws and regulations  including those concerning financial services  financial economic crimes and tax laws  and the interpretation and application thereof (12) geopolitical risks  political instabilities and policies and actions of governmental and regulatory authorities  including in connection with the invasion of Russia into Ukraine and related international response measures (13) legal and regulatory risks in certain countries with less developed legal and regulatory frameworks(14) prudential supervision and regulations  including in relation to stress tests and regulatory restrictions on dividends and distributions (also among members of the group) (15) regulatory consequences of the United Kingdomâ€™s withdrawal from the European Union  including authorizations and equivalence decisions (16) INGâ€™s ability to meet minimum capital and other prudential regulatory requirements (17) changes in regulation of US commodities and derivatives businesses of ING and its customers(18) application of bank recovery and resolution regimes  including write- down and conversion powers in relation to our securities (19) outcome of current and future litigation  enforcement proceedings  investigations or other regulatory actions  including claims by customers or stakeholders who feel misled or treated unfairly  and other conduct issues (20) changes in tax laws and regulations and risks of non-compliance or investigation in connection with tax laws  including FATCA (21) operational and IT risks  such as system disruptions or failures  breaches of security  cyber-attacks  human error  changes in operational practices or inadequate controls including in respect of third parties with which we do business (22) risks and challenges related to cybercrime including the eï¬€ects of cyberattacks and changes in legislation and regulation related to cybersecurity and data privacy (23) changes in general competitive factors  including ability to increase or maintain market share (24) inability to protect our intellectual property and infringement claims by third parties (25) inability of counterparties to meet financial obligations or ability to enforce rights against such counterparties (26) changes in credit ratings (27) business  operational  regulatory  reputation  transition and other risks and challenges in connection with climate change and ESG-related matters(28) inability to attract and retain key personnel (29) future liabilities under defined benefit retirement plans (30) failure to manage business risks  including in connection with use of models  use of derivatives  or maintaining appropriate policies and guidelines (31) changes in capital and credit markets  including interbank funding  as well as customer deposits  which provide the liquidity and capital required to fund our operations  and(32) the other risks and uncertainties detailed in the most recent annual report of ING Groep N.V. (including the Risk Factors contained therein) and INGâ€™s more recent disclosures  including press releases  which are available on www.ING.com.This document may contain inactive textual addresses to internet websites operated by us and third parties. Reference to such websites is made for information purposes only  and information found at such websites is not incorporated by reference into this document. ING does not make any representation or warranty with respect to the accuracy or completeness of  or take any responsibility for  any information found at any websites operated by third parties. ING specifically disclaims any liability with respect to any information found at websites operated by third parties. ING cannot guarantee that websites operated by third parties remain available following the publication of this document  or that any information found at such websites will not change following the filing of this document. Many of those factors are beyond INGâ€™s control.Any forward looking statements made by or on behalf of ING speak only as of the date they are made  and ING assumes no obligation to publicly update or revise any forward-looking statements  whether as a result of new information or for any other reason.This document does not constitute an oï¬€er to sell  or a solicitation of an oï¬€er to purchase  any securities in the United States or any other jurisdictionAttachment,positive,0.98,0.02,0.0,mixed,0.41,0.24,0.35,True,English,"['share buyback programme', 'Progress', 'individual share purchase transactions', 'New York Stock Exchange', 'S&P Global Ratings', 'â‚¬1,5 billion share buyback programme', 'other prudential regulatory requirements', 'currency exchange rates', 'Frequent news updates', 'international response measures', 'interest rate levels', 'state compensation schemes', 'global economic impact', 'global financial institution', 'strong European base', 'ESG material risk', 'ESG index products', 'leading providers Euronext', 'maximum total value', 'financial economic crimes', 'major market participant', 'other forward-looking statements', 'wholesale banking services', 'daily repurchased shares', 'general economic conditions', 'related response measures', 'Group Investor Relations', 'IMPORTANT LEGAL INFORMATION', 'prudential supervision', 'financial services', 'Investor enquiries', 'leading position', 'ESG) rating', 'ESG rating', 'market disruption', 'financial markets', 'European Union', 'regulatory authorities', 'regulatory risks', 'regulatory frameworks', 'regulatory restrictions', 'regulatory consequences', 'total amount', 'total consideration', 'average price', 'detailed information', 'weekly reports', 'Press enquiries', 'INGA NA', 'INGA.AS', 'integral part', 'sector benchmarks', 'Environmental, Social', 'major sustainability', 'FTSE Russell', 'historical facts', 'future expectations', 'current views', 'unknown risks', 'actual results', 'customer behaviour', 'core markets', 'Covid-19 pandemic', 'travel restrictions', 'developing markets', 'fiscal uncertainty', 'United States', 'benchmarkâ€™ indices', 'principal markets', 'capital markets', 'counterparty creditworthiness', 'geopolitical risks', 'political instabilities', 'stress tests', 'United Kingdom', 'equivalence decisions', 'minimum capital', 'derivatives businesses', 'total number', '82,968,216 ordinary shares', 'Group shares', 'Christoph Linke', 'operating company', 'tax laws', 'US commodities', '16,492,184 shares', 'Progress', 'line', 'launch', '3 November', '28 November', '2 December', 'website', 'investorrelations', 'Note', 'editors', 'Newsroom', 'Photos', 'operations', 'buildings', 'executives', 'download', 'Flickr', 'presentations', 'SlideShare', 'PROFILE', 'purpose', 'people', 'life', '58,000 employees', 'retail', 'customers', '40 countries', 'exchanges', 'Amsterdam', 'Brussels', 'ADRs', 'strategy', 'Governance', 'MSCI', 'September', 'August', 'Sustainalytics', 'management', 'June', 'Morningstar', 'Story', 'limitation', 'assumptions', 'uncertainties', 'performance', 'events', 'factors', 'particular', 'regional', 'invasion', 'Russia', 'Ukraine', 'lockdowns', 'counterparties', 'default', 'discontinuation', 'inflation', 'deflation', 'borrower', 'banks', 'scope', 'compliance', 'regulations', 'interpretation', 'application', 'policies', 'connection', 'less', 'dividends', 'distributions', 'members', 'withdrawal', 'authorizations']",2022-12-06,2022-12-06,finance.yahoo.com
14293,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2568604/0/en/Monthly-information-related-to-total-number-of-voting-rights-and-shares-composing-the-share-capital-_October-30-2022.html,Monthly information related to total number of voting rights and shares composing the share capital _October 30  2022,Monthly information related to total number of voting rights and shares composing the share capital _October 30  2022.  Article 223-16...,English FrenchMonthly information related to total number of voting rights and shares composing the share capital _October 30  2022.Article 223-16 of general regulation of French AutoritÃ© des MarchÃ©s FinanciersLyon â€“ FranceListing markets:Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.comDate Total of shares composing the share capital Total of brut (1) voting rightsTotal of net (2) voting rightsDecember 31  2021 31 018 553 32 518 339 32 515 839 January 31  2022 31 018 553 32 518 339 32 515 839 February 28  2022 31 018 553 32 518 547 32 516 047 March 31  2022 31 018 553 32 518 547 32 516 047 April 30  2022 31 018 553 32 518 547 32 516 047 May 31  2022 31 018 553 32 518 547 32 516 047 June 30  2022 31 018 553 32 520 107 32 517 607 July 31  2022 31 018 553 32 521 126 32 518 626 August 31  2022 31 018 553 32 508 024 32 505 524 September 30  2022 31 018 553 32 507 992 32 505 492 October 30  2022 31 018 553 32 507 991 32 505 491(1) Gross voting rights number (or Â« theoretical Â» voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of AutoritÃ© des MarchÃ©s Financiers  this number is calculated on the basis of all shares carrying the single and double voting rights  including shares without voting rights.(2) Without treasury shares.Attachment,neutral,0.0,1.0,0.0,neutral,0.0,0.98,0.02,True,English,"['total number', 'voting rights', 'share capital', 'information', 'shares', 'French AutoritÃ© des MarchÃ©s Financiers', 'Nasdaq Global Select Market', 'Gross voting rights number', 'Market segment C', 'net (2) voting rights', 'theoretical Â» voting rights', 'double voting rights', 'share capital Total', 'English French', 'total number', 'general regulation', 'Listing markets', 'ISIN Code', 'Date Total', 'Euronext Paris', 'treasury shares', 'information', 'Article', 'Lyon', 'France', 'Symbol', 'ERYP', 'United-States', 'Website', 'brut', 'December', 'February', 'April', 'June', 'basis', 'crossing', 'threshold', 'accordance', 'single', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14294,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2567962/0/en/Total-number-of-voting-rights-and-shares-forming-the-share-capital.html,Total number of voting rights and shares forming the share capital,Nanterre  6 December 2022  Total number of voting rights and shares forming the share capital   (Article L.233-8 II of the French...,French EnglishNanterre  6 December 2022Total number of voting rights and shares forming the share capital(Article L.233-8 II of the French Commercial Code and Article 223-16 ofthe General Regulation of the French Financial Markets Authority)__________________Trading place : Euronext ParisCompartment : AISIN code : FR0000121147LEI code : 969500F0VMZLK2IULV85DateNumber of sharesTotal number of voting rights (theoretical) (1)30 November 2022197 089 340199 901 026(1) In accordance with the provisions of Article 223-11 of the General Regulation of the French Financial Markets Authority  the total number of voting rights (theoretical) is calculated on the basis of all the shares to which voting rights are attached  including the shares deprived of voting rights.Inclusion in the bylaws of a clause that requires crossing thresholds declaration in addition to that related to legal thresholds: yesAttachment,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['Total number', 'voting rights', 'share capital', 'shares', 'French Financial Markets Authority', 'Euronext Paris Compartment', 'French Commercial Code', 'French English', 'ISIN code', 'LEI code', 'voting rights', 'share capital', 'General Regulation', 'Trading place', 'thresholds declaration', 'legal thresholds', 'Total number', 'Nanterre', '6 December', 'shares', 'Article', 'Date', 'November', 'accordance', 'provisions', 'basis', 'Inclusion', 'bylaws', 'clause', 'addition', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14295,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2568537/0/en/Vantiva-Information-concerning-the-total-number-of-voting-rights-and-shares.html,Vantiva - Information concerning the total number of voting rights and shares,December 6  2022     Vantiva: Information concerning the total number of voting rights and shares  provided pursuant to Article L.Â 233-8 II of the...,English FrenchDecember 6  2022Vantiva: Information concerning the total number of voting rights and shares  provided pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the AutoritÃ© des marchÃ©s financiersVantiva Shares(ISIN Code FR0013505062) Date Number of Outstanding Shares Number of Voting Rights November 30  2022355 389 840Number of Theoretical Voting Rights(1): 355 389 840Number of Voting Rights Exercisable at Shareholdersâ€™ meeting(2): 355 389 840(1) Calculated  pursuant to Article 223-11 of the General Regulations of the AutoritÃ© des MarchÃ©s Financiers  based on the total number of outstanding shares to which voting rights are attached  including shares with suspended voting rights.(2) Excluding shares with suspended voting rights.* **About Vantivawww.vantiva.com â€“ Follow us: @Vantiva â€“ www.linkedin.com/company/vantiva/Vantiva shares are on the Euronext Paris exchange (VANTI) and traded in the USA on the OTCQX marketplace (OTCQX: TCLRY).Attachment,neutral,0.0,1.0,0.0,neutral,0.01,0.99,0.0,True,English,"['total number', 'voting rights', 'Vantiva', 'Information', 'shares', 'des MarchÃ©s Financiers', 'Euronext Paris exchange', 'French Commercial Code', 'Theoretical Voting Rights', 'English French', 'ISIN Code', 'General Regulations', 'Shareholdersâ€™ meeting', 'OTCQX marketplace', 'Outstanding Shares', 'total number', 'Date Number', 'Article L.', 'Vantiva Shares', 'December', 'Information', 'USA', 'TCLRY', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14296,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2568660/0/en/Information-on-the-Total-Number-of-Voting-Rights-Denominator-following-Conversion-Notice-from-NEGMA.html,Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA,Negma Group has converted 80 convertible bonds in Oxurion resulting in a EUR 200 000 capital increase. This is part of Negma Groupâ€™s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eyâ€¦,English DutchNegma Group has converted 80 convertible bonds in Oxurion resulting in a EUR 200 000 capital increase. This is part of Negma Groupâ€™s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.Leuven  BELGIUM  Boston  MA  US â€“ December 6  2022 â€“ 07.00 PM CET â€“ In accordance with article 15 of the Belgian Act of May 2  2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions  Oxurion NV (Euronext Brussels: OXUR) (the â€œCompanyâ€ or â€œOxurionâ€)  announces the below information  following the issuance of 21 008 403 new ordinary shares on December 5  2022  for a total amount of EUR 200 000  as the result of the conversion of 80 class B convertible bonds  pursuant to the Capital Commitment entered into with Negma Group.Following completion of the capital increase through the conversion of the convertible bonds  the total number of shares issued by Oxurion amounts to 311 281 644  outstanding ordinary shares carrying voting rights (compared to 290 273 241 outstanding ordinary shares previously). This number will be used as the denominator for the calculation of the percentages of shareholdings.Therefore  Oxurion publishes the following updated information:Share capital (EUR) 74 906 161.32 Total number of securities with voting rights (all ordinary shares) 311 281 644 Total number of ordinary shares (= denominator) 311 281 644 Number of outstanding  granted rights to subscribe to securities carrying voting rights not yet issued: 719 500 subscription rights (â€œSRsâ€) issued on November 20  2017  entitling their holders to subscribe to a total number of 719 500 securities carrying voting rights (all ordinary shares);60 000 SRs issued on December 23  2020  entitling their holders to subscribe to a total number of 60 000 securities carrying voting rights (all ordinary shares);1 007 250 SRs issued on April 14  2021  entitling their holders to subscribe to a total number of 1 007 250 securities carrying voting rights (all ordinary shares);550 000 SRs issued on September 22  2021  entitling their holders to subscribe to a total number of 550 000 securities carrying voting rights (all ordinary shares);725 749 SRs issued on December 30  2021  entitling their holders to subscribe to a total number of 725 749 securities carrying voting rights (all ordinary shares);580 convertible bonds issued on September 5  2022  October 21  2022  and November 28  2022  entitling their holder (Negma Group) to subscribe to a total number of securities carrying voting rights (all ordinary shares) in accordance with the terms and conditions set forth in the issuance and subscription agreement entered into between the Company and Negma Group on August 26  2021  and the addendum thereto dated September 2  2022; and100 convertible bonds issued on December 20  2021  entitling their holders (Kreos Capital VI (UK) Limited  Pontifax Medison Finance (Israel) L.P. and Pontifax Medison Finance (Cayman) L.P.) to subscribe to a total number of securities carrying voting rights (all ordinary shares) in accordance with the terms and conditions of these convertible bonds as attached to the Agreement for the provision of a Loan Facility entered into between the Company  Kreos Capital VI (UK) Limited  Pontifax Medison Finance (Israel) L.P. and Pontifax Medison Finance (Cayman) L.P.  on November 21  2021.ENDAbout OxurionOxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies  which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME)  the leading cause of vision loss in working-age people  as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders  including the successful development of THR-149  its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to 50% of DME patients showing suboptimal response to anti-VEGF therapy. Oxurion is headquartered in Leuven  Belgium  with corporate operations in Boston  MA. More information is available at www.oxurion.com.Important information about forward-looking statementsCertain statements in this press release may be considered â€œforward-lookingâ€. Such forward-looking statements are based on current expectations  and  accordingly  entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement  whether as a result of new information  future events  or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Companyâ€™s Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933  as amended  or in compliance with an exemption therefrom  and in accordance with any applicable U.S. state securities laws.For further information please contact:Oxurion NVTom GraneyChief Executive OfficerTel: +32 16 75 13 10tom.graney@oxurion.comMichaÃ«l DillenChief Business OfficerTel: +32 16 75 13 10michael.dillen@oxurion.com USConway CommunicationsBeth Kurthbkurth@conwaycommsir.comICR WestwickeChristopher BrinzeyTel: +1 617 835 9304chris.brinzey@westwicke.com1 Press release Oxurion  06/04/2021 and Press release Oxurion  02/09/2022Attachment,neutral,0.0,1.0,0.0,mixed,0.28,0.23,0.49,True,English,"['Total Number', 'Voting Rights', 'Conversion Notice', 'Information', 'Denominator', 'NEGMA', 'potent plasma kallikrein inhibitor', 'EUR 30 million Capital Commitment1', '80 class B convertible bonds', 'eye drug candidate', 'Pontifax Medison Finance', 'next generation standard', 'diabetic macular edema', 'EUR 200,000 capital increase', 'Kreos Capital VI', 'potential new standard', 'potential market opportunities', 'care ophthalmic therapies', 'outstanding ordinary shares', 'Such forward-looking statements', '21,008,403 new ordinary shares', 'Israel) L.P.', 'Share capital', '80 convertible bonds', '100 convertible bonds', 'regulated market', 'new information', 'English Dutch', 'Negma Group', 'Belgian Act', 'major participations', 'miscellaneous provisions', 'Euronext Brussels', 'total amount', 'Loan Facility', 'retinal disorders', 'leading cause', 'working-age people', 'important role', 'successful development', 'suboptimal response', 'anti-VEGF therapy', 'corporate operations', 'press release', 'current expectations', 'future events', 'other reason', 'other factors', 'voting rights', '719,500 subscription rights', 'total number', 'updated information', 'More information', 'Important information', 'Additional information', 'subscription agreement', 'vision loss', 'novel therapeutic', 'various risks', 'biopharmaceutical company', 'The Company', 'other conditions', 'Oxurion NV', 'DME patients', 'back', 'USD', 'Leuven', 'BELGIUM', 'Boston', 'December', '07.00 PM', 'accordance', 'article', 'May', 'disclosure', 'issuers', 'issuance', 'result', 'conversion', 'completion', 'denominator', 'calculation', 'percentages', 'shareholdings', 'securities', 'SRs', 'November', 'holders', 'April', 'September', 'October', 'terms', 'August', 'addendum', 'UK', 'Cayman', 'Limited', 'treatment', 'THR-149', 'uncertainties', 'assurance', 'obligation', 'business']",2022-12-06,2022-12-06,globenewswire.com
14297,EuroNext,NewsApi.org,https://www.prnewswire.co.uk/news-releases/sigep-observatory-for-christmas-2022-massari-rinaldini-de-riso-the-voices-of-the-greatest-italian-pastry-chefs-for-the-festive-table-301695702.html,Sigep Observatory for Christmas 2022: Massari  Rinaldini  De Riso  the voices of the greatest Italian pastry chefs for the festive table,Italy  where Christmas is dolce. RIMINI  Italy  Dec. 6  2022 /PRNewswire/ -- A return to the origins with clearly recognisable traditional flavours. This is the trend for next Christmas in terms of desserts  detected by the SIGEP OBSERVATORY  part of Italian â€¦,"Italy  where Christmas is dolce.RIMINI  Italy  Dec. 6  2022 /PRNewswire/ -- A return to the origins with clearly recognisable traditional flavours. This is the trend for next Christmas in terms of desserts  detected by the SIGEP OBSERVATORY  part of Italian Exhibition Group  a company headed by President Lorenzo Cagnoni and CEO Corrado Peraboni and one of the top players in global trade shows.The Observatory met world-famous master pastry chefs Iginio Massari  Roberto Rinaldini  Sal De Riso and Alessandro Dalmasso and pastry queen Sonia Balacchi  who have always been linked to Sigep  the international event dedicated to artisan gelato  pastry  chocolate  bakery and coffee  led by Group Exhibition Manager Flavia Morelli  and scheduled to take place from 21st to 25th January 2023 at Rimini Expo Centre in Italy.Christmas Ice panettone by Sonia BalacchiPanettone is the undisputed king of Christmas tables.According to the great  Brescia-born Iginio Massari  70% of customers choose the simplicity and serenity of the classic recipe  while Roberto Rinaldini offers ""solidarity"" panettoni with the Rise Together Foundation. For Salvatore De Riso  specialities from Campania are still an absolute must but there are no less than 16 different panettone cakes in his stores.Alessandro Dalmasso's latest proposals tell of the typicality of his land with his Pangianduja and Panettone Piemontese.Last but not least  Sonia Balacchi  the first Pastry Queen in 2012  suggests a mouth-watering and pyrotechnic Christmas Ice panettone.FOCUS ON SIGEP and A.B. Tech Expo 2023Dates: 21-25 January 2023; Organization: Italian Exhibition Group SpA; editions: 44th Sigep and 7th A.B. Tech Expo; frequency: annual; event: international trade show; entry: for trade only; info: https://en.sigep.itFOCUS ON ITALIAN EXHIBITION GROUPItalian Exhibition Group S.p.A.  a joint stock company listed on Euronext Milan  a regulated market organised and managed by Borsa Italiana S.p.A.  has  with its facilities in Rimini and Vicenza  achieved national leadership over the years in the organisation of trade shows and conferences. The development of activities abroad - also through joint-ventures with global or local organisers  in the United States  United Arab Emirates  China  Mexico  Germany  Singapore  Brazil  for example â€“ now sees the company positioned among the top European operators in the sector.Contact :Italian Exhibition Group Press Contacts  Press Office Manager: Marco Forcellini  marco.forcellini@iegexpo.itInternational Press Office Coordinator: Silvia Giorgi  silvia.giorgi@iegexpo.it  P. +39-0541-744814Photo - https://mma.prnewswire.com/media/1962420/Balacchi_Panettone_Christmas_Ice.jpgLogo - https://mma.prnewswire.com/media/723307/Italian_Exhibition_Group_Logo.jpgSOURCE Italian Exhibition Group",neutral,0.02,0.98,0.0,neutral,0.03,0.97,0.0,True,English,"['greatest Italian pastry chefs', 'Sigep Observatory', 'De Riso', 'festive table', 'Christmas', 'Massari', 'Rinaldini', 'voices', 'Italian Exhibition Group S.p.A.', 'Borsa Italiana S.p.A.', '7th A.B. Tech Expo', 'Group Exhibition Manager Flavia Morelli', 'Italian Exhibition Group Press Contacts', 'Italian Exhibition Group SpA', 'SOURCE Italian Exhibition Group', 'world-famous master pastry chefs', 'International Press Office Coordinator', 'great, Brescia-born Iginio Massari', 'pyrotechnic Christmas Ice panettone', 'pastry queen Sonia Balacchi', 'Press Office Manager', 'first Pastry Queen', 'recognisable traditional flavours', 'President Lorenzo Cagnoni', 'CEO Corrado Peraboni', 'Sal De Riso', 'Salvatore De Riso', 'Rimini Expo Centre', '16 different panettone cakes', 'United Arab Emirates', 'top European operators', 'international trade show', 'joint stock company', 'global trade shows', 'Panettone Piemontese', 'top players', 'international event', 'United States', 'next Christmas', 'Christmas tables', 'The Observatory', 'Roberto Rinaldini', 'Alessandro Dalmasso', 'artisan gelato', '25th January', 'classic recipe', 'solidarity"" panettoni', 'absolute must', 'latest proposals', '21-25 January', 'Euronext Milan', 'regulated market', 'national leadership', 'local organisers', 'Silvia Giorgi', 'Marco Forcellini', 'iegexpo.it', 'SIGEP OBSERVATORY', '44th Sigep', 'Italy', 'Dec.', 'PRNewswire', 'return', 'origins', 'trend', 'terms', 'desserts', 'part', 'chocolate', 'bakery', 'coffee', 'place', '21st', 'king', 'customers', 'simplicity', 'serenity', 'Rise', 'Foundation', 'specialities', 'Campania', 'stores', 'typicality', 'land', 'Pangianduja', 'mouth-watering', 'FOCUS', 'Dates', 'Organization', 'editions', 'frequency', 'entry', 'info', 'facilities', 'Vicenza', 'years', 'organisation', 'conferences', 'development', 'activities', 'joint-ventures', 'China', 'Mexico', 'Germany', 'Singapore', 'Brazil', 'example', 'sector', 'Photo', 'Balacchi_Panettone_Christmas_Ice', 'Logo']",2022-12-06,2022-12-06,prnewswire.co.uk
14298,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2567899/0/en/Global-Bioenergies-Successful-scale-up-of-Pomacle-commercial-unit.html,Global Bioenergies - Successful scale-up of Pomacle commercial unit,Successful scale-up of Pomacle commercial unit  Evry  06 December 2022 â€“ Global Bioenergies announces the successful scale-up of production...,French EnglishSuccessful scale-up of Pomacle commercial unitEvry  06 December 2022 â€“ Global Bioenergies announces the successful scale-up of production at its Pomacle commercial unit. All sub-units are now up and running  a few weeks ahead of schedule.Global Bioenergies announces that its first commercial production unit is now fully operational. All units (biological isobutene production  purification  condensation and packaging) have been validated and are now in operation.FrÃ©dÃ©ric Ollivier  Global Bioenergiesâ€™ Chief Technical Officer  said: â€œAn industrial project is invariably an adventure. This is especially so in these troubled times. Nevertheless  we were able to successfully build and commission the unit in very good conditions. We are now producing about 1 tonne of isobutene per week. I would like to congratulate the entire Global Bioenergies team  who made this success possible.â€Global Bioenergies plans to sell purified isobutene for use in cosmetics and high value-added fuel applications that can cover what remains a very high production cost.Global Bioenergies will also convert some of the isobutene produced  via an established chain of tollers  into cosmetic-grade isododecane for sale to major cosmetic companies under the trademark IsonaturaneÂ® 12. The scale-up of this downstream chain was executed in parallel to the start of operations at the Pomacle unit.Daphne Galvez  Global Bioenergiesâ€™ Head of Sales  said: â€œWe will produce IsonaturaneÂ® 12 by campaigns. The first batch  which will be delivered in a few months  has already been sold in full  and our commercial discussions are now focusing on subsequent batches.â€Marc Delcourt  Global Bioenergiesâ€™ Chief Executive Officer  said: â€œThe primary purpose of this unit is to generate revenue. Its second purpose is to pave the way in commercial  technical and regulatory terms for the 2025 launch of a new unit destined to produce 2 000 tonnes of isobutene and derivatives per year.â€About GLOBAL BIOENERGIESGlobal Bioenergies converts plant-derived resources into compounds used in the cosmetics industry  as well as the energy and materials sectors. After launching the first long-lasting and natural make-up brand LASTÂ® in 2021  Global Bioenergies is now marketing IsonaturaneÂ® 12  its key ingredient  to major cosmetics companies to improve the naturalness of their formulas whilst improving their carbon footprint. In the long run  Global Bioenergies is also aiming at cutting CO 2 emissions in the aviation and road sector and thereby curb global warming. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).Receive information about Global Bioenergies directly by subscribing to our news feed on www.global-bioenergies.comFollow us on LinkedIn: Global BioenergiesContactsGLOBAL BIOENERGIESinvest@global-bioenergies.comPRESS RELATIONSIva Baytchevaibaytcheva@ulysse-communication.comNicolas Danielsndaniels@ulysse-communication.comAttachment,neutral,0.48,0.52,0.0,mixed,0.74,0.01,0.26,True,English,"['Pomacle commercial unit', 'Global Bioenergies', 'Successful scale-up', 'Global Bioenergiesâ€™ Chief Executive Officer', 'Global Bioenergiesâ€™ Chief Technical Officer', 'FrÃ©dÃ©ric Ollivier', 'high value-added fuel applications', 'entire Global Bioenergies team', 'first commercial production unit', 'high production cost', 'major cosmetic companies', 'natural make-up brand', 'Euronext Growth Paris', 'Global Bioenergiesâ€™ Head', 'major cosmetics companies', 'Pomacle commercial unit', 'biological isobutene production', 'commercial, technical', 'Pomacle unit', 'commercial discussions', 'first batch', 'first long-lasting', 'global warming', 'new unit', 'French English', 'industrial project', 'troubled times', 'good conditions', 'established chain', 'cosmetic-grade isododecane', 'downstream chain', 'Daphne Galvez', 'subsequent batches', 'Marc Delcourt', 'primary purpose', 'second purpose', 'regulatory terms', 'plant-derived resources', 'cosmetics industry', 'materials sectors', 'key ingredient', 'carbon footprint', 'long run', 'road sector', 'news feed', 'PRESS RELATIONS', 'Iva Baytcheva', 'Nicolas Daniels', 'Successful scale-up', 'Evry', '06 December', 'sub-units', 'schedule', 'purification', 'condensation', 'packaging', 'operation', 'adventure', '1 tonne', 'week', 'use', 'tollers', 'sale', 'trademark', 'Isonaturane', 'parallel', 'start', 'campaigns', 'months', 'revenue', 'way', '2025 launch', '2,000 tonnes', 'derivatives', 'year', 'compounds', 'energy', 'LASTÂ®', 'naturalness', 'formulas', '2 emissions', 'aviation', 'ALGBE', 'information', 'LinkedIn', 'Contacts', 'communication', 'ndaniels', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14299,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2567921/0/en/EssilorLuxottica-Swarovski-and-EssilorLuxottica-announce-a-ten-year-licensing-agreement.html,EssilorLuxottica: Swarovski and EssilorLuxottica announce a ten-year licensing agreement,Swarovski and EssilorLuxotticaannounce a ten-year licensing agreement  Wattens  Austria and Charenton-le-Pont  France (December 6  2022 â€“ 8am CET) â€“......,English French ItalianSwarovski and EssilorLuxotticaannounce a ten-year licensing agreementWattens  Austria and Charenton-le-Pont  France (December 6  2022 â€“ 8am CET) â€“ Swarovski and EssilorLuxottica announced today that they have signed an exclusive license agreement for the design  manufacture and worldwide distribution of Swarovski Eyewear.The agreement will be effective until December 31  2028  with an automatic renewal option of an additional five years. The first collection under the agreement will be available on the market from September 2023.This agreement combines Swarovskiâ€™s creativity and savoir-faire with the knowledge  innovation  and expertise of EssilorLuxottica.The partnership builds on Swarovskiâ€™s luxury credentials alongside its enduring commitment to eyewear as a key fashion accessory. Swarovski Eyewear  which features designs inspired by the brandâ€™s jewelry families  brings an additional facet to Swarovskiâ€™s customer offering  and complements its extraordinary jewelry  home dÃ©cor and accessories collections.The first collection will be developed under the leadership of Swarovski Creative Director Giovanna Engelbert and launched in time for the FW23 season.Alexis Nasard  CEO of Swarovski  said: â€œWe are delighted to further evolve our Swarovski Eyewear business with global leader EssilorLuxottica. This is in-line with our LUXignite strategy  and is a natural partnership for us  forged from a shared passion for beautiful design coupled with impeccable quality and savoir-faire.â€Francesco Milleri  Chairman and CEO of EssilorLuxottica said: â€œWe are excited to embark on this journey with Swarovski  a brand known for its artful design and incredible attention to detail. We have always seen each pair of frames as a piece of art to be worn  which makes Swarovski and its story such a wonderful fit.â€About SwarovskiSwarovski is a place where magic and science meet. Swarovski unifies all parts of its organization under one spellbinding idea and brings forward a wondrous new world of crystal craftsmanship. Founded in 1895 in Austria  the company designs  manufactures and sells the world's highest quality crystal  gemstones  Swarovski Created Diamonds and zirconia  jewelry  and accessories  as well as crystal objects and home accessories. Together with its sister companies Swarovski Optik (optical devices) and Tyrolit (abrasives)  Swarovski Crystal Business forms the Swarovski Group. A responsible relationship with people and the planet has always been an integral part of Swarovski's heritage. This manifests today in the company's well-established sustainability agenda with youth-focused education programs and foundations to promote human empowerment and conserve natural resources to achieve positive social impact. For more information  please visit swarovski.com.EssilorLuxotticaEssilorLuxottica is a global leader in the design  manufacture and distribution of ophthalmic lenses  frames and sunglasses. Formed in 2018  its mission is to help people around the world to see more and be more by addressing their evolving vision needs and personal style aspirations. The Company brings together the complementary expertise of two industry pioneers  one in advanced lens technology and the other in the craftsmanship of iconic eyewear  to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley  lens technology brands including Varilux and Transitions  and world-class retail brands including Sunglass Hut  LensCrafters  Salmoiraghi & ViganÃ² and GrandVision are part of the EssilorLuxottica family. EssilorLuxottica has approximately 180 000 employees. In 2021  the Company generated consolidated pro forma revenue of Euro 21.5 billion. The EssilorLuxottica share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESLX.PA; Bloomberg: EL:FP. For more information  please visit essilorluxottica.com.Attachment,neutral,0.0,1.0,0.0,positive,0.86,0.14,0.0,True,English,"['ten-year licensing agreement', 'EssilorLuxottica', 'Swarovski', 'Swarovski Creative Director Giovanna Engelbert', 'English French Italian Swarovski', 'The EssilorLuxottica share trades', 'automatic renewal option', 'key fashion accessory', 'one spellbinding idea', 'youth-focused education programs', 'positive social impact', 'personal style aspirations', 'two industry pioneers', 'advanced lens technology', 'new industry standards', 'lens technology brands', 'world-class retail brands', 'pro forma revenue', 'additional five years', 'home dÃ©cor', 'evolving vision needs', 'Influential eyewear brands', 'highest quality crystal', 'Euronext Paris market', 'ten-year licensing agreement', 'exclusive license agreement', 'wondrous new world', 'Swarovski Crystal Business', 'Swarovski Eyewear business', 'additional facet', 'impeccable quality', 'crystal objects', 'vision care', 'The Company', 'home accessories', 'iconic eyewear', 'first collection', 'luxury credentials', 'enduring commitment', 'customer offering', 'FW23 season', 'Alexis Nasard', 'global leader', 'Francesco Milleri', 'incredible attention', 'wonderful fit', 'crystal craftsmanship', 'sister companies', 'optical devices', 'responsible relationship', 'sustainability agenda', 'human empowerment', 'natural resources', 'ophthalmic lenses', 'consumer experience', 'Sunglass Hut', 'CAC 40 indices', 'EL:FP', 'Swarovski Optik', 'Swarovski Group', 'jewelry families', 'extraordinary jewelry', 'accessories collections', 'beautiful design', 'artful design', 'worldwide distribution', 'natural partnership', 'integral part', 'complementary expertise', 'Euro Stoxx', 'EssilorLuxottica family', 'Wattens', 'Austria', 'Charenton-le-Pont', 'December', '8am', 'manufacture', 'September', 'creativity', 'savoir-faire', 'knowledge', 'innovation', 'designs', 'leadership', 'time', 'CEO', 'line', 'strategy', 'passion', 'Chairman', 'journey', 'detail', 'pair', 'frames', 'piece', 'story', 'place', 'magic', 'science', 'parts', 'organization', 'gemstones', 'Diamonds', 'zirconia', 'Tyrolit', 'abrasives', 'people', 'planet', 'heritage', 'foundations', 'information', 'sunglasses', 'mission', 'Ray-Ban', 'Oakley', 'Varilux', 'Transitions', 'LensCrafters', 'Salmoiraghi', 'ViganÃ²', 'GrandVision', '180,000 employees', 'Codes', 'symbols', 'ISIN', 'Reuters', 'ESLX', 'Bloomberg', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14300,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2568271/0/en/PUBLICIS-GROUPE-S-USEFUL-WISHES.html,PUBLICIS GROUPEâ€™S â€˜USEFUL WISHESâ€™,PUBLICIS GROUPEâ€™S â€˜USEFUL WISHESâ€™        With the help of a special guest  Maurice LÃ©vy and Arthur Sadoun put the spotlight on HPV-related cancer.       ...,French EnglishPUBLICIS GROUPEâ€™S â€˜USEFUL WISHESâ€™With the help of a special guest  Maurice LÃ©vy and Arthur Sadoun put the spotlight on HPV-related cancer.Paris â€“ December 6  2022 â€“ 2022 has been a stellar year for Publicis on every front. But rather than celebrate those achievements  the group is leveraging the impact of its annual Wishes film to drive awareness around the Human Papilloma Virus.Despite the fact that 80% of all adults will contract HPV at some point in their lives  for far too long cancers related to this virus have been hidden  shushed  stigmatized. They have therefore become a pervasive silent killer.This is a particularly personal theme for Publicis Groupe CEO Arthur Sadoun as he was diagnosed and treated for HPV-related cancer earlier this year.HPV is linked to a significant rise in cancers in both men and women  despite the availability of a highly effective vaccine. While some countries have made vaccination of young people against the virus a top priority  awareness remains relatively low across the wider population.Joining Maurice and Arthur in this yearâ€™s Wishes is a special guest  who also went through HPV-related cancer  to encourage everyone at Publicis  and hopefully beyond  to protect themselves and their loved ones from this preventable illness. Click here to view this yearâ€™s Wishes.Publicis Groupeâ€™s 2023 Wishes film was created by Le Truc  in partnership with Prodigious.About HPVHuman papillomavirus (HPV) is a very common group of viruses that is linked to several types of cancer  including nearly 100% of cervical cancers  90% of anal cancers and 60% of oropharyngeal cancers (cancers of the back of the throat). Most people  up to 80% of adultsâ€”regardless of ethnicity  race or genderâ€”will be exposed to some type of HPV in their lifetime. HPV is very easily transmitted between people because there are few signs or symptoms. There currently is no treatment for the virus itself. The only reliable method of protection against it is vaccination  which can prevent the most common types of infection. Education and raising awareness is the first step to reducing risk. The earlier you get the vaccine  the more youâ€™re protected. Vaccination is available until the age of 45 in certain countries  including the U.S. and Australia. Find out more about HPV and HPV-related cancers by clicking hereAbout Publicis Groupe - The Power of OnePublicis Groupe [Euronext Paris FR0000130577  CAC 40] is a global leader in communication. The Groupe is positioned at every step of the value chain  from consulting to execution  combining marketing transformation and digital business transformation. Publicis Groupe is a privileged partner in its clientsâ€™ transformation to enhance personalization at scale. The Groupe relies on ten expertise concentrated within four main activities: Communication  Media  Data and Technology. Through a unified and fluid organization  its clients have a facilitated access to all its expertise in every market. Present in over 100 countries  Publicis Groupe employs around 96 000 professionals.www.publicisgroupe.com | Twitter | Facebook | LinkedIn | YouTube | Instagram | Viva la Difference!Find here the press releaseContacts Publicis Groupe,positive,0.82,0.17,0.01,mixed,0.38,0.13,0.48,True,English,"['USEFUL WISHES', 'GROUPE', 'Publicis Groupe CEO Arthur Sadoun', 'pervasive silent killer', 'four main activities', 'digital business transformation', 'Maurice LÃ©vy', 'annual Wishes film', 'Human Papilloma Virus', 'Human papillomavirus', 'marketing transformation', '2023 Wishes film', 'The Groupe', 'French English', 'special guest', 'personal theme', 'significant rise', 'top priority', 'wider population', 'preventable illness', 'Le Truc', 'several types', 'reliable method', 'common types', 'U.S.', 'The Power', 'global leader', 'value chain', 'privileged partner', 'fluid organization', 'press release', 'clientsâ€™ transformation', 'USEFUL WISHES', 'HPV-related cancer', 'long cancers', 'cervical cancers', 'anal cancers', 'oropharyngeal cancers', 'young people', 'Most people', 'effective vaccine', 'common group', 'first step', 'Euronext Paris', 'ten expertise', 'stellar year', 'help', 'spotlight', 'December', 'front', 'achievements', 'impact', 'awareness', 'fact', 'adults', 'point', 'lives', 'women', 'availability', 'countries', 'vaccination', 'everyone', 'loved', 'partnership', 'Prodigious', 'viruses', 'back', 'throat', 'ethnicity', 'race', 'gender', 'lifetime', 'signs', 'symptoms', 'treatment', 'protection', 'infection', 'Education', 'risk', 'age', 'Australia', 'CAC', 'communication', 'consulting', 'execution', 'personalization', 'scale', 'Media', 'Data', 'Technology', 'unified', 'access', '96,000 professionals', 'publicisgroupe', 'Twitter', 'Facebook', 'LinkedIn', 'YouTube', 'Instagram', 'Difference', 'Contacts']",2022-12-06,2022-12-06,globenewswire.com
14301,EuroNext,NewsApi.org,https://www.prnewswire.co.uk/news-releases/dsm---delivery-of-shares-301696052.html,DSM - delivery of shares,This is a press release by Koninklijke DSM N.V. (Royal DSM)  pursuant to the provisions of Sections 13 paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) (the Decree) in connection with the public offer by Danube Aâ€¦,This is a press release by Koninklijke DSM N.V. (Royal DSM)  pursuant to the provisions of Sections 13 paragraphs 1 and 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) (the Decree) in connection with the public offer by Danube AG (to be renamed DSM-Firmenich AG) for all the issued and outstanding ordinary shares in the capital of DSM (the Exchange Offer). This press release does not constitute an offer  or any solicitation of any offer  to buy or subscribe for any securities. This press release is not for general release  publication or distribution  in whole or in part  in or into  directly or indirectly  the United States or any other jurisdiction where such release  publication or distribution would violate applicable laws or regulations.HEERLEN  Netherlands  Dec. 6  2022 /PRNewswire/ -- Following the Offering Circular published on 22 November 2022  Royal DSM is required to announce transactions relating to the ordinary shares in its capital in accordance with the Dutch public offer rules. This includes the delivery of treasury shares to employees in view of settling the vesting of share units or the exercise of stock options.Pursuant to commitments entered into prior to issuing the Offering Circular  DSM has in the period from 23 November up to 6 December  2022  delivered 9 090 ordinary shares to employees in view of settling the exercise of an equivalent number of stock options granted under the respective DSM Incentive Plan (the exercise price of 6 750 stock options was â‚¬50.98  whereas the average exercise price of 2 340 stock options was â‚¬97.90). In the same period  DSM has delivered 7 668 ordinary shares in view of the vesting of an equivalent number of share units that have been granted subject to the terms of the respective DSM Incentive Plan. On the date hereof  the total number of issued and outstanding DSM ordinary shares is 173 072 337. As a consequence of the delivery included herein  the number of outstanding DSM ordinary shares increased by 0.0097%.DSMRoyal DSM is a global  purpose-led company in Health  Nutrition & Bioscience  applying science to improve the health of people  animals and the planet. DSM's purpose is to create brighter lives for all. DSM's products and solutions address some of the world's biggest challenges while simultaneously creating economic  environmental and societal value for all its stakeholders â€“ customers  employees  shareholders  and society at large. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.Or find us on:LinkedIn: http://www.linkedin.com/company/3108Twitter: http://www.twitter.com/DSMFacebook: http://www.facebook.com/DSMcompanyYouTube: http://www.youtube.com/user/dsmcompanyFor more informationDSM Media Relations Gareth Mead tel. +31 (0) 45 5782420 email media.contacts@dsm.com DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 email investor.relations@dsm.comForward-looking statementsThis press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations  estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release  unless required by law. The English language version of the press release is leading.SOURCE Royal DSM,neutral,0.02,0.98,0.0,mixed,0.27,0.13,0.6,True,English,"['DSM', 'delivery', 'shares', 'DSM Media Relations Gareth Mead', 'DSM Investor Relations Dave Huizing', 'Koninklijke DSM N.V.', 'respective DSM Incentive Plan', 'Dutch public offer rules', 'outstanding DSM ordinary shares', 'outstanding ordinary shares', 'Public Takeover Bids', 'English language version', 'future (financial) performance', 'global, purpose-led company', 'SOURCE Royal DSM', 'average exercise price', '9,090 ordinary shares', '7,668 ordinary shares', 'treasury shares', 'Dutch Decree', 'actual performance', 'Sections 13 paragraphs', 'biedingen Wft', 'Danube AG', 'Exchange Offer', 'United States', 'other jurisdiction', 'applicable laws', 'Offering Circular', 'stock options', 'brighter lives', 'biggest challenges', 'economic, environmental', 'societal value', 'Euronext Amsterdam', 'current expectations', 'many factors', 'press release', 'general release', 'equivalent number', 'total number', 'same period', 'Forward-looking statements', 'Such statements', 'More information', 'share units', 'provisions', 'connection', 'capital', 'solicitation', 'securities', 'publication', 'distribution', 'part', 'regulations', 'HEERLEN', 'Netherlands', 'Dec.', 'PRNewswire', '22 November', 'transactions', 'accordance', 'delivery', 'employees', 'view', 'vesting', 'commitments', '23 November', '6 December', 'terms', 'date', 'consequence', 'Health', 'Nutrition', 'Bioscience', 'people', 'animals', 'planet', 'products', 'solutions', 'world', 'stakeholders', 'customers', 'shareholders', 'society', 'LinkedIn', 'Twitter', 'Facebook', 'DSMcompany', 'YouTube', 'position', 'estimates', 'projections', 'readers', 'risks', 'uncertainties', 'obligation']",2022-12-06,2022-12-06,prnewswire.co.uk
14302,EuroNext,NewsApi.org,https://www.prnewswire.com/news-releases/sigep-observatory-for-christmas-2022-massari-rinaldini-de-riso-the-voices-of-the-greatest-italian-pastry-chefs-for-the-festive-table-301695695.html,Sigep Observatory for Christmas 2022: Massari  Rinaldini  De Riso  the voices of the greatest Italian pastry chefs for the festive table,Italy  where Christmas is dolce. RIMINI  Italy   Dec. 6  2022 /PRNewswire/ -- A return to the origins with clearly recognisable traditional flavours. This is the trend for next Christmas in terms of desserts  detected by the SIGEP OBSERVATORY  part of Italianâ€¦,"Italy  where Christmas is dolce.RIMINI  Italy   Dec. 6  2022 /PRNewswire/ -- A return to the origins with clearly recognisable traditional flavours. This is the trend for next Christmas in terms of desserts  detected by the SIGEP OBSERVATORY  part of Italian Exhibition Group  a company headed by President Lorenzo Cagnoni and CEO Corrado Peraboni and one of the top players in global trade shows.The Observatory met world-famous master pastry chefs Iginio Massari  Roberto Rinaldini  Sal De Riso and Alessandro Dalmasso and pastry queen Sonia Balacchi  who have always been linked to Sigep  the international event dedicated to artisan gelato  pastry  chocolate  bakery and coffee  led by Group Exhibition Manager Flavia Morelli  and scheduled to take place from 21st to 25th January 2023 at Rimini Expo Centre in Italy.Christmas Ice panettone by Sonia BalacchiPanettone is the undisputed king of Christmas tables.According to the great  Brescia-born Iginio Massari  70% of customers choose the simplicity and serenity of the classic recipe  while Roberto Rinaldini offers ""solidarity"" panettoni with the Rise Together Foundation. For Salvatore De Riso  specialities from Campania are still an absolute must but there are no less than 16 different panettone cakes in his stores.Alessandro Dalmasso's latest proposals tell of the typicality of his land with his Pangianduja and Panettone Piemontese.Last but not least  Sonia Balacchi  the first Pastry Queen in 2012  suggests a mouth-watering and pyrotechnic Christmas Ice panettone.FOCUS ON SIGEP and A.B. Tech Expo 2023Dates: 21-25 January 2023; Organization: Italian Exhibition Group SpA; editions: 44th Sigep and 7th A.B. Tech Expo; frequency: annual; event: international trade show; entry: for trade only; info: https://en.sigep.itFOCUS ON ITALIAN EXHIBITION GROUPItalian Exhibition Group S.p.A.  a joint stock company listed on Euronext Milan  a regulated market organised and managed by Borsa Italiana S.p.A.  has  with its facilities in Rimini and Vicenza  achieved national leadership over the years in the organisation of trade shows and conferences. The development of activities abroad - also through joint-ventures with global or local organisers  in the United States  United Arab Emirates  China  Mexico  Germany  Singapore  Brazil  for example â€“ now sees the company positioned among the top European operators in the sector.Contact :Italian Exhibition Group Press Contacts  Press Office Manager: Marco Forcellini  [email protected]International Press Office Coordinator: Silvia Giorgi  [email protected]  P. +39-0541-744814Photo - https://mma.prnewswire.com/media/1962420/Balacchi_Panettone_Christmas_Ice.jpgLogo - https://mma.prnewswire.com/media/723307/Italian_Exhibition_Group_Logo.jpgSOURCE Italian Exhibition Group",neutral,0.02,0.98,0.0,neutral,0.03,0.97,0.0,True,English,"['greatest Italian pastry chefs', 'Sigep Observatory', 'De Riso', 'festive table', 'Christmas', 'Massari', 'Rinaldini', 'voices', 'Italian Exhibition Group S.p.A.', 'Borsa Italiana S.p.A.', '7th A.B. Tech Expo', 'Group Exhibition Manager Flavia Morelli', 'Italian Exhibition Group SpA', 'SOURCE Italian Exhibition Group', 'world-famous master pastry chefs', 'great, Brescia-born Iginio Massari', 'International Press Office Coordinator', 'pyrotechnic Christmas Ice panettone', 'pastry queen Sonia Balacchi', 'Press Office Manager', 'first Pastry Queen', 'recognisable traditional flavours', 'President Lorenzo Cagnoni', 'CEO Corrado Peraboni', 'Sal De Riso', 'Salvatore De Riso', 'Rimini Expo Centre', '16 different panettone cakes', 'United Arab Emirates', 'top European operators', 'international trade show', 'joint stock company', 'global trade shows', 'Press Contacts', 'Panettone Piemontese', 'top players', 'international event', 'United States', 'next Christmas', 'Christmas tables', 'The Observatory', 'Roberto Rinaldini', 'Alessandro Dalmasso', 'artisan gelato', '25th January', 'classic recipe', 'solidarity"" panettoni', 'absolute must', 'latest proposals', '21-25 January', 'Euronext Milan', 'regulated market', 'national leadership', 'local organisers', 'Marco Forcellini', 'Silvia Giorgi', 'SIGEP OBSERVATORY', '44th Sigep', 'Italy', 'Dec.', 'return', 'origins', 'trend', 'terms', 'desserts', 'part', 'chocolate', 'bakery', 'coffee', 'place', '21st', 'king', 'customers', 'simplicity', 'serenity', 'Rise', 'Foundation', 'specialities', 'Campania', 'stores', 'typicality', 'land', 'Pangianduja', 'mouth-watering', 'FOCUS', 'Dates', 'Organization', 'editions', 'frequency', 'entry', 'info', 'facilities', 'Vicenza', 'years', 'organisation', 'conferences', 'development', 'activities', 'joint-ventures', 'China', 'Mexico', 'Germany', 'Singapore', 'Brazil', 'example', 'sector', 'Photo', 'Balacchi_Panettone_Christmas_Ice', 'Logo', 'prnewswire']",2022-12-06,2022-12-06,prnewswire.com
14303,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2567910/0/en/BGHL-EUR-NAV-s.html,BGHL (EUR): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED      Ordinary Shares      The Directors of Boussard & Gavaudan...,"BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 05 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5304 Â£ 24.1853 Estimated MTD return 0.02 % 0.07 % Estimated YTD return -5.72 % -4.43 % Estimated ITD return 175.30 % 141.85 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.20 N/A Premium/discount to estimated NAV -19.36 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.31 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 240.6741 Class GBP A Shares (estimated) Â£ 129.0041The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.For further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.2,0.8,True,English,"['BGHL', 'EUR', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'Class GBP A Shares', 'A N/A Average Price', 'London Stock Exchange plc', 'N/A Sterling Shares Amsterdam', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Euro Shares Amsterdam', 'Sterling Shares Shares', 'A N/A Range', 'US Investment Company Act', 'expert financial advice', 'GAVAUDAN HOLDING LIMITED', 'Guernsey Policy Council', 'collective investment scheme', 'UK Listing Authority', 'other professional advice', 'BG Fund ICAV', 'closed-ended investment company', 'US Securities Act', 'Gavaudan Investment Management', 'investment manager fees', 'BG Fund NAV', 'N/A Shares', 'The Shares', 'Dutch Authority', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Financial Markets', 'The Directors', 'Emmanuel Gavaudan', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'main market', 'United States', 'following information', 'information purposes', 'necessary approval', 'future results', 'listed securities', 'Market information', 'LSE) Market', 'BOUSSARD', 'business', 'returns', 'AEX', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14304,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2567909/0/en/BGHL-GBP-NAV-s.html,BGHL (GBP): NAV(s),BOUSSARD & GAVAUDAN HOLDING LIMITED      Ordinary Shares      The Directors of Boussard & Gavaudan...,"BOUSSARD & GAVAUDAN HOLDING LIMITEDOrdinary SharesThe Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.Close of business 05 Dec 2022.Estimated NAVEuro Shares Sterling Shares Estimated NAV â‚¬ 27.5304 Â£ 24.1853 Estimated MTD return 0.02 % 0.07 % Estimated YTD return -5.72 % -4.43 % Estimated ITD return 175.30 % 141.85 %NAV and returns are calculated net of management and performance feesMarket informationEuro Shares Amsterdam (AEX) London (LSE) Market Close â‚¬ 22.20 N/A Premium/discount to estimated NAV -19.36 % N/A Sterling Shares Amsterdam (AEX) London (LSE) Market Close N/A GBX 2 000.00 Premium/discount to estimated NAV N/A -17.31 %Transactions in own securities purchased into treasuryOrdinary Shares Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/A Range of Price N/A N/ALiquidity Enhancement Agreement Euro Shares Sterling Shares Number of shares N/A N/A Average Price N/A N/ABGHL CapitalBGHL Ordinary Shares Euro Shares Sterling Shares Shares Outstanding 12 307 470 126 294 Held in treasury 9 664 N/A Shares Issued 12 317 134 126 294Since the 1st of December 2022  the daily figures take into account the estimated impact of the conversion.Estimated BG Fund NAVClass B Euro Shares (estimated) â‚¬ 240.6741 Class GBP A Shares (estimated) Â£ 129.0041The Class B Euro Shares of BG Fund are not subject to investment manager fees  as the Investment Manager receives management fees and performance fees in respect of its role as Investment Manager of BGHL.For further information please contact:Boussard & Gavaudan Investment Management  LLP.Emmanuel Gavaudan +44 (0) 20 3751 5389 Email : info@bgam-uk.comThe Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the ""Shares"") are listed on Euronext Amsterdam. The Shares are also listed on the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange plc's main market for listed securities.This is not an offer to sell or a solicitation of any offer to buy any securities in the United States or in any other jurisdiction. This announcement is not intended to and does not constitute  or form part of  any offer or invitation to purchase any securities or the solicitation of any vote or approval in any jurisdiction  nor shall there be any sale  issuance or transfer of the securities referred to in this announcement in any jurisdiction in contravention of applicable law.Neither the Company nor BG Fund ICAV has been  and neither will be  registered under the US Investment Company Act of 1940  as amended (the ""Investment Company Act""). In addition the securities referenced in this announcement have not been and will not be registered under the US Securities Act of 1933  as amended (the ""Securities Act""). Consequently any such securities may not be offered  sold or otherwise transferred within the United States or to  or for the account or benefit of  US persons except in accordance with the Securities Act or an exemption therefrom and under circumstances which will not require the issuer of such securities to register under the Investment Company Act. No public offering of any securities will be made in the United States.You should always bear in mind that:all investment is subject to risk;results in the past are no guarantee of future results;the investment performance of BGHL may go down as well as up. You may not get back all of your original investment; andif you are in any doubt about the contents of this communication or if you consider making an investment decision  you are advised to seek expert financial advice.This communication is for information purposes only and the information contained in this communication should not be relied upon as a substitute for financial or other professional advice.Attachment",neutral,0.0,1.0,0.0,negative,0.0,0.2,0.8,True,English,"['BGHL', 'GBP', 'NAV', 'A Liquidity Enhancement Agreement Euro Shares Sterling Shares', 'The Class B Euro Shares', 'BGHL Ordinary Shares Euro Shares', 'Class GBP A Shares', 'A N/A Average Price', 'London Stock Exchange plc', 'N/A Sterling Shares Amsterdam', 'Guernsey Financial Services Commission', 'Dutch Financial Supervision Act', 'Euro Shares Amsterdam', 'Sterling Shares Shares', 'A N/A Range', 'US Investment Company Act', 'expert financial advice', 'GAVAUDAN HOLDING LIMITED', 'Guernsey Policy Council', 'collective investment scheme', 'UK Listing Authority', 'other professional advice', 'BG Fund ICAV', 'closed-ended investment company', 'US Securities Act', 'Gavaudan Investment Management', 'investment manager fees', 'BG Fund NAV', 'N/A Shares', 'The Shares', 'Dutch Authority', 'N/A GBX', 'Euronext Amsterdam', 'US persons', 'Financial Markets', 'The Directors', 'Emmanuel Gavaudan', 'The Company', 'investment performance', 'original investment', 'investment decision', 'performance fees', 'BGHL Capital', 'management fees', 'MTD return', 'YTD return', 'ITD return', 'daily figures', 'estimated impact', 'financieel toezicht', 'Official List', 'applicable law', 'public offering', 'other jurisdiction', 'main market', 'United States', 'following information', 'information purposes', 'necessary approval', 'future results', 'listed securities', 'Market information', 'LSE) Market', 'BOUSSARD', 'business', 'returns', 'AEX', 'Transactions', 'treasury', 'Number', '1st', 'December', 'account', 'conversion', 'respect', 'role', 'LLP.', 'Email', 'article', 'conjunction', 'solicitation', 'announcement', 'part', 'invitation', 'vote', 'sale', 'issuance', 'transfer', 'contravention', 'addition', 'benefit', 'accordance', 'exemption', 'circumstances', 'issuer', 'mind', 'risk', 'past', 'guarantee', 'doubt', 'contents', 'communication', 'substitute', 'Attachment']",2022-12-06,2022-12-06,globenewswire.com
14305,EuroNext,NewsApi.org,https://www.globenewswire.com/news-release/2022/12/06/2567926/0/en/Progress-on-share-buyback-programme.html,Progress on share buyback programme,Progress on share buyback programme  ING announced today that  in line with the launch of its â‚¬1 5 billion share buyback programme announced on 3...,Progress on share buyback programmeING announced today that  in line with the launch of its â‚¬1 5 billion share buyback programme announced on 3 November 2022  the company has repurchased 16 492 184 shares during the week of 28 November 2022 up to and including 2 December 2022.The shares were repurchased at an average price of â‚¬11.53 for a total amount of â‚¬190 079 853.26. For detailed information on the daily repurchased shares  individual share purchase transactions and weekly reports  see the ING website at www.ing.com/investorrelations.The total number of shares repurchased under this programme to date 82 968 216 ordinary shares at an average price of â‚¬11.23 for a total consideration of â‚¬931 740 600.70. To date approximately 62.12% of the maximum total value of the share buyback programme has been completed.Note for editorsFor further information on ING  please visit www.ing.com. Frequent news updates can be found in the Newsroom or via the @ING_news Twitter feed. Photos of ING operations  buildings and its executives are available for download at Flickr. ING presentations are available at SlideShare.Press enquiries Investor enquiries Christoph Linke ING Group Investor Relations +31 20 576 5000 +31 20 576 6396 Christoph.Linke@ing.com Investor.Relations@ing.comING PROFILEING is a global financial institution with a strong European base  oï¬€ering banking services through its operating company ING Bank. The purpose of ING Bank is: empowering people to stay a step ahead in life and in business. ING Bankâ€™s more than 58 000 employees oï¬€er retail and wholesale banking services to customers in over 40 countries.ING Group shares are listed on the exchanges of Amsterdam (INGA NA  INGA.AS)  Brussels and on the New York Stock Exchange (ADRs: ING US  ING.N).Sustainability is an integral part of INGâ€™s strategy  evidenced by INGâ€™s leading position in sector benchmarks. ING's Environmental  Social and Governance (ESG) rating by MSCI was aï¬ƒrmed 'AA' in September 2022. As of August 2022  Sustainalytics considers INGâ€™s management of ESG material risk to be â€˜strongâ€™  and in June 2022 ING received an ESG rating of 'strong' from S&P Global Ratings. ING Group shares are also included in major sustainability and ESG index products of leading providers Euronext  STOXX  Morningstar and FTSE Russell.IMPORTANT LEGAL INFORMATIONCertain of the statements contained herein are not historical facts  including  without limitation  certain statements made of future expectations and other forward-looking statements that are based on managementâ€™s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results  performance or events to diï¬€er materially from those expressed or implied in such statements. Actual results  performance or events may diï¬€er materially from those in such statements due to a number of factors  including  without limitation: (1) changes in general economic conditions and customer behaviour  in particular economic conditions in INGâ€™s core markets  including changes aï¬€ecting currency exchange rates and the regional and global economic impact of the invasion of Russia into Ukraine and related international response measures (2) eï¬€ects of the Covid-19 pandemic and related response measures  including lockdowns and travel restrictions  on economic conditions in countries in which ING operates  on INGâ€™s business and operations and on INGâ€™s employees  customers and counterparties (3) changes aï¬€ecting interest rate levels (4) any default of a major market participant and related market disruption (5) changes in performance of financial markets  including in Europe and developing markets (6) fiscal uncertainty in Europe and the United States(7) discontinuation of or changes in â€˜benchmarkâ€™ indices (8) inflation and deflation in our principal markets (9) changes in conditions in the credit and capital markets generally  including changes in borrower and counterparty creditworthiness (10) failures of banks falling under the scope of state compensation schemes (11) non-compliance with or changes in laws and regulations  including those concerning financial services  financial economic crimes and tax laws  and the interpretation and application thereof (12) geopolitical risks  political instabilities and policies and actions of governmental and regulatory authorities  including in connection with the invasion of Russia into Ukraine and related international response measures (13) legal and regulatory risks in certain countries with less developed legal and regulatory frameworks(14) prudential supervision and regulations  including in relation to stress tests and regulatory restrictions on dividends and distributions (also among members of the group) (15) regulatory consequences of the United Kingdomâ€™s withdrawal from the European Union  including authorizations and equivalence decisions (16) INGâ€™s ability to meet minimum capital and other prudential regulatory requirements (17) changes in regulation of US commodities and derivatives businesses of ING and its customers(18) application of bank recovery and resolution regimes  including write- down and conversion powers in relation to our securities (19) outcome of current and future litigation  enforcement proceedings  investigations or other regulatory actions  including claims by customers or stakeholders who feel misled or treated unfairly  and other conduct issues (20) changes in tax laws and regulations and risks of non-compliance or investigation in connection with tax laws  including FATCA (21) operational and IT risks  such as system disruptions or failures  breaches of security  cyber-attacks  human error  changes in operational practices or inadequate controls including in respect of third parties with which we do business (22) risks and challenges related to cybercrime including the eï¬€ects of cyberattacks and changes in legislation and regulation related to cybersecurity and data privacy (23) changes in general competitive factors  including ability to increase or maintain market share (24) inability to protect our intellectual property and infringement claims by third parties (25) inability of counterparties to meet financial obligations or ability to enforce rights against such counterparties (26) changes in credit ratings (27) business  operational  regulatory  reputation  transition and other risks and challenges in connection with climate change and ESG-related matters(28) inability to attract and retain key personnel (29) future liabilities under defined benefit retirement plans (30) failure to manage business risks  including in connection with use of models  use of derivatives  or maintaining appropriate policies and guidelines (31) changes in capital and credit markets  including interbank funding  as well as customer deposits  which provide the liquidity and capital required to fund our operations  and(32) the other risks and uncertainties detailed in the most recent annual report of ING Groep N.V. (including the Risk Factors contained therein) and INGâ€™s more recent disclosures  including press releases  which are available on www.ING.com.This document may contain inactive textual addresses to internet websites operated by us and third parties. Reference to such websites is made for information purposes only  and information found at such websites is not incorporated by reference into this document. ING does not make any representation or warranty with respect to the accuracy or completeness of  or take any responsibility for  any information found at any websites operated by third parties. ING specifically disclaims any liability with respect to any information found at websites operated by third parties. ING cannot guarantee that websites operated by third parties remain available following the publication of this document  or that any information found at such websites will not change following the filing of this document. Many of those factors are beyond INGâ€™s control.Any forward looking statements made by or on behalf of ING speak only as of the date they are made  and ING assumes no obligation to publicly update or revise any forward-looking statements  whether as a result of new information or for any other reason.This document does not constitute an oï¬€er to sell  or a solicitation of an oï¬€er to purchase  any securities in the United States or any other jurisdictionAttachment,positive,0.98,0.02,0.0,mixed,0.48,0.09,0.43,True,English,"['share buyback programme', 'Progress', 'individual share purchase transactions', 'New York Stock Exchange', 'S&P Global Ratings', 'â‚¬1,5 billion share buyback programme', 'other prudential regulatory requirements', 'currency exchange rates', 'Frequent news updates', 'international response measures', 'interest rate levels', 'state compensation schemes', 'global economic impact', 'global financial institution', 'strong European base', 'ESG material risk', 'ESG index products', 'maximum total value', 'financial economic crimes', 'related response measures', 'major market participant', 'other forward-looking statements', 'wholesale banking services', 'daily repurchased shares', 'general economic conditions', 'Group Investor Relations', 'IMPORTANT LEGAL INFORMATION', 'prudential supervision', 'financial services', 'Investor enquiries', 'ESG) rating', 'ESG rating', 'market disruption', 'financial markets', 'European Union', 'regulatory authorities', 'regulatory risks', 'regulatory frameworks', 'regulatory restrictions', 'regulatory consequences', 'total amount', 'total consideration', 'average price', 'detailed information', 'weekly reports', 'Press enquiries', 'INGA NA', 'INGA.AS', 'integral part', 'leading position', 'sector benchmarks', 'Environmental, Social', 'major sustainability', 'leading providers', 'FTSE Russell', 'historical facts', 'future expectations', 'current views', 'unknown risks', 'actual results', 'customer behaviour', 'core markets', 'Covid-19 pandemic', 'travel restrictions', 'developing markets', 'fiscal uncertainty', 'United States', 'benchmarkâ€™ indices', 'principal markets', 'capital markets', 'counterparty creditworthiness', 'geopolitical risks', 'political instabilities', 'stress tests', 'United Kingdom', 'equivalence decisions', 'minimum capital', 'derivatives businesses', 'total number', '82,968,216 ordinary shares', 'Group shares', 'Christoph Linke', 'operating company', 'tax laws', 'US commodities', '16,492,184 shares', 'Progress', 'line', 'launch', '3 November', '28 November', '2 December', 'website', 'investorrelations', 'Note', 'editors', 'Newsroom', 'Photos', 'operations', 'buildings', 'executives', 'download', 'Flickr', 'presentations', 'SlideShare', 'PROFILE', 'purpose', 'people', 'life', '58,000 employees', 'retail', 'customers', '40 countries', 'exchanges', 'Amsterdam', 'Brussels', 'ADRs', 'strategy', 'Governance', 'MSCI', 'September', 'August', 'Sustainalytics', 'management', 'June', 'Euronext', 'Morningstar', 'limitation', 'assumptions', 'uncertainties', 'performance', 'events', 'factors', 'particular', 'regional', 'invasion', 'Russia', 'Ukraine', 'lockdowns', 'counterparties', 'default', 'discontinuation', 'inflation', 'deflation', 'borrower', 'banks', 'scope', 'compliance', 'regulations', 'interpretation', 'application', 'policies', 'connection', 'less', 'dividends', 'distributions', 'members', 'withdrawal', 'authorizations']",2022-12-06,2022-12-06,globenewswire.com
14306,EuroNext,NewsApi.org,https://www.prnewswire.com/news-releases/sigep-observatory-for-christmas-2022-massari-rinaldini-de-riso-the-voices-of-the-greatest-italian-pastry-chefs-for-the-festive-table-301695702.html,Sigep Observatory for Christmas 2022: Massari  Rinaldini  De Riso  the voices of the greatest Italian pastry chefs for the festive table,Italy  where Christmas is dolce. RIMINI  Italy  Dec. 6  2022 /PRNewswire/ -- A return to the origins with clearly recognisable traditional flavours. This is the trend for next Christmas in terms of desserts  detected by the SIGEP OBSERVATORY  part of Italian â€¦,"Italy  where Christmas is dolce.RIMINI  Italy  Dec. 6  2022 /PRNewswire/ -- A return to the origins with clearly recognisable traditional flavours. This is the trend for next Christmas in terms of desserts  detected by the SIGEP OBSERVATORY  part of Italian Exhibition Group  a company headed by President Lorenzo Cagnoni and CEO Corrado Peraboni and one of the top players in global trade shows.The Observatory met world-famous master pastry chefs Iginio Massari  Roberto Rinaldini  Sal De Riso and Alessandro Dalmasso and pastry queen Sonia Balacchi  who have always been linked to Sigep  the international event dedicated to artisan gelato  pastry  chocolate  bakery and coffee  led by Group Exhibition Manager Flavia Morelli  and scheduled to take place from 21st to 25th January 2023 at Rimini Expo Centre in Italy.Christmas Ice panettone by Sonia BalacchiPanettone is the undisputed king of Christmas tables.According to the great  Brescia-born Iginio Massari  70% of customers choose the simplicity and serenity of the classic recipe  while Roberto Rinaldini offers ""solidarity"" panettoni with the Rise Together Foundation. For Salvatore De Riso  specialities from Campania are still an absolute must but there are no less than 16 different panettone cakes in his stores.Alessandro Dalmasso's latest proposals tell of the typicality of his land with his Pangianduja and Panettone Piemontese.Last but not least  Sonia Balacchi  the first Pastry Queen in 2012  suggests a mouth-watering and pyrotechnic Christmas Ice panettone.FOCUS ON SIGEP and A.B. Tech Expo 2023Dates: 21-25 January 2023; Organization: Italian Exhibition Group SpA; editions: 44th Sigep and 7th A.B. Tech Expo; frequency: annual; event: international trade show; entry: for trade only; info: https://en.sigep.itFOCUS ON ITALIAN EXHIBITION GROUPItalian Exhibition Group S.p.A.  a joint stock company listed on Euronext Milan  a regulated market organised and managed by Borsa Italiana S.p.A.  has  with its facilities in Rimini and Vicenza  achieved national leadership over the years in the organisation of trade shows and conferences. The development of activities abroad - also through joint-ventures with global or local organisers  in the United States  United Arab Emirates  China  Mexico  Germany  Singapore  Brazil  for example â€“ now sees the company positioned among the top European operators in the sector.Contact :Italian Exhibition Group Press Contacts  Press Office Manager: Marco Forcellini  [email protected]International Press Office Coordinator: Silvia Giorgi  [email protected]  P. +39-0541-744814Photo - https://mma.prnewswire.com/media/1962420/Balacchi_Panettone_Christmas_Ice.jpgLogo - https://mma.prnewswire.com/media/723307/Italian_Exhibition_Group_Logo.jpgSOURCE Italian Exhibition Group",neutral,0.02,0.98,0.0,neutral,0.03,0.97,0.0,True,English,"['greatest Italian pastry chefs', 'Sigep Observatory', 'De Riso', 'festive table', 'Christmas', 'Massari', 'Rinaldini', 'voices', 'Italian Exhibition Group S.p.A.', 'Borsa Italiana S.p.A.', '7th A.B. Tech Expo', 'Group Exhibition Manager Flavia Morelli', 'Italian Exhibition Group SpA', 'SOURCE Italian Exhibition Group', 'world-famous master pastry chefs', 'great, Brescia-born Iginio Massari', 'International Press Office Coordinator', 'pyrotechnic Christmas Ice panettone', 'pastry queen Sonia Balacchi', 'Press Office Manager', 'first Pastry Queen', 'recognisable traditional flavours', 'President Lorenzo Cagnoni', 'CEO Corrado Peraboni', 'Sal De Riso', 'Salvatore De Riso', 'Rimini Expo Centre', '16 different panettone cakes', 'United Arab Emirates', 'top European operators', 'international trade show', 'joint stock company', 'global trade shows', 'Press Contacts', 'Panettone Piemontese', 'top players', 'international event', 'United States', 'next Christmas', 'Christmas tables', 'The Observatory', 'Roberto Rinaldini', 'Alessandro Dalmasso', 'artisan gelato', '25th January', 'classic recipe', 'solidarity"" panettoni', 'absolute must', 'latest proposals', '21-25 January', 'Euronext Milan', 'regulated market', 'national leadership', 'local organisers', 'Marco Forcellini', 'Silvia Giorgi', 'SIGEP OBSERVATORY', '44th Sigep', 'Italy', 'Dec.', 'PRNewswire', 'return', 'origins', 'trend', 'terms', 'desserts', 'part', 'chocolate', 'bakery', 'coffee', 'place', '21st', 'king', 'customers', 'simplicity', 'serenity', 'Rise', 'Foundation', 'specialities', 'Campania', 'stores', 'typicality', 'land', 'Pangianduja', 'mouth-watering', 'FOCUS', 'Dates', 'Organization', 'editions', 'frequency', 'entry', 'info', 'facilities', 'Vicenza', 'years', 'organisation', 'conferences', 'development', 'activities', 'joint-ventures', 'China', 'Mexico', 'Germany', 'Singapore', 'Brazil', 'example', 'sector', 'Photo', 'Balacchi_Panettone_Christmas_Ice', 'Logo']",2022-12-06,2022-12-06,prnewswire.com
14307,EuroNext,NewsApi.org,https://www.prnewswire.com/news-releases/wolters-kluwer-launches-new-plan-design-summary-tool-on-ftwilliamcom-301695943.html,Wolters Kluwer Launches New Plan Design Summary Tool on ftwilliam.com,The user-friendly tool will streamline retirement plan installations and save users time to maximize productivity NEW YORK  Dec. 6  2022 /PRNewswire/ -- Wolters Kluwer Legal & Regulatory U.S. today announced the launch of the Plan Design Summary (PDS) for ftwâ€¦,"The user-friendly tool will streamline retirement plan installations and save users time to maximize productivityNEW YORK  Dec. 6  2022 /PRNewswire/ -- Wolters Kluwer Legal & Regulatory U.S. today announced the launch of the Plan Design Summary (PDS) for ftwilliam.com. The new tool enables retirement service plan providers to track the plan installation process and deliver recommendations to plan sponsors during installation via ftwPortal Pro  a portal that provides users with secure  two-way access to plan documents  forms  and other data.Wolters Kluwer Launches New Plan Design Summary Tool on ftwilliam.com Wolters Kluwer Launches New Plan Design Summary Tool on ftwilliam.comThe Plan Design Summary features a detailed tracking log designed to help management stay informed during various steps of the plan installation process. Seamlessly integrated with ftwilliam.com's plan document software checklist  the Plan Design Summary will populate the plan parameters and minimize data entry errors during document preparation via ftwPortal Pro for quick  secure communication with clients. The tool's global and plan level dashboards will enable customers to view all plans and relevant data points to meet their client's evolving needs. Customers will have the ability to create unlimited plan design templates based on their service model and available plan designs.""Having developed this tool based on customer feedback  the Plan Design Summary is designed to simplify the complex installation process  which involves many parties and several stages "" said Holly Roussel-Godfrey  Senior Technology Project & Program Manager for Wolters Kluwer's ftwilliam.com. ""Our user-friendly tool contains several features  including notification manager and document change tracking  which will help our users increase efficiency  mitigate errors  and reduce costs.""ftwilliam.com is a leading provider of software and services to retirement plan service providers. Providing modern  cloud-based employee benefits software  ftwilliam.com's offerings include retirement plan documents  government forms  compliance testing  and reporting and distribution tracking.To learn more  visit: https://www.wolterskluwer.com/en/solutions/ftwilliam/ftwilliam-tools-software/plan-design-summaryAbout Wolters Kluwer Legal & Regulatory U.S.Wolters Kluwer (WKL) is a global leader in professional information  software solutions  and services for the healthcare; tax and accounting; governance  risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.Wolters Kluwer reported 2021 annual revenues of â‚¬4.8 billion. The group serves customers in over 180 countries  maintains operations in over 40 countries  and employs approximately 19 800 people worldwide. The company is headquartered in Alphen aan den Rijn  the Netherlands.Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).For more information  visit www.wolterskluwer.com  follow us on LinkedIn  Twitter  Facebook  and YouTube.MEDIA CONTACT:Linda GharibDirector  Brand & CommunicationsWolters Kluwer Legal & Regulatory U.S.Tel: +1 (646) 887-7962Email: [email protected]SOURCE Wolters Kluwer Legal & Regulatory U.S.",neutral,0.0,1.0,0.0,positive,0.95,0.05,0.0,True,English,"['New Plan Design Summary Tool', 'Wolters Kluwer', 'modern, cloud-based employee benefits software', 'New Plan Design Summary Tool', 'Alphen aan den Rijn', 'Level 1 American Depositary Receipt', 'unlimited plan design templates', 'plan document software checklist', 'The Plan Design Summary', 'retirement service plan providers', 'plan level dashboards', 'available plan designs', 'retirement plan installations', 'secure, two-way access', 'quick, secure communication', 'deep domain knowledge', 'Linda Gharib Director', 'plan installation process', 'detailed tracking log', 'relevant data points', 'document change tracking', 'complex installation process', 'Senior Technology Project', 'Regulatory U.S.', 'retirement plan documents', 'Wolters Kluwer shares', 'data entry errors', 'Wolters Kluwer Legal', 'new tool', 'service providers', 'NEW YORK', 'plan parameters', 'document preparation', 'regulatory sectors', 'software solutions', 'other data', 'service model', 'distribution tracking', 'user-friendly tool', 'specialized technology', 'various steps', 'evolving needs', 'customer feedback', 'many parties', 'several stages', 'Holly Roussel-Godfrey', 'Program Manager', 'several features', 'notification manager', 'leading provider', 'critical decisions', '2021 annual revenues', 'Euronext Amsterdam', 'Euronext 100 indices', 'ADR) program', 'counter market', 'MEDIA CONTACT', 'expert solutions', 'government forms', 'compliance testing', 'global leader', 'professional information', 'users', 'time', 'productivity', 'Dec.', 'PRNewswire', 'launch', 'PDS', 'recommendations', 'sponsors', 'portal', 'management', 'clients', 'customers', 'plans', 'ability', 'efficiency', 'costs', 'services', 'offerings', 'reporting', 'wolterskluwer', 'ftwilliam-tools-software', 'WKL', 'healthcare', 'tax', 'accounting', 'governance', 'risk', 'group', '180 countries', 'operations', '40 countries', '19,800 people', 'company', 'Netherlands', 'AEX', 'ADRs', 'WTKWY', 'LinkedIn', 'Twitter', 'Facebook', 'YouTube', 'Brand', 'Communications', 'Tel', 'Email', 'SOURCE']",2022-12-06,2022-12-06,prnewswire.com
14308,EuroNext,NewsApi.org,https://www.finextra.com/pressarticle/95147/broadridge-appoints-martin-koopman-chief-product-officer,Broadridge appoints Martin Koopman chief product officer,Broadridge Financial Solutions  Inc. (NYSE: BR)  a global Fintech leader  is pleased to announce the appointment of Martin Koopman as Chief Product Officer  effective January 1  2023.,Source: Broadridge Financial SolutionsBroadridge Financial Solutions  Inc. (NYSE: BR)  a global Fintech leader  is pleased to announce the appointment of Martin Koopman as Chief Product Officer  effective January 1  2023.In this role  Martin will lead the Product Management team working across all business units to collectively drive Broadridgeâ€™s delivery of world-class SaaS and other service offerings to leading financial services clients. He will be responsible for Broadridgeâ€™s enterprise product vision and strategy  building enterprise-wide platforms to benefit Broadridge clients  empowering product management teams  and accelerating innovation in partnership with our technology teams.â€œMartin has a proven record of driving product innovation both at Broadridge and at previous companies â€ said Tim Gokey  Chief Executive of Broadridge. â€œHis vision and proven ability to execute will be invaluable as we become the foremost SaaS provider to the financial services industry.â€â€œIâ€™m excited to lead our efforts as we scale to become the leading global FinTech serving Governance  Capital Markets  and Wealth and Investment Management â€ said Martin Koopman  Chief Product Officer of Broadridge. â€œI look forward to working with our clients and our talented product management and technology associates to ensure that we continue to deliver world-class solutions for our clients.â€In his new role  Martin will report directly to CEO Tim Gokey. Martin joined Broadridge in 2014 as Head of Strategy for Broadridgeâ€™s Investor Communication Services business. In 2017  he was named President  Bank Broker-Dealer (BBD)  where he helped steer that business through a period of double-digit growth and innovation. Martin oversaw the successful launch of 70+ product initiatives  including the Shareholder Rights Directive solution in Europe with 300+ new clients; retail shareholder tools  including the ProxyVote app  proxyvote.com and external APIs. Martin has 23 years of industry experience across both investor communications and capital markets/institutional trading  and he has held positions at NYSE Euronext  Boston Consulting Group  and Itiviti/Orc Software after its acquisition of Cameron Systems  which he co-founded.,neutral,0.0,0.99,0.0,positive,0.85,0.14,0.0,True,English,"['Martin Koopman chief product officer', 'Broadridge', 'leading global FinTech serving Governance', 'Shareholder Rights Directive solution', 'Investor Communication Services business', 'global Fintech leader', 'retail shareholder tools', 'other service offerings', 'Boston Consulting Group', '70+ product initiatives', 'financial services industry', 'Product Management team', 'talented product management', 'Chief Product Officer', 'foremost SaaS provider', 'financial services clients', 'CEO Tim Gokey', 'enterprise product vision', '300+ new clients', 'Broadridge Financial Solutions', 'investor communications', 'Investment Management', 'Chief Executive', 'world-class solutions', 'world-class SaaS', 'technology teams', 'industry experience', 'business units', 'product innovation', 'enterprise-wide platforms', 'previous companies', 'Capital Markets', 'technology associates', 'new role', 'double-digit growth', 'successful launch', 'external APIs', 'institutional trading', 'NYSE Euronext', 'Itiviti/Orc Software', 'Cameron Systems', 'Broadridge clients', 'proven record', 'ProxyVote app', 'Martin Koopman', 'Source', 'appointment', 'delivery', 'strategy', 'partnership', 'ability', 'efforts', 'Wealth', 'Head', 'Broker', 'Dealer', 'BBD', 'period', 'Europe', '23 years', 'positions', 'acquisition']",2022-12-06,2022-12-06,finextra.com
14309,EuroNext,Bing API,https://finance.yahoo.com/news/exor-included-aex-index-euronext-180000328.html,Exor included in the AEX Index at Euronext,EXOR N.V. (AMS: EXO) (â€œExorâ€) has been selected for inclusion in the AEX Index after its listing on Euronext Amsterdam on 12 August 2022. This was announced by Euronext Amsterdam today following its December quarterly review.,BenzingaWarren Buffett arrived in Sun Valley  Idaho  with an unpopular warning â€” one the visionaries in the room were in no mood to hear. The tech leaders gathered there were bent on changing the world and had already made fortunes doing it. And in a year where some tech stocks were surging as much as 27-fold  many were sitting on investments with sky-high valuations that they felt just fine about. Donâ€™t Miss: The Company Solving Traffic and Climate Change Together There were polite nods as Buffett took,neutral,0.0,1.0,0.0,mixed,0.62,0.04,0.34,True,English,"['AEX Index', 'Exor', 'Euronext', 'Sun Valley', 'unpopular warning', 'sky-high valuations', 'The Company', 'Climate Change', 'polite nods', 'Warren Buffett', 'Benzinga', 'Idaho', 'visionaries', 'room', 'mood', 'leaders', 'world', 'fortunes', 'year', 'stocks', 'investments', 'Traffic']",2022-12-06,2022-12-06,finance.yahoo.com
14310,EuroNext,Bing API,https://nz.finance.yahoo.com/news/information-total-number-voting-rights-180000306.html,Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA,Negma Group has converted 80 convertible bonds in Oxurion resulting in a EUR 200 000 capital increase. This is part of Negma Groupâ€™s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.,Oxurion NVNegma Group has converted 80 convertible bonds in Oxurion resulting in a EUR 200 000 capital increase. This is part of Negma Groupâ€™s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5 billion.Leuven  BELGIUM  Boston  MA  US â€“ December 6  2022 â€“ 07.00 PM CET â€“ In accordance with article 15 of the Belgian Act of May 2  2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions  Oxurion NV (Euronext Brussels: OXUR) (the â€œCompanyâ€ or â€œOxurionâ€)  announces the below information  following the issuance of 21 008 403 new ordinary shares on December 5  2022  for a total amount of EUR 200 000  as the result of the conversion of 80 class B convertible bonds  pursuant to the Capital Commitment entered into with Negma Group.Following completion of the capital increase through the conversion of the convertible bonds  the total number of shares issued by Oxurion amounts to 311 281 644  outstanding ordinary shares carrying voting rights (compared to 290 273 241 outstanding ordinary shares previously). This number will be used as the denominator for the calculation of the percentages of shareholdings.Therefore  Oxurion publishes the following updated information:Share capital (EUR) 74 906 161.32 Total number of securities with voting rights (all ordinary shares) 311 281 644 Total number of ordinary shares (= denominator) 311 281 644 Number of outstanding  granted rights to subscribe to securities carrying voting rights not yet issued: 719 500 subscription rights (â€œSRsâ€) issued on November 20  2017  entitling their holders to subscribe to a total number of 719 500 securities carrying voting rights (all ordinary shares);60 000 SRs issued on December 23  2020  entitling their holders to subscribe to a total number of 60 000 securities carrying voting rights (all ordinary shares);1 007 250 SRs issued on April 14  2021  entitling their holders to subscribe to a total number of 1 007 250 securities carrying voting rights (all ordinary shares);550 000 SRs issued on September 22  2021  entitling their holders to subscribe to a total number of 550 000 securities carrying voting rights (all ordinary shares);725 749 SRs issued on December 30  2021  entitling their holders to subscribe to a total number of 725 749 securities carrying voting rights (all ordinary shares);580 convertible bonds issued on September 5  2022  October 21  2022  and November 28  2022  entitling their holder (Negma Group) to subscribe to a total number of securities carrying voting rights (all ordinary shares) in accordance with the terms and conditions set forth in the issuance and subscription agreement entered into between the Company and Negma Group on August 26  2021  and the addendum thereto dated September 2  2022; and100 convertible bonds issued on December 20  2021  entitling their holders (Kreos Capital VI (UK) Limited  Pontifax Medison Finance (Israel) L.P. and Pontifax Medison Finance (Cayman) L.P.) to subscribe to a total number of securities carrying voting rights (all ordinary shares) in accordance with the terms and conditions of these convertible bonds as attached to the Agreement for the provision of a Loan Facility entered into between the Company  Kreos Capital VI (UK) Limited  Pontifax Medison Finance (Israel) L.P. and Pontifax Medison Finance (Cayman) L.P.  on November 21  2021.ENDAbout OxurionOxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies  which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME)  the leading cause of vision loss in working-age people  as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders  including the successful development of THR-149  its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to 50% of DME patients showing suboptimal response to anti-VEGF therapy. Oxurion is headquartered in Leuven  Belgium  with corporate operations in Boston  MA. More information is available at www.oxurion.com.Story continuesImportant information about forward-looking statementsCertain statements in this press release may be considered â€œforward-lookingâ€. Such forward-looking statements are based on current expectations  and  accordingly  entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement  whether as a result of new information  future events  or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Companyâ€™s Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933  as amended  or in compliance with an exemption therefrom  and in accordance with any applicable U.S. state securities laws.For further information please contact:Oxurion NVTom GraneyChief Executive OfficerTel: +32 16 75 13 10tom.graney@oxurion.comMichaÃ«l DillenChief Business OfficerTel: +32 16 75 13 10michael.dillen@oxurion.com USConway CommunicationsBeth Kurthbkurth@conwaycommsir.comICR WestwickeChristopher BrinzeyTel: +1 617 835 9304chris.brinzey@westwicke.com1 Press release Oxurion  06/04/2021 and Press release Oxurion  02/09/2022Attachment,neutral,0.0,1.0,0.0,mixed,0.31,0.26,0.43,True,English,"['Total Number', 'Voting Rights', 'Conversion Notice', 'Information', 'Denominator', 'NEGMA', 'potent plasma kallikrein inhibitor', 'EUR 30 million Capital Commitment1', '80 class B convertible bonds', 'eye drug candidate', 'Pontifax Medison Finance', 'next generation standard', 'diabetic macular edema', 'EUR 200,000 capital increase', 'Kreos Capital VI', 'potential new standard', 'potential market opportunities', 'care ophthalmic therapies', 'outstanding ordinary shares', 'Such forward-looking statements', '21,008,403 new ordinary shares', 'Israel) L.P.', 'Share capital', '80 convertible bonds', '100 convertible bonds', 'regulated market', 'new information', 'Negma Group', 'Belgian Act', 'major participations', 'miscellaneous provisions', 'Euronext Brussels', 'total amount', 'Loan Facility', 'retinal disorders', 'leading cause', 'working-age people', 'important role', 'successful development', 'suboptimal response', 'anti-VEGF therapy', 'corporate operations', 'press release', 'current expectations', 'future events', 'other reason', 'other factor', 'voting rights', '719,500 subscription rights', 'total number', 'updated information', 'More information', 'Important information', 'Additional information', 'subscription agreement', 'vision loss', 'novel therapeutic', 'various risks', 'biopharmaceutical company', 'The Company', 'other conditions', 'Oxurion NV', 'DME patients', 'back', 'Leuven', 'BELGIUM', 'Boston', 'December', 'accordance', 'article', 'May', 'disclosure', 'issuers', 'issuance', 'result', 'conversion', 'completion', 'denominator', 'calculation', 'percentages', 'shareholdings', 'securities', 'SRs', 'November', 'holders', 'April', 'September', 'October', 'terms', 'August', 'addendum', 'UK', 'Cayman', 'Limited', 'treatment', 'THR-149', 'Story', 'uncertainties', 'assurance', 'obligation', 'business', '07.00']",2022-12-06,2022-12-06,nz.finance.yahoo.com
14311,EuroNext,Bing API,https://finance.yahoo.com/news/veon-appoints-group-diversity-inclusion-130000261.html,VEON Appoints Group Diversity and Inclusion Officer,(NASDAQ and Euronext Amsterdam: VEON)  a global digital operator that provides converged connectivity and online services  announces that it has established the Group Diversity and Inclusion Officer position as it continues to strengthen commitment to diversity and inclusion.,VEON Ltd.AMSTERDAM  6 December â€“ VEON Ltd. (NASDAQ and Euronext Amsterdam: VEON)  a global digital operator that provides converged connectivity and online services  announces that it has established the Group Diversity and Inclusion Officer position as it continues to strengthen commitment to diversity and inclusion.Ana  VEONâ€™s current Director Financial Control  will assume the new role effective of 1st of January 2023 in addition to her current responsibilities. In this capacity she will report to Michael Schulz  Group Chief People Officer and continue to report to Serkan Okandan  Group Chief Financial Officer  on the finance and financial control matters.In her new position Ana will champion initiatives across VEONâ€™s markets of operations  chairing VEONâ€™s Diversity & Inclusion Forum and promoting cross-cultural  inclusive and collaborative way of working.â€œDiversity & inclusion is in our DNA as we work across the markets in Eastern Europe  Central and Southern Asia. Anaâ€™s appointment will reinforce our commitment to diversity & inclusion  which is paramount for VEON as an equal opportunities employer â€ said Kaan Terzioglu  CEO of VEON Group. â€œHer exemplary work for VEON during the past seven years  her passion and leadership in creating diverse working environments across the Group  her international background of working in Mexico  USA and Netherlands  leading global teams across the world  make her an ideal fit for the inclusion role.â€â€œI am thrilled with this opportunity to make a difference  join the efforts of our leaders and colleagues across VEON geographies and contribute to the matter that is close to my heart â€ said Ana. â€œVEON is one of the most forward-looking digital operators in the world. Our innovation in services for finance  education  entertainment and healthcare has driven digital inclusion in emerging economies.In my new role  I will focus on leveraging the immensely rich experience of our operating companies such as digital inclusion  supporting female entrepreneurship  and fostering exchange between the countries in which we operate.â€ expressed Ana de Kok-Reyes.Story continuesAbout VEONVEON is a digital operator that currently provides converged connectivity and online services to over 200 million customers. Operating across seven countries that are home to more than 8% of the worldâ€™s population  VEON is transforming peopleâ€™s lives  empowering individuals and driving economic growth. Headquartered in Amsterdam  VEON is listed on NASDAQ and Euronext.DisclaimerThis release contains â€œforward-looking statements â€ as the phrase is defined in Section 27A of the U.S. Securities Act of 1933  as amended  and Section 21E of the U.S. Securities Exchange Act of 1934  as amended. Forward-looking statements are not historical facts  and include statements relating to  among other things  our management team and certain diversity and inclusion initiatives. Forward-looking statements are inherently subject to risks and uncertainties  many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate. The forward-looking statements contained in this release speak only as of the date of this release. VEON does not undertake to publicly update  except as required by U.S. federal securities laws  any forward-looking statement to reflect events or circumstances after such dates or to reflect the occurrence of unanticipated events.Contact Information:VEON GroupGroup Communications DirectorMarina Levinapr@veon.comTUVA PartnersJulian Tannerjulian.tanner@tuvapartners.com,neutral,0.01,0.99,0.0,mixed,0.49,0.13,0.38,True,English,"['Inclusion Officer', 'VEON', 'Group', 'Diversity', 'U.S. federal securities laws', 'U.S. Securities Exchange Act', 'U.S. Securities Act', 'VEON Group Group Communications Director', 'current Director Financial Control', 'Group Chief Financial Officer', 'Group Chief People Officer', 'financial control matters', 'equal opportunities employer', 'diverse working environments', 'past seven years', 'looking digital operators', 'Inclusion Officer position', 'global digital operator', 'Ana de Kok-Reyes', 'current responsibilities', 'new position', 'global teams', 'Group Diversity', 'digital inclusion', 'converged connectivity', 'new role', 'Michael Schulz', 'Serkan Okandan', 'cross-cultural, inclusive', 'collaborative way', 'Eastern Europe', 'Southern Asia', 'Kaan Terzioglu', 'exemplary work', 'international background', 'emerging economies', 'rich experience', 'operating companies', 'female entrepreneurship', '200 million customers', 'seven countries', 'economic growth', 'historical facts', 'other things', 'management team', 'forward-looking statement', 'Contact Information', 'Marina Levina', 'TUVA Partners', 'Inclusion Forum', 'inclusion role', 'online services', 'unanticipated events', 'VEON Ltd', 'VEON geographies', 'inclusion initiatives', 'Julian Tanner', 'Euronext Amsterdam', 'statements', '6 December', 'NASDAQ', 'commitment', '1st', 'January', 'addition', 'capacity', 'finance', 'markets', 'operations', 'DNA', 'Central', 'appointment', 'CEO', 'passion', 'leadership', 'Mexico', 'USA', 'Netherlands', 'leading', 'world', 'opportunity', 'difference', 'efforts', 'colleagues', 'heart', 'innovation', 'education', 'entertainment', 'healthcare', 'Story', 'population', 'lives', 'individuals', 'Disclaimer', 'release', 'phrase', 'Section', 'risks', 'uncertainties', 'accuracy', 'date', 'circumstances']",2022-12-06,2022-12-06,finance.yahoo.com
14312,EuroNext,Bing API,https://uk.finance.yahoo.com/news/quadient-named-approved-cloud-software-164500767.html,Quadient Named an Approved Cloud Software Supplier on UK Governmentâ€™s Digital Marketplace,Quadient Named an Approved Cloud Software Supplier on UK Governmentâ€™s Digital Marketplace Paris  6  2022 Quadient (Euronext Paris: QDT)  a leader in helping businesses create meaningful customer connections through digital and physical channels ,QUADIENTQuadient Named an Approved Cloud Software Supplier on UK Governmentâ€™s Digital MarketplaceParis  December 6  2022Quadient (Euronext Paris: QDT)  a leader in helping businesses create meaningful customer connections through digital and physical channels  announced today it has been awarded a place on the UK governmentâ€™s new G Cloud 13 framework  managed by Crown Commercial Service (CCS). G Cloud provides organizations  across both central government and the wider public sector  with an online digital marketplace to procure cloud-based software solutions.The Digital Marketplace also allows organizations to easily procure required services at competitive prices  protecting the public purse.Quadient has been a long-time provider of solutions to the UK central government and wider public sector organizations  having been awarded places on multiple previous framework agreements. G Cloud 13 further builds on these relationships  providing access to Quadientâ€™s broad portfolio of cloud-based software solutions.As part of the successful acceptance to G Cloud 13  organizations can now access seven Quadient cloud-based solutions via the Digital Marketplace  across the applications below:Accounts payable automationAccounts receivable automationMultichannel communicationsCustomer experience managementDocument managementPostal address validationâ€œWe are delighted to have been awarded a place on G Cloud 13  a clear indication of our commitment to supporting UK government and the wider public sector â€ said Craig Spencer  Director of Public Sector Strategy at Quadient UK. â€œG Cloud 13 presents a real opportunity for organizations to access leading-edge SaaS technologies simply and at competitive rates.â€Quadientâ€™s growing software business has more than 12 000 customers worldwide  78% of which rely on the companyâ€™s SaaS solutions. The companyâ€™s Intelligent Communication Automation (ICA) cloud-based platform includes a comprehensive offering for accounts payable (AP) and accounts receivable (AR) automation and management  customer communications management (CCM) and document automation and customer journey mapping (CJM).Story continuesAbout QuadientÂ®Quadient is the driving force behind the worldâ€™s most meaningful customer experiences. By focusing on three key solution areas  Intelligent Communication Automation  Parcel Locker Solutions and Mail-Related Solutions  Quadient helps simplify the connection between people and what matters. Quadient supports hundreds of thousands of customers worldwide in their quest to create relevant  personalized connections and achieve customer experience excellence. Quadient is listed in compartment B of Euronext Paris (QDT) and is part of the SBF 120Â®  CACÂ® Mid 60 and EnterNextÂ® Tech 40 indices.For more information about Quadient  visit www.quadient.com.Contacts Joe Scolaro  Quadient Dominic Walsh  Spark Communications Global Press Relations Manager +44 (0)20 7436 0420 +1 203-301-3673 quadient@sparkcomms.co.uk j.scolaro@quadient.comAttachment,neutral,0.0,1.0,0.0,positive,0.84,0.16,0.0,True,English,"['Cloud Software Supplier', 'UK Government', 'Digital Marketplace', 'Spark Communications Global Press Relations Manager', 'multiple previous framework agreements', 'three key solution areas', 'new G Cloud 13 framework', 'seven Quadient cloud-based solutions', 'wider public sector organizations', 'Public Sector Strategy', 'ICA) cloud-based platform', 'meaningful customer connections', 'Crown Commercial Service', 'Postal address validation', 'growing software business', 'customer journey mapping', 'meaningful customer experiences', 'relevant, personalized connections', 'customer experience excellence', 'EnterNextÂ® Tech 40 indices', 'customer communications management', 'cloud-based software solutions', 'Intelligent Communication Automation', 'Parcel Locker Solutions', 'leading-edge SaaS technologies', 'Cloud Software Supplier', 'Customer experience management', 'Contacts Joe Scolaro', 'online digital marketplace', 'The Digital Marketplace', 'Quadient Dominic Walsh', 'Accounts receivable automation', 'Accounts payable automation', 'UK central government', 'Multichannel communications', 'SaaS solutions', 'public purse', 'AR) automation', 'document automation', 'Mail-Related Solutions', 'UK Government', 'Document management', 'physical channels', 'required services', 'competitive prices', 'long-time provider', 'broad portfolio', 'successful acceptance', 'clear indication', 'Craig Spencer', 'real opportunity', 'competitive rates', 'comprehensive offering', 'driving force', 'compartment B', 'CACÂ® Mid', 'Quadient UK', 'Euronext Paris', 'QUADIENT Quadient', 'QuadientÂ®', 'December', 'QDT', 'leader', 'businesses', 'CCS', 'places', 'relationships', 'access', 'applications', 'commitment', 'Director', '12,000 customers', 'company', 'CCM', 'CJM', 'Story', 'world', 'people', 'hundreds', 'thousands', 'quest', 'SBF 120Â®', 'information', 'Attachment']",2022-12-06,2022-12-06,uk.finance.yahoo.com
14313,EuroNext,Bing API,https://electricenergyonline.com/article/energy/category/financial/51/994262/voltalia-announces-the-success-of-its-approximately-490-million-euros-capital-increase-with-preferential-subscription-rights.html,Voltalia announces the success of its approximately 490 million euros capital increase with preferential subscription rights,Highlights The gross final amount of the capital increase (including the issue premium) is 489 990 254.40 euros and results in the issuance of 35 765 712 new shares The capital incre. . .,"HighlightsThe gross final amount of the capital increase (including the issue premium) is 489 990 254.40 euros and results in the issuance of 35 765 712 new sharesThe capital increase has been the subject of a total demand of 40 280 324 shares  i.e. a subscription rate of 112.62% (including 98.71% on an irreducible basis)Voltalia's market capitalisation is 2 350 million euros on an undiluted basis following the creation of 35 765 712 new shares  based on a closing price of 17.92 euros as of 2 December 2022Following their subscriptions  Voltalia Investissement  Voltalia's reference shareholder  holds 71.30% 1 of the share capital of Voltalia and Proparco holds 2.50%of the share capital of Voltalia and Proparco holds 2.50% The free float  on an undiluted basis  amounts to 573 million euros as of 2 December 2022 compared to 427 million euros on the eve of the capital increase and represents 24.40% of the share capital compared to 23.72% before the capital increaseThe net proceeds of the Capital Increase with PSRs are intended to provide the Company with additional means to finance its target of a consolidated capacity in operation or under construction of at least 5.0 GW by 2027  for which the Company considers that the amount of investment required is between 2.5 and 3 billion euros.Voltalia (the ""Company"") announces today (Dec 5) the success of its capital increase in cash with preferential subscription rights (""PSR"") in a gross amount of approximately 490 million euros (the ""Capital Increase with PSRs""). The Capital Increase with PSRs will result in 35 765 712 new shares being issued (the ""New Shares"")  at a subscription price of 13.70 euros per share.""I sincerely thank  on behalf of all Voltalia employees  the numerous shareholders who have shown their support by participating in this capital increase and contributing to its success. This strong mobilization motivates us even more to commit ourselves to pursue the mission that drives us on a daily basis to improve the global environment by promoting local development. The funds raised will enable us to accelerate our strategic roadmap with a view to achieve the ambitions we have set ourselves for 2027. Faced with the challenges of climate emergency and energy independence which have become crucial in the context of an unprecedented energy crisis in Europe in particular  Voltalia's teams are responding by providing concrete and realistic solutions to build a more sustainable world. This is the cornerstone to our success. "" says SÃ©bastien Clerc  CEO of Voltalia.***Reasons for the Capital Increase with PSRsThe issue of the New Shares is intended to provide the Company with additional means to finance its target of a consolidated capacity in operation or under construction of at least 5.0 GW by 2027  for which the Company considers that the amount of investment required is between 2.5 and 3 billion euros. In this respect  the Company plans to allocate at least 450 million euros of the funds raised to the construction of its new production capacity by 2027.The balance of the funds raised will be used to finance (i) the Company's growth in services in order to reach its objective of operating and maintaining more than 8 GW of power plants on behalf of third parties and (ii) possible targeted acquisitions  in particular to strengthen the Company's presence in its new geographical areas in Africa  Latin America or Europe.Results of the Capital Increase with PSRsThe gross amount of the Capital Increase with PSRs (including the issue premium) is 489 990 254.40 euros and results in the issue of 35 765 712 New Shares at a subscription price of 13.70 euros per New Share (i.e. a nominal value of 5.70 euros and an issue premium of 8.00 euros).Following the subscription period which ended 30 November 2022  total demand amounted to 40 280 324 shares  representing a subscription rate of 112.62%.35 304 924 New Shares have been subscribed on an irreducible basis and represent approximately 98.71% of the New Shares to be issued;Demand on a reducible basis represented 4 975 400 New Shares and will therefore only be partially allocated  460 788 New Shares being allocated according to a coefficient of 0.06254025 calculated on the basis of the number of PSRs underlying subscriptions made on an irreducible basis without it resulting in an allocation of fractions of New Shares and without the allocation of more shares than the number of New Shares requested on a reducible basis.Subscription commitments and subscription intentions of the main shareholders of the Company or members of its administrative or management bodies or anyone intending to subscribe to more than 5% of the New SharesAs of the date of the launch of the Capital Increase with PSRs  the Company had subscription commitments (the ""Subscription Commitments"")  on an irreducible basis  for a total amount of 357 454 262.40 euros  representing approximately 72.95% of the Capital Increase with PSRs  based on a subscription price of 13.70 euros per New Share.Voltalia Investissement   which held on 31 October 2022  71.30% of the capital and 82.77% of the voting rights of the Company  has subscribed directly and indirectly to 25 196 682 New Shares for a total amount of 345 194 543.40 euros.which held on 31 October 2022  71.30% of the capital and 82.77% of the voting rights of the Company  has subscribed directly and indirectly to 25 196 682 New Shares for a total amount of 345 194 543.40 euros. The SociÃ©tÃ© de Promotion et de Participation pour la CoopÃ©ration Economique (""Proparco"")  which held on 31 October 2022  2.50% of the capital and 1.48% of the voting rights of the Company  has subscribed to 894 870 New Shares for a total amount of 12 259 719 euros.In addition  the corporate officers of the Company mentioned below have each subscribed to the Capital Increase with PSRs: Laurence Mulliez  Chairman of the Board of Directors  for an amount of approximately 57 000 euros  The Green Option  director  for an amount of approximately 100 000 euros and SÃ©bastien Clerc  Chief Executive Officer  for an amount of around 190 000 euros.Impact of the Capital Increase with PSRs on the allocation of the share capitalFollowing the Capital Increase  Voltalia's share capital will amount to 747 503 380.80 euros and will consist of 131 140 944 shares with a nominal value of 5.70 euros each. It will break down as follows:Lock-up commitment of the CompanyAs of the date of approval by the AutoritÃ© des marchÃ©s financiers (""AMF"") on the prospectus relating to the Capital Increase with PSRs  i.e. 15 November 2022  and for a period expiring 180 calendar days following the settlement-delivery date of the New Shares  subject to certain standard exceptions.Lock-up commitments of Voltalia Investissement and ProparcoAs of the date of approval by the AMF on the prospectus relating to the Capital Increase with PSRs   i.e. 15 November 2022  and for a period expiring 180 calendar days following the settlement-delivery date of the New Shares  subject to certain standard exceptions.Indicative timetableThe settlement-delivery and admission of the New Shares to trading on Euronext Paris (Compartment B) will take place on 7 December 2022. New shares will immediately entitle their holders to receive dividends. They will be immediately fungible with existing shares of the Company  and will be traded on the same line under the ISIN code FR0011995588.The Capital Increase with PSRs was conducted by BNP Paribas and Goldman Sachs Bank Europe SE as structuring agents and global coordinators  lead managers and joint bookrunners  Banco Santander  S.A.  CrÃ©dit Agricole Corporate and Investment Bank and Natixis  as global coordinators  lead managers and joint bookrunners (together  the ""GlobalCoordinators  Lead Managers and Joint Bookrunners"")  as well as with CIC and Portzamparc as co-lead managers (together with the Global Coordinators  Lead Managers and Joint Bookrunners  the ""Financial Institutions"").Information of the publicThe prospectus  which was approved by the AMF on 15 November 2022 under the number 22-447 is composed of (i) the Universal Registration Document filed with the AMF on 2 May 2022 under the number D.22-0410  (ii) an amendment to the Universal Registration Document filed with the AMF on 15 November 2022 under the number D.22-0410-A01  (iii) the securities note (Note d'OpÃ©ration) dated 15 November 2022 and (iv) a summary of the prospectus (included in the securities note).Copies of the prospectus may be obtained free of charge and upon request from the company  84  boulevard de SÃ©bastopol  75003 Paris  France - and from the internet websites of Voltalia (www.voltalia.com) and the AMF (www.amf-france.org).Voltalia draws the public's attention to chapter 2  ""Risk factors and Risk Management""  of the Universal Registration Document filed with the AMF  chapter 5 ""Main Risks and Trends as of 30 June 2022"" of the amendment of the Universal Registration Document  and to chapter 2 ""Risk factors related to the offering"" of the Note d'OpÃ©ration.About Voltalia (www.voltalia.com) Voltalia is an international player in the renewable energy sector. The Group produces and sells electricity generated from wind  solar  hydraulic  biomass and storage facilities that it owns and operates. Voltalia has a generating capacity in operation and under construction of 2.4 GW and a portfolio of projects under development representing a total capacity of 13.6 GW.Voltalia is also a service provider and supports its investor clients in renewable energy projects during all phases  from design to operation and maintenance.As a pioneer in the corporate market  Voltalia provides a global offer to private companies  ranging from the supply of green electricity and energy efficiency services to the local production of their own electricity.With more than 1 450 employees in 20 countries on 4 continents  Voltalia has the capacity to act globally for its customers.Voltalia is listed on the regulated market of Euronext Paris  compartment B (FR0011995588 - VLTSA) and is part of the EnterNext Tech 40  CAC Mid & Small and Euronext Tech Leaders indices. The Group is also included in the GaÃ¯a-Index  an index for socially responsible midcaps. Voltalia shares are PEA eligible  under certain conditions. ContactsVoltaliaInvestor Relations: invest@voltalia.comT. +33 (0)1 81 70 37 00ActifinPress Contact: Loris Daougabelldaougabel@actifin.fr. T. +33 6 59 01 36 64DisclaimerNo communication and no information in respect of Voltalia's share capital increase with shareholders' preferential subscription rights  may be distributed to the public in any jurisdiction in which such registration or approval is required. No action has been or will be undertaken outside of France in any jurisdiction in which such actions would be required. The issue  the exercise or the sale of preferential subscription rights  and the subscription for or the purchase of new shares or preferential subscription rights may be subject to specific legal or regulatory restrictions in certain jurisdictions. Voltalia assumes no responsibility for any violation of any such restrictions by any person.This announcement is an advertisement and not a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (as amended  the ""Prospectus Regulation"").With respect to the member States of the European Economic Area  other than France (each  a ""Relevant Member State"")  no action has been or will be undertaken to make an offer to the public of the securities requiring a publication of a prospectus in any relevant member State. As a result  the preferential subscription rights and the new shares may not and will not be offered except in accordance with the exemptions set forth in Article 1(4) of the Prospectus Regulation or under any other circumstances that do not require the publication by Voltalia of a prospectus pursuant to Article 3 of the Prospectus Regulation and/or to applicable regulations of that Relevant Member State e.This press release and the information it contains are being distributed to and are only intended for persons who are (x) outside the United Kingdom or (y) in the United Kingdom who are qualified investors (as defined in the Prospectus Regulation as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) and are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005  as amended  (the ""Order"")  (ii) high net worth entities and other such persons falling within Article 49(2)(a) to (d) of the Order (""high net worth companies""  ""unincorporated associations""  etc.) or (iii) other persons to whom an invitation or inducement to participate in investment activity (within the meaning of Section 21 of the Financial Services and Market Act 2000) may otherwise lawfully be communicated or caused to be communicated (all such persons in (y)(i)  (y)(ii) and (y)(iii) together being referred to as ""Relevant Persons""). Any invitation  offer or agreement to subscribe  purchase or otherwise acquire securities to which this press release relates will only be engaged with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this press release or any of its contents.This press release does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities nor of any offer or solicitation to sell securities in the United States of America. The preferential subscription rights and the new shares of Voltalia have not been and will not be registered under the U.S. Securities Act of 1933  as amended (the ""U.S. Securities Act"")  and may not be offered or sold  directly or indirectly  within the United States of America except pursuant to an exemption from or in a transaction not subject to  the registration requirements of the Securities Act. Voltalia does not intend to register any portion of the proposed offering in the United States of America nor to conduct an offering of securities to the public in the United States of America.The distribution of this document in certain countries may constitute a breach of applicable law. The information contained in this document does not constitute an offer of securities for sale in the United States of America  Canada  Australia or Japan.This press release may not be published  forwarded or distributed  directly or indirectly  in the United States of America  Canada  Australia or Japan.1 Including the shares loaned by Voltalia Investissement under the share loan arrangement set up with BNP Paribas Arbitrage SNC  Goldman Sachs Bank Europe SE and Natixis (the ""Borrowers"") (according to the information provided by the Borrowers) as part of the issue of green bonds convertible into and/or exchangeable for new and/or existing shares issued on 13 January 2021 and supplemented by the issue of fully fungible Green OCEANEs on 29 July 2022 (together  the ""Green OCEANEs"").",neutral,0.1,0.9,0.0,mixed,0.67,0.17,0.16,True,English,"['490 million euros capital increase', 'preferential subscription rights', 'Voltalia', 'success', 'SÃ©bastien Clerc', 'possible targeted acquisitions', 'unprecedented energy crisis', 'new geographical areas', 'preferential subscription rights', 'new production capacity', 'gross final amount', 'The Capital Increase', 'energy independence', 'consolidated capacity', 'gross amount', 'subscription rate', 'subscription price', 'subscription period', 'Subscription commitments', 'subscription intentions', 'total demand', 'market capitalisation', 'closing price', 'reference shareholder', 'free float', 'net proceeds', 'additional means', 'numerous shareholders', 'strong mobilization', 'global environment', 'local development', 'strategic roadmap', 'climate emergency', 'realistic solutions', 'sustainable world', 'power plants', 'third parties', 'Latin America', 'nominal value', 'main shareholders', 'management bodies', 'New Share', 'irreducible basis', 'undiluted basis', 'daily basis', 'share capital', 'total amount', 'issue premium', 'underlying subscriptions', '350 million euros', '573 million euros', '427 million euros', '3 billion euros', '490 million euros', '450 million euros', 'Voltalia Investissement', 'Voltalia employees', '40,280,324 shares', '489,990,254.40 euros', '17.92 euros', '13.70 euros', '5.70 euros', '8.00 euros', '4,262.40 euros', 'Highlights', 'results', 'issuance', 'subject', 'creation', '2 December', 'Proparco', 'PSRs', 'Company', 'operation', 'construction', '5.0 GW', 'investment', 'success', 'cash', 'behalf', 'support', 'mission', 'funds', 'view', 'ambitions', 'challenges', 'context', 'Europe', 'teams', 'concrete', 'cornerstone', 'CEO', 'Reasons', 'respect', 'balance', 'growth', 'services', 'order', 'objective', '8 GW', 'presence', 'Africa', 'coefficient', 'number', 'allocation', 'fractions', 'members', 'administrative', 'launch', '31 Oc', '24.', '2.5', '2027', '112.', '357']",2022-12-06,2022-12-06,electricenergyonline.com
14314,EuroNext,Twitter API,Twitter,Euronext Announces December 2022 Quarterly Review Results Of The AEXÂ® Family https://t.co/xHWJ2fLdi2,nan,Euronext Announces December 2022 Quarterly Review Results Of The AEXÂ® Family https://t.co/xHWJ2fLdi2,neutral,0.0,1.0,0.0,neutral,0.0,1.0,0.0,True,English,"['December 2022 Quarterly Review Results', 'The AEXÂ® Family', 'Euronext', 'December 2022 Quarterly Review Results', 'The AEXÂ® Family', 'Euronext']",2022-12-06,2022-12-06,Unknown
14315,EuroNext,Twitter API,Twitter,Exor included in the AEX Index at Euronext https://t.co/xOotMrwaYs,nan,Exor included in the AEX Index at Euronext https://t.co/xOotMrwaYs,neutral,0.01,0.99,0.0,neutral,0.01,0.99,0.0,True,English,"['AEX Index', 'Exor', 'Euronext', 'AEX Index', 'Exor', 'Euronext']",2022-12-06,2022-12-06,Unknown
14316,EuroNext,Twitter API,Twitter,Exor included in the AEX Index atÂ Euronext https://t.co/ipKIYYMri5,nan,Exor included in the AEX Index atÂ Euronext https://t.co/ipKIYYMri5,neutral,0.02,0.97,0.0,neutral,0.02,0.97,0.0,True,English,"['AEX Index', 'Exor', 'Euronext', 'AEX Index', 'Exor', 'Euronext']",2022-12-06,2022-12-06,Unknown
14317,EuroNext,Twitter API,Twitter,StoneX is pleased to attend the Gong Ceremony at Euronext Amsterdam and celebrate trading on Euronext for 10+ yearsâ€¦ https://t.co/XxSzkl8q3B,nan,StoneX is pleased to attend the Gong Ceremony at Euronext Amsterdam and celebrate trading on Euronext for 10+ yearsâ€¦ https://t.co/XxSzkl8q3B,positive,0.91,0.09,0.0,positive,0.91,0.09,0.0,True,English,"['Gong Ceremony', '10+ years', 'Euronext Amsterdam', 'StoneX', 'trading', 'XxSzkl8q3B', 'Gong Ceremony', '10+ years', 'Euronext Amsterdam', 'StoneX', 'trading', 'XxSzkl8q3B']",2022-12-06,2022-12-06,Unknown
14318,EuroNext,Twitter API,Twitter,With special thanks to our sponsors:@JPMorganAM @GlobalXETFsEU@euronext @Fidelity_UK@dilloneustace1@LSEGplc,nan,With special thanks to our sponsors:@JPMorganAM @GlobalXETFsEU@euronext @Fidelity_UK@dilloneustace1@LSEGplc,positive,0.67,0.32,0.0,positive,0.67,0.32,0.0,True,English,"['special thanks', 'sponsors', 'GlobalXETFsEU', 'euronext', 'Fidelity_UK', 'dilloneustace1', 'LSEGplc', 'special thanks', 'sponsors', 'GlobalXETFsEU', 'euronext', 'Fidelity_UK', 'dilloneustace1', 'LSEGplc']",2022-12-06,2022-12-06,Unknown
14319,EuroNext,Twitter API,Twitter,@GlennRcrypto Euronext Brussels. If you like passive income it's definitly worth it on these levels.,nan,@GlennRcrypto Euronext Brussels. If you like passive income it's definitly worth it on these levels.,positive,0.99,0.01,0.0,positive,0.99,0.01,0.0,True,English,"['GlennRcrypto Euronext Brussels', 'passive income', 'levels', 'GlennRcrypto Euronext Brussels', 'passive income', 'levels']",2022-12-06,2022-12-06,Unknown
14320,EuroNext,Twitter API,Twitter,#Cac40 CAC 40 6 676 19 | Euronext Live cours de bourse https://t.co/Iqh8wn15YL https://t.co/avZPquI9K7,nan,#Cac40 CAC 40 6 676 19 | Euronext Live cours de bourse https://t.co/Iqh8wn15YL https://t.co/avZPquI9K7,neutral,0.11,0.88,0.01,neutral,0.11,0.88,0.01,True,English,"['Euronext Live cours', 'Cac40', 'bourse', 'avZPquI9K7', 'Euronext Live cours', 'Cac40', 'bourse', 'avZPquI9K7']",2022-12-06,2022-12-06,Unknown
14321,EuroNext,Twitter API,Twitter,StoneX is pleased to attend the Gong Ceremony at @euronext_nl and celebrate trading on Euronext for 10+ years. We'râ€¦ https://t.co/mfUzhjGLdL,nan,StoneX is pleased to attend the Gong Ceremony at @euronext_nl and celebrate trading on Euronext for 10+ years. We'râ€¦ https://t.co/mfUzhjGLdL,positive,0.91,0.09,0.0,positive,0.91,0.09,0.0,True,English,"['Gong Ceremony', '10+ years', 'StoneX', 'trading', 'Euronext', 'Gong Ceremony', '10+ years', 'StoneX', 'trading', 'Euronext']",2022-12-06,2022-12-06,Unknown
14322,EuroNext,Twitter API,Twitter,During the week of November 25 â€“ December 1 rapeseed price on the Euronext exchange dropped by EUR 15.5 to EUR 585.â€¦ https://t.co/uFXfU5PUPu,nan,During the week of November 25 â€“ December 1 rapeseed price on the Euronext exchange dropped by EUR 15.5 to EUR 585.â€¦ https://t.co/uFXfU5PUPu,neutral,0.09,0.89,0.02,neutral,0.09,0.89,0.02,True,English,"['Euronext exchange', 'week', 'November', 'December', 'price', 'Euronext exchange', 'week', 'November', 'December', 'price']",2022-12-06,2022-12-06,Unknown
